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Bacteroides fragilis is a member of the normal microbiota that resides in the human 
lower gastrointestinal tract. This bacterium is of clinical significance because it is the 
most frequently isolated Gram-negative obligate anaerobe from peritoneal abscesses 
and bloodstream infections. Human fibrinogen is a hexameric-glycoprotein that is 
important for fibrin-mediated abscess formation and  limiting the spread of infection. 
B. fragilis can bind and degrade fibrinogen which may aid in its escape from 
abscesses into the bloodstream, thereby promoting bacteraemia.  
In addition to fibrinogen, binding of B. fragilis to fibronectin, a component of the 
extracellular matrix, found in association with fibrinogen at wound sites, has also 
been reported. An outer membrane protein, BF1705, expressed by B. fragilis was 
found to share homology with BspA from Tannerella forsythia which is known to 
bind fibrinogen. The gene encoding BF1705 was deleted from the B. fragilis NCTC 
9343 genome in the present work using a markerless gene deletion technology. 
Proteins derived from the outer membranes of wild-type B. fragilis were able to bind 
fibronectin and fibrinogen in far-western blots. Similar protein extracts from the 
ΔBF1705 strain did not bind fibrinogen and fibronectin, which confirms the role of 
BF1705 in adhesive interactions with proteins of the host extracellular matrix. 
The possible involvement of BF1705 in fibrinogen degradation was ruled out 
because the ΔBF1705 strain still degraded fibrinogen. To identify the proteases 
involved in degradation of fibrinogen, four genes encoding putative extracellular 
metallo- and serine proteases in the size range 45-50 kDa were  deleted from the 
NCTC 9343 genome. All of the single and multiple mutants defective in these 
selected proteases were still capable of degrading fibrinogen as determined by 
zymography. Expression of eight B. fragilis proteases in E. coli did not lead to 







alone cannot degrade fibrinogen and either that an unidentified protease is 
responsible for degradation or that there is redundancy in the proteases involved.   
Under conditions of nitrogen limitation bacteria resort to scavenging nitrogen from 
the environment to replenish the depleting intracellular nitrogen content. By 
examining the differential regulation of the B. fragilis transcriptome under nitrogen 
replete and depleting conditions, a potential role for BF1705 and secreted proteases 
in nutrient binding and assimilation were studied. Growth on conventional glucose 
defined medium with ammonia as the nitrogen source was compared to growth in 
defined medium with glutamine as nitrogen source. A reduced doubling time and 
diauxic growth in the medium containing glutamine indicated nitrogen limitation. 
Comparison of the transcriptome derived from  cultures of B. fragilis grown on either 
ammonia or glutamine by RNA-Seq did not reveal a significant upregulation of 
BF1705 in response to nitrogen limitation. This observation in conjunction with its 
inability to degrade fibrinogen suggests that the primary role of BF1705 might be as 
an adhesin and does not act directly in nutrient binding and degradation. 
Nevertheless, nitrogen limitation was found to induce the expression of four 
protease-encoding genes by over a 2-fold (adjusted p value < 0.05). The molecular 
weight of three of these proteases were identified to be within the size range of 45-55 
kDa which corresponded to the lysis bands detected by fibrinogen zymography with 
wild-type B. fragilis protein extracts. Therefore the possible involvement of these 
three proteases in fibrinogen degradation could be assessed. A 155-fold upregulation 
(adjusted p value < 0.05) in asnB, encoding a homologue of asparagine synthetase B, 
under conditions of nitrogen limitation suggest a previously uncharacterised aspartate 
metabolism pathway for ammonia generation via arginine catabolism in B. fragilis. 
Ammonia thus formed might aid in sustaining B. fragilis growth under nitrogen 
deprived conditions. In addition to nitrogen assimilation, significant upregulation 
was observed in the expression of genes involved in regulation of oxidative stress 
and metronidazole resistance. The observed changes in the transcriptome will add to 
our understanding of the B. fragilis metabolism and potential assist with unravelling 









Bacteroides fragilis is a bacterium found in the human gut and is a member of the 
commensal microbiota, or 'good' bacteria, which have a positive impact on human 
health and nutrition. However, B. fragilis is also the most frequently isolated  
obligate anaerobe from peritoneal abscesses and bloodstream infections when it 
accidentally escapes from the gastrointestinal tract, following injury. Human 
fibrinogen is a plasma glycoprotein and is converted by thrombin into fibrin, which 
helps in the formation of blood clots and abscesses, thereby curtailing infection. B. 
fragilis can bind and degrade fibrinogen which might aid in the escape of the 
bacterium from abscesses, leading to infection dissemination and bacteraemia. 
B. fragilis can also bind fibronectin, a component of the host extracellular matrix, 
which function in wound healing in association with fibrinogen. BF1705, an outer 
membrane protein expressed by B. fragilis was found to share homology with 
previously annotated fibrinogen binding protein in another bacteria. The gene 
encoding BF1705 was deleted from the genome of the B. fragilis strain NCTC 9343  
using a markerless gene deletion technology. Proteins derived from the outer 
membranes of wild-type B. fragilis, by concentrating the cell-free culture 
supernatants, were observed to bind to fibrinogen and fibronectin. On the contrary, 
similar protein extracts from the gene deletion mutant, ΔBF1705, did not bind 
fibrinogen and fibronection, which confirms the role of BF1705 in adhesive 
interaction with proteins of the extracellular matrix. 
BF1705 was not involved in fibrinogen degradation by B. fragilis because in situ  
degradation of fibrinogen was observed when the protein was incubated with the 
ΔBF1705 strain. Zymography experiments with fibrinogen as the substrate revealed 
a zone of lysis at  ̴ 45 kDa for wild-type B. fragilis. Therefore, four genes encoding 
putative proteases in the size range 45-50 kDa were deleted from the NCTC 9343 







multiple mutants defective in the selected proteases were generated and the deletion 
mutants were still able to degrade fibrinogen. Expression of eight additional B. 
fragilis proteases in E. coli also did not lead to detectable degradation of fibrinogen. 
Therefore, the proteases analysed in the present study cannot degrade fibrinogen on 
their own. Either the fibrinogenolytic protease is yet to be identified or there is 
redundancy in the proteases involved.    
Growth under nitrogen limiting conditions urges the bacteria to 'search' for nitrogen 
from the environment to restore the depleting intracellular nitrogen content, which is 
essential for survival and biosynthetic processes. Therefore the differential regulation 
of the B. fragilis transcriptome under nitrogen abundant and nitrogen limiting 
conditions were examined to find a potential role for BF1705 and secreted proteases 
in nutrient binding and nitrogen assimilation. Whole transcriptome analysis under the 
two conditions was performed by RNA Sequencing, which reveals a snapshot of 
RNA presence and quantity from a genome at a given point in time. Although 
BF1705 was not significantly differentially regulated in response to nitrogen 
limitation, expression of four protease-encoding genes were induced over a 2-fold in 
the nitrogen limiting condition when compared to the nitrogen abundant condition. 
The molecular weight of three of these induced proteases were within the range of 
45-55 kDa which corresponded to the lysis bands detected by fibrinogen zymography 
with wild-type B. fragilis protein extracts and therefore might potentially be involved 
in degrading fibrinogen. An alternative pathway for ammonia generation under 
nitrogen limiting conditions was suggested owing to a 155-fold upregulation of a 
gene encoding an asparagine synthetase B homologue. Formation of ammonia 
through the aspartate metabolism pathway via arginine degradation has not been 
previously characterised in B. fragilis and might account for the sustenance of B. 
fragilis growth under nitrogen limiting conditions. Moreover, the significant 
upregulation observed in the expression of genes involved in regulation of oxidative 
stress and metronidazole resistance will potentially assist with unravelling the 







Chapter 1 Introduction: The Human Microbiome 
 
The adult human body harbours a wide range of microorganisms, the cells of which  
( ̴ 10
14
) outnumber that of the human body ( ̴ 10
13
) by an order of ten (Hattori and 
Taylor, 2009).The statistics are further magnified at the genetic level where the 
close-knit interactions between human and microbiome system could be considered 
as a human 'superorganism' model. Albeit the human microbiota is primarily 
composed of bacteria, a large number of diverse viruses, fungi and protozoa are also 
present in the human body (Breitbart and Rohwer, 2005; Furuse et al., 1983). 
Following a natural childbirth, infants obtain their initial microbial inoculum from 
the mother followed by a progression of events resulting in the development of a 
child's own microbiome. By three years of age, the microbiota stabilizes in 
composition and numbers while discretely being involved in shaping the host 
immune system (Proctor, 2014). One of the theories that explains the basis of the 
successful host-bacterial partnership is the hologenome theory. The theory advocates 
the evolution of an organism along with its microbiome, comprising parasites, 
mutualists, synergists and amenalists, as a result of co-development of the host and 
symbionts. Although the human microbiome is colon-biased, each region in the 
human body is defined by its own distinct microbial community. The human 
microbiome project has identified Staphylococcus epidermidis as a frequent 
colonizer of the skin with a higher prevalence of Propionibacterium acnes on facial 
skin and nose whereas Streptococcus spp. dominate the oral cavity. Among the intra-
body microbiota, Lactobacillus spp. are predominant in the vagina and  the genus 
Bacteroides is the most abundant in the gut of healthy subjects (Bakhtiar et al., 
2013). 




 bacteria and archaea in 




bacteriophages, viruses and parasitic eukaryotic microbes 
(Aziz, 2009). Examination of human faeces has revealed ~10
12
 viable bacterial cells 







2005; Hooper and Gordon, 2001). 16S rRNA analysis, performed as part of the 
Human Microbiome Project, has revealed that the majority of the human intestinal 
microbiota belong to four bacterial divisions : Firmicutes (64%), which includes the 
genera Clostridium, Eubacterium etc.; Bacteroidetes (23%),  which includes the 
genus Bacteroides; Proteobacteria (8%) and Actinobacteria (3%) (Hattori and 
Taylor, 2009; Seksik et al., 2003). The remaining minor taxonomic divisions display 
great inter-individual diversity. The infant intestinal microbiota differs from the adult 
and is mostly composed of genera such as Staphylococcus, Streptococcus, 
Bifidobacterium and Enterobacteria; certain species of which are known to be 
transmitted from mother to baby (Hattori and Taylor, 2009; Ley et al., 2006). The 
composition of the microbiota within each adult is distinct and surprisingly stable 
over a normal healthy life span (Dethlefsen et al., 2007). 
1.1. Commensalism in the Human Intestine 
The gut microbiome, which is estimated to contain  more than 100 times the number 
of genes in the human genome, endows the host with metabolic activities that 
humans are incapable of (Bäckhed et al., 2005). For instance, the host does not 
possess the enzymatic ability  to degrade complex non-starch polysaccharides 
(dietary fiber) that enter the colon (Comstock, 2009).  The anaerobic bacteria 
residing in the gut degrade these polysaccharides, including plant-derived pectin and 
cellulose, thus indicating a commensal relationship where the host gains carbon and 
energy, through the production of fermentative end products in the form of short-
chain fatty acids (SCFA), and the microbes are provided with glycans and a 
protected anoxic environment (Bäckhed et al., 2005). 
The Bacteroides spp. have evolved enzymatic systems to harvest both complex plant 
polysaccharides from the human diet and host muco-polysaccharides, derived from 
the mucus layer overlaying the intestinal epithelial surface. The genome of 
Bacteroides thetaiotaomicron contains polysaccharide utilization loci (PULs) that 
encode proteins involved in sensing, importing and degrading specific glycans of the 







starch utilization is comprised of eight genes encoding SusR and SusA-SusG, that 
include a regulatory protein, five outer membrane proteins involved in starch 
binding, degradation and import into the periplasm and two periplasmic 
glycohydrolases with neopullulanase and alpha-glucosidase activity (D’Elia and 
Salyers, 1996). Although different PULs are dedicated to different repertoires of 
functional products involved in the utilization of specific polysaccharides, in general, 
PULs contain genes encoding hybrid two-component histidine kinase response 
regulators, Extracytoplasmic Function (ECF)-type sigma factors and anti-sigma 
factors, outer membrane proteins involved in nutrient binding and import (SusD and 
SusC paralogues) and glycohydrolases that enzymatically  cleave the glycosidic 
linkages of specific glycans (Martens et al., 2008). The genome of B. 
thetaiotaomicron strain VPI-8254 which contains 88 PULs efficiently utilises the 
host-derived glycans heparin, chondroitin and hyaluronan (Xu et al., 2007). Diet-
associated changes in glycan foraging behaviour of B.  thetaiotaomicron  are 
accompanied by changes in the expression of its capsular polysaccharide 
synthesizing loci. This indicates that B. thetaiotaomicron is able to change its 
carbohydrate surface depending upon nutrient availability (Bäckhed et al., 2005). 
Other Bacteroides species possess glycolytic capabilities absent in 
B.thetaiotaomicron, such as the large complement of enzymes expressed by B. 
vulgatus that target pectin (Xu et al., 2007). In Bacteroides fragilis, the dietary or 
host glycans first bind to a glycan-specific SusD-like outer surface lipoprotein. The 
outer surface glycohydrolases degrade the polymer into smaller oligosaccharides 
which are then transported into the periplasm by the outer membrane TonB-
dependent β-barrel SusC-like proteins. In the periplasm, additional glycohydrolases 
further degrade the molecules to monosaccharide components that are transported to 
the cytoplasm by sugar-specific permeases. The uncharged monosaccharides thus 
formed can either be destined for incorporation into bacterial glycans or for 
catabolism (Comstock, 2009). The B. fragilis genome encodes at least two enzymes, 
Fkp and a putative CMP-sialic acid synthetase, that can directly convert 







nucleotide-activated forms for incorporation into bacterial glycans (Coyne et al., 
2005). Fkp, a characteristic feature of intestinal Bacteroidales, is a protein which 
shares homology to mammalian L-fucose-1-P-guanyl transferase in N terminus and 
to L-fucose kinases in the C terminus, and is involved in generating GDP-L-fucose 
from exogenous L-fucose followed by its incorporation into capsular polysaccharide 
(CPS) glycan structures thereby linking L-fucose availability in the organism's 
intestinal habitat to CPS capsular structure (Coyne et al., 2005). The capsular 
polysaccharides, extracellular polysaccharides and glycoproteins thus formed, are 
essential for bacterial survival in the intestine and can also provide 
immunomodulatory properties to the host when they are released as outer membrane 
vesicles by the bacteria (Patrick et al., 1996). The other uncharged monosaccharides 
are acted upon by enzymes, such as RokA and HexA cytoplasmic hexokinases which 
phosphorylate hexoses on the sixth carbon (Brigham and Malamy, 2005). 
Subsequent to phosphorylation, the monosaccharides could be converted to their 
nucleotide-activated forms and directed into synthesis of bacterial glycans. 
Alternatively, the  monosaccharides can be catabolised  by different enzymes to 
provide SCFAs as an end product which is excreted into the lumen and utilised by 
host cells as an energy source. Butyrate, an SCFA has been demonstrated to have 
anticancer properties (Hamer et al., 2008). The participation of the monosaccharides 
in either glycan synthesis or catabolism is governed by the enzymes competing to 
divert substrates into these pathways. 
Methanogenic archaea, such as Methanobrevibacter smithii  provide the last link in 
the metabolic chain of polysaccharide processing where methanogens lower the 
partial pressure of any hydrogen formed by generating methane. The reduction in 
pressure may also increase microbial fermentation rates (Miller et al., 1982). 
The indigenous gut inhabitants are also important for  host defence because they 
inhibit the growth of potentially pathogenic microorganisms by the depletion of 
nutrients, prevention of access to adherence sites and production of inhibitory 







natural inhabitants of the gastrointestinal tract possess probiotic qualities and are 
beneficial in the treatment of murine colitis and against tetanus toxin (Ahrné et al., 
1998; Grangette et al., 2002; Steidler et al., 2000). 
Paneth cells, and dendritic cells present below the mammalian epithelia are sources 
of endogeneous antimicrobial substances including lysozymes, phospholipases and 
various antimicrobial peptides, such as alpha-defensins, angiogenin 4 (Ang 4) and 
RegIIIϒ. B. thetaiotaomicron can stimulate production of Ang 4 that can kill 
pathogenic organisms such as Listeria monocytogenes (Hooper et al., 2003). It has 
also been shown that B.thetaiotaomicron promotes angiogenesis and post natal 
development of small intestinal villi in newborn mice  (Stappenbeck et al., 2002). 
B.thetaiotaomicron induced peroxisome proliferators-activated receptorϒ (PPARϒ)- 
mediated cytoplasmic redistribution of the Nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-κB) subunit v-rel avian reticuloendotheliosis viral oncogene 
homolog A (RelA) in intestinal cells, thereby attenuating the inflammatory response 
and promoting the intestinal survival of the microbe (Kelly et al., 2004). 
Enterococcus strains have also been shown to regulate phosphorylation of PPARϒ to 
induce the expression of interleukin (IL)-10, an anti-inflammatory cytokine (Are et 
al., 2008). In addition to anti-cancer properties, butyrate, one of the end products of 
glycan utilisation by intestinal microbes induces the expression of antimicrobial 
cathelicidin, LL-37. Induction of LL-37 controls unnecessary inflammatory 
responses by preventing excessive bacterial contact with the epithelium (Pamer, 
2007). 
Host interactions with the commensal gut microbiota, that aid in nutritional and 
immunomodulatory functions, are  exquisitely equilibriated  between pro-
inflammatory and anti-inflammatory responses. The host preserves intestinal 
microbes while still being able to sense  bacteria that penetrate intestinal borders. 
Selective pressures exerted on the intestinal microbiota by dietary constituents and 
antibiotic treatment can alter its stability. The growth of opportunistic pathogens, 







health outcomes (Donskey, 2004). Studies in humans and germfree mice have also 
shown that the respective levels of the two main intestinal phyla, the Bacteroidetes 
and the Firmicutes, are linked to obesity by carbohydrate metabolism (Gill et al., 
2006; Ley et al., 2005; Turnbaugh et al., 2006). The microbiota of obese individuals 
are more heavily enriched with bacteria of the phylum Firmicutes and less with 
Bacteroidetes, suggesting that this mix is more efficient at extracting energy from a 
given diet than the microbiota of lean individuals. The genome of Eubacterium 
rectale (a member of Firmicutes division) is significantly enriched for glycoside 
hydrolases compared to several genomes of Bacteroides sp, which might explain a 
more efficient energy extraction by the former (Turnbaugh et al., 2006). 
1.2. Bacteroides fragilis 
The cultured human gut microbiota categorised within the Gram-negative 
Bacteroidetes phylum belong chiefly to the order Bacteroidales and comprises two 
predominant genera, namely Bacteroides and Parabacteroides (Comstock, 2009). 
Bacteroides spp. account for  ̴ 30% of the 10
12
 viable cells per gram colonic content 
that constitute the faecal microbiota (Hooper and Gordon, 2001; Salyers, 1984). B. 
vulgatus predominates the faecal microbial content at  ̴ 45% of the total bacteria 
present (Patrick et al., 1995a). The prevalence of B. fragilis in the faecal isolates 
ranges from 4-13% and is 10 to 100-fold lower than those of other intestinal 
Bacteroides spp. (Namavar et al., 1989; Salyers, 1984; Willis, 1991). However, B. 
fragilis is the most studied among the Gram-negative anaerobic gut bacteria owing to 
their significant role in glycan-synthesis and utilisation, and host immunomodulation. 
B. fragilis becomes part of  the human microbiota from the earliest stages of life 
since they are passed from mother to child during vaginal birth (Turnbaugh et al., 
2006). Although  B. fragilis is poorly represented in the colonic microbiota, studies 
by Namavar et al. (1989) suggest that they comprise 42% of the adherent colonic 
mucosa which might explain why B. fragilis is the most frequent isolates from 
clinical specimens (Sheila Patrick et al. 1995; Wexler 2007). Bowel surgery is the 







into the peritoneal cavity, thus triggering abscess formation (Cohen-Poradosu et al., 
2011). 
1.2.1. Polysaccharide Synthesis 
The great expansion of the PUL (polysaccharide utilisation loci) in the genomes of 
many members of Bacteroides genome is complemented by an expansion of loci 
involved in bacterial glycan synthesis. The B. fragilis NCTC 9343 genome encodes 
~80 predicted glycosyltansferases and dedicates ~215,000 kb of its genome to the 
synthesis and regulation of glycans (Cerdeño-Tárraga et al., 2005; Coyne et al., 
2008). The genome contains ten annotated regions (PS A-J) for the synthesis of 
polysaccharides, comprising antigenically distinct, within-strain variable, large 
capsule (extracellular polysaccharide), small  capsule and micro-capsules (electron 
dense layer) (Cerdeño-Tárraga et al., 2005; Patrick et al., 1986, 2009). Although the 
B. thetaiotaomicron genome possesses a more extensive starch utilisation system 
with 172 glycosylhydrolases and 163 homologues of starch binding proteins when 
compared to B. fragilis genome, the latter is more adept at phase variation of the 
antigenic surface polysaccharides (Kuwahara et al., 2004). Variable micro-capsule 
expression is related to eight loci (PS A-H) in the genome where each locus is a set 
of 11-21 genes under the control of a single promoter. Phase variation is attributed to 
7 of the 8 loci which are switched on and off by site-specific  inversion of promoter 
sequences  mediated by  serine recombinases (Coyne et al., 2003; Liu et al., 2008; 
Patrick et al., 2003). Therefore a strain of B. fragilis is composed of subsets of 
populations simultaneously expressing a variable combination of capsular 
polysaccharides at any given point in time. Theoretically, 256 different surface 
profiles are possible due to within-strain phase variant micro-capsule synthesis which 
renders B. fragilis competent for host intestinal survival (Krinos et al., 2001). On the 
contrary, a situation where a sub-population of B. fragilis experiences the phasing off 
of all eight micro-capsules would not be encountered under wild-type conditions 
since the PS C promoter does not invert. Also, PS C is not expressed when other 







acapsular mutant, which is deficient in the synthesis of sugars associated with micro-
capsule polysaccharides, to effectively colonise the intestine of a mouse has been 
reported by Coyne et al. (2008). Therefore, PS C might pose as a 'fool-proof' 
mechanism which ensures that the bacterium produces at least one capsule all the 
time. Nine of the ten polysaccharide biosynthesis loci contain genes predicted to 
encode Wzx and Wzy proteins which are  flippases and polymerases (Patrick et al., 
2009). In E. coli and Salmonella enterica, these proteins transport oligosaccharides 
across the inner membrane and polymerise the polysaccharides required for the 
production of lipopolysaccharides (LPS) and capsules (Whitfield, 2006). Post 
polymerisation, the polysaccharides are either ligated to a lipid-A-core by WaaL for 
LPS production or transported directly beyond the outer membrane by Wza for 
capsular polysaccharide production. The Bacteroides fragilis genome, however, 
encodes only one potential Wza homologue and no identifiable homologue of  WaaL 
(Patrick et al., 2009). Deletion studies involving genes encoding a putative Wzz 
protein and WbaP protein in B. fragilis conducted by Patrick et al. (2009) indicated 
the dependence of the micro-capsules on Wzz, which suggested a link to LPS 
biosynthesis. Similarities in the mechanisms of synthesis of micro-capsules and 
phase-variable large capsule to the respective lipid A-linked KLPS/O-antigen and to 
colanic acid-related group 1 and 4 capsules encoded by E. coli describes the variation 
in B.fragilis-mediated polysaccharide synthesis. 
The synthesis of multiple phase-variable capsular polysaccharides is a conserved 
feature of the intestinal species within the order Bacteroidales which confers them 
with an advantage over other species for survival in the intestine (Coyne et al., 2008). 
Genomic comparisons of  the B. fragilis strains, NCTC 9343, 638R and YCH46 
revealed 28 divergent polysaccharide biosynthesis loci amongst the three strains. 
YCH46 shares one locus with NCTC 9343 and another with 638R (Patrick et al., 







1.2.2. Polysaccharide A 
Polysaccharide A (PS A) and PS B are two of the micro-capsule (MC) 
polysaccharides synthesised by B. fragilis. PS A and PS B along with several other 
MC-associated polysaccharides belong to a class of zwitterionic  polysaccharides 
(ZPS) which are characterised by the presence of both a positive and a negative 
charge within each repeating unit (Tzianabos et al., 1993). ZPS have also been 
identified from other bacterial species, including type 1 Streptococcus pneumoniae 
capsular polysaccharide (CP1) and type 5 and type 8 Staphylococcus aureus capsular 
polysaccharides, however, PS A is the best characterised ZPS (Tzianabos et al., 
2001). 
ZPS are capable of inducing a CD4
+
 T cell-dependent immune response in a similar 
manner to protein antigens that evoke an IgG  response. Since the activation of  
CD4
+
 T cells requires the specific interaction of the alpha-beta T cell receptor (TCR) 
on the T cell with the antigen presented by major histocompatibility complex II 
(MHC II) on a professional antigen-presenting cell, PS A is chemically processed in 
the endocytic pathway and presented on an MHC II molecule (Watts and Powis, 
1999). Studies on oral treatment of mice with fluorescently labelled PS A have 
shown that PS A specifically associates with CD11c
+
 dendritic cells, but not with 
CD4
+
 T cells or CD19
+ 
B cells in mesentric lymph nodes (Mazmanian et al., 2005). 
Activation of CD11c
+ 
dendritic cells proceeds through Toll-like receptor 2 (TLR2) 
stimulation, thereby upregulating MHC II as well as co-stimulatory CD86. 
Presentation of the antigen on MHC II in the presence of appropriate co-stimulatory 
molecules is essential for the subsequent activation of T cells (Pasare and Medzhitov, 
2004; Troy and Kasper, 2010). Mono-colonisation of previously germ-free (GF) 
mice with B. fragilis alone corrected the CD4
+ 
T cell deficiencies and resulted in a 
more defined splenic architecture with larger lymphoid follicles. Thus commensal 
bacteria have a positive impact on development of gut-associated lymphoid tissue, 
intraepithelial lymphocytes and mucosal IgA production. Experiments have shown 
that this effect is mediated by PS A which diminishes the CD4
+ 
T cell deficiency in 
the spleen of GF mouse (Mazmanian et al., 2005).  CD4
+







sub-types known as T-helper 1, T-helper 2 and T-helper 17 cells (Th1, Th2 and 
Th17), each of which induce distinct and opposing immune responses. Th1 cells 
promote the development of cell-mediated immunity and host defense against viral 
and bacterial pathogens. Th2 cells mediate host defence against helminths (Anthony 
et al., 2007; Murphy and Reiner, 2002). Th17 are important mediators of 
inflammation and protect the host from extracellular bacteria and fungi (Chen and 
O’Shea, 2008; Matsuzaki and Umemura, 2007). Imbalanced Th1 or Th2 responses 
may result in autoimmune diseases while an overactive Th2 response has been 
implicated in asthma and predisposition to allergy (Kidd, 2003; Wills-Karp et al., 
2001). 
Th1/Th2 imbalances in germ-free mice can be corrected through bacterial 
colonisation. Th1 cells are characterised by the production of interferon (IFN)-
gamma and Th2 by the production of IL-4. The majority of mammalian immune 
systems including that of GF mice are intrinsically skewed towards Th2 cytokine 
production . Stimulation of the GF mouse immune system with PS A generated a 
Th1 response that corrected the imbalance and restored IFN-gamma production to 
levels found in conventionally colonized mice (Mazmanian et al., 2005). The ability 
of PS A to stimulate IFN-gamma production by T cells represents a Th1 response for 
which signalling by both IL-12 and signal transducer and activator of transcription 
protein (Stat4) (Th1-specific transcription factors) is required. TLR2 stimulation by 
PS A produces IL-12 from activated dendritic cells (Wang et al., 2006). IL-12 binds 
the IL-12 receptor on T cells  and signals the activation of Stat4 (Macatonia et al., 
1995). IL-10, a potent anti-inflammatory cytokine produced by CD4
+ 
T cells is 
synthesized following signalling through TLR2 and is  required for protection against 
inflammation. Therefore, TLR2 activation which was previously considered to 
promote immunity is resultant of PS A detection by the immune system thereby 
restraining anti-bacterial response (Round et al., 2011). Animal models of diseases 
replicating uncontrolled inflammatory responses, such as Inflammatory Bowel 
Disease (IBD) reveal that PS A administration prevents these diseases by reducing 







(TNF)-alpha and lL-17 which, is a result of repression of Th17 cells and activation of 
IL-10 production (Mazmanian et al., 2008). A subset of CD4
+ 
T cells known as 
foxp3
+ 
regulatory T cells are required for B. fragilis-mediated Th17 suppression.  
1.2.3. Outer Membrane Vesicles 
Outer membrane vesicles (OMV) have been studied extensively in Gram-negative 
bacteria and contain biologically active proteins, lipoproteins, phospholipids and 
LPS, mostly of outer membrane and periplasmic origin, which perform diverse 
biological processes such as horizontal gene transfer, intercellular communication, 
transfer of contents to host cells and eliciting immune responses (reviewed in Kulp & 
Kuehn 2010; Kulkarni & Jagannadham 2014). OMVs released by Gram-negative 
bacteria are small spherical structures ranging from 10-300 nm in diameter (Kulp and 
Kuehn, 2010; McBroom and Kuehn, 2005). They are released by a mechanical 
process of 'bulging away and pinching off' from the outer membrane of the cell, 
which is independent of ATP/GTP hydrolysis (Kulp and Kuehn, 2010). Although 
vesicles have been best characterised in pathogens with respect to their toxin delivery 
and other virulence factors, they do perform a protective role in bacteria by reducing 
the levels of toxic compounds and aiding in the release of attacking phages, thereby 
promoting bacterial survival in a hostile environment (reviewed in Kuehn & Kesty 
2005). OMVs enable bacteria to secrete insoluble molecules in combination with 
soluble material which are destined to distant, otherwise inaccessible, targets in the 
host in a concentrated, protected and targeted form (Kulp and Kuehn, 2010). The 
inability to generate non-vesiculating mutants in bacteria to date, except for 
modulation of OMV-release, emphasizes the significance of OMV-mediated 
functions in the growth of a bacterium (McBroom et al., 2006). Release of OMV by 
B. fragilis was first suggested by Macfarlane et al. (1992) who analysed protease 
synthesis by the bacterium and detected  ̴ 10% of the extracellular proteolytic activity 
to be association with particulate matter. Immuno-analysis with monoclonal 
antibodies, flow cytometric detection and further enzymatic analysis by Lutton et al. 







dense layer (EDL)-enriched population of B. fragilis. EDL refers to a type of capsule 
expressed by B. fragilis which is not visible by light microscopy and accounts for 
<5% of the laboratory culture population. Labelling with monoclonal antibodies 
(mAbs) specific for surface polysaccharides indicated the presence of outer 
membrane epitopes in B. fragilis OMVs. Later, vesicles with diameter ranging from 
30-80 nm was observed in B. fragilis by transmission-electron microscopy (TEM), 
and these OMV were smaller when compared to the vesicular sizes of many other 
Gram-negative bacteria (Elhenawy et al., 2014). Arousing the mammalian immune 
system is an inevitable consequence of OMVs since they deliver antigenic OM 
components, LPS and toxins (Kondo et al., 1993). Therefore certain bacteria, both 
pathogens and non-pathogens, have incorporated proteins into their OMVs which aid 
in immune suppression and promote bacterial survival in the host. UspA1/A2 
virulence factors found in Moraxella catarrhalis OMVs were observed to bind and 
inactivate C3 complement protein and Neisseria OMVs removed bactericidal factors 
found in serum. OMVs released by P. gingivalis, a periodontal pathogen which is 
evolutionarily close to B. fragilis, caused CD14 degradation on human macrophages 
by incorporating gingipain proteases into their vesicular content (Duncan et al., 
2004). 
Similar to the immunosuppression exhibited by other bacteria, Shen et al. (2012) 
detected immunomodulatory polysaccharide PS A and PS B in the OMVs secreted 
by B. fragilis. A TLR2-mediated sensing of OMV-associated PS A presented by 
dendritic cells (DCs) activated regulatory T cells and IL-10 anti-inflammatory 
cytokine production in the presence of Growth Arrest and DNA-Damage-Inducible 
(Gadd45α) protein. Expression of Gadd45α protein by DCs has previously been 
shown to promote T cell responses (Jirmanova et al., 2007). Shen et al., (2012) 
suggested a therapeutic role of B. fragilis OMVs where OMV-treated DCs prevented 
experimental colitis through the production of IL-10 anti-inflammatory cytokine and 







observed that the absence of PS A blocked the ability of B. fragilis OMV to promote 
regulatory T cells by dendritic cells (Shen et al., 2012).  
Another mechanism by which OMVs support the survival of bacteria in the host 
environment is by the sequestration and inactivation of antibiotics. OMVs can pose 
as decoy targets that protect cells by titration of phages and antibiotics (Manning and 
Kuehn, 2011). In addition, proteins that degrade antibiotics have been identified in 
bacterial OMVs, such as β-lactamase in the OMVs released by M. catarrhalis and 
the Gram-positive bacterium, S. aureus (Lee et al., 2009; Schaar et al., 2011). Such 
enzymatic functions with respect to antibiotics also account for community-
associated functions by which the OMVs provide transient antibiotic resistance for 
neighbouring cells, thereby promoting their survival within the host. OMVs  
facilitate long-term drug resistance in a population by horizontal gene transfer. The 
identification of cephalosporinase (BtCepA), which was exposed on the surface of 
vesicles produced by a majority of Bacteroides spp., was observed to degrade the 
antibiotic, cefotaxime, a third-generation cephalosporin. It was also demonstrated 
that these cephalosporinase-loaded OMVs could protect Salmonella typhimurium 
and Bifidobacterium breve from β-lactam activity (Stentz et al., 2015). Thus 
Bacteroides spp. which constitute a major part of the human gastrointestinal tract  
microbiota confer antibiotic resistance to enteric pathogens and commensals. Since 
there has been growing evidence of the adverse effects of antibiotic treatments which 
lead to intestinal dysbiosis and increased susceptibility to IBD, cephalosporinases 
secreted by Bacteroides might play a significant role in maintaining a balanced 
intestinal microbiota through resisting the inhibitory responses of cephalosporin 
antibiotic. 
OMVs also play a role in bacterial nutrition, often exhibiting a community-related 
role by facilitating inter- and intra-species nutrient transfer. In addition to enzymes 
that degrade complex biomolecules and allow nutrient uptake, OMVs collect and 
concentrate metal ions for bacterial consumption (Kulp and Kuehn, 2010). 







species of bacteria and cyanobacteria was demonstrated by Biller et al. (2014). In 
similar terms, a model proposed by Rakoff-Nahoum et al. (2014) suggested that 
OMVs secreted by certain species of the intestinal microbiota are able to break down 
polysaccharides for the benefit of other species in the community. Recent Mass 
Spectrometry (MS) analysis of the proteome of the outer membrane and OMV 
released by B. fragilis and B. thetaiotaomicron has revealed the presence of more 
than 40 proteins that are exclusive to the OMV. 24 of the proteins present in OMVs 
were hydrolases and 80% of the OMV-specific proteins were acidic in nature. The 
OMV-proteome was in stark contrast with the outer membrane proteins which 
contained very few hydrolases with only 2 out of the 33 OM-specific proteins 
possessing an acidic isoelectric point. The selective sorting of proteins in OMVs 
confirms the biogenesis of B. fragilis OMV  as a directed process (Elhenawy et al., 
2014). Similar patterns of cargo selection have been observed in Pseudomonas 
aeruginosa and Porphyromonas gingivalis by which particular LPS subtypes are 
enriched in OMVs to enhance their virulence-associated functions (Haurat et al., 
2011; Kadurugamuwa and Beveridge, 1995). In addition to A-band LPS, OMVs 
released by P.gingivalis were enriched in a class of proteases known as gingipains 
which enabled degradation of host proteins. The regulation of genes encoding 
preferentially packed OMV proteins depends on the host environment. Enrichment of 
aminopeptidase was observed in OMVs released from  clinical isolates of P. 
aeruginosa which facilitated association of vesicles with cultured epithelial cells 
when compared to lab strain-derived OMVs (reviewed in Kuehn & Kesty 2005). A 
similar upregulation in the activity of α-L fucosidase, an OMV-exclusive sugar 
hydrolase, was observed in B. fragilis in the presence of fucose. Since fucose 
metabolism, in addition to its utilisation in polysaccharides, is a major function of the 
Bacteroides spp., regulation of the OMV content to optimise fucose breakdown is of 
advantage to the species. Additionally, the glycosidases exclusive to B. fragilis 
OMVs can degrade a variety of polysaccharides which could be utilised by another 
bacterium deficient in glycolytic activity (Elhenawy et al., 2014). Furthermore, 







pathogens such as S. enterica and C. difficile and promotes their colonisation in the 
gut (Ng et al., 2013). Since Elhenawy et al. (2014) also suggested that the sorting 
mechanism is conserved within the genus despite variability among related species, a 
similar function of sugars liberated by OMVs might exist in B. fragilis as that 
observed in B. thetaiotaomicron. Thus the selective packing of acidic hydrolases 
along with the ability to agglutinate erythrocytes suggests a virulent role for B. 
fragilis OMVs which is discussed in detail in the next section (Patrick et al., 1996). 
1.2.4. Pathogenic factors 
B. fragilis accounts for 50%-70% of the intestinal anaerobes isolated from 
opportunistic infections including peritonitis, intra-abdominal sepsis, soft tissue 
abscesses, brain abscesses and bacteraemia (Lobo et al., 2013; Patrick, 2002; Patrick 
and Duerden, 2006; Patrick et al., 1995b). The B. fragilis group is responsible for 45-
65% of nosocomial and community acquired anaerobic bacteraemia with a reported 
mortality rate of 24%-31% (Blairon et al., 2006; Brook, 1990). B. fragilis dons the 
role of an opportunistic pathogen when it escapes from the gastrointestinal tract into 
the peritoneal cavity owing to surgical, traumatic or a disease-induced disruption of 
the intestinal mucosal integrity (Coyne et al., 2001). B. fragilis accounts for only 4%-
13% of the normal faecal microbiota and is isolated from 63%-80% infections 
caused by Bacteroides spp., whereas B. thetaiotaomicron which constitutes 15%-
29% of the luminal content accounts for only 13%-17% of the infection cases 
(Cerdeño-Tárraga et al., 2005). 
The adherent nature of the B. fragilis capsular polysaccharide surface which was 
evident in the sodium periodate-sensitive adherence to Caco-2 cells, allows the 
bacterium to establish at the site of an infection (Ferreira et al., 2002). In addition to 
adherence, the respective roles of large capsule and micro-capsules in resistance to 
phagocytic-uptake and serum bactericidal activity have been reported earlier by Reid 
& Patrick (1984). Therefore the presence of multiple intra-strain phase-variant 
polysaccharides ensure there is always a sub-population of B. fragilis that can 







It was suggested that incomplete opsonisation of the large capsule with limited 
amounts of an essential opsonin, such as IgM, led to impaired phagocytosis (Reid 
and Patrick, 1984). The most distinct and characteristic feature of the pathogenic 
phase of B. fragilis is abscess formation. Studies by Gibson et al. (1998)  on mouse 
models identified the role of the capsular polysaccharide complex in coordinating 
cellular events that resulted in abscess development. Adherence of B. fragilis surface 
polysaccharides to murine mesothelial cells (MMCs) stimulated TNF-α production 
by peritoneal macrophages. Cytokine stimulation led to Intercellular Adhesion 
Molecule-1 (ICAM-1) production by MMCs which supported increased 
polymorphonuclear leukocyte (PMNL) binding to the site, thus inducing an abscess. 
Later on, several studies including generation of gene-deletion mutants narrowed 
down the sole abscess-inducing region of B. fragilis strain 9343  to the unusual free 
amino sugar residue, acetamido-amino-2,4,6-trideoxy galactose (AATGal), on the 
zwitterionic PS A repeating unit (Coyne et al., 2001). Each repeating unit of PS A 
contains both positively charged and negatively charged groups and this zwitterionic 
nature of the polysaccharide is essential for abscess induction. Conservation of the 
regions flanking each side of the PS A locus was evident in the Polymerase Chain 
Reaction (PCR) analysis of fifty B. fragilis isolates. Downstream conserved region 
includes two terminal PS A biosynthesis genes, wcfR which is likely responsible for 
amino sugar transfer on the AATGal residue and, wcfS, a putative transferase 
responsible for transfer of AATGal nucleotide precursor to an undecaprenyl-
phosphate lipid carrier marking the first step in synthesis of the PS A repeating unit. 
Conservation of these genes suggested that this sugar is present in the PS A of all 
serotypes and might explain the abscessogenic nature of this bacterium across many 
strains. The study also predicted the presence of AATGal in a similar, but more 
complex PS A locus of B. fragilis strain 638R. However, whole genome sequence 
comparisons conducted by Patrick et al. (2010) on 3 strains, NCTC 9343, 638R and 
YCH46 revealed that the PS A/2 locus is not conserved and is exclusive to the NCTC 







in the PS loci of 638R and YCH46  suggested the possible production of a different 
cluster of abscess-producing polysaccharides in these strains. 
As mentioned in the last section, PS A is delivered to the host by means of OMVs 
released by B. fragilis (Shen et al., 2012). Therefore the accidental displacement of 
the bacterium into the peritoneal cavity leads to the release of OMVs that promote 
abscess formation. Several studies have demonstrated a key role played by OMVs in 
various stages of infection. Hypervesiculating mutants were observed to combat 
conditions of stress in a better manner owing to the release of misfolded proteins, 
thereby safeguarding bacterial integrity (reviewed in Kulkarni & Jagannadham 
2014). In events of infection-induced stress, bacteria responded by upregulating 
OMV production which was accompanied by increase in toxicity and activation of 
host immune responses (Kulp and Kuehn, 2010). Studies in enterotoxigenic and non-
enterotoxigenic E. coli suggest that pathogenic bacteria release more vesicles than 
their non-pathogenic counterparts (Horstman and Kuehn, 2002). On comparison of 
various B. fragilis clinical isolates, Pumbwe et al. (2006) observed an accelerated 
OMV production in certain isolates which might suggest a pathogenic role. 
Enrichment of virulence factors in OMVs have been observed in pathogens, such as, 
P. gingivalis which excludes a multitude of outer membrane proteins (OMP) and 
preferentially packs gingipains, a proteolytic virulence factor in its OMVs (Haurat et 
al., 2011). Adherence of OMVs released by Pseudomonas aeruginosa, a respiratory 
pathogen, to the cultured lung epithelial cells was found to be strengthened by the 
OMV enrichment of aminopeptidase (reviewed in Kuehn & Kesty 2005). Proteome 
analysis in B. fragilis has identified a sorting mechanism by which acidic hydrolases 
are preferentially packed into OMVs. Although this accounts for a beneficial role 
wherein the glycolytic end products released by the OMVs promote self and inter-
species nutrition in the gut, it could turn unfavourable when it enhances the survival 
rate of enteric pathogens (Elhenawy et al., 2014). Additionally, it has been observed 
that OMVs released by Myxococcus xanthus exhibit a predative role and lytic 
activity against E. coli owing to the presence of a high number of digestive 







The selective packing of hydrolases in B. fragilis might also target the host mucus 
glycans and mucin protein which aid in epithelial invasion. Previous studies which 
demonstrate haemagglutination, sialidase, as well as other enzymatic activities with 
respect to B. fragilis OMVs suggest that the vesicles attack host cells following an 
initial attachment (Patrick et al., 1996; Tanaka et al., 1992). Vesicles purified from 
the oral bacterium Treponema denticola have been found to possess a protease, 
dentilysin, which allows the bacterium to penetrate the epithelial barrier by 
disrupting tight junctions (Chi et al., 2003). Furthermore, studies have been initiated 
to identify a possible role of OMVs released by colonic bacteria in depression-related 
disorders with regard to the 'leaky gut' syndrome. Previous studies have reported that 
OMVs can affect the blood-brain-barrier permeability which provides a lead to its 
role in entering systemic circulation and being delivered to the brain which might 
contribute to depression-related disorders (Muraca et al., 2015). 
B. fragilis  strains isolated from intestinal infections secreted very high levels of an 
antibacterial chemical, bacteriocin, and were resistant to bacteriocins secreted by 
other strains of B. fragilis. Bacteriocins are known to attack closely-related species or 
strains of the producers, thus competing for a similar ecological niche. However,  
non-intestinal isolates such as, strains isolated from intra-abdominal infections, 
bacteraemia and aquatic environments secreted lower amounts of bacteriocin and 
were more susceptible to that produced by other strains. A bacteriocin-producing B. 
fragilis strain which inhibited RNA polymerase specifically of other B. fragilis 
strains in vivo was found to have a slightly wider activity spectrum in vitro 
(reviewed in Wexler 2007).  In addition to the factors discussed above, a wide range 
of potential virulence mechanisms are prevalent in B. fragilis which might promote 
the dissemination of opportunistic infections. The contributing factors include 
adherent surface proteins, fimbriae, enterotoxin, haemolysins, neuraminidase, and 
OMV-dependent and independent enzymatic activities which are explained in detail 








Chapter 2 Materials and Methods 
2.1. Strains 
The strains used in this study and their sources are shown in Table 2.1. 
 
Table 2.1: List of strains 
Strain Genotype Source 
E. coli BL21 Star 
(DE3) 
F- ompT hsdSB (rB
-mB
-) gal dcm 
rne131 (DE3) 
Invitrogen 
E. coli MG1655 F- λ- ilvG- rfb-50 rph-1 Maurice Gallagher 
E. coli S17-1 (λpir) recA thi pro hsdRM+ RP4::2-
Tc::mu::Km Tn 7 λ pir 
Simon et al 1983 
E. coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacΧ74 recA1 
araD139 Δ(ara-leu)7697 galU galK 
rpsL (StrR) endA1 nupG 
Invitrogen 
B. fragilis ΔBF1708 NCTC 9343 ΔBF1708 David Roberts 
B. fragilis NCTC 
9343 
clinical isolate Sheila Patrick 
 
2.2. Bacterial culture conditions 
B. fragilis strain NCTC 9343 was grown in a MiniMacs anaerobic work station (Don 
Whitley Scientific, UK) at 37°C with an anaerobic gas mix (10% Hydrogen 10% 
Carbon dioxide and 80% Nitrogen), in Brain Heart Infusion broth (BHI) (Difco, 
USA) supplemented with 5% cysteine, 10% sodium bicarbonate, 50 μg/ml haemin 
and 0.5 μg/ml menadione or defined medium (DM) (Van Tassell & Wilkins, 1978) 
supplemented with 10% glucose or 2% fucose. E. coli strains were grown in Luria-
Bertani Broth (LB) (Difco, USA) shaken at 200 rpm, or on LB agar at 37 °C. For 
analysing the effect of nitrogen limitation,  B. fragilis was grown in glucose-DM 
containing +5x, -5x and -10x times the normal concentration of ammonium sulphate. 
Experiments for analysing nitrogen limitation were also performed by growing E. 







with 0.2% glutamine or glutamic acid and sub-culturing in 0.1% glutamine or 
glutamic acid. Strains were stored in a final concentration of 50% glycerol at -80°C. 
2.3. Oligonucleotides 
Oligonucleotides used in this study are shown in Table 2.2. The Artemis genome 
browser was used to design oligonucleotide primers to amplify coding regions or 
flanking regions (Carver et al., 2008). PCR amplification was carried out as 








Table 2.2: List of oligonucleotides  
Oligonucleotide primers designed for gene deletion and gene amplification along with their 
loci in artemis genome browser. 4 sets of primers were designed to amplify the flanking 
regions of each gene to be deleted. Regions of the primer sequence indicated in green are for 
compatibility between inside primers designed for each gene. Regions of the primer 
sequence indicated in blue are for compatibility with the cloning vector. Forward and reverse 
primers were designed for each protease-encoding gene to be amplified. Region of the 
forward primer sequence indicated in red is for compatibility with the expression vector 
used. Commercial primers used in library construction and sequencing experiments are also 
shown.     
Primer (locus in 
artemis)   
Sequence 



















0657  left outside 
forward 
(788674…788693) 
ATCGATAAGCTTGATTTCTCCGTTCGCCGACTACC        
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3775 left outside 
forward 
(4457633…4457652
)   
ATCGATAAGCTTGATGCAACTGATGGCAGAAATCG   
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1705 left outside 
forward (1984400-
1984422)   
ATCGATAAGCTTGATTAATCAATCGATCAAGAAGT
AGC 






















































































2.4. Bacterial techniques 
2.4.1. B. fragilis growth curves 
A single colony was used to inoculate 5 ml BHI-S broth or DM, containing 
antibiotics if appropriate and incubated overnight at 37°C anaerobically. A 1:100 
dilution was made into fresh pre-reduced BHI-S broth or DM without antibiotic 
selection and incubated anaerobically at 37°C. Optical density readings at 600 nm 
(OD600) were taken at 45 or 60 min intervals for strains grown in BHI-S and DM, 
respectively. Before readings were recorded, samples were diluted in the appropriate 
medium to ensure the OD600 readings did not exceed 1. Measurements were 
multiplied by the dilution factor to obtain the optical density. Readings were taken 
until stationary phase was reached. All growth experiments were performed in three 
or six biological replicates. 
2.4.2. Preparation of chemically competent cells 
Solutions 
Transformation Buffer 1 (TFB1): 30 mM Potassium acetate, 10 mM CaCl2, 50 mM 
MnCl2, 100 mM RbCl, 15% v/v glycerol (pH 5.8) in 100 ml dH2O 
Transformation Buffer 2 (TFB2): 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15% 
v/v glycerol (pH 6.5) in 10 ml dH2O   
Competent E. coli cells were prepared using the rubidium chloride method. 20 mM 
MgSO4  was added to a 1:100 dilution of overnight culture in pre-warmed LB. The 
cells were grown at 37
o







centrifugation at 4500xg at 4
o
C for 5 min and resuspended in 100 ml ice-cold TFB1 
before incubation on ice for 5 min. Cells were again pelleted by centrifugation and 
resuspended in 10 ml ice-cold TFB2. Cells were incubated on ice for an hour before 
snap freezing in liquid N2 and storing at  -80
o
C in 100 or 200 µl aliquots. 
2.4.3. Transformation: Heat-shock method 
For transformation, 2-5 µl of DNA were added to 100 µl competent cells. The 
transformation mix  was incubated on ice for 30 min before giving a heat shock at 
37
o
C for 2 min followed by incubation on ice for 5 min. The cells were revived on 
LB for an hour. The revived cells were spread onto LB plates containing the 
antibiotic of selection and incubated overnight at 37
o
C. Individual colonies were 




2.4.4. Transformation: Electroporation method 
The overnight culture of B. fragilis NCTC 9343 was diluted 1:40 in pre-warmed and 
pre-reduced BHI-S broth and grown anaerobically at 37
o
C to an OD600 of 0.4. 10 ml 
of the culture were centrifuged at 2600xg for 15 min at 4
o
C. The pelleted cells were 
washed in 10 ml ice-cold pre-reduced dH2O. Washing was repeated three times and 
the cells were finally resuspended in 100 µl dH2O. The washed cells were left on ice 
until required. 40µl of cells were placed in a pre-chilled 0.1 cm gap Gene Pulser® 
electroporation cuvette (Bio-Rad), to which 1 µl of DNA was added. The cells were 
electroporated in a MicroPulser™ (Bio-Rad) at a voltage of 2kV. 1ml of pre-warmed 
BHI-S was quickly added to the cells followed by anaerobic incubation at 37
o
C 
overnight. The cultures were centrifuged in a 5415 D centrifuge (Eppendorf) at 
13000 rpm for 2 min and then resuspended in 200µl of pre-warmed BHI-S. The cells 
were spread on BHI-S plates containing appropriate antibiotics and incubated for 1-2 
days in an anaerobic atmosphere at 37
o
C. The antibiotic resistant colonies were re-







2.4.5. Conjugation of  E. coli S17-1 λpir with B. fragilis NCTC 9343 
Cultures of the donor E. coli S17-1 λpir  and B. fragilis were  grown overnight.  E. 
coli was sub-cultured 1:50 into fresh LB and  B. fragilis 1:40 into fresh BHI-S 
without antibiotic selection. Both the cultures were grown to an OD600 of 0.2 and 
donor to recipient were mixed in a ratio of 1:10. 200-300 µl of the mixed cultures 
were spotted onto BHI-S plates and incubated aerobically for 1-2 hours before 
transferring into the anaerobic cabinet for overnight incubation. The cells were 
washed and scraped from the plate using 1 ml BHI-S. 200 µl aliquots were spread 
onto selective BHI-S plates containing gentamicin and the appropriate antibiotic,  
and incubated overnight at 37
o
C in the anaerobic cabinet. Resistant colonies were 
picked and restreaked on BHI-S agar plates containing gentamicin and the approriate 
antibiotic. 
2.4.6. Screening for Deletion genotypes 
The colonies resistant to the appropriate antibiotic were streaked on DM containing 
fucose (0.2%) and the antibiotic, and incubated anaerobically for 1-2 days at 37
o
C. 
The individual colonies were picked and patched on BHI-S plates and BHI-S plates 
containing the sensitive antibiotic using sterile toothpicks. The sensitive colonies 
represented strains that had resolved to either wild-type or deletion genotype. 
 
2.5. DNA techniques 
2.5.1. Genomic DNA extraction 
Genomic DNA was extracted from 5 ml overnight cultures using the Wizard 
Genomic DNA purification kit (Promega) following the manufacturer's instructions. 
The extracted DNA was resuspended in 100 µl rehydration solution. 
2.5.2. Plasmid DNA extraction 
Cultures were grown overnight in 5 ml broth, containing antibiotics if appropriate. 








2.5.3. Polymerase Chain Reactions 
Oligonucleotides were synthesised by MWG Operon (Eurofins, Germany) and the 
sequences are shown (Table 2.2). PCR reactions were performed in a Techne 
Progene Thermal Cycler (Bibby Scientific Limited, UK) or a Mastercycler gradient 
cycler (Eppendorf). A standard 50 μl reaction contained 1 μl forward primer (10 
pmol/μl), 1 μl reverse primer (10 pmol/μl), 1 μl dNTP’s (10mM), 10 μl 5x reaction 
buffer, 0.5 μl Phusion polymerase (2000 U/ml) (New England Biolabs, UK), 1 μl 
~0.1 ng/μl template DNA and 35.5 μl dH2O. The thermal program was 1 cycle at 
98°C for 1 min, 30 cycles at 98°C for 30 seconds, x°C for 30 seconds, 72°C for 45 
seconds per kb, followed by a final extension of 72°C for 15 min, where x represents 
the annealing temperature of each primer pair. 
2.5.4. Agarose Gel Electrophoresis 
Solutions 
50X Tris Acetate EDTA (TAE) electrophoresis buffer: 242g Tris base, 57.1 ml 
Glacial acetic acid, 100 ml 0.5M EDTA (pH 8.0) in 1l dH2O     
Agarose gel electrophoresis of DNA fragments was carried out in 1% (w/v) agarose 
gels (Invitrogen, USA), with 1x Tris-acetate EDTA buffer (TAE). 1 x DNA loading 
buffer (New England Biolabs, UK) was added to DNA samples before loading onto 
the gel alongside molecular weight markers, 100 bp or 1 kb DNA ladder (New 
England Biolabs, UK). Electrophoresis was carried out at 80V for 60 min. Gels were 
stained in 1 μg/ml ethidium bromide for 10 min and de-stained in dH2O for 10 min. 
Gels were visualised using a UVP VisiDoc-It Imaging system (UVP LLC, USA). 
2.5.5. DNA purification 
PCR products were purified using the Wizard SV Gel and PCR Clean-up System 







2.5.6. DNA quantification 
DNA concentration (ng/μl) was determined using a nanodrop ND-1000 
spectrophotometer (Thermo Scientific, USA) by measuring the absorbance of the 
sample at a wavelength of 260 nm according to the manufacturer’s instructions. 
2.5.7. Restriction Digestion 
Digestions were carried out using restriction enzymes and their appropriate buffers as 
outlined in the manufacturer’s instructions (New England Biolabs, UK). A standard  
50 µl digestion contained: 0.5 µl BSA, 5µl 10X reaction buffer, 3 µl restriction 
enzyme, 10 µl plasmid DNA and 33.5 µl dH2O. The reaction mixes were incubated 
at 37
o
C overnight for digestion. 
2.5.8. Cloning 
Cloning of the deletion constructs into pGB910 vector was performed in a ligation- 
independent manner using the Infusion cloning kit (Clontech). The vector and insert 
were mixed in appropriate ratios according to the manufacturer’s instructions along 
with the enzyme mix. The expression constructs of the protease-encoding genes were 
cloned into pET100/D-TOPO vector using Champion pET Directional TOPO 
Expression Kit (Invitrogen) by following directions outlined in the manufacturer's 
instructions. 
2.5.9. Single Colony Assay 
Solutions 
Single Colony Forming (SCF) buffer: 2.5% Ficoll, 1.25% SDS, 0.015% 
Bromophenol blue, 10 µg/ml RNAse A 
Cells from a patch plate were re-suspended in 200 µl SCF buffer and incubated at 
room temperature for 20 min. Samples were then centrifuged at 13000 rpm for 30 
min. 30 µl of supernatant were loaded onto 1% agarose gel, and the appropriate 








2.5.10. Sanger-based Plasmid Sequencing 
5µl clean DNA (33-83 ng/µl)  and 1µl sequencing primer (3.2 pmol/µl) were mixed 
in 0.2 ml tubes. The plasmids were sequenced by Sanger sequencing at the 
Edinburgh Genomics facility. 
 
2.6. RNA Sequencing 
2.6.1. RNA Extraction 
Solutions 
Nuclease-free water (Qiagen) 
DiEthyl PyroCarbonate (DEPC) (Sigma-Aldrich)  
Ethanol 
β-Mercaptoethanol 
15 mg/ml lysozyme (Sigma-Aldrich) 
Proteinase K (Qiagen) 
Tris EDTA (30 mM Tris from 1M DNase- and RNase-free Tris-HCl (Sigma-Aldrich) 
and 1 mM EDTA from 0.3 M EDTA stock concentration) pH 8.0 
RNase ZAP (Sigma-Aldrich) 
Prior to RNA extraction, water and other solutions were treated with 0.1% DEPC to 
inactivate RNases by covalent modification. 0.1 ml DEPC solution were added to 
100 ml solution, shaken vigorously and incubated for 12h at 37
o
C. DEPC treated 
solutions were autoclaved at 100
o
C for 15 min to remove DEPC traces. Glasswares 
were made RNase-free by treating with 0.1% DEPC-water for 12h at 37
o
C followed 
by heating to 100
o
C for 15 min to remove residual DEPC. Nuclease-free water was 







with RNA extraction were wiped with RNase ZAP to remove RNase contamination. 
Hand gloves were changed frequently to inhibit RNase introduction. 
Total RNA was extracted from B. fragilis cultures grown to appropriate time points 
by following enzymatic lysis and proteinase K digestion using RNA protect Bacteria 
Reagent (Qiagen) and purified using RNeasy Mini Kit (Qiagen) according to the 
manufacturer's instructions. Extracted RNA samples were quantified using Nanodrop 
(2.5.6). In-solution DNase digestion of the RNA samples was performed using 
RNase-free DNase kit (Qiagen) according to the manufacturer's instructions. Final 
clean-up and concentration of the RNA samples was carried out using RNA Clean 
and Concentrator-5 (Zymo Research) following manufacturer's instructions. The 
concentrated RNA was eluted in 30 µl elution buffer and quantified again using 
Nanodrop. rRNA was depleted from the extracted RNA using Ribo-Zero-rRNA 
Removal Kit for Bacteria (Illumina) as per the manufacturer's instructions at the 
Edinburgh Genomics Facility. 
2.6.1.1. Agarose Gel Electrophoresis of RNA 
1X TAE was prepared in DEPC-treated water since adding DEPC directly to Tris 
buffers inactivates primary amines. The electrophoresis tank and combs were wiped 
with RNase ZAP to remove RNase contamination. 10 µl RNA was treated with 2 µl 
6X DNA dye (New England Biolabs, UK) and 12 µl formamide. The RNA samples 
were heated at 65-70
o
C for 10 min and electrophoresed on 1%  agarose-TAE gels at 
70V for 30 min. 
2.6.2. Library Preparation 
Stranded libraries were constructed for each RNA sample using TruSeq Stranded 
Total RNA Library Prep Kit (Illumina) at the Edinburgh Genomics facility. 10 cycles 
of PCR were performed using TruSeq Universal Adapter (Table 2.2) according to the 
manufacturer's instructions. The libraries were pooled and paired-end sequencing 
was performed in HiSeq v4 HO sequencer (Illumina) using Illumina Multiplexing 







2.7. Protein techniques 
2.7.1. Preparation of Whole cell protein extracts 
B. fragilis and E. coli strains were grown overnight in BHI-S or glucose-DM. Cells 
were pelleted by centrifugation at 16000xg for 5 min and re-suspended in 500 μl 3x 
SDS Sample Buffer (New England Biolabs, UK). Samples were stored at -20ᵒC. 
2.7.2. Preparation of Concentrated culture supernatants 
Concentrated supernatants were prepared based on a previously described method 
(Horstman and Kuehn, 2000) with modifications for B. fragilis. B. fragilis was 
grown overnight in BHI-S or glucose-DM (200-250 ml), were aseptically transferred 
to polypropylene containers and cells were harvested by centrifugation at 10000xg at 
4
o
C for 10 min using a Sorvall RC-5B Refrigerated Superspeed Centrifuge (Dupont 
Instruments). The supernatant was separated from the cell pellet and centrifuged for a 
further 15 min at 4
o
C. The supernatant was filtered using 0.45 µm low protein-
binding syringe filters (Millipore) following which the filtrate was aseptically 
transferred to 100 kDa Molecular Weight Cut-Off (MWCO) Centricon Plus-70 
centrifugal filters (Millipore), sealed using parafilm tape and concentrated following 
the manufacturer's instructions. Supernatant (~25 ml at a time) was concentrated at 
4
o
C by centrifugation at 3500xg for 15-40 min until 200 ml of culture supernatant 
were concentrated to ~2 ml volume. The concentrate was recovered by spinning the 
inverted concentrate cup at 1000xg for 2 min. 5µl of 3x SDS-PAGE sample buffer 
(New England Biolabs, UK) were added and mixed with 20 µl of each concentrated 
supernatant sample. Samples were stored at -20
o
C. 
2.7.3. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
Solutions 
10X Tris-glycine running buffer:  30g Tris base, 144g Glycine in 1l dH2O  
1X Tris-glycine running buffer (Working concentration): 100 ml 10X stock, 10 ml 







Separating gel buffer: 1.5 M Tris-HCl pH 8.8 
Stacking gel buffer: 0.5 M Tris-HCl pH 6.8 
12% Separating gel solution: 4.8 ml 30% acrylamide/BIS, 3 ml separating gel buffer, 
120 µl 10% SDS, 4 ml dH2O, 8 μl TEMED, 100 µl 10% APS 
5% Stacking gel solution: 1.5 ml 30% acrylamide/BIS, 2.25 ml stacking gel buffer, 
90 μl 10% SDS, 5 ml dH2O, 8 μl TEMED, 100 µl 10% APS 
Concentrated supernatants and other protein samples were analysed using SDS-
PAGE. Glass plates were cleaned with ethanol and dH2O, and assembled according 
to manufacturer’s instructions (Bio-Rad Mini Protean III). Gels measuring 
70x85x0.5mm and consisting of separating gel and stacking gel were electrophoresed 
in parallel for 60 min at 125V.  
2.7.4. Staining/Destaining of gels 
Solutions 
Staining solution:  25% Methanol, 10% Acetic acid, 64.9% ultrapure water, 0.1% 
w/v Coomassie brilliant blue R-250 
Destaining solution: 25% Methanol, 10% Acetic acid, 65% ultrapure water 
Gels were briefly rinsed in distilled water and stained for 2h at room temperature 
with gentle agitation in staining solution. After 2h, the protein gels were destained 
for 16h to 24h at room temperature with gentle agitation in 300 ml destaining 
solution. When clear bands were observed, the gel images were digitally saved using 
the Image Lab Software in a ChemiDoc instrument (Bio-Rad) following 
manufacturer's instructions. 
2.7.5. Zymography  
Solutions 
Fibrinogen solution (Stock): 2 mg/ml human fibrinogen (Sigma-Aldrich) was layered 
on top of 0.85% w/v NaCl and placed in 37
o







gentle agitation. The solution was then filtered through a 0.22 µm syringe filter 
(Millipore) and stored at 4
o
C. 
10% Separating gel solution: 3.333 ml 30% acrylamide/BIS, 2.5 ml separating gel 
buffer, 0.1 ml 10% SDS, 4.5 ml 2.0 mg/ml plasminogen-free human fibrinogen 
dissolved in ultra-pure water, 5µl TEMED, 50 µl 10%APS 
4% Stacking gel solution: 0.666 ml 30% acrylamide/BIS, 1.25ml stacking gel buffer, 
50 µl 10% SDS, 3 ml ultra-pure water,  2.5 µl TEMED, 50 µl 10% APS 
Serine protease activating buffer: 50 mM tris-HCl, 150 mM NaCl, 5 mM CaCl2 pH 
8.2 
Metalloprotease activating buffer: 50 mM tris-HCl, 200 mM NaCl, 5 mM CaCl2, 1 
µM ZnCl2, 0.02% Brij-35 pH 7.6 
Zymography was performed based on a previously described method (Houston et al., 
2010). Following SDS-PAGE using 10% Separating gel solution and 4% Stacking 
gel solution, the gels were washed to remove SDS which prevents proteases from 
renaturing and exerting their proteolytic activity on the copolymerised fibrinogen. 
Each zymogram was washed 2x15 min at room temperature with gentle agitation on 
a rocker (Model R100 Luckham) in 250 ml of 2.5% triton-X-100 dissolved in ultra 
pure water. The zymograms were then washed 2x15 min at room temperature with 
gentle agitation on  the rocker in 250 ml of 2.5% triton-X-100 dissolved in 50 mM 
tris-HCl (pH 7.5). Finally, washes were performed in 50 mM tris-HCl (pH 7.5) as 
described above.  
The washed gels were incubated in appropriate activation buffers for 48h at 37
o
C 
with gentle agitation on a rocker. 
2.7.6. Preparation of samples for Immunoblot analysis 
Appropriate concentrations of whole cell pellets, concentrated supernatants and 
purified protein were treated with 1X SDS sample buffer containing 0.1 M DTT. 







boiled for 10 min at 98
o
C. The treated samples were electrophoresed on a SDS 
PAGE, comprising 12% separating gel and 5% stacking gel for 60 min at 150V. 
2.7.7. Transfer of proteins by Wet Electroblotting 
Solutions 
1X Transfer buffer: 14.4 g Glycine, 3.02 g Tris base, 100 ml Methanol in 1 l dH2O 
1X Tris Buffered Saline-Tween 20 (TBS-T) buffer: 6.06 g Tris, 8.77 g NaCl, 500 µl 
Tween 20 in 1 l dH2O 
Blocking Buffer: 5% dried skimmed milk powder (Marvel) in TBS-T  
Polyvinylidene fluoride (PVDF) membrane was cut to the size of the SDS protein gel 
and wetted in methanol followed by soaking in cold transfer buffer. Fibrous pads and 
filter papers were also soaked in cold transfer buffer. The protein gel was then placed 
in the ‘transfer sandwich’ (filter paper-gel-membrane-filter paper), cushioned by 
fibrous pads and pressed together by a cassette. The gel and membrane were inserted 
into a transfer tank (Bio-Rad) filled with transfer buffer. The electroblotting was 
performed at 100V, 350A for 60 min. Ice packs were placed in the tank to mitigate 
the heat produced. After the transfer, the membrane was blocked overnight at 4
o
C in 
5% skimmed milk blocking buffer. 
2.7.8. Development of Western blots and Far-western blots 
The blocked membrane was washed 3x15 min in TBS-T. Far-western blotting was 
performed by incubating the washed membrane blot  in TBS-T containing 10 μg/ml 
fibrinogen or fibronectin (Sigma-Aldrich) at room temperature for an hour. The 
membrane was rinsed in TBS-T to remove the unbound fibrinogen. Protein 
incubation step in far-western blotting was followed by steps in western blotting 
wherein the membrane  was incubated in appropriate dilutions of primary antibody 
(1:10000/1:20000)  in blocking buffer for an hour on a rocker (Model R100 
Luckham). The primary antibodies used were Anti-Fibrinogen antibody produced in 







and Anti-1705 antibody produced in rabbit (Patrick Lab). The unbound primary 
antibody was rinsed off with TBS-T and the membrane was incubated for an hour in 
HRP-conjugated secondary antibody (1: 40000) for detection. Anti-Goat IgG (whole 
molecule)-Peroxidase antibody produced in rabbit and Anti-Rabbit IgG (whole 
molecule)-Peroxidase antibody produced in goat were the respective secondary 
antibodies used. Excess antibody was rinsed off and the membrane blot was treated 
with a 1:1 mix of detection reagent 1 and detection reagent 2 from Amersham 
Enhanced chemiluminescence (ECL) Prime Western Blotting Detection Reagent (GE 
Healthcare) in the developing room. Excess reagent was shaken off after 5 min. The 
membrane blot was wrapped in a plastic saran wrap and the air pockets were 
smoothed out carefully. Lights were switched off and an Amersham imaging 
hyperfilm ECL (GE Healthcare) was placed on top of the blot. The film was exposed 
for 1 min for initial detection,  and was developed in an X-Ray film developer. The 
exposure was repeated, varying the time for optimal detection of signals.  
2.7.9. Stripping Antibodies from Immunoblots 
Stripping Buffer: 1.5g Glycine, 1.24g Tris, 0.58g NaCl, 0.5g SDS, 1 ml Tween 20  in 
100 ml dH2O pH 2.2 
Antibodies were stripped off to facilitate reprobing of the PVDF membrane blots 
with a different set of antibodies. The membrane blots were removed from saran 
wrap and submerged in pure H2O. The blots were placed on a rocker for 15 min 
followed by washing in TBS-T for 2x15 min. TBS-T was then replaced with 
stripping buffer and placed on the rocker for 30 min at room temperature. Blots were 
washed in H2O for 3x5 min. Finally, H2O was replaced with blocking buffer and kept 
at 4
o
C without shaking for atleast 1h.  
2.7.10. Protein Expression 
Solutions 








The protease-encoding genes were expressed in E. coli BL21 cells using the 
Champion pET Directional TOPO Expression Kit (Invitrogen) as per the instructions 
outlined by the manufacturer. 
For BF1705 expression, a single colony of the E. coli strain transformed with 
pET15b recombinant vector carrying the BF1705 insert was inoculated into 1 ml of 
LB containing 50 µg/ml ampicillin, which was then immediately inoculated into 10 
ml of LB containing  ampicillin and incubated aerobically in a shaker at 37
o
C, 225 
rpm until the OD600 reached 0.8. Once the required growth was achieved, the whole 
10 ml of culture were inoculated into 1l of pre-warmed LB containing 50µg/ml 
ampicillin in a 2.5l capacity ful-baf Tunair shake flask capped with dri-gauze filter 
lining (Sigma-Aldrich). The large scale culture was incubated at 37
o
C and 230 rpm 
in an orbital incubator (Gallenkamp, England) until the OD600 reached between 0.9-
1.0. The culture was then cooled on ice to 15-18
o
C. 500 µl of 1M Isopropyl-β-D-
thiogalactoside (IPTG), giving a final concentration of 0.5mM, were added to the 
culture to induce expression of the recombinant protein. Protein induction and 
overexpression was performed between 15-18
o
C for 16h at 200 rpm in an orbital 
incubator (Gallenkamp, England). Recombinant protein expression was carried out at 
a low temperature in order to facilitate folding, solubilisation and to allow the host 
cells to direct most of their energy to recombinant protein expression. 10 ml of 
overnight growth were stored at -20
o
C for quality control analysis. The remaining 
990 ml of culture were harvested by centrifugation at 6000xg at 4
o
C for 20 min in a 
Sorvall RC-5B Refrigerated Superspeed Centrifuge (Dupont Instruments). The 
supernatant was discarded and the pellets were resuspended by vortexing in 35 ml of  
cold sterile filtered binding buffer. The cell suspension was then poured into four 50 
ml Falcon tubes and treated with 2 tablets of protease inhibitor cocktail (Sigma-
Aldrich) by mixing. The suspension was then flash frozen in dry ice layered with 
ethanol for 5-10 min and stored at -80
o








2.7.11. Protein Purification by Nickel Affinity Chromatography 
Solutions 
500 ml loading buffer: 1.56g NaH2PO4, 14.61g NaCl, 0.68g Imidazole, 1 ml PMSF 
(0.05 M PMSF dissolved in 99% ice-cold ethanol), 6 protease inhibitor tablets pH7.5  
100 ml elution buffer: 0.312g NaH2PO4, 2.92g NaCl, 3.4g Imidazole pH 7.4 
1l Gel filtration buffer: 0.271g NaH2PO4, 1.405g Na2HPO4, 8.0g NaCl, 0.8 ml DTT, 
0.292g EDTA, 100 ml Glycerol pH 7.4 
Frozen samples were thawed on ice and the cells were disrupted by passing the 
sample through a French press along with 35 ml cold sterile filtered loading buffer.   
The pressed samples were pelleted at 14000 rpm for 60 min at 4
o
C and the 
supernatant was filtered through 0.2 μm filters (Millipore). The filtered samples were 
stored on ice. 5 ml nickel solution were added to a ready-made Nickel-nitrilotriacetic 
acid (Ni-NTA) sepharose column (Qiagen) and equilibrated with 5X loading buffer 
(25 ml). The filtered sample was loaded onto the column and the flow-through was 
collected in a Falcon tube. The column was washed a second time with 25 ml loading 
buffer and the flow-through collected. Filtered elution buffer was added to the 
column and the flow-through was collected in 1.5 ml micro centrifuge tubes. After 
protein elution, the column was washed with loading buffer, sealed and stored in the 
refrigerator. 
Approximately 5 ml of the nickel-column purified sample was subjected to higher 
grade purification by gel-filtration column chromatography. Pre-packed Hi-Prep 
Sephacryl S-200 HR gel filtration column (GE Healthcare Life Sciences) of 120 ml 
volume (1.6 cm x 60 cm), with a separation range of 5 kDa-250 kDa was used to 
obtain purified BF1705 protein. Prior to chromatography the column was 
equilibrated with sterile filtered gel filtration buffer. The elutes from column 







2.7.12. Protein Estimation by Bradford assay 
The quantification of proteins was performed by Bradford assay (Bio-Rad). 
Standards (0-12 µg/ml) were prepared using Bovine Serum Albumin (BSA) (800 µl) 
and Bradford reagent (200 µl) to a final volume of 1 ml. The unknown samples  were  
prepared in 1:100 or 1:1000 dilution ratio and made up to 1 ml using Bradford 
reagent (Bio-Rad). The samples were mixed and left in the dark for 15 min. The OD 
was measured at 595 nm. Absorbance was plotted against concentration of the 
known BSA samples. The concentrations of unknown samples were calculated using 
the standard curve equation (Figure 2.1). 
 
 
Figure 2.1: BSA standard curve using the Bradford assay for protein estimation 
Readings at OD600 was obtained for 0-12 µg/ml BSA concentrations plotted in a log-based 









2.7.13. Immunofluorescence Microscopy (IFM) 
IFM experiments were performed based on a previously described method (Houston 
et al., 2010) with slight modification. B. fragilis NCTC 9343 was grown to late 
exponential phase (16h) in BHI-S broth. 10 ml of culture were then harvested by 
centrifugation at 1610xg for 25 min at room temperature. The cell pellet was washed 
3 x 20 min in autoclaved PBS by centrifugation at 1610xg at room temperature. The 
pellet was then resuspended in sterile PBS to OD600 0.3. 
2.7.13.1. Assay 1 (On-slide fibrinogen incubation) 
20 μl of resuspended cells (OD600 0.3) were pipetted onto 12 well Teflon poly-L-
lysine coated slides and air-dried at 37
o
C. Slides were then fixed in 100% methanol 
at -20
o
C for 20 min. The fixed slides were dried at room temperature and washed in 
sterile Phosphate-buffered saline (PBS) bath for 20 min. The fixed cells were 
incubated with 20 μl 1.0 mg/ml or 0.1 mg/ml fibrinogen for 12-14h. Excess 
fibrinogen was washed off by placing the cells in a PBS bath. Care was taken in the 
subsequent steps to prevent the slides from drying. To inhibit non-specific binding, 
slides were blocked by adding 10 μl 2% BSA-PBS to each well and incubating at 
room temperature for 15 min. BSA-PBS was aspirated and 20 μl of primary antibody 
(1:300/1:3000 dilution) were added to the slides and incubated in a humidified box at 
37
o
C for 1h. Anti-Fibrinogen antibody produced in goat (Sigma-Aldrich F8512) was 
the primary antibody used. Excess antibody was washed off using a PBS bath and the 
region in between the wells were wiped dry using a filter paper. The slides were then 
incubated with Fluorescein isothiocyanate (FITC)-conjugated secondary antibody to 
detect fluorescence (1:100 dilution). Anti-Goat IgG (whole molecule)-FITC antibody 
produced in rabbit was the secondary antibody used. Secondary antibody incubation 
was followed by PBS wash to remove excess antibody. The slides were mounted 
with glycerol-PBS and sealed with a cover slip using varnish. The sealed slides were 
then examined under a microscope in 100X oil emulsion and in fluorescence mode. 
Two sets of negative controls were used : Negative control 1 (No fibrinogen added): 







Negative control 2: 20 μl of 100 μg/ml plasminogen-free human fibrinogen in 
ultrapure water were applied to 12 well Teflon coated slide, dried for 3h and fixed.   
2.7.13.2. Assay 2 (Pre-incubation with fibrinogen in vitro) 
Resuspended cells (OD600 0.3) were incubated with 100 μg/ml and 1 mg/ml 
plasminogen-free human fibrinogen at 37
o
C for 2h and 12h with occasional agitation. 
Following incubation, excess fibrinogen was removed by washing the cells using 
centrifugation at 1610xg for 3x10 min in sterile PBS. 20 μl of resuspended cells were 




2.8.1. Quality control of RNA extracts 
The quality of the extracted RNA samples were analysed before and after rRNA 
depletion using RIN software (Agilent Technologies) at the Edinburgh Genomics 
Facility. 
2.8.2. RNA Sequencing data, Assembly and Annotation 
The quality of the read pair sequences obtained in the fastq format from the 
Edinburgh Genomics Facility were assessed using the FastQC tool ( FastQC 
v0.11.3). The adapter sequencers from the read pair files were trimmed using the 
cutadapt tool (cutadapt 1.8.1). Reads shorters than 20 nucleotides and longer than 50 
nucleotides were discarded. Total number of reads processed and the number of 
reads that passed the filters are shown in Table 2.3. The trimmed reads were aligned 
against the reference genome using Bowtie tool (Bowtie2-2.2.5). The parameters 
chosen for alignment were 'end-to-end' in the 'sensitive' mode. The aligned output 
from Bowtie was obtained in SAM format. The SAM files were converted to BAM 
format by running the Samtools (SAMtools-1.0). The Samtools command 'sort' was 
used to sort the alignment file by name and by position. Index command was used to 







browser. The aligned reads were counted to quantitate the genes using htseq-count 
(HTSeq-0.6.1). The information about the differentially expressed genes were 
obtained using deseq tool (DESeq2_1.6.1). The test type and dispersion method were 
set as 'Wald' and 'parametric', respectively. 
 
Table 2.3: List of read pairs after trimming the adapter sequences 
Trimming of the adapter sequences was performed using cutadapt tool. The table indicates 
the number of read pairs processed from each read pair input file, read1 and read2 with 
adapter, pairs that were too short and too long, and number of read pairs that passed the 
specified filters. 





















































18,321,211 897,982 1,033,971 65,964 0 18,255,
247 













































23,240,069 1,262,839 1,331,587 52,223 0 23,187,
846 








Chapter 3 Binding of Host Proteins by Bacteroides fragilis 
3.1. Introduction 
Completion of the human microbiome project in 2012 unveiled the plethora of 
microbes that thrive within the human body, occupying different habitats such as 
mouth, gut, skin and vagina. This vast microbiota is  subject to variation within and 
between individuals (Huttenhower et al., 2012). Microbes exist in a symbiotic 
relationship with the host, however, occasional breaches of which, resulting in 
unfavourable health conditions have been documented (Winkler et al., 1987). 
Bacteria constitute the majority of the microbial inhabitants, along with viruses and 
bacteriophages (Breitbart et al., 2003). The presence of smaller proportions of archae 
and eukarya has also been reported (Eckburg et al., 2003).  
Bacteria thrive in a wide range of microhabitats and metabolic niches in mucus layer 
lining the gut and mucosa, which require adherence to the mucus layer and deep 
penetrations into the crypt channels to withstand the rapid turnover of epithelial cells 
and fast rate of peristalsis. They must also be competent to overcome mechanical 
defence mechanisms operating at tissue surfaces (Smith 1995). Certain bacteria, such 
as those belonging to the genera Enterococcus, Bifidobacterium and Bacteroides can 
flourish in biofilms, wherein individual groups of bacteria form microcolonies or 
associate with other species and inhabit the mucosal layer and particulate surfaces in 
the gut lumen facilitating nutrient harvest and exchange (Macfarlane and Dillon, 
2007). Extracellular matrix (ECM) is a major structural component 
compartmentalising and safeguarding the epithelium, lining the various multicellular 
structures from the surrounding endothelial cells and connective tissue. Although the 
commensal microbiota adheres to the mucosal layer and ECM for effective 
colonisation, ECM adhesive mechanisms employed by pathogens are of major 
therapeutic interest. Such interactions have been studied extensively with respect to 
both endogenous opportunistic pathogens and exogenous pathogens seeking passage 







ECM adhesins  range from carbohydrate-protein interactions to  protein-protein  
bivalent soluble target proteins (Westerlund and Korhonen, 1993).  
This chapter deals with the ability of Bacteroides fragilis, an opportunistic pathogen 
associated with blood-related infections, to bind host fibrinogen, explained in terms 
of pathogenic microbial interactions with the ECM macromolecules observed in 
various bacteria. 
3.1.1. Structure of the Extracellular Matrix (ECM) 
Extracellular matrix, consisting of a basement membrane and an interstitial matrix, is 
an important structural component underlying epithelial cells, endothelial cells and 
surrounding connective tissue cells (Hay, 1991) (Figure 3.1). ECM is comprised of 
three major classes of macromolecules, namely proteoglycans, adhesive 
glycoproteins and fibres (Szöke et al., 1996). Resident cells secrete these molecules 
into the matrix via exocytosis and fill the interstitial space by forming an interlocking 
network which acts as a shock-absorber in the matrix. The basement membranes are 
sheet-like depositions of ECM present in close proximity to the epithelial cells 
(Figure 3.1). Although the composition of ECM varies between multi cellular 
structures, the common functions include segregating different cell types, providing 
tissue structure and elasticity and serving as a reservoir for growth factors by 
isolating and protecting them in the microenvironment. ECM also acts as a structural 
barrier, preventing the entry of invading pathogens into the endothelium and 
bloodstream. Components of the ECM engage in interactions with specific adhesion 
receptors on cell surfaces and promote multiple cell functions including adhesion, 












Figure 3.1: Schematic of the extracellular matrix 
Basement membrane and interstitial matrix are components of the extracellular matrix 
underlying the epithelial cells, endothelial cells and surrounding connective tissue cells. 
Collagen, laminin and proteoglycan that constitute the basement membrane, which is linked 
to the epithelium and endothelium via integrins are illustrated. The interstitial matrix is 
composed of fibrillar collagens, elastin, proteoglycan and hyaluronan. (www.studyblue.com, 
Rosalind Franklin University)  
 
ECM proteins exhibit functional motifs which recognise and adhere to specific cells 
and proteins. The adhesive glycoproteins also share the ability to form fibrils and aid 
in structural support. The major adhesive proteins in the ECM and basement 
membrane include: 
3.1.1.1. Fibronectin 
Fibronectin is a 440 kDa dimeric glycoprotein, consisting of repeating units of amino 
acids forming three domains, namely, type I, II and III present in 2 similar disulphide 
linked subunits, each of ~250 kDa in size. The domains enable fibronectin to interact 
with a variety of cells through both integrin and non integrin receptors. Alternative 
mRNA splicing of the type III domain leads to 20 isoforms of fibronectin in humans 
(Schwarzbauer, 1991). Formation of mature mRNA encoding fibronectin from pre 







variable amounts of alternative splice forms results in the presence of two types of 
fibronectin in vertebrates. These are, soluble plasma fibronectin, a component of 
blood plasma produced by hepatocytes, and insoluble cellular fibronectin, a major 
ECM component, secreted locally by fibroblasts as a soluble dimer and later 
immobilized into the matrix (Romberger, 1997). Assembling fibronectin into matrix 
fibrils requires the interaction of the former with activated integrin receptors on cell 
surfaces (Wu et al., 1995). Fibronectin contains discrete binding sites for 
extracellular molecules, such as fibrin, heparin and collagen (Joh et al., 1999). 
Migration of cells through the ECM is brought about by fibronectin mediated cellular 
connection with collagen fibers. At a site of tissue injury, fibronectin binds to 
platelets via integrins and facilitates cellular movement for wound healing (Pereira et 
al., 2002).  
3.1.1.2. Collagen 
Collagen is a fibrous protein accounting for 30% of total proteins in mammalian 
bodies (Watanabe, 2004) . Various types of collagen are secreted by connective 
tissue as well as other cell types and constitute a major structural component of skin 
and bone (Alberts et al., 2002; Watanabe, 2004). Collagens are long, stiff proteins 
formed by three α polypeptide chains helically wound around one another in a rope-
like superhelix (Alberts et al., 2002). Pro-α chains, precursors of individual collagen 
polypeptide chains are synthesised on membrane-bound ribosomes and injected into 
the lumen of endoplasmic reticulum (ER). Apart from the amino terminal signal 
peptide, pro-α chains also possess additional amino acids, called propeptides, at their 
N- and C- terminal ends. In the lumen, selected prolines and lysines undergo 
hydroxylation to form hydroxyproline and hydroxylysine, respectively, followed by 
glycosylation of specific hydroxyprolines. Each pro-α chain then combines with two 
others to form hydrogen-bonded, triple-stranded helical molecule known as 
procollagen. Post secretion, propeptides of fibrillary procollagen molecules are 
removed by specific extracellular proteolytic enzymes. Collagen molecules thus 







collagen molecules are composed of numerous repeats of a tripeptide unit, Gly-Pro-
X, where X is usually a post-translationally modified hydroxy-proline. High content 
of proline is a distinct feature of collagens (Watanabe, 2004). Glycine, which is the 
second most abundant amino acid residue in collagens, contributes to the tight 
structure of the protein. 20 types of collagen have been identified, which are formed 
from 25 distinct collagen α chains, each encoded by a separate gene. Connective 
tissue secretes types I, II, V and XI collagens, type I being the principle collagen 
present in skin and bone. Type I is the most common form of collagen and is a 
representative of fibril-forming collagens, which, after being secreted into the 
extracellular space, assemble into higher-order collagen fibrils (Figure 3.1). The 
fibrils then cluster into larger cable-like bundles known as collagen fibers. Collagen 
type IX and XII form the fibril-associated collagens, which constitute the surface of 
collagen fibrils and connect fibrils to one another and other ECM components. Type 
IV and VII are network-forming collagens. Type IV collagen forms a meshwork 
assembly in the basal laminae whereas type VII assemble into structures known as 
anchoring fibrils in the skin (Alberts et al., 2002) (Figure 3.1). 
3.1.1.3. Laminin 
Laminins are heterotrimeric glycoproteins of high molecular weight (~400 kDa), 
containing α, β and γ chains, and are found in the basal laminae where they intersect 
to form cross-like structures that bind to other ECM molecules, such as, type IV 
collagen (Figure 3.1). Laminins are large, multi-domain matrix glycoproteins 
occurring in 5, 4 or 3 genetic variants that are named according to the chain 
composition. 15 isoforms of laminin have been identified, with laminin-I being the 
classical laminin composed of 3 long polypeptide chains (α, β and γ) arranged in an 
asymmetric cross and held together by disulphide bonds. Several isoforms of each 
type of laminin chain can associate in different combinations to form large family of 
laminins. Like type IV collagen, laminins can self-assemble in vitro into felt-like 
sheet through interactions with laminin ends which might play a role in formation of 







cell adhesion and regulates cell behaviour by integrin interaction through several 
functional domains, which may help in organizing the assembly of basal lamina (De 
et al., 2006).  
3.1.1.4. Elastin 
Elastin is the major constituent of insoluble elastic fibers and are about 750 amino 
acids long (Alberts et al., 2002; Vrhovski and Weiss, 1998). Two major components 
that contribute to the complex structure of elastic fibers include an amorphous 
component, consisting of extensively cross linked elastin protein which makes up 
more than 90% of elastin fiber and a fibrillar component, composed of microfibrils 
rich in acidic glycoproteins and structured into 8 nm-16 nm fibrils of beaded 
appearance. Elastin is rich in non-glycosylated hydroxy-proline and glycine. Soluble 
tropoelastin, precursor of elastin, is secreted into extracellular space and assembled 
into insoluble elastic fibers near the plasma membrane (Figure 3.1). Crosslinking 
between lysine residues makes the mature elastin protein insoluble. 11 human 
tropoelastin splice variants have been identified with respect to 6 exons. The highly 
cross-linked mature elastin fibers provide elasticity and resilience to tissues which 
require ability to deform repetitively and reversibly. Tissues rich in elastin include 
aorta and major vascular vessels, lung, elastic ligaments, tendon and skin. Long, 
inelastic collagen fibres are interwoven with elastic fibers to restrict extent of 
stretching and prevent tissue tearing. 
3.1.1.5. Glycosaminoglycans 
Glycosaminoglycans (GAGs) are unbranched polysaccharide chains composed of 
repeating disaccharide units. One of the 2 sugars in repeating disaccharide is an 
amino sugar (N acetyl glucosamine/galactosamine), which is sulphated in most cases 
and a second uronic acid sugar (glucuronic/ iduronic). GAGs are highly negatively 
charged owing to the abundance of suphate or carboxyl groups on most of the sugars. 
GAGs can be classified into four main groups depending upon their sugars, type of 
linkage between sugars and the number and location of sulphate groups, namely 







keratan sulphate. The rigid nature of polysaccharide chains block them from being 
folded up into globular structures of polypeptide chains and promotes adoption of 
highly extended conformations occupying huge volume and forming gels at very low 
concentrations. Due to the high density of negative charges on GAGs, large amounts 
of water gets sucked into the matrix which creates a turgor pressure and helps to 
withstand compressive forces. GAGs contribute to less than 10% of the weight of 
fibrous proteins in connective tissue. However, they fill most of extracellular space 
by porous hydrated gel formation and provide mechanical support to the tissue. 
i. Hyaluronic acid 
Hyaluronan is the simplest GAG and are disaccharides consisting of up to 25000 
alternating residue repeats of D-glucuronic acid and non sulphated N-
acetylglucosamine. They are found in variable amounts in all adult tissues and fluids, 
but are abundant in early embryos. In hyaluronan, the disaccharide units are 
generally not covalently linked to a core protein. Hyaluronans are synthesised 
directly on cell surface by an enzyme complex embedded in plasma membrane. 
Functions of hyaluronan depend on specific interactions with other ECM molecules. 
They resist compressive forces in tissues and joints and act as space filler during 
embryonic development. Hyaluronan regulates wound healing and is present in joint 
fluid as a lubricant. 
ii. Proteoglycans 
Proteoglycans are GAG chains covalently linked to a core protein, which is 
synthesised on membrane-bound ribosomes and threaded into ER lumen. The 
assembly of polysaccharide chains on the core protein takes place in golgi apparatus 
and is initialised by a tetrasaccharide link on a serine side chain followed by 
glycosyltranferase mediated addition of sugars. Proteoglycans differ from 
glycoproteins on  the nature of sugar side chains. Atleast one of the sugar side chains 
in a proteoglycan has to be a GAG. Glycoproteins contain 1-60% carbohydrate by 







whereas proteoglycans contain 95% carbohydrate by weight composed mostly of 
long, unbranched GAG chains. The core proteins can vary greatly in the number and 
types of attached GAG chains. Thus, proteoglycans can be regarded as highly 
glycosylated glycoproteins whose functions are mediated by both core proteins and 
GAG chains that constitute them. Three proteoglycans present in vascular and 
epithelial basement membrane of mammalian organisms include perlecan, agrin and 
bamacan.  
Heparan sulphate is a linear polysaccharide present in all animal tissues and is 
closely related to heparin. It consists of variably sulphated repeating disaccharide 
units, the most common unit being glucuronic acid linked to N-acetylglucosamine 
which contributes to 50% of the total disaccharide units. In its proteoglycan form, 2-
3 heparan sulphate chains are attached in close proximity to ECM proteins and 
regulates biological activities such as developmental processes, angiogenesis, blood 
coagulation and tumour metastasis. Perlecan is a heparan sulphate proteoglycan 
present in basal lamina of kidney glomerulus and filters molecules passing into urine 
from bloodstream. Heparin sulphate chains also bind to fibroblast growth factors, 
stimulates cell proliferation and oligomerises growth factor molecules enabling them 
to cross link and activate cell-surface receptors. These  proteoglycans immobilise 
chemokines on endothelial surface of a blood vessel at inflammatory sites, thereby 
stimulating White Blood Cells (WBC) migration to injury sites. Syndecans are 
plasma membrane proteoglycans carrying up to three chondroitin sulphate and 
heparin sulphate GAG chains. They are located on the surface of many types of cells 
including fibroblasts and epithelial cells, and serve as receptors for matrix proteins. 
In fibroblasts, syndecans modulate integrin function by interacting with fibronectin 
on cell surface and with signalling and cytoskeletal proteins within the cell. 
Chondroitin sulphate chains provide the tensile strength to cartilage, tendons, 
ligaments, aorta walls and are also implicated in regulation of cell migration and 
pattern formation in developing peripheral nervous system (Iozzo, 1998). Bamacan is 
a chondroitin sulphate proteoglycan and is located in basement membrane of 







sulphate chains have a variable sulphate content and are present in cornea and bones. 
Aggrecan is a keratin sulphate proteoglycan, which is a major component of 
cartilaginous tissues (Iozzo, 1998). 
3.1.2. Microbial Surface Components Recognised by Adhesive Matrix Molecules 
(MSCRAMMs) in Bacteria 
Owing to their adhesive properties, the components of ECM act as major substrates 
for microbial attachment. Adherence to the ECM is facilitated by MSCRAMMs 
(Microbial Surface Components Recognised by Adhesive Matrix Molecules) present 
on the bacterial surface (Patti et al., 1994). For a component to be termed as an 
MSCRAMM, it has to be: 
i. Present on the bacterial surface 
ii. The microbial component must recognise a macromolecular component of the 
ECM 
iii. The recognition must be of high affinity and specificity without the interference 
of other molecules 
Binding of microbial cell surface receptors to adhesive glycoproteins of the ECM 
plays a dual role in host-microbial relationships. Adherence mechanisms of 
commensal bacteria enable members of the normal microbiota to transform into 
opportunistic pathogens in different parts of the human body (Nagy et al., 1994). 
Following tissue injury, the components of ECM get exposed on the epithelial 
surface which allows recoginition and adhesion by microbial components (Patti et 
al., 1994). Bacterial binding to plasma proteins like fibronectin mask the 
immunogenic epitopes and prevent recognition of bacteria by the host immune 
system (Dinkla et al., 2003). The bacterial colonisation of ECM might initiate 
translocation through endothelial tissue, invasion of adjacent tissues and eventually 
reaching the bloodstream, thus playing a major role in aetiology of infection 







bacteria can promote adhesion, invasion and evasion of host defences and 
antimicrobial agents (Patti et al., 1994). 
3.1.2.1. MSCRAMMs in Staphylococcal and Streptococcal groups 
Several MSCRAMMs involved in the recognition of the same matrix molecule have 
been studied in some bacterial species, such as, fibronectin binding to Fibronectin 
Binding Protein A (FnBPA) and Fibronectin Binding Protein B (FnBPB) proteins 
expressed by Staphylococcus aureus, the Gram-positive Firmicute inhabiting the skin 
and respiratory tract (Westerlund and Korhonen, 1993). The gene encoding the 200 
KDa FnBPA was the first gene of a bacterial ECM binding protein to be 
characterised  and fibronectin was the first ECM protein to be experimentally shown 
as a eukaryotic substrate for adhesion (Flock et al., 1987; Guan, 1990).  Sequence 
analysis revealed similarities in functional domains and fibronectin binding 
mechanisms adopted by proteins FnBPA and FnBPB of S. aureus, SfbI of S. 
pyogenes, FnBA and FnBB of S. dysgalactiae and FSE of S. equisimilis, respectively  
(Westerlund and Korhonen, 1993). Around a dozen fibronectin binding proteins have 
since been identified in the Staphylococcus and Streptococcus genera (Joh et al., 
1999). The C terminal regions of these MSCRAMMs encode tandem repeats of 35-
45 highly conserved amino acid residues such as, D1,D2 and D3 in FnBPA. In 
addition, an incomplete repeat D4 and a less conserved fifth Du unit, located next to 
the D1 unit are present in FnBPA. Each of these units bind individually to the 29 kDa 
N-termial region of fibronectin, which contains a string of five type I F1 modules (1 
F1- 5 F1). There are additional binding units that facilitate weak interactions with 
other parts of fibronectin like the UR sequence located upstream of the tandem 
repeats in fibronectin binding protein F1/SfbI of S. pyogenes. UR sequence binds to 
the 40kDa collagen binding region in fibronectin, which is adjacent to the 29 kDa N 
terminal binding region. The collagen binding region and the C terminal heparin 
binding region in fibronectin are also characterised by F1 module pairs. The 
unorganised residues of the bacterial MSCRAMMs attain conformational order only 







D3 subunit of S. aureus FnBPA undergoes extension upon binding to 4F1-5F1 
fibronectin modules (Penkett et al., 2000). Gunasekaran et al. (2003) have 
hypothesised that disordered proteins are able to form larger interfaces with the 
ligands when compared to stably folded proteins. FnBP-mediated fibronectin binding 
in Staphylococcal and Streptococcal groups might prove an example for this 
proposed mechanism.  
Bacterial uptake into non-phagocytic mammalian cells is promoted by fibronectin 
binding which enables S. aureus and S. pyogenes to invade host tissue, ‘hide’ from 
phagocytes and spread infection. Invasion is achieved via a molecular bridge 
between FnBPs on the bacterial surface and integrins on the host cell (Joh et al., 
1999). Internalisation of S. aureus into endothelial cells, osteoblasts, keratinocytes, 
mammary gland cells, corneal epithelial cells and skin fibroblasts has been observed 
(reviewed in Schwarz-Linek et al. 2004). Fibronectin binding integrins avβ3 and β1 
promoted invasion of cultured human epithelial cells by S. pyogenes mediated by F1 
fibronectin binding protein (Joh et al., 1999). α5β1 integrin has been implicated in 
FnBP mediated invasion of epithelial cells in S. aureus and S. pyogenes 
(Dziewanowska et al., 1999; Ozeri et al., 1998). The bridging mechanism might be 
mediated by FnBPA binding to heat shock protein Hsp60 which act as a co-receptor 
with β1 integrins linked through fibronectin, thus enhancing bacterial internalisation 
by epithelial cells (Dziewanowska et al., 2000).  
Binding of S.aureus to cartilage, rich in type II collagen, allowed the identification of 
a collagen binding protein which shares functional similarity with the fibronectin 
binding molecule. The addition of soluble plasma fibronectin promoted binding of 
S.suis to type IV collagen present in basement membranes (Esgleas et al., 2005). In a 
similar manner, SfbI protein, an allelic variant of F1 protein, of S. pyogenes interacts 
with collagen via surface bound fibronectin, thereby forming bacterial aggregates 
embedded in a fibronectin-collagen matrix. This interaction blocks 
Polymorphonuclear leukocyte (PMN) binding to Streptococci and protects the 







(Dinkla et al., 2003). Their role in infection has been shown by mutant strains which 
are less virulent than the wild-type. However, the Streptococcal Toxic Shock 
Syndrome (STSS) inducing GrpA Streptococci harbour a more virulent M1 protein 
that blocks phagocytosis (Macheboeuf et al., 2011).  
3.1.2.2. MSCRAMMs in other bacteria 
Although fibronectin binding has been studied extensively in Staphylococcal  and 
Streptococcal species, it has been found in other microbes like Mycobacterial spp. 
and E. coli. Three distinct classes of fibronectin binding proteins have been identified 
in Mycobacterial spp. : i) BCG 85, an antigen complex, comprising 3 closely related 
components of 30-31 kDa molecular mass, secreted by Mycobacterium bovis that 
binds to soluble fibronectin (Westerlund and Korhonen, 1993). ii) a 55-60 kDa 
fibronectin binding protein (Abou-Zeid et al., 1988). iii) a 120 kDa β1 integrin on the 
surface of M. avium and M. intracellulare that adhere immobilised fibronectin, 
laminin and type I collagen, and cross-react with polyclonal antibodies against 
human-laminin binding integrin α3β1 and human-fibronectin binding antibody α5β1 
(Rao et al., 1992). Enterobacterial fimbrae has also been implicated in ECM 
adherence. E. coli fimbriae bind fibronectin and also adhere to fibroblasts via 
fibronectin. Fimbrial adhesion is mediated by protein subunits present at the tip of 
these structures. P fimbriae binds to immobilised fibronectin and sequence analysis 
has detected similarity to fibronectin binding repeats of Staphylococcal and 
Streptococcal MSCRAMMs (Joh et al., 1999). Type I and S fimbriae in E. coli, 
associated with meningitis, bind to oligosaccharides of laminin and promote 
proteolytic penetration through the basement membrane into the circulatory system 
(Westerlund and Korhonen, 1993). 
3.1.2.3. Fibrinogen Binding 
In addition to fibronectin binding, S. aureus FnBPA has also been implicated in 
fibrinogen binding via the N terminal A region of the MSCRAMM (Wann et al., 
2000). Fibrinogen is an essential clotting plasma glycoprotein of 340 kDa, secreted 







pairs of  Aα-, Bβ- and ϒ-chains in a symmetrical, dimeric arrangement. Platelet 
adherence at injury sites is mediated by this clotting protein via α11bβ3 platelet 
integrin interaction, during which the fibrinogen concentration in blood increases two 
fold (Herrick et al., 1999). This glycoprotein is incorporated into the extracellular 
matrix fibrils during active fibronectin polymer elongation. Fibrinogen deposition 
alters ECM topology and provides a surface for cell migration and matrix 
remodelling during tissue repair (Pereira et al., 2002). Fibrinogen undergoes α 
thrombin proteolytic cleavage, with the release of fibrinopeptides A and B from the 
amino termini of the Aα- and Bβ-chains, respectively to form insoluble fibrin, which 
is a major component in blood clots. FnBPA binding has been localised to the C 
terminal ϒ region in fibrinogen, a domain which is also recognised by ClfA 
(clumping factor A) protein of S. aureus that binds fibrinogen. The surface adhesin 
FnBPA of S. aureus mediates  fibrinogen and fibronectin binding which is required 
for enhancing the infection in an experimental model of endocarditis. Attachment 
and internalisation into eukaryotic cells is mediated by fibronectin binding, however, 
fibrinogen binding accelerates these processes to enable valve colonisation and 
disease induction (Piroth et al., 2008). The N terminal A region of FnBPA shares 
~46% amino acid identity to the minimum region for fibrinogen binding in ClfA and 
thus competes with ClfA for fibrinogen binding. However, the recombinant protein, 
Clf40, containing the fibrinogen binding region of ClfA was a more potent inhibitor 
of ClfA-mediated binding to immobilised fibrinogen than its counterpart, rFnBPA, 
derived from  FnBPA. Clf40 also inhibited ClfA-mediated bacterial cell clumping 
more efficiently than rFnBPA(Figure 3.2) (Wann et al., 2000). ClfA-mediated 
bacterial adherence to fibrinogen promoted platelet activation which is regarded as 
an important virulence factor in the aetiology of infective endocarditis. Platelet 
activation required the binding of IgG molecules to the A domain in ClfA 








Figure 3.2: Structural organization of FnBps and ClfA of Staphylococcus aureus 
S, signal sequence; A, a unique N terminal region is known to bind fibrinogen in ClfA; Du-
D4, Fn-binding repeat units; R, serine-aspartate repeat region; W, wall-spanning region; M, 
membrane-spanning region. The LPXTG motifs that anchor the proteins to the cell wall 
peptidoglycan are indicated. The recombinant proteins (with N terminal His tags) and the 
amino acid residues (in parantheses) contained in each construct are indicated. (Wann et al., 
2000) 
 
Interactions of Streptococcus spp. with fibrinogen is of pathogenic interest and has 
been studied in great detail. The M1 protein expressed by GrpA Streptococci plays a 
role in the resistance of phagocytic killing  in blood through the interaction with D 
fragments of fibrinogen, generated by plasmin degradation of the fibrin matrix. M1 
organises the D fragments of four fibrinogen molecules into a cross-like pattern, 
which is essential for neutrophil activation, that induces sepsis and circulatory failure 
(Macheboeuf et al., 2011). Fibrinogen binding has also been proposed as a 
mechanism to evade complement- mediated extracellular host defenses in tularaemia 







replicate in host cells, including phagocytes, with the eventual microbial release 
causing flu-like symptoms. F. tularensis binds plasminogen on its surface, which is 
converted into plasmin and interacts with fibrinogen. The bound fibrinogen appears 
to recruit host factor H which inhibits formation of C3 convertase enzyme and serves 
as a co-factor for complement inhibitory host factor I binding which subsequently 
mediates the cleavage of C3b into inhibitory C3bi and C3d. These subunits prevent  
Membrane Attack Complex (MAC)-mediated membrane lysis and promote 
opsonophagocytosis by binding to the CR3 receptor on the surface of phagocytes. 
Ingestion by phagocytes promotes effective subversion of host defenses by the 
bacterium and facilitates replication in a non-optimal manner (Jones et al., 2012).  
3.1.3. MSCRAMMs expressed in Intestinal Microbiota 
The gastrointestinal tract of a healthy mammalian body harbours a wide range of 
microorganisms, which benefit the host in terms of nutrient utilisation and 
immunomodulation (Sonnenburg et al. 2004). The estimated density is  ̴ 10
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microbes per ml of luminal contents in the distal gut, belonging to 500-1000 diverse 
species (Savage, 1977; Xu and Gordon, 2003). The epithelium lining the human 
intestine is highly dynamic in structure  owing to the constant motion of semi-
digested food by peristalsis and of excretory materials for cleansing purposes (Joh et 
al., 1999; Sonnenburg et al., 2004). These processes lead to a large number of  
epithelial cells being shed every hour, in the colon and small intestine, respectively 
(Xu and Gordon, 2003). Therefore, the gut colonizers must develop strong 
interactions with the layers of the intestinal epithelium to ensure their survival in the 
intestine (Patti et al., 1994). It has been shown that B. fragilis can specifically bind to 
mucin present in the mucosa, a viscous layer separating epithelial cells from the gut 
lumen and preventing pathogenic infections (Huang et al., 2011). This interaction 
might be achieved through the expression of phase variable SusC/SusD protein 
homologues that binds starch present in the mucin glycoprotein (Nakayama-Imaohji 
et al., 2009). Such physical interactions help the bacteria in long-term gut 







2011). MSCRAMMs expressed on the surfaces of commensal members of intestinal 
microbiota aid in proper colon colonisation as seen in B. vulgatus binding to 
fibronectin. However, MSCRAMMs have also been associated with the spread of 
opportunistic infections in Yersinia spp. and B. fragilis via ECM adherence. 
3.1.3.1. ECM binding in Yersinia spp.  
A single MSCRAMM can be implicated in the binding of several ECM ligands as 
seen in the Gram-negative intestinal pathogenic bacterium Yersinia enterocolitica. 
This bacterium expresses YadA protein that binds to collagen (types I,III,IV and V), 
laminin and immobilised cellular fibronectin, with the highest affinity for collagen 
binding, conferring a multi-adhering nature to the protein. YadA is a 200-240 kDa 
protein expressed by the yadA gene located in a 70 kb virulence plasmid. In addition 
to epithelial cell adhesion, YadA might play a role in attaching the bacterium to the 
surface of phagocytes for the efficient delivery of anti phagocytic effector Yop 
proteins into these cells. Human serum resistance which is a common attribute of 
many pathogens is also mediated by YadA in Y. entericolitica. YadA binds host 
serum factor H which leads to reduced deposition of C3b and C9, components of the 
complement system on the bacterium, thereby evading the cell-killing membrane 
attack complex (El Tahir and Skurnik, 2001). 
3.1.3.2. Surface adhesins of B. fragilis 
The environmental conditions defining the microhabitat in which a bacterium resides 
has an influence on the bacterium's surface adhesins that mediate binding to ECM 
components. In vitro experiments, such as agglutination assays, immuno blotting and 
affinity column chromatography suggest that binding of B. fragilis to ECM proteins, 
laminin and fibronectin, was more intense in cultures grown under oxidising 
conditions compared to those grown under reducing conditions (Ferreira et al., 2008; 
Pauer et al., 2009). There was also an increase in general protein expression when 
OMP electrophoretic profiles from the two conditions were compared. These 
observed differences in laminin and fibronectin binding, coupled with the fact that B. 







infections and soft tissue abscesses, provide valuable insight into the conditions that 
facilitate the shift of B.fragilis from an intestinal commensal to an opportunistic 
pathogen in vivo. Lesions, injury and other factors that disrupt the tissue integrity 
lead to an oxidising environment near the intestinal epithelium. In this oxidised 
condition, an increase in expression of ECM binding proteins  by B. fragilis might 
promote the dissemination of infection (Ferreira et al., 2008; Pauer et al., 2009). In 
1993, Goldner et al.  demonstrated the ability of B. fragilis to penetrate into HeLa 
cells at high redox levels, whereas lower redox levels did not support tissue cell 
invasion. Therefore outer membrane surface adhesins pose as essential virulence 
factors in B. fragilis. Moreover, proteases, capsular polysaccharide complex, 
fimbriae, enterotoxin, neuraminidases and hemolysins play additional roles in 
pathogenesis (Guzmán et al., 1990; Hofstad, 1992; Myers et al., 1984; Robertson et 
al., 2006). 
The majority of B. fragilis strains screened were able to bind laminin I, independent 
of integrin (De et al., 2006). Affinity column chromatography conducted on cultures 
grown in both reduced and oxidised media identified a laminin I binding outer 
membrane protein of 60 kDa, most probably a member of the glycoprotein family 
(Ferreira et al., 2008). Sequence analysis identified  98% identity to a putative 
plasminogen binding protein. It was shown experimentally that the laminin binding 
protein was also able to bind to the circulating precursor, plasminogen, and convert it 
to active serine protease, plasmin, via the tissue type plasminogen activator. The 
inherent function of this protease is to solubilise fibrin present in blood clots but has 
also been implicated in ECM protein degradation in many pathogens expressing 
plasminogen receptors (Ferreira et al., 2009). Owing to this host-dependent 
proteolytic ability inherent to B. fragilis, the bacterium is able to induce tissue injury 
and also activate other matrix degrading  proteolytic enzymes. As laminin is found in 
close association with collagen in the basement membrane, the plasmin degrades 
fibrin, collagen and other tissue components resulting in the destruction of ECM 
basement membrane barrier (Ferreira et al., 2013). Collagen binding was observed in 







associated with a 34 kDa glycosylated Collagen Binding Protein (CbpI),  but 
glycosylation was not a prerequisite for binding. Adhesion to collagen type I was 
detected by the protein encoded by BF0586 in B. fragilis NCTC 9343. Analogue of 
BF0586 is also present in YCH46 and 638R B. fragilis. The study also indicated that 
more than one surface component contributes to collagen binding since no marked 
difference was observed between the collagen binding ability of whole cells of wild-
type and cbpI
-
 mutant strain (Galvão et al., 2014). 
Since the early 1990s, non-covalent fibronectin binding via the N terminal domain of 
fibronectin has been identified in clinical samples of B. fragilis isolated from healthy 
individuals and from wounds. Fibronectin binding is mostly accompanied by binding 
to vitronectin, another ECM glycoprotein in this bacterium (Nagy et al., 1994). 
Among the strains studied, B. fragilis 1405 which was isolated from a bacteraemia 
case exhibited the greatest difference when plasmatic fibronectin adherence levels 
were compared between strains grown under oxidising and reducing conditions. 
Electrophoretic profiles of protein expression were higher under oxidising conditions 
and increased binding to fibronectin was detected under these conditions. Western 
blot analysis demonstrated a 102 kDa fibronectin binding protein encoded by the 
bf1991 gene which was identified as a TonB-dependent outer membrane protein and 
was detected in all the strains studied. In E. coli, TonB functions as an energy 
transducer that couples proton motive force for active transport of iron siderophores 
across the outer membrane. The bulk of the TonB protein extends into the periplasm. 
Therefore, in B. fragilis this protein might play a role in the transport of tightly 
bound ligands into the periplasmic space, which might suggest host interaction 
(Pauer et al., 2009). However, the TonB-dependent protein was not distributed 
uniformly on the cell surface and a mutant harbouring an inactivated bf1991 
exhibited increased adhesion to fibronectin. These findings suggest that there are 
other fibronectin binding proteins encoded by the B. fragilis genome. Nonetheless, 
the TonB-dependent protein plays a major role in pathogenesis as the mutant strain 
was phagocytosed more readily by peritoneal macrophages than the wild-type (Pauer 







Once the epithelium of the intestine is breached and B. fragilis escapes into the 
peritoneal cavity, the bacterium is confronted by the peritoneal macrophages, which 
are the first line of host immunological defence mechanisms. Macrophages present 
antigens and secrete cytokines such as TNF-α and IL-1. Microbicidal function is 
promoted by activated macrophages through the production of cytotoxic radicals, one 
of them being IFN-ϒ-mediated Inducible Nitric Oxide Synthase (iNOS) expression, 
which is co-localised with the microfilamental network of macrophages. Interaction 
with B. fragilis results in macrophage membrane rupture which render the cytoplasm 
of macrophages disorganised and granulated owing to cytoplasmic extrusions 
through pore-like structures in the membrane (Vieira et al., 2005). These events 
culminate in a necrosis-like condition in the macrophages (Vieira et al., 2009). 
Significant decrease in nitric oxide production was observed as the actin filament 
guided iNOS outside the cell via the pores formed, thus enabling B. fragilis cells to 
evade macrophage killing and persist in the peritoneal cavity.  
Capsule PS A of B. fragilis promotes formation of intra abdominal abscess which 
helps in the containment of polymicrobial infections, such as peritonitis, caused by B. 
fragilis along with other opportunistic pathogens residing in the intestinal cavity. 
Abscess formation is a host-mediated mechanism to isolate bacteria, leucocytes, 
tissue debris and inflammatory exudates in fibrin-mediated abscess walls to prevent 
the dissemination of infection (Tally and Ho, 1987). To invade neighbouring tissues 
and spread blood related infections, it is essential to escape the fibrin mediated 
abscess walls. Also, fibrinogen, the soluble form of fibrin, is incorporated into the 
ECM by active deposition of fibronectin and many pathogens are capable of 
fibrinogen interactions for better chances of survival in the host. Studies by Houston 
et al. (2010) have suggested that B. fragilis is able to bind and degrade fibrinogen. 
This interaction can be regarded as a mechanism by which the bacterium inhibits the 
formation, or rupture, of abscesses and enhances the spread of infection. Fibrinogen 
adhesion is brought about by Bacteroides fragilis Fibrinogen Binding Protein (BF-
FBP), a putative surface protein, encoded by BF1705 in NCTC 9343 (Houston et al., 







Tannerella forsythia, a periodontitis causing oral pathogen in humans, which binds to 
fibrinogen and fibronectin (Houston et al., 2010). It is an important virulence factor 
which helps during epithelial cell invasion and specific antibodies against BspA have 
been detected in adult patients suffering from periodontitis (Sharma et al., 1998).  
Following escape from abscesses, B. fragilis needs to combat the MAC-mediated 
bactericidal activity of the serum and neutrophil-mediated opsonophagocytosis and 
cause bacteraemia. Rotimi & Eke (1984) observed that some B. fragilis isolates 
possess an increased ability to inhibit killing by normal human serum and serum 
from infected patients when compared to other members of the Bacteroides genus. 
Resistance to phagocytic uptake and killing by neutrophils in bacterial concentrations 
comparable to those in naturally occurring in vivo in abscesses, was also observed in 
B. fragilis studies conducted by Ingham et al., (1981). In polymicrobial abscesses, 
the obligate anaerobe competed with facultative anaerobes like E. coli for opsonins 
in a synergistic manner, thereby impairing opsonophagocytosis and intracellular 
killing. Succinate, the end product of B. fragilis fermentative metabolism, has been 
implicated in preventing neutrophil migration and killing activity in conditions 
mimicking the extracellular environment (Rotstein et al., 1987). The antigenically 
distinct and phase variable capsular polysaccharide surface of B. fragilis has been 
studied extensively with regard to its role in evasion of neutrophil-mediated as well 
as serum killing (Kasper, 1976; Onderdonk et al., 1977; Reid and Patrick, 1984; 
Simon et al., 1982). Examination of fibrinogen binding to the surface of B. fragilis 
for a potential role in preventing complement mediated bactericidal activity by a 











 To investigate the role of BF1705 protein, present in the B. fragilis NCTC 
9343 genome, in fibrinogen binding by expression and reverse genetics 
 To examine the possible role of capsular polysaccharides in fibrinogen 
binding by markerless gene deletion and Immunofluorescence Microscopy 
studies 
 To determine binding of fibrinogen by whole protein extracts and protein 
extracts from the outermembrane of B. fragilis wild-type and deletion 
mutants in immunoblots 
 To test a possible involvement of the ΔBF1705 in degradation of fibrinogen 









Figure 3.3: Electron micrograph of B. fragilis NCTC 9343 
The location of BF1705, a putative surface protein associated with fibrinogen binding, is 
indicated (tram line A). The electron dense layer (EDL and tram line B) is observed on the 
surface of some cells (1.2.1). BF1708 protein contributes to the assembly of high molecular 
mass polysaccharides into a long-chain-length polymer, thereby involving in the production 
of EDL and is discussed later in this chapter (3.7). BF1705 and BF1708 proteins are likely to 
be associated with the outer membrane based on bioinformatics analysis. (Patrick et al., 
1986)  
 
3.2. Choice of bacterial strains  
All experiments were conducted using the non enterotoxin-producing B. fragilis 
(NTBF) national collection of type cultures (NCTC) 9343 strain, which was 
originally isolated from a human peritoneal abscess at St Bartholomew’s Hospital, 
London, UK in 1955 (Culture collection, Public Health England). The complete 







involving genetic manipulation of the bacterium amenable (Cerdeño-Tárraga et al., 
2005). NCTC 9343 comprises a single circular chromosome of 5,205,140 bp, 
predicted to encode 4274 genes, and a plasmid pBF9343. Shotgun assembly of the 
genome revealed that specific inversions of sequences occurred at high frequency 
within the DNA extracted from bacterial population used for sequencing (Cerdeño-
Tárraga et al., 2005). These invertible regions can be grouped into two depending on 
the inverted repeat sequences that flank them. Identified invertible regions contain a 
consensus promoter, which suggests  they control the expression of downstream 
genes. Seven of the group I invertible promoters have been associated with 7 of the 
10 polysaccharide biosynthesis gene clusters. Thus, expression of within-strain phase 
and antigenic variation of capsular polysaccharide surface components, which is a 
characteristic feature of B. fragilis, is controlled by upstream invertible regions.  
Apart from NCTC 9343, diversity in polysaccharide loci has also been identified in 
the published complete genome sequences of two other non toxigenic strains, 
YCH46, a blood culture isolate from Japan and 638R, a plasmid-free spontaneous 
rifampicin- resistant clinical isolate from Chicago, USA (Kuwahara et al., 2004; 
Patrick et al., 2010). This demonstrates the diversity of the B. fragilis pan-genome. In 
addition to promoter sequences, B. fragilis harbours intergenic shufflons that are 
involved in the inversion of complete and partial coding sequences. Therefore, DNA 
inversion events mediated by B. fragilis  play an important role in controlling the 
expression of surface and secreted components, regulatory molecules and restriction-
modification proteins in the bacterium. Recently, Nikitina et al. (2015) have 
published the complete genome sequence of an enterotoxigenic B. fragilis (ETBF) 
clinical isolate, BOB25, from a stool sample of a dysbiosis patient. A pathogenicity 
island identified within a conjugative transposon is a unique feature of this ETBF 
strain which was not present in previously published sequences of NTBF strains and 








3.3. Generation of Markerless deletions in Bacteroides fragilis NCTC 9343 
genome 
Reverse genetics was employed to analyse the interaction of specific proteins 
encoded by the bacterium with components of the host. Construction of gene deletion 
mutants provides an effective way to characterise gene functionally. However, 
restriction/modification (R/M) systems that recognise and cleave foreign invading 
bacteriophage DNA can also destroy DNA introduced by techniques such as 
electroporation, thereby posing a barrier to genetic manipulation of many bacteria, 
including B. fragilis. One of the  intergenic shufflons present in B. fragilis NCTC 
9343 generates eight different HsdS proteins that provide DNA target specificity for 
a type I R/M system. Two further type I and two type III R/M systems are also 
present in NCTC 9343 genome. The ability to transform 638R explains why this 
strain has mostly been involved in the production of mutations in B. fragilis in the 
past. The B. fragilis 638R genome specifies two type I, one type IIS and one type III 
R/M systems. In addition to the classical R/M systems, NCTC 9343 encodes proteins 
sharing homology with the type IV restriction endonuclease McrBC, which cleaves 
specific DNA sequences modified with 5-methylcytosine (Patrick et al., 2010). The 
absence of these genes in 638R might aid in the effective transformation of 638R 
strain using Dcm methyltransferase-modified DNA from E. coli K12. To make 
deletions, Coyne et al. (2003); Coyne et al. (2008)  developed a method that depends 
on integration of an altered sequence into the NCTC 9343 chromosome followed by 
screening for spontaneous resolution of the diploid to yield the desired product. This 
technique is not only time consuming, but also fails to generate the required mutant if 
the diploid is stable. Alternatively, trimethoprim resistance has been utilised for 
enriching resolved diploids by introducing a chromosomal thyA mutation into B. 
fragilis which is complemented with a functional copy of thyA in a suicide plasmid 
(Baughn and Malamy, 2002). This method leads to a thyA mutation in all resulting 
strains due to the mutation in the primary engineered B. fragilis strain, which might 







thyA mutants when not supplied with exogenous thymine (Begg and Donachie, 
1978). 
The present study adopts a modification of a reliable method developed by Patrick et 
al. (2009) for generating deletion mutants in B. fragilis NCTC 9343. The method was 
originally developed for mutational analysis of genes involved in B. fragilis LPS and 
capsular polysaccharide biosynthesis. Furthermore, these non-polar gene deletions 
can be complemented, which is important for confirming phenotypes in B. fragilis 
genetic studies. In the polysaccharide studies conducted by Patrick et al. (2009), the 
mutants generated were marked with an erythromycin resistance determinant, 
whereas the present work relies on generation of markerless gene deletions. To 
generate deletions, approximately 500 bp of  nucleotides, flanking (upstream and 
downstream regions) the sequence to be deleted, were amplified by polymerase chain 
reactions. Markerless deletion constructs were prepared by fusing the amplified 
flanks using cross-over PCR. The amplicon was cloned into the multiple cloning site 
of an RP4-based conjugative vector, pGB910, which contains an ISce-I 
meganuclease recognition sequence. Recombinant pGB910 vector carrying the 
markerless deletion constructs were then recovered in E. coli S17-1 λpir. E. coli 
transformants positive for the recombinant vector were selected for chloramphenicol 
resistance and the presence of deletion constructs were confirmed by PCR.  The 
deletion constructs were mobilized from E. coli S17-1 λpir to B. fragilis NCTC 9343 
(Figure 3.4 A). Transconjugants were grown in the presence of erythromycin to 
select for the integrated recombinant pGB910 plasmid. Diploids were resolved by 
transforming strains, carrying the plasmid integrant, with pGB920 that expresses the 
I-SceI meganuclease under the control of the B. fragilis fucR promoter, with 
selection for tetracycline resistance (Figure 3.4 B). Selected transformants were 
grown on defined medium containing fucose, which induces an ISce-I mediated 
double-strand break (Figure 3.4 C), resulting in the resolution of diploid by 
homologous recombination into either wild-type (Figure 3.4 E) or deletion genotype 
(Figure 3.4 D). Colonies were then screened for loss of resistance to erythromycin 







fragilis to many antibiotics restricts the number of selection markers that can be 
employed for genetic studies in this bacterium. An advantage  of  markerless gene 
deletions over marked deletions is that they can be complemented using plasmids 
bearing the same antibiotic resistance determinant as the one used for integrant 









Figure 3.4: Schematic of the generation of markerless chromosomal deletions in B. 
fragilis 
(A) A suicide plasmid, containing an I-SceI recognition site (blue box) and sequences 
homologous to chromosomal DNA (X and Z), replacing the gene to be deleted (Y), are 
introduced into B. fragilis by conjugation. Plasmid integrants are selected for resistance to 
erythromycin. (B) Diploids are transformed with a plasmid expressing I-SceI under the 
control of the fucose-inducible promoter PfucR. (C) Growth on defined medium in the 
presence of fucose leads to an I-SceI-mediated double strand break ( ) and resolution of the 
diploid to generate either the deletion (D) or wild-type (E) genotypes by homologous 
recombination. Chromosomal DNA is indicated as dashed blue lines and plasmid DNA is 









3.4. Fibrinogen binding studies previously conducted in B. fragilis 
The present study aims to apply reverse genetics by generation of markerless 
BF1705 gene deletion mutants to confirm the fibrinogen binding function of BF1705 
protein and also attempts to identify other cell surface components involved in host 
fibrinogen associations. Interaction of B. fragilis cells with human fibrinogen, a 
major clotting protein, via one or more cell surface components, was initially 
identified by Houston et al. (2010) using IFM studies. Subsequent sequence analysis 
revealed an  ̴  57 kDa cell surface  protein encoded by BF1705 as a putative 
fibrinogen binding protein (Table 3.1). The BF1705 protein contains a signal 
sequence and a membrane lipoprotein lipid attachment site. Leucine-rich repeats 
(LRRs) present in the protein sequence suggested probable protein-protein 
interactions. NCBI protein BLAST analysis predicted an E value of 1.1 e-17 with 
32.8% sequence identity in 295 aa to the LRR-containing surface antigen BspA of 
Tannerella forsythia, a periodontal disease causing bacterium, which binds human 
fibrinogen. Binding of purified BF1705 protein to fibrinogen was observed in a dose-
dependent manner in dot blots, while far-western analysis identified strong 
interaction of BF1705 protein with Bβ-chain and weakly with Aα- and ϒ-chains of 
fibrinogen (Houston et al., 2010). However, the possible involvement of other cell 
surface components in fibrinogen binding detected by IFM studies, was not 
investigated in the previous study. Also, the analysis of BF1705 regulation under 
nitrogen limiting conditions would reveal a potential role of the protein encoded by 
BF1705 in nutrient binding, thereby facilitating nitrogen replenishment through 








Table 3.1: Description of BF1705 using artemis genome browser (Carver et al., 2008)  
The protein sequence (520 aa) shared 32.8% identity in 295 aa to BspA, an outer membrane 
surface protein  of Tannerella forsythia with an E value of 1.1 e-17. 
 
 
3.5. Generation of a markerless  deletion of  BF1705 encoding a putative 
fibrinogen-binding protein in B. fragilis 
3.5.1. Primer design for amplifying the upstream and downstream regions of  
BF1705 gene 
A primer set, comprising four individual primers (LOF, LIR, RIF and ROR), was 
designed to amplify the region flanking BF1705 using the Artemis genome browser 
(2.3). Artemis  provides a  graphic interpretation of the gene arrangement of the 
NCTC 9343 genome along with nucleotide and amino-acid sequences, which 
facilitated primer design (Carver et al., 2008). The left outside forward (LOF) and 
left inside reverse (LIR) primers were designed to amplify ~500 bp upstream of the 
BF1705 gene whereas the right inside forward (RIF) primer and right outside reverse 
(ROR) primers were generated to amplify the region flanking the sequence 
downstream (Figure 3.5). Primer sequences were in the range of 20-24 bases in 
length and care was taken to avoid poly T sequences and GC rich areas. The melting 
temperature (Tm) values of the primer sequences were restricted to 60-66
o
C. Primers 
designed for the outside region of flanks (left outside and right outside primers) were 
attached with ~15 bp overlap from the vector sequence in order to ensure 
compatibility while cloning. In a similar manner, the left inside and right inside 
primers were prefixed with reverse complements of primer sequences from each 









Figure 3.5: Graphic representation of BF1705 and the flanking regions  
BF1705 (red box) with left outside (LOF) and left inside (LIR) primers designed for 
amplifying the upstream region (denoted in blue) and right inside (RIF) and right outside 
(ROF) primers designed for amplifying the downstream region (denoted in green). 
 
3.5.2. Generation of the BF1705 deletion construct 
To generate the deletion construct, the left upstream and right downstream regions of 
BF1705 gene were amplified following appropriate PCR conditions (2.5.3) using 
specific primers (2.3) and NCTC 9343 genomic DNA template (2.5.1). The 
amplified left and right flanks of BF1705 were visualised after electrophoresis 
through 1% agarose gels and were detected at ~500 bp and ~550 bp in size (Figure 
3.6 A lane 1 and Figure 3.6 B lane 1). The observed amplicons were in agreement 
with expected sizes of 533 bp and 563 bp, respectively. The amplified flanks were 
then subjected to fusion PCR using left outside forward primer and right outside 
reverse primer to fuse together the left and right flanking regions and generate a 1096 
bp deletion construct. Agarose gel analysis of the fusion PCR product confirmed a 
band at ~1000 bp (Figure 3.6 C lane 1). 
  































































































































































































































































































































































































































3.5.3. Cloning the BF1705 deletion construct into pGB910 
The deletion amplicon was cloned into a NotI restriction site in the multiple cloning 
site (MCS) region of linearised pGB910 by Infusion cloning, a ligation independent 
cloning method (Clonetech; 2.5.8). The Infusion enzymes fuse DNA fragments or 
PCR generated sequences with linearised vectors, efficiently and precisely by 
recognising a 15 bp overlap at their ends. The infusion cloning reaction was 
performed by incubating the BF1705 deletion construct (flanked by a 15 bp vector 
sequence), linearised vector and the infusion enzymes (2.5.8). Plasmid pGB910 is a 
5305 bp RP4-based conjugative vector (Patrick et al., 2009) (Figure 3.7) generated 
by inserting an ermF cassette in the KpnI site of pGB909, a pEP185.2 derivative 
containing an I-SceI meganuclease recognition sequence inserted at the SacI site. 
pGB910 also harbours cat, a chloramphenicol resistance marker inserted at the 
EcoRI site. Resistance to chloramphenicol is required for selection of transformants 
in E. coli. ermF allows selection of B. fragilis transconjugants carrying the plasmid 
integrant and also allows screening of recombinants that lost the plasmid derived 
ermF post resolution. pGB910 plasmid is maintained in an E.coli S17-1 λpir strain. 
In the present study, the vector was linearised by digesting with NotI restriction 








Figure 3.7: Vector map of pGB910 
pGB910 was constructed by Blakely lab for bacterial conjugation experiments. Size of the 
vector is 5305 bp. ermF is inserted in the KpnI site. The vector contains multiple BamHI, 












Figure 3.8: Restriction profiling of pGB910 for cloning experiments 
The supercoiled pGB910 (lane 1) was linearised using NotI restriction enzyme . Arrows and 
numbers on the left side indicate size of DNA in kilo bases (kb) in a 1kb DNA ladder (M). 
The linearised pGB 910 (lane 2) was of  ̴ 5000 bp in size which is in agreement with the 
expected size of pGB910 mentioned in the graphic representation.   
 
The infusion cloning mixture was used to transform E.coli S17-1 λpir (2.4.3) with 
selection for chloramphenicol resistance. The E. coli S17-1  strain contains the pir 
gene, a replication intiator for plasmid R6K (Rakowski and Filutowicz, 2013). The 
S17-1 strain has chromosomally integrated RP4-based conjugal transfer functions. 
Chloramphenicol resistant colonies carrying the recombinant pGB910 vector were 
confirmed by PCR amplification of the deletion construct. Amplified bands 
corresponding to ~1000 bp on an agarose gel (Figure 3.9 lane 1 and 2) confirmed the 
presence of the BF1705 deletion construct in the recombinant vector. Sanger-based 
sequencing of the recombinant vector was also performed to check for the presence 










Figure 3.9: Confirmation of the BF1705 deletion construct in the recombinant vector 
Amplification was performed using LOF and ROR primers. Arrows and numbers on the left 
side indicate size of DNA in kb in a 1kb DNA marker (M) . The BF1705 deletion construct 
was of  ̴ 1000 bp in size (lane 1 and 2) and is in agreement with the expected size of 1096 bp 
indicated in the graphic representation. 
 
3.5.4. Conjugal transfer of the ΔBF1705 construct into B. fragilis NCTC 9343  
The recombinant vector carrying the ΔBF1705 construct was mobilized from E. coli 
S17-1 λpir  into B. fragilis NCTC 9343 by conjugation (2.4.5). The transfer was 
originally based on a filter mating method developed by Valentine et al. (1988) for 
mobilisation of Bacteroides plasmids by Bacteroides conjugal elements. Post 
conjugation, the strains were plated onto BHI-S agar containing gentamicin sulphate, 
to counter-select  E. coli, and erythromycin, to select B. fragilis transconjugants 
carrying the recombinant pGB910 vector. The plated cells were grown anaerobically 
for 2 days prior to confirming the presence of integrated plasmids in the 
erythromycin resistant colonies by PCR using left and right outside primers. 







partial diploid state and therefore PCR amplification with left outside forward and 
right outside reverse primers resulted in amplicons corresponding to the size of the 
deletion construct (1096 bp) as well as the combined size of the wild-type gene and 
the flanking region (2535 bp) as observed on 1% agarose gels (Figure 3.10 lane 2). 
The partial diploids carrying the integrated plasmids were thus generated 
successfully.  
 





























































































































































































































































































































































































































































































































































































































































3.5.5. Resolution of partial diploid B. fragilis strains carrying the deletion 
construct 
The partial diploid strains were transformed by electroporation with pGB920 (2.4.4). 
The I-SceI expressing pGB920 plasmid was generated from pLYL01 (Figure 3.11) 
and consists of an I-SceI coding region under the control of the B. fragilis fucR 
promoter with selection for resistance to tetracycline. Tetracycline resistant colonies 
were selected and streaked on defined medium containing 2% fucose, which 
triggered an I-SceI mediated double-strand break. Thus, diploids were resolved by 
homologous recombination into either wild-type or deletion genotypes. Colonies 
grown on fucose were patched onto plain BHI-S medium and BHI-S medium 
containing erythromycin to screen for loss of erythromycin resistance. Chromosomal 
DNA from the erythromycin sensitive colonies (2.5.1) were subjected to PCR 
amplification using left outside and right outside primers to confirm the presence of 
deletion constructs  at  ̴ 1000 bp (Figure 3.12 lanes 1 and 4). However, the diploids 
that resolved into wild-type resulted in bands corresponding to the size of the wild-
type gene along with flanking regions of ~2500 bp (Figure 3.12 lanes 5 and 7). The 
expected size of the wild-type gene + flanks is 2534 bp which is in agreement with 
the observed bands. 
I-SceI mediated break enhances the resolution of diploids. Therefore most 
transformants were resolved into either mutant or wild-type thus eliminating the need 
to repeatedly subculture diploid strains  and screen large number of colonies for 








Figure 3.11: Vector map of pGB920 
pGB920 was constructed by Blakely lab for I-SceI expression. Expression is controlled by a 
promoter derived from the fucose operon and is regulated by FucR. tetQ is the tetracycline 
selection marker. pGB920 is used for diploid resolution initiated by fucose induced I-SceI  
double-strandbreak. 























































































































































































































































































































































































































































































































3.6. IFM analysis of fibrinogen binding by the ΔBF1705 strain  
Binding of fibrinogen by wild-type NCTC 9343 cells and ΔBF1705 cells was 
examined by IFM. IFM slides were prepared by incubating cells fixed on glass slides 
with 0.1 mg/ml fibrinogen for 12 h followed by washing and labelling with               
1
o 
antibody, anti-fibrinogen produced in goat and anti-goat FITC conjugated 
                 
2
o
 antibody to detect fluorescence of fibrinogen bound cells (2.7.13.1). The prepared 
slides were viewed using microscope in phase contrast and fluorescence mode. 
Fluorescence was observed in wild-type as well as ΔBF1705 cells. Adherence of 
fibrinogen to wild-type cells as indicated by fluorescence (Figure 3.13 B), agreed 
with the results of IFM studies conducted by Patrick et al. (2009), where fibrinogen 
binding by wild-type cells had attained saturation levels within a 2h exposure. 
ΔBF1705 cells exhibited a similar adhesion pattern as observed in the wild-type 
(Figure 3.13 D). Bright regions of fluorescence which lit up the cell outline was 
observed against a dark background. However, no fluorescence was detected in E. 
coli Top10 cells, which was used as a negative control (Figure 3.13 F). Background 
fluorescence was observed in E. coli Top10-immobilised slides, in spite of  blocking 
the free binding sites on slides and cells with bovine serum albumin-phosphate-
buffered saline (BSA-PBS) blocking agent to prevent non-specific binding. Further, 
2x10 minute washes in PBS were also performed after each antibody incubation to 
wash away unbound antibodies. There has been no evidence that E. coli cells of the 
K12 genotype bind fibrinogen, and hence the choice of the same as negative control. 
This supports the specificity of the observed fibrinogen binding to B. fragilis wild-
type and mutant cells. IFM results suggest that the fibrinogen-binding ability of       
B. fragilis is retained even in the absence of BF1705, an identified fibrinogen-
binding protein. 









Figure 3.13: Immunofluorescence microscopy analysis of wild-type and ΔBF1705 cells 
incubated with fibrinogen 
(A) Diluted wild-type NCTC 9343 cells incubated with 0.1 mg/ml fibrinogen for 12 h in 
phase contrast mode and (B) fluorescence mode. (C) Diluted ΔBF1705 cells incubated with 
0.1 mg/ml fibrinogen for 12h in phase contrast mode and (D) fluorescence mode. (E) Diluted 
E.coli Top10 cells (negative control) incubated with 0.1 mg/ml fibrinogen for 12h in phase 
contrast mode and (F) fluorescence mode. Fluorescence observed in (B) and (D) indicates 







3.7. Investigating the role of capsular polysaccharides in fibrinogen binding 
The observation that ΔBF1705 could still bind fibrinogen suggested that other 
surface components were capable of binding fibrinogen. A distinct feature of the B. 
fragilis surface is the expression of antigenically distinct large, small and micro-
capsule polysaccharides (Lutton et al., 1991). The micro-capsule polysaccharides 
(electron-dense layer) have  been implicated in colonization of the intestinal tract and 
in complement-mediated resistance by B. fragilis (Coyne et al., 2008; Reid and 
Patrick, 1984) (Figure 3.3). Sequence homology identified ten regions (PS A-J) in 
the B. fragilis genome annotated for capsular polysaccharide production, out of 
which eight are related to the production of phase variable micro-capsules (Cerdeño-
Tárraga et al., 2005; Patrick et al., 2003). Patrick et al. (2009) observed that a marked 
deletion of BF1708 prevented assembly of  High Molecular Mass Polysaccharides 
(HMMPs) into a long-chain-length polymer, thereby blocking micro-capsule 
production (Figure 3.3). BF1708 has been identified as a chain-length determining 
protein of ~41 kDa in B. fragilis and shared 20% identity to E. coli WzzB, a member 
of the polysaccharide copolymerase1 class that modulates the polymerase activity of 
the Wzy proteins involved in LPS biosynthesis to produce a distinctive modal 
distribution of O-antigen chain lengths (Franco et al., 1998). BF1708 also shares  ̴ 
25% identity in 183 aa to Thermoanaerobacter tengcongensis capsular 
polysaccharide biosynthesis with an e value of 0.00032  (Table 3.2). The sequence 
homology of BF1708 to Wzz coupled with the inability of ΔBF1708 to produce 
micro-capsule layers confirmed the role of BF1708 in polysaccharide 
copolymerisation. Since micro-capsule expression has been associated with host 
attachment, colonisation and evasion of immune responses, the potential role of B. 
fragilis capsular polysaccharide in interacting with fibrinogen was examined using a 
ΔBF1708 deletion mutant. 
3.7.1. Generation of a markerless double deletion of  BF1705 and BF1708  
For the generation of ΔBF1705ΔBF1708, a markerless gene deletion construct for 







maintained in E. coli S17-1 λpir strain. The BF1708 deletion construct was mobilised 
from E.coli into the ΔBF1705 B. fragilis strain by conjugation (2.4.5). Erythromycin 
resistant transconjugants were selected and then electroporated with pGB920 
followed by streaking tetracycline resistant colonies on fucose-containing defined 
medium. The resolved diploids were screened for the loss of erythromycin resistance 
and the ΔBF1705ΔBF1708 double mutants were confirmed by PCR using primers 
specific for BF1705 deletion construct and BF1708 deletion construct (Figure 3.14 
lane 1 and 2). PCR-amplified products were of ~1000 bp in size which were in 
agreement with the expected sizes of deletion constructs for BF1705 and BF1708. 
3.7.2. IFM analysis of fibrinogen binding in ΔBF1705ΔBF1708 cells 
The role of micro-capsule polysaccharide as a fibrinogen-binding surface component 
was examined in the absence of BF1705. IFM slides were prepared by incubating 
ΔBF1705ΔBF1708 double mutant cells, fixed on glass slides using 100% methanol, 
with 0.1 mg/ml fibrinogen for 12h followed by washing and incubation in anti-
fibrinogen 1
o
 antibody and anti-goat FITC conjugated 2
o 
antibody to detect 
fluorescence of fibrinogen bound cells (2.7.13.1). The prepared slides were viewed 
using microscope in phase contrast and fluorescence mode. Clumping was observed 
in the ΔBF1705ΔBF1708 cells in phase contrast mode (Figure 3.15 A) when 
compared to the cell distribution pattern in wild-type 9343 and ΔBF1705 IFM slides 
(Figure 3.15 D and F). In addition to clumping, flocculation of double mutant cells 
were also observed in liquid culture medium. These distinct phenotypic features 
could be attributed to the altered cell-surface properties brought about by BF1708 
deletion (Patrick et al., 2009). However, the ΔBF1705ΔBF1708 cells still bound 
fibrinogen as indicated from the fluorescence observed (Figure 3.15 C). Binding of 
fibrinogen was also detected in the positive control, wild-type 9343 cells, and 
ΔBF1705 cells (Figure 3.15 E and G). Binding of fibrinogen by the 
ΔBF1705ΔBF1708 cells indicates that B. fragilis can interact with fibrinogen in the 
absence of both BF1705 fibrinogen-binding protein and micro-capsule 







might enhance the accessibility of other surface components involved in fibrinogen 
interaction as observed in the non-capsulated strain of S. aureus which facilitated 
fibrinogen interaction with bound coagulase to prevent phagocytic uptake (Kapral, 
1966). 
 
Table 3.2: Description of BF1708 using artemis genome browser 
BF1708 is a chain-length determining protein in B. fragilis with sequence homology to 
Thermoanaerobacter tengcongensis capsular polysaccharide biosynthesis  (E value of 
0.00032 and 25.13% identity in 183 aa), present in NCTC 9343 genome, using artemis 
genome browser.  
 

























































































































































































































































































































































































































































































































































Figure 3.15: Immunofluorescence microscopy analysis of wild-type and 
ΔBF1705ΔBF1708 cells incubated with fibrinogen 
(A) ΔBF1705ΔBF1708 cells incubated with 0.1mg/ml fibrinogen for 12 h in phase contrast 
mode. Clumping of cells can be observed. (B) ΔBF1705ΔBF1708 cells incubated with 
0.1mg/ml fibrinogen for 12 h in phase contrast mode and (C) fluorescence mode. (D) Wild-
type 9343 cells incubated with 0.1mg/ml fibrinogen for 12 h in phase contrast mode and (E) 
fluorescence mode. (F) ΔBF1705 cells incubated with 0.1mg/ml fibrinogen for 12 h in phase 
contrast mode and (G) fluorescence mode. Fluorescence observed in (C), (E) and (G) 
indicate fibrinogen binding by the cells. 
 
3.8. Expression and Purification of the BF1705 protein 
Studies by Houston et al. (2010) have confirmed the ability of purified BF1705 
protein to bind fibrinogen. Binding of fibrinogen by biotinylated his-tagged 
recombinant BF1705 was demonstrated using dot-blots and far-western-analysis. For 
expression, the mature BF1705 coding sequence (signal sequence and lipoprotein 
lipid attachment sites truncated) was amplified from B. fragilis NCTC 9343 genome 
and ligated into the MCS region of the pET-15b N terminal 6xHis-tag expression 
vector (Novagen). The expression vector was used to transform E. coli BL21(DE3) 
cells and the resultant clone was confirmed by DNA sequencing. The expression 
construct obtained from this work was used for BF1705 protein expression and 
purification in the present study. The purpose of purification was to use BF1705 as a 
positive control to detect fibrinogen binding in the subsequent blot analyses 
involving wild-type and ΔBF1705 concentrated cell-free supernatant extracts. 
3.8.1. Transformation of E. coli BL21 cells with the pET-15b expressing BF1705 
Recombinant pET-15b, carrying the BF1705 expression construct (gifted by Prof. 
Sheila Patrick, Queen’s University, Belfast, UK), was recovered in E. coli BL21 
(2.4.3). The resulting ampicillin resistant transformants were checked for the 
presence of recombinant pET15b by single colony analysis, restriction digestion 
analysis on 1% agarose gels  and Sanger-based sequencing. Single colony analysis 
was performed by incubating the amplicillin resistant transformants in appropriate 







the vector-backbone, due to the presence of BF1705 expression construct, on agarose 
gels (Figure 3.16 A). The presence of the expression construct in the isolated 
recombinant vectors were further confirmed by gel electrophoresis of extracted 
plasmids in comparison to the empty pET-15b vector backbone. Backbone and 
recombinant vectors were digested with ApaI enzyme and the linearised plasmids 
were checked for size by electrophoresis. A size difference corresponding to ~1.5 kb 
confirming the presence of BF1705 construct was observed in pET15b recombinant 
vectors (Figure 3.16 B lanes 1-4). Recombinant plasmids were subjected to Sanger-
based sequencing and analysed by nucleotide BLAST. Two stretches of matches 
with 94% and 96% sequence identity confirmed the presence of BF1705 expression 









Figure 3.16: Confirmation of the recombinant vector carrying the BF1705 expression 
construct  
(A) Agarose gel analysis of single colony assay showing the recombinant vector in 
supercoiled form (lanes 1 and 2) (B) Agarose gel analysis of Apa1 digests of recombinant 
vector (lanes 2-4) in comparison with the vector backbone (lane 1). A shift in the size of 
recombinant pET-15b can be observed when compared to vector backbone (5708 bp). 
Arrows and numbers on the left side indicate size of DNA in kb (M). pET-15b backbone and 











3.8.2. BF1705 protein expression 
Expression of the BF1705 protein was brought about by growing ampicillin resistant 
BL21 derivatives carrying BF1705 expression construct in LB followed by induction 
at appropriate cell density using 0.5mM IPTG (2.7.10). Whole cell extracts were 
electrophoresed on 12% SDS- polyacrylamide gels and the induced BF1705 sample 
was compared with the uninduced sample. The expression band of the mature protein 
was confirmed at ~54 kDa, since the signal peptide sequence was eliminated while 
designing the expression construct (Figure 3.17 lanes 1,3,5).  
3.8.3. Protein purification 
A volume of 1l culture of BL21 derivative carrying BF1705 expression construct 
was induced with IPTG for 16h at 17
o
C in a 200 rpm shaker. 250 ml of the culture, 
expressing the BF1705 protein was centrifuged, and the pellet was resuspended in 
appropriate buffer and treated with protease inhibitor cocktail to prevent protein 
degradation (2.7.10). Cell pellet containing the crude protein extract was mixed with 
35 ml loading buffer and passed through a french pressure cell press, in order to 
disrupt the cell membrane and recover the expressed protein. The sample was 
centrifuged and the supernatant containing the expressed protein was filter-sterilised. 
Primary protein purification was performed on 5 ml Ni-NTA agarose column that 
was washed 5 times with loading buffer (2.7.11). Samples were loaded and collected, 
followed by a column-wash and finally, elution buffer was loaded to the column to 
recover the his-tagged protein from the nickel column in 1ml aliquots. The loaded, 
washed and eluted samples were checked on SDS gels along with the induced culture 
and partially purified protein was identified in the eluted sample (Figure 3.18 A lanes 
4-9 and B lanes 7,8,9).  ̴ 5 ml volume aliquots of partially purified BF1705 protein 
sample corresponding to high-concentration bands in the SDS gel (Figure 3.18 A 
lanes 4-7) were subjected to gel-filtration column chromatography. Pre-packed gel 
filtration columns (Hi-Prep Sephacryl S-200 HR) of 120 ml volume (1.6 cm x 60 
cm), with a separation range of 5 kDa-250 kDa was used to obtain purified BF1705 







buffer) at a maximum back pressure of 0.15 MPa and recovery flow rate of 0.5 
ml/min. The protein samples were examined on SDS PAGE and highly concentrated 
single bands were observed at the expected size of ~54kDa which corresponded to a 
single intensity peak in the UV280 absorbance graph (Figure 3.19 A, B and C). Since 
the purified sample was of high concentration, fractions corresponding to 1D1, 1D3 
and 1D4 in the absorbance graph (Figure 3.19 C) were electrophoresed on SDS gel 
(Figure 3.19 A lane 3,2 and B lane 1) and concentrations were determined  as 0.38 
mg/ml, 0.42 mg/ml and 0.4 mg/ml, respectively by nanodrop. These three individual 
fractions from the purified protein sample were of optimal concentrations and were 









Figure 3.17: Expression of BF1705 in E. coli  
SDS-PAGE analysis of IPTG-induced E. coli BL21 cells expressing the BF 1705 protein 
(lanes 1,3,5) at ̴ 54 kDa in comparison with uninduced cultures (lanes 2,4,6). The positions 
of molecular weight markers (M) in kDa are shown adjacent to the gel. 
 
Figure 3.18: Purification of BF1705 by nickel column chromatography  
SDS-PAGE analysis of (A) load buffer (lane 1), wash buffer (lane 2), induced culture (lane 
3) eluted his-tagged BF1705 protein (lanes 4-9) and (B) uninduced culture (lane 1), eluted 
his-tagged BF1705 protein (lanes 2-9). The positions of molecular weight markers (M) in 
kDa are shown adjacent to the gel. The purified BF1705 protein was observed in the eluted 










Figure 3.19: Purification of BF1705 by gel filtration column chromatography 
SDS-PAGE analysis of gel filtration column purified fractions of BF1705 protein. Highly 
purified concentrated fractions were observed in (A) (lanes 1-4) and (B) (lane 1, lanes 2-5). 
The positions of molecular weight markers (M) in kDa are shown adjacent to the gel. (C) 
Graphical representation of UV absorbance at 280 nm vs fraction of the purified BF1705 
protein. Fractions 1D1-1D8, corresponding to the peak in the graph were highly concentrated 
as observed in (A) 1D1 (lane 1) 1D2 (lane 2) 1D3 (lane 3) and (B) 1D4 (lane 1) 1D5 (lane 2) 
1D6 (lane 3) 1D7 (lane 4) and 1D8 (lane 5). Fractions 1D1 (0.38 mg/ml), 1D3 (0.4 mg/ml) 







3.9. Analysis of fibrinogen binding by B. fragilis concentrated culture 
supernatants in Immunoblots 
Binding of fibrinogen by wild-type 9343, ΔBF1705 and ΔBF1705ΔBF1708 whole 
cells had been previously observed by IFM (3.7.2). Western blot experiments were 
designed to further analyse the IFM results by determining the sizes of individual 
surface proteins of wild-type and mutant cells involved in fibrinogen interaction. 
Concentrated culture supernatants and whole cell fractions of wild-type and mutant 
strains were electrophoresed on SDS-gels and transferred onto PVDF membranes by 
wet blotting (2.7.3 and 2.7.7). Immunoblots on PVDF membrane was blocked using 
dried skimmed-milk to prevent non-specific binding. The blocked membranes were 
incubated in appropriate concentrations of fibrinogen protein and antibody solutions. 
Fibrinogen binding to fractionated proteins blotted on the PVDF membrane was 
detected as signals on X ray films by chemical luminescence of the blots. 
3.9.1. Choice of sample preparation methods for Immunoblot analyses 
BF1705 has been identified as a protein expressed on the surface of B. fragilis. 
Interaction with the host is facilitated by the outer membrane and OMVs secreted by 
bacteria. Therefore, preparation of samples in a manner that emphasises the outer 
membrane of the cell would be effective in detecting fibrinogen binding by BF1705 
and potentially, by other surface proteins. Cell-free culture supernatants of stationary 
phase cultures of ΔBF1705 and  wild-type 9343 strains grown in glucose DM 
medium were concentrated using 100 kDa MWCO centrifugal filters (2.7.2). The 
concentrated supernatants of ΔBF1705 and wild-type 9343 stationary phase cultures 
were analysed on SDS-polyacrylamide gels (Figure 3.20 lane 1 and 3) along with 
BF1705 uninduced, induced cultures of E. coli BL21 (Figure 3.20 lane 4 and 5) and 
purified BF1705 protein (Figure 3.20 lane 6) to confirm protein size and 
concentration before commencing western blot analyses of the samples. 
Concentrated culture supernatants provide a representation of the outer membrane of 
the cell with respect to secreted proteins, enzymes, OMVs and surface associated 







and previous studies have emphasized their role in processes such as intercellular 
communication, transfer of contents to host cells and eliciting immune responses 
(Kulkarni and Jagannadham, 2014). Therefore, concentrated supernatants were the 
preferred choice for analysing interactions of fibrinogen protein with the cell surface 
of B. fragilis. Concentration of purified protein and culture supernatants were 
determined by Bradford protein assay (2.7.12). 
 
 
Figure 3.20: Analysis of concentrated culture supernatants and BF1705  
SDS-PAGE analysis of concentrated culture supernatants of ΔBF1705 (lane 1), ΔBF1705 
ΔBF1708 (lane 2; will be discussed later), wild-type 9343(lane 3), uninduced and induced 
culture for BF1705 expression (lane 4 and 5), purified BF1705 protein (lane 6). The 
positions of molecular weight markers (M) in kDa are shown adjacent to the gel. A band at  ̴ 








3.9.2. Detection of BF1705 protein in concentrated supernatant samples 
Identification of the BF1705 protein in concentrated wild-type 9343 supernatant 
samples would provide an indication of the presence of surface proteins in the 
prepared concentrated culture supernatants. Wild-type 9343 and ΔBF1705 strains, 
and dilutions of purified BF1705 protein were analysed by incubating the PVDF 
membrane blots of the electrophoresed samples (Figure 3.21 A) with 1
o
 antibody, 
polyclonal anti-1705 produced in rabbit and anti rabbit hrp-conjugated 2
o 
antibody   
(2.7.7 and 2.7.8).Visualisation of PVDF blots on X-ray film at two different exposure 
times revealed a single band at ~54 kDa for concentrated wild-type 9343 supernatant 
(Figure 3.21 B lane 3 and C lane 3) whereas no bands were observed for the 
ΔBF1705 concentrated supernatant. High intensity signals were detected for the 
positive control, BF1705 protein samples, even at a low concentration of 0.4 µg and 
0.06 µg of the protein (Figure 3.21 B lane 1, 4 and C lane 1, 4) which confirms 
specificity of the protein to the antibody. The banding patterns of BF1705 at its 
expected size in the  concentrated wild-type 9343 supernatant suggest the presence of 
the protein in OMV released by B. fragilis. Absence of bands in concentrated 













Figure 3.21: Detection of BF1705 in concentrated culture supernatants 
(A) SDS-PAGE analysis of  diluted BF1705 purified protein (0.4 µg) (lane 1), concentrated 
culture supernatants of ΔBF1705 (35 μg) (lane 2) and wild-type 9343 (35 μg) (lane 3) and 
diluted BF1705 protein (0.06 µg) (lane 4). (B) and (C) Immunoblots of the corresponding 
samples using anti-1705 antibody for (A) 2s and (B) 10s exposure. The positions of 
molecular weight markers (M) in kDa are shown adjacent to the gel. A band was observed 
at  ̴ 54 kDa in immunoblots of BF1705 protein (B) (lane 1, 4) and (C) (lane 1, 4) and of wild-








3.9.3. Far-western analysis of fibrinogen binding in ΔBF1705 
Further investigation of the binding results obtained from IFM (3.6) was done using 
far-westen blots to analyse fibrinogen binding by concentrated cell supernatants and 
the positive control, BF1705 protein. PVDF membrane blots were blocked in dried, 
semi-skimmed milk to prevent non-specific binding and incubated in 10 µg/ml 
fibrinogen solution. Fibrinogen binding to the blotted samples was detected by 
incubation with 1
o 
antibody, anti-fibrinogen produced in goat and anti goat hrp-
conjugated 2
o
antibody (2.7.7). Visual analysis of PVDF blots on X-ray films (2.7.8) 
revealed multiple bands at ~54 kDa and ~57 kDa for 1x and 2x dTT treated  
concentrated wild-type 9343 supernatants (Figure 3.22 B lane 1 and 2). Bands were 
not present in concentrated culture supernatants of ΔBF1705 (Figure 3.22 B lane 3). 
Also, fibrinogen binding was not observed in the purified BF1705 protein at a 
concentration of  ̴ 2 µg (Figure 3.22 B lane 4). However, a band corresponding to 
~54 kDa was observed in purified BF1705 protein of ~5 μg (Figure 3.23 B lane 1, 
Figure 3.24 B lane 3 and C lane 3). Multiple bands were still observed for 9343 
concentrated supernatants on replicate analyses (Figure 3.23 B lane 3 and Figure 
3.24 B lane 4). Fibrinogen binding was not detected in concentrated ΔBF1705 
supernatant as no bands were observed (Figure 3.23 B lane 5 and Figure 3.24 B lane 
6). E. coli Top10 whole protein extract was used as a negative control which did not 
show any binding (Figure 3.23 B lane 4 and Figure 3.24 B lane 5). Top10 strain is 
derived from E. coli K12 and no fibrinogen binding has been reported in this strain. 
The inability to bind fibrinogen by Top10 cells has also been observed in IFM 
conducted in the present study. On increasing the exposure time of X-ray film to 5 
min, faint bands were observed at the expected size for diluted samples of BF1705 
protein (Figure 3.24 C lane 1 and 2). The far-western analysis of purified protein 
confirm fibrinogen binding to BF1705 at high concentrations of the surface protein 
(> 4 μg) (Figure 3.23 B lane 1 and Figure 3.24 B lane 3). This indicates that 
fibrinogen binding by BF1705 protein is concentration-dependent and is facilitated 
only at relatively higher concentrations of the latter. Multiple bands observed in the 







protein at ~54 kDa as well as the native protein at ~57 kDa. The involvement of 
disulphide bonds in the observed multiple banding is not likely since the 
concentrated supernatant extracts were treated with varying concentrations of dTT to 
reduce disulphide bridges. The lower bands might be fibrinogen binding to the 
degradation products of BF1705 in concentrated wild-type supernatants. The 
probability of non-specific binding can be ruled out since the blots were blocked in 
dried skimmed milk and no binding was observed in the mutant extract. The absence 
of bands in ΔBF1705 extract also indicate the absence of other surface proteins 









Figure 3.22: Analysis of fibrinogen binding by the wild-type and ΔBF1705 culture 
supernatants 
(A) SDS-PAGE analysis of concentrated culture supernatants of wild-type 9343 (70 μg) 
(lane 1), ΔBF1705 (70 μg) (lane 2) and purified 1705 protein (2 μg) (lane 3). (B) 
Immunoblot of 1x dTT treated and 2x dTT treated concentrated culture supernatants of wild-
type 9343 (70 µg) (lane 1 and 2), concentrated culture supernatant of ΔBF1705 (70 µg) (lane 
3) and purified BF1705 protein (2 µg) (lane 4) incubated in fibrinogen followed by labelling 
with anti-fibrinogen antibody. The positions of molecular weight markers (M) in kDa are 
shown adjacent to the gel. Multiple bands were observed at  ̴ 57 kDa, ̴ 54 kDa and at lower 
molecular sizes in 1xdTT treated (B) (lane 1) and 2xdTT treated (B) (lane 2) concentrated 









Figure 3.23: Detection of fibrinogen binding by BF1705 
(A) SDS-PAGE analysis of concentrated purified BF1705 protein (5 μg) (lane 1),  diluted 
BF1705 protein (0.3 μg) (lane 2), concentrated culture supernatant of wild-type 9343 (35 μg) 
(lane 3), E. coli Top10 whole cell fraction (lane 4) and concentrated culture supernatant of 
ΔBF1705 (35 μg) (lane 5) and (B) Immunoblot of corresponding samples incubated with 
fibrinogen followed by labelling with anti-fibrinogen antibody (lanes 1,2, 3-5) for 10 min 
exposure. The positions of molecular weight markers (M) in kDa are shown adjacent to the 
gel. A band was observed at ̴ 54 kDa in concentrated purified BF1705 protein (B) (lane 1) 









Figure 3.24: Analysis of fibrinogen binding by the wild-type and differing BF1705 
concentrations 
(A) SDS-PAGE analysis of dilutions of purified BF1705 protein (2 µg) (lane 1) (0.35 µg) 
(lane 2) , concentrated BF1705 protein (5 μg) (lane 3), concentrated culture supernatant of 
wild-type 9343 (35 μg) (lane 4), E.coli Top10 whole cell lysate (lane 5) and concentrated 
culture supernatant of ΔBF1705 (35 μg) (lane 6) and (B) Immunoblots of the corresponding 
samples incubated in fibrinogen followed by labelling with anti-fibrinogen antibody (lanes 1-
6) for (B) 2 min. and (C) 5 min. exposure. The positions of molecular weight markers (M) in 
kDa are shown adjacent to the gel. Bands were observed at ̴ 54 kDa in concentrated BF1705 
protein (B) (lane 3) (C) (lane 3) and smeared multiple bands in concentrated wild-type 
culture supernatant (B) (lane 4) (C) (lane 4). On extending exposure time to 5 min., bands 








3.9.4. Analysis of fibrinogen binding by ΔBF1705ΔBF1708 cells in Immunoblots 
The binding of fibrinogen observed by IFM in mutant cells fixed on slides 
contradicted the far-western results, in which no binding was observed in the mutant 
extract. This might be due to the presence of fibrinogen-binding surface components 
on whole cells observed in IFM which were absent in concentrated supernatant 
extracts that were fractionated on SDS-polyacrylamide gels. However, non-specific 
background fluorescence observed in a few IFM slides, even after blocking the slides 
and repeated washes, could pose a hindrance in accurate interpretation of binding 
observed by IFM. Therefore, owing to the sensitivity and relative reliability of far-
western analysis, diluted whole cells incubated with fibrinogen were washed, 
electrophoresed and blotted on to PVDF membranes. The blotted membranes were 
analysed for presence of fibrinogen by incubating in specific antibodies. Fibrinogen 
protein was used as a positive control and E. coli Top10 cells were used as negative 
control. Interactions of 9343, ΔBF1705 and ΔBF1705ΔBF1708 whole cells with 
fibrinogen were analysed by incubating 0.5 ml diluted cultures with 0.1 mg/ml 
fibrinogen. After 10h, excess fibrinogen was washed off by centrifuging the treated 
cells thrice in 1 ml PBS. SDS-polyacrylamide electrophoresed samples were 
transferred by membrane blotting and incubated with fibrinogen-specific antibody 
followed by incubation with hrp-conjugated 2
o 
antibody for detection. Fibrinogen 
bands, corresponding to the three chains, were observed even in the negative control, 
E. coli Top10 (Figure 3.25 B lane 4). Although fibrinogen binding has been reported 
in a few clinical isolates of E.coli strains implicated in bacteraemia, it has not been 
detected in the K12 genotype to which E.coli Top10 belongs. Also, fibrinogen 
binding by E.coli Top10 cells was not observed in IFM and far-western analysis 
performed in the present study. Therefore, the presence of fibrinogen observed in the 
immunoblot of E.coli whole cell fraction could be regarded as an artefact. The 
presence of fibrinogen in the residual volume after the PBS washes performed to 
remove excess fibrinogen might have accounted for a positive signal in the E.coli 
whole cell fraction. The observed artefact, owing to the sensitivity of the technique 







and increasing the number of washes to remove unbound fibrinogen. Therefore, the 
immunoblots were repeated by incubating whole cells with 0.015 mg/ml fibrinogen 
and increasing the number of PBS washes to 5 times. The signals were not over 
exposed due to the lower concentration of fibrinogen used. However, fibrinogen 
binding by E. coli was still observed (Figure 3.26 B lane 4). This might still account 
for a false-positive band or could suggest fibrinogen binding by E. coli  that was not 
detected by less sensitive techniques. The evidence that  ̴ 20% of E.coli genome 
accounts for unknown genes coupled with the fact that E. coli co-exists with B. 
fragilis in the gastrointestinal tract and has been isolated from polymicrobial 
infections suggests that E. coli might harbour surface components involved in 
fibrinogen binding. Moreover, Shen et al. (1995) observed that E. coli strains from 
patients with colonic disorders expressed binding of fibrinogen which may promote 









Figure 3.25: Analysis of fibrinogen binding (0.1 mg/ml) by whole cell lysates of wild-
type and  deletion mutants 
(A) SDS-PAGE analysis of diluted lysates of wild-type 9343 (lane1), BFΔ1705 (lane 2), 
BFΔ1705Δ1708 (lane 3), E. coli Top10 (negative control) (lane 4) incubated with 0.1 mg/ml 
fibrinogen and 0.1 mg/ml fibrinogen (positive control) (lane 5) and (B) Immunoblot of 
corresponding samples labelled with anti-fibrinogen antibody (lane 1-4) for 10s exposure. 
The positions of molecular weight markers (M) in kDa are shown adjacent to the gel. Bands 
are observed at ̴ 60 kDa, ̴ 50 kDa and ̴ 40kDa in wild-type 9343 lysate (B) (lane 1) BFΔ1705 
lysate (B) (lane 2) BFΔ1705Δ1708 lysate (B) (lane 3) and E.coli Top10 lysate (B) (lane 4) 









Figure 3.26: Analysis of fibrinogen binding (0.015 mg/ml) by whole cell lysates of wild-
type and  deletion mutants 
(A) SDS-PAGE analysis of diluted cultures of wild-type 9343 (lane1), BFΔ1705 (lane 2), 
BFΔ1705Δ1708 (lane 3) and E. coli Top10 (lane 4) incubated with 0.015 mg/ml fibrinogen 
and (B) Immunoblot of corresponding samples labelled with anti-fibrinogen antibody (lanes 
1-4) for 5s exposure. The positions of molecular weight markers (M) in kDa are shown 
adjacent to the gel. Bands are observed at ̴ 60 kDa,  ̴ 50 kDa and  ̴ 40kDa in wild-type 9343 
lysate (B) (lane 1) BFΔ1705 lysate (B) (lane 2) BFΔ1705Δ1708 lysate (B) (lane 3) and 
E.coli Top10 lysate (B) (lane 4). 
 
3.10. Detection of fibrinogen degradation by the ΔBF1705 strain 
Lantz, Allen, Vail, et al. (1991) identified a 150-kDa cell surface protein in the 
periodontal pathogen, Porphyromonas gingivalis, that mediated binding and 
degradation of human fibrinogen. It was hypothesised that the fibrinogen binding 
component was a non-catalytic form of fibrinogen degrading component. It has been 
demonstrated that B. fragilis can degrade fibrinogen, in addition to binding 
fibrinogen (Houston et al. 2010). However, the role of  the identified fibrinogen-
binding protein, BF1705 in B. fragilis-mediated degradation of fibrinogen was not 
investigated. The genetic similarity between the two bacteria might suggest a similar 
mechanism for fibrinogen degradation in B. fragilis as observed in P. gingivalis 
albeit there is no significant similarity between the two surface proteins. Binding of 
fibrinogen followed by its degradation could provide an effective strategy for B. 







and abscess formation. Ability of BF1705 protein to degrade fibrinogen was 
analysed by incubating 0.1mg/ml fibrinogen  with ΔBF1705 strain and 9343 wild-
type strain in two separate tubes of BHI-S followed by analysis of the culture 
supernatants at 3 h and 48 h time periods in SDS-polyacrylamide gels for 
degradation of fibrinogen bands. Fibrinogen incubated in plain BHI-S served as the 
control sample. Complete degradation of the Aα-chain, as observed by the 
disappearance of the band, and partial degradation of Bβ- and ϒ-chains of fibrinogen 
were observed in both the cultures after 48h (Figure 3.27 lane 2 and 6) when 
compared to intact bands in the control-BHI-S sample (Figure 3.27 lane 8). Partial 
degradation of the Aα-chain was observed in the 3h culture samples (Figure 3.27 
lane 1 and 5). BF1705 protein does not play a  role in the ability of B. fragilis to 
degrade fibrinogen as the wild-type and mutant strains degraded fibrinogen when 
compared to the control sample, which is evident from the disappearance of bands 
corresponding to the Aα-chain. These observations suggest that fibrinogen 
degradation by B. fragilis might take place independently of fibrinogen binding. 




Figure 3.27: Analysis of fibrinogen degradation by the wild-type and ΔBF1705 cultures 
SDS-PAGE analysis of in situ fibrinogen degradation by 3h (lane 1) and 48h (lane 2) grown 
cultures of wild-type 9343 and 3h (lane 5) and 48h (lane 6) grown cultures of ΔBF1705 on 
comparison to fibrinogen in control BHI-S medium (lanes 7 and 8). Disappearance of 
fibrinogen α-band is observed in 48h grown culture of wild-type 9343 (lane 2) and 48h 
grown culture of ΔBF1705 (lane 6). Intact bands are observed in control BHI-S medium 








3.11. Binding potential of BF1705 protein to fibronectin by far-western analysis 
Fibronectin is a glycoprotein present in the ECM that binds other components of the 
ECM, such as, collagen, fibrin and heparan sulphate, in addition to membrane 
spanning integrins. Pereira et al. (2002) observed that incorporation of fibrinogen 
into ECM during events of tissue repair required active elongation of fibronectin 
polymers into matrix fibrils. This observation provided a link between fibrinogen and 
fibronectin functions in the host. Interestingly, studies by Lantz, Allen, Vail, et al. 
(1991); Lantz, Allen, Duck, et al. (1991) suggested that fibrinogen and fibronectin 
are recognised and modified by the same 150 kDa cell surface component on P. 
gingivalis. However, the affinity of P. gingivalis for fibrinogen was ten-fold higher 
than that observed for fibronectin. In a similar manner, a bifunctional surface protein, 
FnbpA, has been identified in Staphylococcus aureus that binds fibrinogen in 
addition to fibronectin and interdependently promote endothelial invasion by           
S. aureus (Piroth et al., 2008; Wann et al., 2000). Studies by Pauer et al. (2009) 
identified a 102-kDa TonB-dependent protein as a potential fibronectin binding 
protein in B. fragilis strain 1405. The putative fibronectin binding protein was 
examined by reverse genetics. Enhanced binding of fibronectin by a gene-inactivated 
mutant (Δbf1991) in B. fragilis strain 638R  was observed in latex agglutination 
assays when compared to the wild-type. Western blot analysis detected an increase in 
the expression of an unknown 30 kDa protein in the absence of the TonB-dependent 
fibronectin binding protein. Increased  fibronectin binding observed in the TonB-
dependent protein encoding gene-inactivated mutant suggests the role of other 
components that might mediate fibronectin binding by B. fragilis (Pauer et al., 2013). 
These observations regarding microbial interaction with fibronectin suggests a 
possible role played by BF1705 in fibronectin binding by B. fragilis. 
An attempt was made to identify potential fibronectin adhering functions of BF1705 
by performing  far-western  analysis using human fibronectin. Concentrated culture 
supernatants of  9343 and ΔBF1705, concentrated BF1705 protein, human 
fibronectin (positive control) and BSA (negative control) were electrophoresed on 







Membrane blot was blocked and incubated  with 10μg/ml fibronectin, followed by  
labelling with 1
o 
antibody, anti-fibronectin produced in rabbit and anti-rabbit hrp 
conjugated 2
o
 antibody (2.7.7 and 2.7.8). Visualisation of the incubated blot on X-ray 
films revealed an intense band for the positive control, fibronectin (Figure 3.28 B 
lane 2), a faint band at ~54 kDa for BF1705 protein sample (Figure 3.28 B lane 3) 
and a smeared band with a distinct intensity at ~32 kDa for the wild-type 
concentrated supernatant (Figure 3.28 B lane 4). No fibronectin binding was 
observed for the negative control BSA (Figure 3.28 B lane 1) and for ΔBF1705 
concentrated culture supernatant (Figure 3.28 B lane 5). These observations indicate 
that BF1705 protein can bind fibronectin in addition to fibrinogen. Although, the 
band at ~32 kDa in 9343 suggest fibronectin binding by surface components other 
than BF1705 (Figure 3.28 B lane 4), the absence of BF1705 seems to inhibit 
fibronectin binding by the concentrated culture supernatant (Figure 3.28 B lane 5). 
However, a band at 102 kDa, corresponding to the previously studied putative 
fibronectin-binding protein was absent in our study. The absence of the TonB-
dependent fibronectin-binding protein might be due to the difference in B. fragilis 
strains used between the two studies . The band at  ̴ 32 kDa in the present study could 
even be a degradation product of BF1705 in the wild-type concentrated supernatant 
which binds fibronectin. The probability of non-specific fibronectin binding by 
BF1705 protein could be ruled out since the blots were treated with dried skimmed 
milk to block the free binding sites. Alternatively, the band observed at  ̴ 32 kDa 
might be similar to the band observed by Pauer et al. (2013) in the fibronectin 









Figure 3.28: Analysis of fibronectin binding by BF1705 and wild-type and ΔBF1705 
culture supernatants 
(A) SDS-PAGE analysis of BSA negative control (2 μg) (lane 1), fibronectin (6 μg) (lane 2), 
purified BF1705 protein (4 μg) (lane 3), concentrated culture supernatants of wild-type 9343 
(35 μg) (lane 4) and BFΔ1705 (35 μg) (lane 5) and (B) Immunoblots of corresponding 
samples incubated in 10μg/ml fibronectin and labelled with anti fibronectin antibody for 2.5 
min. exposure. The positions of molecular weight markers (M) in kDa are shown adjacent to 
the gel. Over-exposure is observed in fibronectin positive control (B) (lane 2), band at  ̴ 54 
kDa was observed in purified BF1705 protein (B) (lane 3) and a smeared band with intensity 









Binding of host proteins by commensals of the gastrointestinal tract has been 
regarded as an effective mechanism for microbial survival. Bacterial adherence to the 
host epithelium is essential for obtaining nourishment and for evading adverse host 
immune responses (Sonnenburg et al., 2004). However, binding of opportunistic 
pathogens to the host matrix-associated proteins has been implicated in infections 
(Westerlund and Korhonen, 1993). In the present study, the fibrinogen binding 
function of BF1705 protein in B. fragilis was confirmed by generating BF1705 gene-
deletion mutants in the NCTC 9343 strain. The reverse genetic studies conducted 
also provided an opportunity to identify other surface components in B. fragilis that 
might bind fibrinogen in the absence of BF1705. 
Houston et al. (2010) demonstrated the ability of B. fragilis whole cells to bind 
human fibrinogen  with the identification of a putative fibrinogen-binding protein 
(BF-FBP) encoded by BF1705 in NCTC 9343, by virtue of its homology to 
fibrinogen binding antigen BspA of Tannerella forsythia. The gene encoding the 
protein was also identified in the genomes of B. fragilis strains 638R and YCH46 
isolated from abscess and bacteraemia patients (Patrick et al., 2010). 
Fibrinogen binding might interfere with the process of fibrin-mediated blood clotting 
and abscess formation, thereby promoting the survival of B. fragilis in abscesses and 
dissemination of infections. Interaction of fibrinogen with the coagulase bound on 
the cell surface of non-encapsulated Staphylococcus aureus causes clumping and has 
been reported to block phagocytosis (Kapral, 1966). Clumping of cells facilitated by 
fibrinogen might have a protective effect on the bacterium in early abscess formation 
and during later stages of persistent infections (Dominiecki and Weiss, 1999). Many 
fibrinogen-binding MSCRAMMs have been identified on the surface of S. aureus. 
One of them, Clumping factor A (ClfA) which binds within the C terminus of 
fibrinogen γ-chain mediates platelet aggregation and has been postulated as a 
virulence determinant in animal models of septic arthritis and infective endocarditis 
(Ganesh et al., 2008; McDevitt et al., 1997). The importance of ClfA-fibrinogen 







demonstrated by an impeded virulence state exhibited by mice expressing mutant 
forms of fibrinogen lacking the motif recognised by ClfA (Flick et al., 2013). More 
recent studies have identified an additional binding protein in S. aureus, the 
extracellular fibrinogen binding protein (Efb) which expresses a distinctively higher 
affinity for fibrinogen than the previously characterised MSCRAMMs. Fibrinogen 
binding by Efb blocks the interaction of fibrinogen with the leucocyte integrin 
receptor αMβ2, thereby evading an inflammatory immune response and promoting 
bacterial virulence (Ko et al., 2011). Additionally, a model has been proposed in 
Francisella tularensis, an airborne pathogen, in which the bacterium indirectly 
recruits fibrinogen to the outer membrane to escape complement-mediated 
membrane attack complex (Jones et al., 2012). Therefore the specific interactions of 
B. fragilis with the host fibrinogen identified by Houston et al. (2010) is of 
significance and might be related to the higher frequency of isolation of this obligate 
anaerobe in clinical samples of soft tissue abscesses, peritonitis and bacteraemia. 
In the present study, it was observed that B. fragilis harbours additional components 
on the cell surface that might be involved in fibrinogen binding in the absence of 
BF1705, since ΔBF1705 cells retained the ability to bind fibrinogen in IFM analysis 
(Figure 3.13). Markerless gene deletions were generated by a method adopted from 
Patrick et al. (2009) which involved development of the deletion constructs on a 
suicide plasmid in E. coli and integration of the construct into the chromosome of B. 
fragilis NCTC 9343 via conjugal transfer followed by resolution of the partial 
diploids (Figure 3.4). The difficulties associated with the successful genetic 
manipulation of Bacteroides spp. have already been reported (Smith, 1995a). 
Introduction of foreign DNA into B. fragilis using methods such as electroporation 
are cumbersome owing to the protective R-M systems operating in the bacterium. 
Three type I and two type III R-M systems have been identified in the genome of the 
strain NCTC 9343. One of the hsds genes, encoding a subunit of the type I R-M 
system, which dictates DNA binding specificity of methyl transferase and 
endonuclease, is subjected to a shufflon-mediated site-specific rearrangement of the 







resulting in eight different possible polypeptide combinations, producing an equal 
number of DNA recognition specificities for the HsdS subunit. Moreover, the NCTC 
9343 genome encodes proteins sharing homology to type IV restriction endonuclease 
McrBC which cleaves specific DNA sequences modified with 5-methylcytosine 
(Patrick et al., 2010). The successful deletion of BF1705 in the present study was 
hence confirmed by PCR and immunoblot analysis (Figure 3.12 and Figure 3.21). 
The observed binding ability of ΔBF1705 strain is not surprising as many pathogens 
mediate interactions with the host through multiple microbial components, as 
observed in S. aureus. The possible ability of within-strain phase and antigenically 
variable micro-capsule (MC) polysaccharides (electron dense layer) present on the 
outer membrane of B. fragilis to bind fibrinogen was analysed by generating 
ΔBF1705ΔBF1708 strains (Figure 3.14). 
The genome sequence of three strains of B. fragilis identified 28 separate divergent 
polysaccharide (PS) loci each potentially dedicated to the expression of a distinct 
polysaccharide, of which only two were conserved between two strains (Patrick et 
al., 2010). Variable MC expression in the NCTC 9343 genome is assigned to 8 (A-I) 
out of the 10 identified PS loci and 7 of them are controlled by site-specific inversion 
of promoter sequences (Patrick et al., 2003). Micro-capsules form a marginal 
electron-dense layer of  ̴ 35 nm in size outwith the outer membrane and are invisible 
by light microscopy (Patrick et al., 1986). Sodium periodate-sensitive adhesion of B. 
fragilis to human colon carcinoma cells, Caco-2, identified the involvement of 
capsular polysaccharides in cellular adherence. Also, the strongest adherence to 
polarized Caco-2 cells was exhibited by the strain with the highest percentage of 
capsulated cells (Ferreira et al., 2002). Micro-capsules have been associated with the 
colonization of the gastrointestinal tract since a stable acapsular mutant which was 
deficient in synthesising all eight micro-capsules failed to colonise the mouse 
intestine when compared to the wild-type B. fragilis (Coyne et al., 2008). In addition 
to being implicated in complement resistance, the MC specific to PS A/2 locus has 
been involved in abscess formation (Coyne et al., 2001; Reid and Patrick, 1984). 







capsule that are visible by light microscopy are also expressed by B. fragilis (Patrick 
and Lutton, 1990). Large capsule has been reported to resist phagocytic uptake and 
killing of B. fragilis by PMNLs in vitro. The presence of common epitopes indicates 
co-expression of large capsule (LC) with the MCs (Lutton et al., 1991; Reid and 
Patrick, 1984). These adherent and evasive functions associated with the capsular 
polysaccharides urged us to analyse the role of capsules in fibrinogen binding 
(Patrick and Lutton, 1990). BF1708 present at J/10 in the PSJ locus is conserved 
among all three sequenced strains and encodes a putative PS chain-length 
determining protein, the only Wzz protein homologue identified in B. fragilis 
(Patrick et al., 2010). Deletion of BF1708 in NCTC 9343 genome gave rise to a 
population of cells expressing a single microcapsule polysaccharide specific to PSD 
locus, instead of an antigenically mixed population identified by the different MC-
specific monoclonal antibodies (Lutton et al., 1991; Patrick et al., 2009). The 
ΔBF1708 strain was also characterised by an absence of high -molecular-mass 
polysaccharides associated with the PSD gene cluster and an aberrant capsular 
phenotype in  ̴ 10% of LC cells (Patrick et al., 2009). Fibrinogen binding by the 
ΔBF1705ΔBF1708 double gene deletion mutants in the present study indicates the 
participation of other adhesins, apart from the putative BF-FBP and MC 
polysaccharide layer in interactions with fibrinogen (Figure 3.15). However, since 
the ΔBF1708 strain still expresses large capsule, small capsule and might also 
harbour undetectable amounts of short-chain repeats of the MCs synthesised by other 
loci, the contribution of these polysaccharides to the observed fibrinogen binding 
cannot be ruled out. At the same time, the fibrinogen binding by the ΔBF1708 strain 
could be regarded as a consequence of the absent electron-dense layer which 
enhances the ability of other surface components involved in fibrinogen interaction. 
Exposure of other cell surface adhesins in the absence of capsular exopolymer 
expression has been reported to mediate interaction of B. fragilis with non-polarised 
Caco-2 cell surfaces (Ferreira et al., 2002). A similar mechanism was observed in the 
encapsulated Smith strain of S. aureus which prevented the interaction of bound 







blocked uptake by phagocytes as a result of fibrinogen-mediated clumping (Kapral, 
1966). In a similar manner, the inactivation of a gene encoding a fibronectin-binding 
protein in B. fragilis was observed to enhance its fibronectin-binding ability and was 
more adherent in biofilms when compared to the wild-type (Pauer et al., 2013). 
Therefore, the role of the remaining capsules as well as other surface adhesins in the 
observed fibrinogen binding by NCTC 9343 whole cells needs to be further 
investigated. 
Nonetheless, the specific involvement of the BF1705 protein in binding fibrinogen 
was observed when cell-free culture supernatants of the wild-type and mutant strains 
were concentrated through membranes with a 100 kDa cut off and used in far-
western analysis. Presence of BF1705 in the concentrated wild-type supernatant was 
evident from the detection of a band close to the position of the purified BF1705 
protein on cross-reaction with anti-1705 polyclonal antibody in immunoblots (Figure 
3.21). Absence of the band in concentrated culture supernatants of ΔBF1705 strain 
was consistent with the deletion of the protein-encoding gene in the same. These 
findings indicate the potential presence of BF1705 surface protein in OMV released 
by B. fragilis. A similar method of concentrated sample preparation and immuno 
analysis  has previously suggested the presence of a ubiquitin homologue, BfUbb, in 
B. fragilis OMV (Patrick et al., 2011). OMVs are secretory vesicles predominant in 
Gram-negative bacteria and are conventionally surrounded by an outer membrane-
derived bilayer membrane ranging between 25 and 200 nm in diameter (Kulp and 
Kuehn, 2010). These extracellular complexes function to deliver bacterial 
components to host cells and tissues as well as other bacteria (Kuehn and Kesty, 
2005). Recent transmission electron microscopy (TEM) and mass-spectrometry (MS) 
studies on the structure and proteome of OMVs harvested from B. fragilis reveal the 
presence of outer membrane and periplasmic proteins in 30-80 nm sized vesicles. It 
was observed that proteins in OMV possess either a lipoprotein signal or a 
transmembrane domain which indicate that they are destined to the outer membrane 
before being included in OMVs (Elhenawy et al., 2014). Albeit the study did not 







revealed a signal sequence as well as a membrane lipoprotein lipid attachment site, 
thus indicating the expression of a putative cell-surface lipoprotein (Houston et al., 
2010). These findings corroborate our assumptions that BF1705 is released into the 
intestinal milieu within secretory vesicles. Moreover, a recent unpublished study has 
identified BF1705 protein in the concentrated culture supernatant of wild-type 9343  
by liquid chromatography-MS/MS technique (M. Kowal, pers. comm.). OMVs have 
been implicated in spread of infections owing to the transport of toxins and virulence 
factors produced by pathogenic bacteria (Bomberger et al., 2009). Therefore, the 
presence of BF1705 in OMV might enhance the virulence activity of B. fragilis by 
being able to interact with fibrinogen in extraintestinal abscesses. 
A smeared band, with a distinct intensity close to the size of the BF1705 holoprotein 
as well as the matured protein confirmed binding of fibrinogen by concentrated wild-
type 9343 supernatants (Figure 3.22, Figure 3.23 and Figure 3.24). The ΔBF1705 
strain did not cross-react with anti-fibrinogen antibody in far-western analysis which 
confirms the specific role of BF1705 protein in fibrinogen binding. However, the 
presence of  smeared multiple-intense bands for the wild-type far-immune blots 
raises questions on the mechanism of BF1705 secretion and fibrinogen binding. 
Smeared bands have often been associated with glycosylated proteins (Patrick et al., 
2011). Since the triplet codons characteristic of consensus recognition site for B. 
fragilis O-glycosylation are absent in the BF1705 amino acid sequence, the possible 
involvement of this post-translation modification in the observed smearing could be 
ruled out (Fletcher et al., 2011). However, BF1705 possesses a lipid attachment site 
and the attached lipids might account for the observed smeared bands. There are two 
explanations plausible for the  multiple-banding pattern in the wild-type concentrated 
supernatant. One of them would be with reference to the adopted sample preparation 
method. The conventional technique for extraction of pure OMVs involves further 
ultra centrifugation or chemical treatment of the concentrated cell-free supernatants 
(Bauman and Kuehn, 2006). The unprocessed cell-free supernatants might contain 
variable proportion of other components besides vesicles which might hinder the 







membrane protein and secreted proteins in addition to OMV. Since the samples in 
the present study were restricted to crude concentrated supernatants, the BF1705 
holoprotein might have been pulled down in the concentrated supernatant sample 
along with the processed protein, present on the cell surface. The detection of 
holoproteins that possess the signal peptide sequence in cell-free supernatant is rare 
since signal peptidases cleave the leader sequence once the protein is transported to 
its final destination. Thus, the holoprotein is generally detected only in the whole cell 
extract in most cases (Patrick et al., 2011). Proteins of the inner membrane and 
cytoplasmic components have not been reported in B. fragilis vesicles till date, 
although rare cases have been studied in an antarctic psychrotolerant bacterium, 
Shewanella vesiculosa M7
T 
(Pérez-Cruz et al., 2013). Investigations by cryo -TEM 
identified a complex type of double -bilayered OMVs characterised by the presence 
of plasma membrane , cytoplasmic proteins as well as entrapped DNA which 
constituted  ̴ 0.1% of the total vesicles released by Shewanella vesiculosa M7
T
. The 
presence of BF1705 full-length protein in the concentrated supernatant and its 
interaction with fibrinogen suggests that fibrinogen can bind to BF1705 both in the 
processed and unprocessed forms of the BF1705 protein. A similar double-band 
pattern was observed earlier in far-western analysis of collagen binding in OMP 
fraction of B. fragilis, wherein both glycosylated and non-glycosylated versions of 
the Cbp 1 protein bound collagen (Galvão et al., 2014). Another possibility is that the 
mature BF1705 protein might not be present in the pure OMV extracts after all, 
which might have prevented its detection from the reported OMV proteome studies. 
It might either be present as a surface exposed lipoprotein or follow a different 
secretory mechanism which allows the detection of full-length protein before signal 
cleavage. A recent analysis of outer membrane proteome and secretome of B. fragilis 
detected a multitude of secretion mechanisms operating in the bacterium. The study 
identified a large number of lipoproteins both on the cell surface as well as among 
the secreted proteins. Analysis of OMVs were excluded from the study which 
predicts an alternative fate for the BF1705 lipoprotein other than OMV-inclusion. 







them were of unknown function and were suggested to be either peripherally 
associated with OM, bound to OMPs or embedded in OM by a novel mechanism 
independent of a β barrel structure. Apart from two predicted lipoproteins, of which 
one was a putative adherence protein and the other, a homologue of TonB-dependent 
transporter (TBDT)-associated heme-binding protein, HmuY, the remaining six 
identified in the secretome could not be assigned a specific function. Proteins of the 
secretome that contain a signal sequence are targeted to ABC transporter/TolC based 
export system following an initial periplasmic translocation mediated by Sec 
pathway (Wilson et al., 2015). These proteomic studies provide evidence of an 
OMV-independent existence of BF1705 protein that led to the detection of the full 
length protein in the sample preparation. The second explanation for the presence of 
multiple bands in the wild-type concentrated culture supernatant could be the 
presence of other fibrinogen-binding proteins in addition to BF1705 concurrent with 
the IFM results. However, this possibility could be ruled out since the mutant did not 
show binding to fibrinogen in far-western analysis. The lower molecular bands might 
suggest the presence of BF1705 degradation products that bind fibrinogen or even 
fibrinogen degradation products that cross-react with the anti-fibrinogen antibody. In 
the studies conducted by Elhenawy et al. (2014), a significant proportion of proteins 
that were exclusive to the OMV harvested from concentrated supernatants were 
identified as hydrolytic proteases. The retention of proteolytic activity by at least 
some of these proteases were detected by gelatin zymography. These intra-vesicular 
active proteases might have contributed to fibrinogen degradation in far-western 
analysis. Moreover, fibrinogenolytic activity has already been reported as an 
extracellular phenomenon in B. fragiilis using culture supernatants in fibrinogen 
zymography (Houston et al., 2010). Studies in P. gingivalis have identified a 150 
kDa fibrinogen binding protein on its cell surface which is partially associated with 
temperature-mediated fibrinogen degradation in combination with another 120 kDa 
degrading component. Experimental evidence suggests that the binding of fibrinogen 
to the cell surface is followed by its proteolytic degradation into discrete peptides by 







binding on the bacterial surface (Lantz et al., 1991a). The probable presence of a 
similar BF1705-mediated fibrinogenolytic activity in B. fragilis was investigated. 
Fibrinogen binding by BF1705 was independent of fibrinogen degradation since 
bioinformatic analysis of BF1705 mentions no obvious catalytic domain (Figure 
3.27). 
A relatively high concentration of purified BF1705 protein was required to detect 
fibrinogen binding in far-western blots. A dose-dependent manner of fibrinogen  
binding by BF1705 was also observed in the studies by Houston et al. (2010). The 
dependence on concentration suggests that higher amounts of BF1705 protein are 
required for effective binding to fibrinogen. A previous study had revealed that 
BF1705 interacted strongly with the Bβ-chain of fibrinogen in addition to weaker 
interactions with the Aα- and γ-chains. Recent studies on the interaction of Efb 
protein harboured by S. aureus with fibrinogen have detailed the use of surface 
plasmon resonance (SPR) and isothermal titration calorimetry (ITC) techniques to 
confirm the specific interaction of N-terminal half of Efb protein with the D fragment 
of fibrinogen (Fg) (Ko et al., 2011). Characterisation of  Efb-Fg interaction by using 
Biacore 3000 system with specific sensor chips derived with either Fg-D or with his-
tagged Efb revealed full length Efb and Efb-N and not Efb-C bound to Fg-D. Efb-N 
bound to Fg-D in a dose-dependent manner with a KD of 0.23 nM based on kinetic 
data. The stability of the complex formed was revealed by a reasonably fast on rate 
and slow off rate. Reversal of the system identified that Fg-D bound to Efb-N chip in 
a dose-dependent manner with a higher KD of 2.67 nM due to a faster off rate. ITC 
examined the binding affinity of 2 GST tagged Fg-binding sites in Efb, namely Efb-
A and Efb-O using plasmin-generated Fg-D fragments. Affinity of Efb-O for Fg-D 
was found to be 200 times higher than that of Efb-A with dissociation constants of 
4.66 nM and 1.0 µM, respectively. Hence, further work involving point mutation 
studies and surface  plasmon resonance could be carried out to identify the domain-








Since fibrinogen is not present in the gastrointestinal tract, B. fragilis does not 
encounter this glycoprotein in its commensal niche. B. fragilis  becomes exposed to 
fibrinogen only when this opportunistic pathogen is accidentally released from its 
normal habitat into the peritoneal cavity and encounters an infected site. Fibrinogen 
is recruited at the site of infection to initiate blood clotting and to form fibrin-
mediated abscesses (Herrick et al., 1999). During this exposure, the binding of 
fibrinogen by B. fragilis might delay the process of defence and promote infection 
dissemination. However, the absence of fibrinogen in the bacterium's natural niche 
suggests one or more additional functions for the BF1705 protein in B. fragilis. Since 
the sequence analysis identified homology to cell surface proteins in Tannerella 
forsythia (32.88% identity in 295 aa), B. thetaiotaomicron (33.33% identity in 411 
aa) and Trichomonas vaginalis (29.29% identity in 297 aa) as well as Pfam match 
entries to LRRs which facilitate protein-protein interactions, the BF1705 protein 
might perform an adherent function (Kobe and Kajava, 2001). Earlier studies have 
reported the increase in frequency of B. fragilis isolates from 4% in faeces to 42% in 
colonic mucosa cultures (Namavar et al., 1989). The mucosal layer comprises the 
viscous stratum that separates epithelial cells from the gut lumen and poses as a 
crucial barrier against pathogenic infection. Since only a small proportion of the 
endogeneous intestinal microbiota can penetrate mucus and interact with the 
epithelial surface, the predominance of B. fragilis as a member of the adherent 
colonic microbiota when compared to the other Bacteroides spp. might have 
implications on the high prevalence of this species in gut associated infections 
(Swidsinski et al., 2005). Furthermore, invasion of mucus via mucin binding and 
degradation by B. fragilis to fulfil its nutritional purposes has been reported. Invasion 
of the mucosal layer confers epithelial attachment to B. fragilis (Huang et al., 2011). 
Frequent sloughing of epithelial cells might expose components of the extracellular 
matrix. Binding of  B.vulgatus, the most common Bacteroides spp. of the faecal 
microbiota, to fibronectin has been regarded as a means of enhanced colonic 
establishment. The results presented here indicate a similar fibronectin-binding 







infections and binding to fibronectin might confer an invasive role to B. fragilis 
(Figure 3.28). It has been reported that fibrinogen expression is upregulated during 
an inflammatory response and is deposited in the ECM in a fibrillar form where 
fibrinogen colocalises with fibronectin fibrils (Pereira et al., 2002). Fibronectin 
possesses a fibrin-binding site and is codeposited at the site of injury to form a clot 
and protect the underlying tissue. Therefore it can be suggested that during 
opportunistic infections, the fibronectin-binding ability of B. fragilis undergoes 
transition to fibrinogen binding to persist in and spread infections. Binding and 
degradation of fibronectin by P. gingivalis, which is genetically close to B. fragilis, 
seemed to be mediated by the same surface protein that bound and degraded 
fibrinogen (Lantz et al., 1991b). A bifunctional protein, FnbpA, which binds 
fibrinogen in addition to fibronectin has also been identified in Staphylococcus 
aureus (Wann et al., 2000). Moreover, a TonB-dependent protein (encoded by 
bf1991) of 102 kDa in size had been identified as a fibronectin binding protein in B. 
fragilis strain 1405 (Pauer et al., 2009). However, this protein was not detected in the 
present study possibly due to use of a different strain. Also, BF1705 does not share 
significant homology to S. aureus  FnbpA or the TonB-dependent protein encoded by 
bf1991 (BF0466) in B. fragilis.  Nonetheless, an  ̴ 32 kDa band was observed in the 
fibronectin far-western analysis in the present study which seems to be consistent 
with the band observed in the bf1991 gene-inactivated strain  (Pauer et al., 2013). 
Alternatively, it could be hypothesised that fibronectin possesses a greater binding 
affinity to a BF1705 degradation product at  ̴ 32 kDa. Binding affinity studies need to 
be conducted to investigate this hypothesis. The concentrated supernatant of 
ΔBF1705 failed to cross-react with anti-fibronectin antibody, therefore the 
fibronectin binding function of BF1705 within the gastrointestinal tract might be 
modified to fibrinogen binding in extraintestinal infections. The possibility of other 
outer membrane proteins adhering to fibrinogen, as observed in IFM results, and 
fibronection cannot be ruled out since far-western blots can detect the functional role 
of only those proteins that can renature after SDS treatment (Lantz et al., 1991a). 







well as pathogenic phase of B. fragilis. Future in vivo experiments using mouse 
models are essential to elucidate the intra- and extraintestinal functions of the 








Chapter 4 Degradation of Fibrinogen by Bacteroides fragilis 
4.1. Introduction 
Adhesion of bacterial surface proteins to host epithelium and extracellular matrix, as 
reviewed in the previous chapter, might be succeeded by effective interactions to 
invade and colonise the host for the spread of opportunistic infections. Proteolytic 
degradation of host tissue is a common pathogenic interaction that can spread 
infections and trigger intense immune responses. The ability of the laminin-binding 
protein in B. fragilis to bind and activate plasminogen into a serine protease that 
degrades host matrix tissue has been documented (Ferreira et al., 2013). In a similar 
manner, pathogens can recruit as well as secrete a wide range of proteases and 
interfere with the host matrix. A brief outline of the effect of proteolytic interactions 
of pathogens on host is provided along with the proteolytic ability of B. fragilis and 
the consequences on host health. 
4.1.1. Proteases 
Proteases, also known as peptidases, are enzymes that catalyse the cleavage of 
peptide bonds in other proteins with which they interact. Proteases can act as positive 
and negative effectors of biological processes. The functions of proteases can be 
classified broadly as catalysts of protein degradation and specifically as selective 
agents that control physiological processes (Neurath, 1984). The significance of the 
different families of proteases is evident from the fact that 2-4% of genes in the 
human genome comprises the degradome (genes involved in protein degradation), 
whose gene products are vital for diverse functions (Puente et al., 2005). Enzymatic 
activity is also associated with the human microbiome, the microbes residing within 
humans, which secrete proteases involved in biological processes such as 
metabolism, development and virulence.  
4.1.1.1. Classification 
Proteases are multi-domain proteins with catalytic activity restricted to a single 







structure, despite having a specific enzymatic function (Carroll and Maharshak, 
2013). A broad method of classification is where proteases are grouped as 
endopeptidases or exopeptidases depending on the cleavage location. Exopeptidases 
cleave peptide bond proximal to amino- or carboxy- termini of substrates. 
Endopeptidases cleave peptide bonds distant from termini of their substrates. Further 
classification outlines 5 distinct groups of proteases on the basis of the chemical 
nature of groups responsible for their catalytic activity namely aspartic, 
cysteine/thiol, metallo-, serine and unidentified proteases (Barrett et al., 2003). 
Additionally, Rawlings & Barrett  (1993) developed a comprehensive method of 
classifying groups of enzymes on the basis of type of reaction they catalyse, 
chemical nature of catalytic site and evolutionary structure. This method of grouping 
is thus based on a hierarchical system of classification levels with 84 different 
proteases families being classified initially. The subsequent massive in-flow of 
information in the form of amino-acid sequence data and 3D pattern structures 
demanded an update in the classification system (Carroll and Maharshak, 2013). The 
MEROPS database thus came into existence and provides additional information 
regarding protein inhibitors of peptidases, small-molecule inhibitors and a collection 
of known protease cleavage sites and substrates (Rawlings & Barrett 1999; Rawlings 
2004; Rawlings & Morton 2008; Rawlings 2009). 
4.1.2. Microbial proteases 
Microbes synthesise a vast array of aspartic, cysteine, metallo- and serine proteases 
which might be cell-associated or extracellular in action. Microbial aspartic proteases 
are specific for aromatic or bulky amino acid residues on both sides of a peptide 
bond and are broadly divided into pepsin- and rennin-like enzymes. Cysteine 
proteases are generally active in the presence of reducing agents and have been 
implicated in numerous virulence and inflammatory responses (Oido-Mori et al., 
2001). Metallo-proteases require a divalent metal ion for activity and are classified 







1995). Serine proteases are characterised by a serine group at the active site and 
possess a broad substrate specificity (Róka et al., 2007). 
4.1.2.1. Proteases in the Intestinal Tract 
Of all the organ systems in the human body, the gastrointestinal tract contains the 
highest levels of endogenous and exogenous proteases. Intestinal epithelium 
performs digestive, absorptive and secretory functions and transmits information to 
mucosal, immune, vascular and nervous system. Proteases in the gastrointestinal tract 
can be luminal, circulating, secreted, intracellular, intramembrane or pericellular 
enzymes (Antalis et al., 2007). The majority of proteases are synthesised as inactive 
precursors, known as zymogens, which are then activated through proteolytic 
cleavage. Linderstrom-Lang coined the term ‘limited proteolysis’ to recognise 
proteases elaborating intestinal epithelial cell (IEC) function through signalling 
processes (Neurath, 1999). IEC proteases regulate the intestinal environment via 
ECM remodelling (Medina and Radomski, 2006).   
The gut microbiota synthesises substantial amounts of serine, cysteine and metallo-
proteases. Macfarlane et al., (1986) examined the degradation of casein and BSA by 
human faecal-slurries to produce trichloroacetic acid (TCA)-soluble peptides, 
ammonia and volatile fatty acids over a 96h period and confirmed the prominence of 
proteolysis in the large intestine. Bacteroides spp., and Propionibacterium spp. were 
identified as the predominant proteolytic bacteria in faecal samples followed by 
lesser proportions belonging to the genera Streptococcus, Clostridium, Bacillus and 
Staphylococcus. Protein breakdown can be regarded as the first step in protein 
utilisation by gut commensals where large oligopeptides are progressively degraded 
into smaller peptides and amino acids by the combined activity of microbial and 
pancreatic proteolytic enzymes, which are then assimilated directly into microbial 
protein or fermented with the production of ammonia and volatile fatty acids. 
Uncontrolled proteolysis, during events like premature activation of zymogens and 
intestinal dysbiosis by opportunistic infections, can lead to tissue invasion and 







intestinal barrier, thereby exposing the enteric immune system to luminal antigens 
(Carroll and Maharshak, 2013). Activation of intestinal macrophages which are the 
first line of defence, results in inflammatory responses in the gastrointestinal tract. 
Inflammatory bowel disease such as colitis is caused by dysregulated immune 
responses towards microbial antigens in genetically predisposed hosts and during 
conditions of intestinal barrier dysfunction. Adherent and invasive E. coli (AIEC), an 
enteric opportunistic pathogen has been implicated in gelatin degradation and biofilm 
formation, which has been observed in IBD. Biofilm formation in AIEC involves 
environmental stress-upregulation of genes encoding proteases by ϭE-mediated 
upregulation of genes followed by proteolytic processing of bacterial aggregation 
proteins to promote intercellular aggregation (Martinez-Medina et al. 2009; 
Chassaing & Darfeuille-Michaud 2013).  
4.1.2.2. Microbial proteases degrading fibrin and fibronectin 
The ability of bacteria to degrade specific host proteins is a significant virulence 
factor, especially with regard to structural and defense proteins, such as fibrin and 
fibronectin. In the event of injury, accumulation of fibrin protects surrounding tissue 
from microbial invasion. High levels of fibrinogen, the precursor of fibrin, have been 
often detected in the blood of patients suffering from infectious diseases. Therefore, 
fibrinogen degradation products might delay fibrin polymerisation and prolong 
bleeding in infections (Wikstrom et al., 1983). 
Oral bacterial species isolated from infections ranging from angular cheilitis and 
subgingival-related periodontal destructions were examined for fibrin and fibrinogen 
degrading ability. Degradation of fibrin and fibrinogen or one of them was detected 
in microbes isolated from all the sampling sources. Activity was predominant in 
strains belonging to Actinomyces, Bacteroides/Porphyromonas, Fusobacterium, 
Peptococcus, Propionibacterium and Staphylococcus spp. Enzyme specificity was 
observed and more strains were able to degrade fibrinogen than fibrin. Degradation 
of both the substrates were detected in Clostridium, S. aureus and Streptococcus 







considerable proportion of these strains tested positive for fibronectinolytic activity 
too. Interaction with fibronectin is significant for initiation and progression of oral 
infectious processes. A few strains from the non-oral Bacteroides spp, B. 
assacharolyticus and B. fragilis, also revealed fibronectinolytic activity. 
Interestingly, fibronectin degradation was not observed in relation to cariogenic 
Streptococci, which exhibited fibronectin binding (Wikstrom and Linde, 1986). 
Matsuka et al. (1999) studied S. pyogenes-associated fibrinogenolysis in detail and 
attributed the same to an extracellular cysteine protease known as streptopain or 
streptococcal pyrogenic exotoxin B (SpeB). The protease is expressed as an inactive 
40 kDa precursor, which is converted into the 28kDa active enzyme by the 
autocatalytic removal of NH2-terminal propeptide. SpeB-mediated fibrinogenolysis 
degraded the Aα-chain of fibrinogen and the degradation was specific to the COOH-
terminal region as analysed by western-blotting. In addition to fibrinogen, SpeB has 
been implicated in the cleavage of matrix proteins, such as fibronectin and 
vitronectin, resulting in loss of host tissue integrity. S. pyogenes expresses proteins 
that bind fibrinogen with  fibrinogen-binding M1 protein being the most virulent 
(Esgleas et al., 2005; Macheboeuf et al., 2011). Therefore initial host surface 
attachment might be succeeded by the action of degrading enzymes that invade and 
colonise the host tissues, as seen in invasive diseases like STSS and necrotizing 
fasciitis caused by S. pyogenes. Furthermore, the contribution of SpeB protease to the 
bacterial virulence is evident by the production of defensive anti-streptococcal 
protease antibody in humans which readily inhibits SpeB mediated proteolysis. 
Lantz et al. (1991) reported a coupled activity of fibrinogen binding, followed by 
degradation mediated by a 150kDa protein localised on the cell surface of P. 
gingivalis W12, a common periodontal pathogen. The cell-associated proteolytic 




C with the release of 
distinct fibrinogenolytic fragments of 97kDa and 50 kDa. Zymography analysis 
using substrate-containing gels identified two major fibrinogen degrading 







fibrinogenolysis on reducing agents and protease inhibitor studies indicated that the 
degrading components were thiol-dependent proteases that exhibited trypsin-like 
substrate specificity. Further studies suggested the involvement of the same surface 
component in similar interactions with fibronectin (Lantz et al., 1991b). Competitive 
inhibition studies identified unlabelled fibrinogen as a more potent inhibitor of 
labelled fibronectin binding, than unlabelled fibronectin. Fibrinogen was also 
observed to displace cell-associated fibronectin and its degradation products from 
P.gingivalis. However, the detection of fibronectinolytic activity at a relatively low 
temperature of 4
o
C, confirms fibronectin as a better substrate for P. gingivalis 
proteases than fibrinogen across varying temperatures. Periodontitis is associated 
with loss of connective tissue and bone from dental root areas, resulting in inflamed 
soft tissue pockets. Bacteria colonise these pockets and are submerged in gingival 
crevicular fluid containing plasma and tissue proteins. Thus, the complex adherence 
and degradation events displayed by the cell surface proteins allow P. gingivalis to 
attach and detach from inflamed tissue pockets and interfere with tissue repair. In 
addition to the mentioned surface component, P. gingivalis protease activity in cells, 
vesicles and spent medium have been shown to degrade collagen, C3, C5 and C5a 
receptors. 85-95% of the total proteolytic activity was attributed to three proteinases, 
PrtP, Rgp-1 and Rgp-2 of the cysteine protease family, encoded by 3 related genes 
(Barkocy-Gallagher et al., 1999). 
4.1.3. Enzymatic activities of Bacteroides spp. 
4.1.3.1. Glycosyl hydrolases  
In a commensal interaction, B. thetaiotaomicron and B. fragilis have been identified 
to encode 172 and 89 glycosyl hydrolases, respectively. These enzymes in 
combination with starch binding proteins have been involved in binding and 
utilisation of dietary and host-derived polysaccharides (Xu and Gordon, 2003). 
However, the non-commensal proteolytic interactions of the genus Bacteroides have 
been of interest since the 1970s when  the production of extracellular histolytic 







chondroitin sulphatase activities were detected in all the subspecies of B. fragilis 
tested. Elastase was associated with B. coagulans. It was hypothesised that these 
histolytic enzymes could have a potential invasive role in the infectious process of 
this genus through the degradation of the extracellular matrix. 
Later on, Riepe et al. (1980) reported the destruction of human brush border sucrase 
and maltase activity on exposure to B. fragilis elastase-like serine proteases. 
Diminished disaccharidase activity caused brush border damage and altered the 
surface membrane of mucosal cells, as observed in blind loop syndrome associated 
with bacterial over growth in humans. The glycoprotein degrading ability of B. 
fragilis was examined to assess their role in mucin degradation (Macfarlane and 
Gibson, 1991). Mucins cover the mucosal surface of the large intestine and offer a 
slippery gel-like texture which prevent pathogenic attachment besides maintaining 
colonic health and integrity. The B. fragilis NCDO2217 strain produced cell-
associated hydrolytic enzymes such as neuraminidase, fucosidase, N-
acetylgalactosaminidase, β-galactosidase and N-acetylglucosaminidase which were 
able to degrade carbohydrate moieties of mucin glycoproteins. Due to the hydrolytic 
nature of the organism, they are able to grow on diverse substrates by inducing 
differential enzymatic production. 
Guzmán et al. (1990) observed 24 out of 50 clinical samples of B. fragilis exhibiting 
a neuraminidase (NA) mediated attachment to mammalian epithelial cells. The 
adhesion was epithelial cell-specific and did not mediate attachment to PMNLs. The 
bacterium produced cell-bound neuraminidase which exposed a galactoside residue 
present on a mammalian cell receptor, thereby promoting adhesion of B. fragilis. 
Neuraminidase-dependent adhesion of epithelial cells to B. fragilis was  
competitively inhibited by galactosidase treatment which confirmed the significance 
of the residue in the process. A pili-independent increase in haemagglutination titre 
was also observed with RBCs pre-treated with NA, which coincided with an 
increased adherence efficiency to NA treated epithelial cells. Neuraminidase 







and glycolipids, thereby altering cellular integrity and inter-cellular relationships 
(Godoy et al., 1993). Bacterial neuraminidase activity might progressively strengthen 
a capsule/pili mediated bacterial adherence to host epithelial cells. As protease 
treatment was found to reduce adhesion, the adhesin was identified as an outer 
membrane protein that extends across the capsular layer, when present (Guzmán et 
al., 1990).  
4.1.3.2. Protease activities 
Protease production by B. fragilis has been compared in continuous and batch 
cultures in multiple studies to determine the effect of nutrient limitation. Gibson & 
Macfarlane (1988) studied the strain NCDO2217 of B. fragilis and reported cell-
bound proteolytic activity which was eventually released from the bacterial cells 
during stationary phase. Therefore the bacterium might contribute to gut-associated 
extracellular proteolysis as well as that concerning self. Hydrolysis of casein, trypsin, 
chymotrypsin, azocasein and arylamidase activity against leucine p-nitroanilide 
(LPNA), leucine β-naphthylamide, glycyl-proline p-niotroanilide (GPRPNA) and 
valyl-alanine p-nitroanilide (VAPNA) were exhibited by the bacterium. There was 
no hydrolysis reported with respect to globular proteins. B.fragilis NCDO2217 could 
utilise an array of nitrogen sources for its growth, such as ammonia, casein and 
peptone. Growth on trypsin and chymotrypsin was also observed, which describe the 
bacterium's role in degrading pancreatic proteases. Collagenolytic activity was not 
detected in B. fragilis as the protein was degraded by pancreatic proteases, trypsin 
and chymotrypsin, leaving the substrate unavailable for proteases in the large 
intestine. The fastest growth was measured on ammonia and the usage of casein as 
substrate exhibited the highest protease activity. Cell-bound protease activity was 
observed to be growth rate dependent, especially in nitrogen-limited cultures. 
Slowing of growth in stationary phase marked the accumulation of protease activity 
in the medium, accompanied by a slight reduction in cell-bound protease activity. No 
such accumulation was observed in medium in continuous culture, although,  ̴ 25% 







continuous cultures. Thus, constitutive protease production was evidently influenced 
by nutrient availability and culture conditions. A similar influence was observed in 
protease synthesis and release in B. fragilis ATCC25285 grown in continuous and 
batch cultures (Macfarlane et al., 1992). Secretion of proteases in stationary phase 
was a distinct event and not associated with general lytic release of cytoplasmic 
contents. This was evident from the decline in the release of cell-bound marker 
enzymes β-galactosidase and alkaline phosphatase in stationary phase. In continuous 
culture, the ratio of intracellular: whole cell protease activity increased with growth 
rate and extracellular protease activity was detected in trace amounts at the lowest 
dilution rate, probably due to cell lysis. The secretory behaviour in continuous 
culture indicates that initiation of protease secretion requires a specific signal that is 
produced only at the end of active growth. The signal was suggested to be activated 
as a response to nitrogen depletion in stationary phase of batch cultures. The 
observed relationship between protease secretion to nutrient availability was 
correlated to in vivo conditions where B. fragilis synthesises high levels of cell-
bound proteases during growth in the nutrient-rich cecum followed by release of 
enzymes in the nutrient limited distal colon. Thus it could be hypothesised that 
nitrogen limitation in the distal colon could signal the release of cell-bound proteases 
by B. fragilis. An increase in cell-associated protease production in exponential 
phase and subsequent release in stationary phase in batch cultures was also observed 
in B. splanchnicus NCTC10825, protease activities of which were similar to that of 
B. fragilis and differed only on the basis of inability to grow on sucrose and a few 
other disaccharides. Inhibition experiments in  NCTC10825  indicated the presence 
of serine, thiol and possibly metallo-proteases, as was observed in B. fragilis 
(Macfarlane and Gibson, 1993). Further, the activity of three proteases, P1, P2 and 
P3 produced by B. fragilis NCDO2217  were examined in order to determine their 
substrate specificity, location and type.  Cell fractionation demonstrated that P1 was 
located intracellularly and in the periplasm, whereas P2 and P3 were outer 
membrane- associated. Substrate specificities of the three enzymes were tested on 







characterised as an unusual thiol-group dependent serine exoprotease as it strongly 
hydrolysed VAPNA, GPRPNA and weakly hydrolysed azocasein, which was 
inhibited by phenylmethylsulfonyl fluoride (PMSF) and thimerosal a.k.a thiomersal 
in U.K. Since P2 and P3 hydrolysed azocasein and LPNA, they were regarded as 
endopeptidases, owing to the high protease : arylamidase ratios. Since P2 hydrolytic 
activity was inhibited by Ethylenediaminetetraacetic acid (EDTA) and P3 by 
thimerosal a.k.a thiomersal in U.K. and iodoacetate, they were recognised as 
metalloprotease and cysteine protease, respectively. Thus, the function of P2 and P3 
proteases might be initiation of protein breakdown at the cell surface with P1 
mediating further hydrolysis of peptides produced by outer membrane proteases 
(Gibson and Macfarlane, 1988b). 
B. fragilis strains secreting an enterotoxin (BFT) belonging to the zinc 
metalloprotease family were implicated in diarrheal disease in animals. The secretion 
of enterotoxin is a unique feature of enterotoxigenic B. fragilis (ETBF) strains, which 
encode three isotypes of BFT on distinct bft loci present on a B. fragilis 
pathogenicity island (6kb) (Sears, 2001). Enterotoxin activity was first detected by 
Myers et al. (1984) using intestinal loop tests of B. fragilis strains isolated from 
faeces of 24-48h old lambs suffering from acute diarrhoea. Enterotoxigenic B. 
fragilis strains were first isolated from humans in 1987 and were later identified as a 
common causative agent of infant diarrhoea (Myers et al. 1987; Sack et al. 1994). 
Isolation of ETBF from sewage plants suggest that these strains could be members of 
the normal colonic microbiota (Shoop et al., 1990). B. fragilis strains lacking the 
enterotoxin gene (NTBF) failed to produce diarrhoea in rabbit models and there was 
no indication of bacteraemia, adherence or invasion of epithelial cells in the disease 
model (Myers et al., 1989). The extracellular enterotoxin was purified and 
characterised as a  ̴ 20 kDa single polypeptide (Van Tassell et al., 1992). Further 
analysis post cloning the gene encoding the polypeptide into E. coli identified a zinc 
binding motif which is a characteristic feature of the metzincin family of 
metalloproteases. Proteolytic activity at 37
o
C revealed autodigestion of enterotoxin 







chelators thus confirming metalloprotease activity (Moncrief et al., 1995). In vivo, 
the secreted enterotoxin (fragilysin) induces the release of colonic epithelial cell 
surface proteins and cleavage of E-cadherin, the primary protein of  zonula adherens 
epithelial tight junctions. Loss of intestinal tight junctions contributes to a reduction 
of the colonic barrier. Subsequent fluid accumulation results in ETBF-associated 
diarrhoea, loss of appetite and depression (Wu et al., 1998). However, more recent 
studies by the same group introduced a model by which the catalytic domain of BFT 
processes its receptor protein inducing cellular signal transduction that mediates the 
biological activity of BFT (Wu et al., 2006). Obiso et al. (1997) observed 
morphologic alterations and increased permeability of the paracellular barrier of HT-
29 cells by enterotoxin. Enterotoxin-mediated intoxication of the paracellular barrier 
was independent of endocytosis and was also observed in kidney and lung epithelium 
by in vitro assays. The disruption of tight junctions on rat lung and canine kidney 
epithelium by enterotoxin suggest a possible role of the toxin in extraintestinal 
infections (Obiso et al., 1997). Studies have already identified the presence of ETBF 
in a larger proportion of B. fragilis isolated from human blood cultures suggesting a 
correlation to bacteraemia (Kato et al., 1996). Łuczak et al. (2001) detected the 
enterotoxin encoding gene in 12 out of 65 investigated B. fragilis strains isolated 
from extraintestinal clinical specimens from four countries.  
4.1.3.3. Proteases induced by B. fragilis under different host conditions 
B. fragilis was found to induce the release of host degrading proteases during its 
forage for nutrients, as observed in the bacterial requirement of heme for growth. 
Limitation of heme was a signal to induce protease expression for the release from 
heme-binding plasma proteins. Bacteriostatic conditions were observed immediately 
after the addition of hemopexin, a heme-binding plasma protein, which limited the 
availability of heme for B. fragilis growth. Eventually, production of hemopexin-
degrading proteases by B. fragilis facilitated the release of heme from hemopexin. A 
heme-witholding mechanism contributes to host defence against infections by heme-







membrane proteins. Black-pigmented members of the B. fragilis group degrade 
serum heme-carrier to provide free heme. Inhibition studies suggested that 
hemopexin degradation was caused by a serine protease in B. fragilis (Rocha et al., 
2001). 
Four homologues of gene encoding SpeB, a member of the C10 family of cysteine 
proteases have been identified in B. fragilis (bfp1-bfp4) and B. thetaiotaomicron 
(btpA, btpB, btpC and btpZ). bfp1 and bfp2 were present in all three strains studied 
whereas bfp3 and bfp4 were exclusive to the 638R strain and were present on mobile 
genetic elements (Thornton et al., 2010). C10 proteases are a group of papain-like 
cysteine proteases including Spe B and Interpain A produced by Prevotella 
intermedia. The contribution of these proteases to virulence has been studied 
extensively in SpeB-mediated cleavage  of host matrix proteins, cytokines and 
release of kinin from kininogen. C3 degradation observed in Interpain A has also 
been associated with SpeB (Kagawa et al., 2000; Potempa et al., 2009). Therefore, 
the presence of C10 homologues in Bacteroides spp. could predict the ability of 
B.fragilis to disseminate infections. SpeB and Staphopain, a C47 cysteine protease 
expressed in staphylococci were transcriptionally coupled to genes encoding specific 
protease inhibitors, Spi and Staphostatin, respectively. A similar mechanism of 
coupling was observed in bfp1 and bfp4 encoded by B. fragilis and in btpA, btpB and 
btpz encoded by B. thetaiotaomicron. These inhibitory mechanisms could prevent 
bacterial cells from ectopic proteolytic damage. There was an increase in the 
expression levels of bfp1 and bfp4 encoding B. fragilis C10 proteases in response to 
oxygen. A similar inducible effect was observed in corresponding B. 
thetaiotaomicron C10 proteases as well, except btpA expression, which was 
stimulated in the presence of blood. The differential expression of these Bacteroides 
secreted proteases were observed only in extraintestinal habitats, such as blood and 
oxygen, whereas no induced expression was determined in caco-2 cell cultures. The 
observed differential expression with respect to the habitat contribute to its  predicted 
role in spreading extraintestinal infections, as suggested in other members of C10 







Hemolysins secreted by bacteria benefit pathogenesis by weakening the immune 
system and gaining access to nutrients. B. fragilis was considered as a non-hemolytic 
bacterium until Robertson et al. (2006) identified ten genes in B. fragilis which 
shared homology to other bacterial hemolysins. The identified hemolysins, HlyA - 
HlyI and HlyIII were subjected to functional analysis by cloning into a non-
hemolytic E. coli strain. Subsequent analysis on blood agar plates detected hemolytic 
activity by the recombinant E. coli. HlyH was exclusive to the genome of B. fragilis 
NCTC 9343. A synergistic effect on hemolytic activity by HlyA and HlyB identified 
a two-component hemolysin. Differential regulation of HlyB and HlyA expression in 
the presence of oxygen and iron suggests that HlyBA is associated with B. fragilis 
pathogenicity in an oxygen- and iron- limited environment. This is in agreement with 
the observation that an oxygen limiting condition is required  at the site of infection 
for the aetiology of extraintestinal anaerobic infection by B. fragilis. Further, in 
addition to a reported heme-degrading serine protease activity, B. fragilis might be 
able to overcome the host-imposed iron-limiting conditions through the  regulation of 
HlyBA expression in iron depleted conditions. In vivo expression of hemolysins and 
role of HlyBA as a virulence factor was also addressed by Lobo et al. (2013) in an 
intra-abdominal infection model. Expression of eight hemolysin mRNAs were 
induced at different levels post-infection and there was a distinct reduction in the 
growth rate of a hlyBA mutant strain after 8 days following infection.  
4.1.3.4. OMV-related enzymic activity 
Macfarlane et al. (1992) had reported that ̴ 10% of the extracellular proteases in cell-
free culture supernatants of B. fragilis were associated with particulate fractions 
exhibiting high specific protease activities, reminiscent of P. gingivalis OMVs. 
Observations made in this study were strengthened by the work of Patrick et al. 
(1996) which provided evidence of haemagglutination and enzymic activity in 
relation to outer membrane vesicles, that were released from the B. fragilis outer 
membrane. OMV released by P. gingivalis had been implicated in virulence which 







(Mayrand and Grenier, 1989). Therefore, enzymic activity in terms of alkaline 
phosphatase, lipase, β galactosidase, glucosminidase and glucosidase detected in 
OMV secreted by B. fragilis could possibly mediate tissue destruction by the 
degradation of host glycoproteins. Recently, a comparison profile of OM and OMV 
proteome in B. fragilis indicated a higher proportion of glycosidases and proteases in 
the OMV with more than  40 proteins being OMV-specific (Elhenawy et al., 2014). 
MS analysis identified a quarter of the proteins present in OMVs as glycosidases, 
peptidases, a phosphatase and a lipase. 80%  of the OMV-specific proteins were 
acidic as indicated by isoelectric points. In contrast, OM proteome, which was more 
basic in nature, exhibited a higher proportion of TonB-dependent receptors and a 
lower abundance of hydrolases. The OMV proteome demonstrated proteolytic 
activity in zymograms against gelatin. Secretion of hydrolytic OMVs enhances the 
degradation of polysaccharides and glyco-conjugates which would contribute to 
microbial nutrition in the gut. The nutrients released by degradation could also help 
pathogenic gut-colonizers. A high level of digestive hydrolases detected in the OMV 
of bacterial predator, Myxococcus xanthus, were detected to have predatory effects 
and lytic activity against E. coli. Therefore, the B. fragilis-secreted hydrolytic OMVs 
could also operate against host tissue, such as mucus glycans, allowing unfavourable 
destruction and immune responses (Elhenawy et al., 2014).  
4.1.3.5. Fibrinogen-degradation by B. fragilis 
The ability of non-oral B. fragilis to degrade fibronectin was proposed in an earlier 
study (Wikstrom and Linde, 1986). Later, studies by Chen et al. (1995) purified and 
characterised a 100 kDa fibrinogen-degrading protease from B. fragilis strain 
YCH46. Inhibition studies revealed the purified enzyme to be a serine-thiol-like 
protease. In addition to fibrinogen, proteolytic activity was detected against casein, 
azocoll and gelatin. The protease was involved in the cleavage of Aα-chain of 
fibrinogen, within a 10h time period, and repressed thrombin-mediated coagulation 
of fibrinogen. The crude extract of B. fragilis YCH46 was reported to cleave all three 







purified protease, it was suggested that  B. fragilis might encode other proteases with 
fibrinogenolytic activity. Further analysis by Houston et al. 2010 predicted the 
involvement of extracellular metalloproteases and a cysteine protease in 
fibrinogenolysis exhibited by strains NCTC 9343, 638R and YCH46, respectively. 
Analysis of exponential and stationary phase culture supernatants using zymograms 
identified fibrinogenolysis at ̴ 45 and 50 kDa. Protease-specific activation buffers 
indicated metallo-proteolytic activity in fibrinogen degradation observed in NCTC 
9343 and 638R. Comparison of fibrinogen degradation profiles of these strains and a 
further six clinical isolates showed that most of them initiated Aα-chain degradation 
during exponential growth phase, followed by Bβ-chain hydrolysis. Hydrolysis of γ-
chain hydrolysis was variable across the strains studied and commenced only in the 
stationary phase. However, MS analysis of proteins within the detected 
fibrinogenolytic range obtained from concentrated supernatants of the mid-
exponential phase cultures of B. fragilis failed to identify any proteases predicted by 
the complete genome sequence annotation. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) activity, associated with virulence in certain pathogens, 
and the presence of lipoproteins was observed in MS analysis which might suggest 
the involvement of OMVs in the detected fibrinogenolysis (Houston et al., 2010). 
B. fragilis, being the most common obligate anaerobe isolated from soft tissue 
abscesses and blood-related infections, might be able to prevent or delay the 
formation of the fibrin-mediated abscess wall, which normally curtails the spread of 
infections. The role of fibrinogenolytic proteases secreted by B. fragilis might 
accelerate infection dissemination by delaying the formation of fibrin walls, 
however, B. fragilis comes into contact with extraintestinal fibrinogen only when the 
intestinal barrier is disrupted. It has been suggested that the secretion of proteases 
might be triggered by the depletion of nutrients in the growth environment. 
Therefore, the secretory behaviour and regulation of proteases involved in fibrinogen 
degradation in nitrogen limiting conditions would open avenues to study the 
transition of this commensal into an opportunistic pathogen in extraintestinal 








 To test fibrinogen degradation in B. fragilis NCTC 9343. 
 To analyze the role of protease-encoding genes present in NCTC 9343 in 
fibrinogen degradation by zymography. 
 To analyse the potential role of multiple proteases in fibrinogen degradation 
by generating multiple gene deletion mutants followed by their zymography. 
 To express the extracellular NCTC 9343 proteases in E. coli and to 
investigate their specific role in fibrinogen degradation. 
4.2. Fibrinogen degradation detected in B. fragilis strain NCTC 9343 
Fibrinogen degradation was previously detected in B. fragilis NCTC 9343 grown at 
37
o
C in supplemented Brain Heart Infusion medium containing 100 µg/ml 
plasminogen-free human fibrinogen. Detection of fibrinogenolysis by B. fragilis, 
subsequent to fibrinogen binding, might suggest a mechanism by which this 
opportunistic pathogen escapes from fibrin-mediated abscess walls in peritoneal 
infections, prevents clot formation and promotes blood-stream infections in humans 
(Houston et al., 2010; Patrick and Duerden, 2006; Patrick et al., 1995b). Partial Aα-
chain degradation was detected in 3h grown B. fragilis culture (Figure 4.1 A lane 1)  
followed by complete degradation of the  Aα-chain of fibrinogen after 48 h 
incubation, along with partial degradation of  Bβ- and ϒ-chains (Figure 4.1 A lane 
2). The Aα-chain has been suggested to be an accessible target for proteolytic 
activity owing to its characteristic location in the fibrinogen molecule, where the  
chain protrude outwards via the D domain (Weisel, 2005). Fibrinogen was not 
degraded in BHI-S media even after a 48 h incubation period (Figure 4.1 A lane 4) 
indicating that the growth medium does not contribute to the observed degradation of 
fibrinogen. The ability of B. fragilis NCTC 9343 concentrated culture supernatant to 
degrade fibrinogen was studied using 0.1% fibrinogen SDS-zymography 
experiments. Supernatants of stationary phase cultures grown in BHI-S as well as 
glucose-DM were concentrated by centrifugation through a membrane with a 100 
kDa molecular weight cut-off (MWCO) (2.7.2) to get a better representation of the 







The concentrated culture supernatants were electrophoresed separately on SDS-
PAGE gels containing 10% separating gel and on 0.1% fibrinogen SDS-zymogram 
as (2.7.3 and 2.7.5). Following protein refolding and incubation in serine protease 
and metalloprotease activation buffers, and visualisation, (2.7.5 and 2.7.4), 
fibrinogenolytic activity at ~45 and 50 kDa was detected in zymograms of  BHI-S 
grown culture (Figure 4.1 B lane 1). However in glucose-DM grown culture, a zone 
of fibrinogenolysis was observed only at ~45 kDa (Figure 4.1 C lane 1). Activity was 
compared to negative control samples of concentrated BHI-S broth, in which no 
fibrinogenolytic bands were observed even after a 48h incubation in activation 
buffers (Figure 4.1 C lane 2). The results obtained were in agreement with fibrinogen 
degradation studies carried out by Houston et al. (2010) and confirmed that 
fibrinogen degradation is associated with non cell-related material since the culture 
supernatants exhibited fibrinogen degradation ability. However, a difference in 
fibrinogenolytic activity between the two media was not reported in the previous 
study. The observed difference suggests a variation in the mechanism of proteolysis 









Figure 4.1: Detection of fibrinogen degradation by the wild-type 9343 
(A) SDS-PAGE analysis of fibrinogen degradation by 3h (lane 1) and 48h (lane 2) grown 
cultures of wild-type 9343 in comparison with fibrinogen in BHI-S media as negative control 
at 3h (lane 3) and 48h (lane 4) incubation. Complete degradation of Aα-chain and partial 
degradation of Bβ- and γ-chains were observed in 48h grown culture (lane 2). (B) 0.1% 
fibrinogen zymography of  concentrated B. fragilis strain NCTC 9343 supernatant grown in 
BHI-S medium observed as two distinct bands of fibrinogenolysis (lane 1) (C) 0.1% 
fibrinogen zymography of concentrated B. fragilis strain NCTC 9343 supernatant grown in 
glucose-DM observed as a single band of fibrinogenolysis (lane 1) when compared to 
concentrated BHI-S medium as negative control (lane 2). 
 
4.3. Generation of markerless protease-encoding gene deletion mutants in         
B. fragilis 
Although fibrinogen zymography studies by Houston et al. (2010) suggested the 
involvement of metalloproteases in non-cell-associated fibrinogenolysis of B. fragilis 
strain NCTC 9343, MS analysis failed to reveal any specific proteases acting within 
the fibrinogenolytic range. However, studies conducted in other bacteria, such as 
Pseudomonas aeruginosa, Streptococcus pyogenes, Staphylococcus aureus and 
Porphyromonas gingivalis have confirmed fibrinogenolytic activity dependent on 
cysteine proteases and a metalloprotease (Ciborowski et al., 1994; Komori et al., 







identified a 150 kDa cell surface component involved in fibrinogen binding and 
degradation by P. gingivalis, while Ciborowski et al. (1994) suggested that the two 
cell surface-associated fibrinogenolytic proteases at 150 and 120 kDa were 
conformational variants of a 180 kDa cysteine protease, porphypain.  
To investigate the role of secreted proteases in fibrinogenolysis we used reverse 
genetics to delete genes encoding putative proteases. Four protease encoding genes 
were identified in the genome of B. fragilis NCTC 9343 using artemis genome 
browser, all of which encoded  signal peptide sequences suggesting the expression of 
secreted proteases. The molecular-weight range of the identified extracellular 
proteases were  ̴ 45-50 kDa, which was within the range of  observed 
fibrinogenolytic bands in the culture supernatant zymogram. The secreted proteases 
belonged to metallopeptidase and serine protease families and BLAST analyses 
revealed similarities to expressed  proteases in other bacterial species (Table 4.1). 
Gene BF0275 encoded a metalloendopeptidase which was  ̴ 50 kDa in size and 
shared sequence homology with a putative peptidase BT3464 in Bacteroides 
thetaiotaomicron (80.77% identity in 437 aa) whereas BF0657 expressed a secreted 
metalloendopeptidase of ̴ 37 kDa with sequence similarity to a putative 
aminopeptidase SCO4589 secreted by Streptomyces coelicolor (34.55% identity in 
191 aa). Serine proteases of  ̴ 49 kDa encoded by BF1979 and BF3775 genes shared 
sequence homology with putative periplasmic protease BT0154 of B. 
thetaiotaomicron (43.86% identity in 440 aa) and putative secreted peptidase 
SCO7188 of S. coelicolor (28.53% identity in 431 aa). Expression studies conducted 
later have considered 27 other protease encoding genes containing signal peptide 








Table 4.1: Description of the selected protease encoding genes using artemis genome 
browser 
BF0275 (metalloendopeptidase), BF0657 (secreted metallopeptidase), BF1979 (periplasmic 
serine protease) and BF3775 (exported serine protease) present in NCTC 9343. The selected 
protein sequences shared identities with a putative peptidase from B. thetaiotaomicron, a 
putative aminopeptidase from S. coelicolor, a putative periplasmic protease from B. 
thetaiotaomicron and a putative secreted peptidase from S. coelicolor, respectively.   
Feature Name CDS Size Hit 
BF0275          
Metallo 
endopeptidase 
304996...306306 1311 bp 437 aa 




BT3464 (435 aa) E 
value : 1.4e-99 and 
80.77% identity in 
437 aa 
BF0657         
Secreted 
metalloendopeptidase 





SCO4589 (324 aa) E 
value : 2.4e-08 and 
34.55% identity in 
191 aa 
BF1979         
Putative periplasmic 
serine protease 






(484 aa) E value : 
1.1e-27 and 43.86% 





4458153...4459505                                              
 






SCO7188 (1239 aa) 
E value : 2.4e-07 and 
28.53% identity in 








4.3.1. Primer design for amplifying the upstream and downstream regions of the 
selected protease-encoding genes 
To amplify the upstream and downstream regions, four individual primer sets were 
designed for each gene using the Artemis genome browser and annotation tool and  
as explained in Chapter 3 (3.5.1). The left outside forward and left inside reverse 
primers were designed to amplify ~500 bp upstream of the desired gene whereas the 
right inside forward primer and right outside reverse primers were generated to 
amplify the region flanking the gene downstream (Figure 4.2 A, B, C and D). Primer 
sequences were in the range of 20-24 bases in length and melting temperature (Tm) 
values of the primer sequences were restricted to 60-66
o
C. Primers designed for the 
outside region of flanks (left outside and right outside primers) were attached with 
~15 bp overlap from the vector sequence in order to ensure compatibility while 
cloning. To facilitate fusion PCR, the left inside and right inside primers were 



















Figure 4.2: Graphic representation of the selected protease encoding genes and 
flanking regions  
Graphic representation of (A) BF0275, (B) BF0657, (C) BF1979 and (D) BF3775 (red 
boxes) with left outside primers and left inside primers (LOF1-LOF4 and LIR1-LIR4)  
designed for amplifying the upstream regions of each gene (denoted in blue) and right inside 
and right outside primers (RIF1-RIF4 and ROR1-ROR4) designed for amplifying the 
downstream regions (denoted in green). Sizes of the genes, upstream and downstream 
amplicons are also indicated.  
 
4.3.2. Generation of the deletion constructs 
The deletion constructs for the protease-encoding genes were generated by 
amplifying the left upstream and right downstream flanks of each gene according to 
appropriate PCR conditions (2.5.3) using NCTC 9343 genomic DNA as the template. 
The amplified flanks of each gene were visualised after electrophoresis on 1% 
agarose gels and were in the range of 500-625 bp (Figure 4.3). The amplified flanks 
were then subjected to fusion PCR using left outside forward primer and right 
outside reverse primer to fuse the flanking sequences and generate 1000-1200 bp 
sized deletion constructs (Figure 4.4). 





















































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.3. Cloning the deletion constructs into pGB910  
The deletion constructs were cloned into the NotI restriction site in the multiple 
cloning site (MCS) region of linearised pGB910 by Infusion cloning, a ligation 
independent cloning method (2.5.8). The Infusion enzymes fuse DNA fragments, 
PCR generated sequences and linearised vectors, efficiently and precisely by 
recognising a 15 bp overlap at their ends. Infusion cloning reactions were set up by 
incubating each of the protease-encoding gene deletion constructs, linearised vector 
and the infusion enzymes (2.5.8). The pGB910 vector used for infusion cloning is 
an  ̴  5300 bp RP4-based conjugative vector (3.5.3). In the present study, the vector 
was linearised by digesting with NotI (Figure 3.8). The infusion cloning mixture was 
used to transform E.coli S17-1 λpir  (2.4.3). The transformants were selected for 
chloramphenicol  resistance on LB agar plates. Resistant colonies carrying the 
recombinant pGB910 vector were confirmed by PCR amplification of the deletion 
constructs (Figure 4.5 A, B and C) and Sanger-based sequencing (2.5.10).





   
 
 












































































































































































































































































































































































































































4.3.4. Conjugal transfer of gene deletion constructs into B. fragilis strain NCTC 
9343 
The recombinant vectors carrying the deletion constructs were mobilized from E. 
coli S17-1 λpir  into B. fragilis NCTC 9343 by conjugation (2.4.5).  Post-
conjugation, the strains were plated on BHI-S agar containing antibiotics, gentamicin 
sulphate to select against E. coli and erythromycin to select B. fragilis 
transconjugants carrying the recombinant pGB910 vector. The plated transconjugants 
were grown anaerobically for 2 days prior to confirming the presence of integrated 
plasmids in the erythromycin resistant colonies by PCR amplification of 
chromosomal DNA using left and right outside primers designed for the protease 
gene deletion constructs.  Following conjugation, the B. fragilis strains carrying the 
integrated plasmid are partial diploids and therefore PCR amplification with left 
outside forward and right outside reverse primers of each protease encoding gene 
would result in amplicons corresponding to the size of the wild-type gene combined 
with the flanks  as well as the size of the deletion construct (Figure 4.6 A, B, C and 
D). PCR amplification using left outside forward and right outside reverse primers, 
LOF2 and ROR2, specific to ΔBF0657 resulted in a band with an expected size of 
2038 bp, corresponding to the size of the wild-type 0657 gene along with left and 
right flanks as well as a band at 1072 bp, which corresponded to the size of deletion 
construct (Figure 4.6 B lane 1). Likewise, the transconjugant  partial diploid of 
BF3775 gene resulted in a band at 2414 bp and 1187 bp corresponding to the wild-
type + flanks and the deletion construct, respectively on PCR amplification with 
LOF4 and ROR4 primers (Figure 4.6 D lane 1). 











































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.5. Resolution of partial diploids carrying the deletion constructs 
The resulting partial diploid strains were transformed by electroporation with 
pGB920 (2.4.4). Tetracycline resistant colonies were selected and streaked on DM 
containing 2% fucose, which induced an I-SceI mediated double-strand break and 
allowing diploids to resolve to either wild-type or deletion genotypes. Colonies 
grown on fucose were patched onto plain BHI-S medium and BHI-S medium 
containing erythromycin to screen for loss of erythromycin resistance. Chromosomal 
DNA extracts of the erythromycin sensitive colonies were subjected to PCR 
amplification using left outside (LOF1-LOF4) and right outside (ROR1-ROR4) 
primers to confirm the presence of deletion constructs of BF 0275 at  ̴  1000 bp 
(Figure 4.7 A lane 3), BF0657 at  ̴ 1000 bp (Figure 4.7 B lane 2), BF1979 at  ̴ 1100 
bp (Figure 4.7 C lanes 3 and 4) and BF3775 at  ̴  1200 bp (Figure 4.7 D lanes 1-3). 
However, the diploids that resolved into wild-type genotype resulted in a band 
corresponding to the size of the wild-type gene along with flanking regions (Figure 
4.7 A lanes 1, 2, 4, B lane 1, C lanes 1, 2 and D lane 4). 
































































































































































































































































































































































































































































































































































































































4.4. Analysis of fibrinogen degradation by protease-encoding gene deletion 
mutants 
Fibrinogen degradation by the deletion mutants was analysed by fibrinogen 
zymography in the present study. Mass-Spectrometry analysis by Elhenawy et al. 
(2014) identified 25% of the proteins present in OMVs released by B. fragilis strain 
NCTC 9343 to be homologous to hydrolases, of which 7 peptidases were exclusive 
to OMV and not detected in the outer membrane- proteome. Houston et al. (2010) 
have already indicated the role of non cell-associated proteases in fibrinogenolytic 
activity exhibited by B. fragilis. Therefore, supernatants of  BHI-S grown stationary 
phase cultures of the wild-type strain NCTC 9343 and the four protease-encoding 
gene deletion mutants were concentrated by centrifuging in membranes containing a 
100 kDa MWCO and analysed for their fibrinogenolytic ability in zymography 
experiments. Zymography is the electrophoretic separation of non-reduced proteins 
through a polyacrylamide gel containing a proteolytic substrate. The denaturing 
electrophoresis was followed by protein renaturation and incubation in appropriate 
buffers for activation of  proteolytic activity. 0.1% fibrinogen was used as the 
proteolytic substrate in 10% SDS polyacrylamide gels. The SDS-fractionated protein 
samples were renatured and incubated in metalloprotease and serine protease 
activation buffers (2.7.5). After proteolytic activation, SDS-zymograms were 
checked for the presence of lytic bands in the form of clearance zones. Proteolytic 
bands were identified at ~50 kDa for the wild-type sample as well as for all the four 
single gene deletion mutants, ΔBF0275, ΔBF0657, ΔBF1979 and ΔBF3775 strains 
(Figure 4.8 B lanes 1,2,3,4 and 5). The presence of fibrinogenolytic bands confirmed 









Figure 4.8: Analysis of fibrinogen degradation of the deletion mutants by zymography 
(A) SDS-PAGE analysis of concentrated culture supernatants of BHI-S-grown  wild-type 
9343 (lane 1), ΔBF0275 (lane 2), ΔBF0657 (lane 3), ΔBF1979 (lane 4) and ΔBF3775 (lane 
5) and (B) Fibrinogen zymography of the corresponding samples (lanes 1-5). The positions  
of molecular weight markers (M) in kDa are shown adjacent to the gel. The observed 
clearance bands in the zymogram indicate the presence of a fibrinogen degrading component 
at   ̴ 50 kDa. 
 
4.5. Analysis of fibrinogen degradation by the generation of multiple protease-
encoding gene deletion mutants in B. fragilis  
The study of virulence-associated proteases in the periodontal pathogen, P. gingivalis 
showed significant decreases in collagenolytic activity with respect to prtP single-
knockout mutant as well as rgp-1 prtP double-knockout mutant. It was also 
hypothesised that a triple-knockout mutant involving the protease-encoding genes, 
prtP, rgp-1 and rgp-2 would block the P.gingivalis-mediated collagenolytic activity 
completely (Barkocy-Gallagher et al., 1999). The role of multiple proteases in 
fibrinogren degradation in the present study was investigated by performing step-
wise deletions of all the four selected proteases in a single B. fragilis strain. 
Since the functional analysis of single gene deletion mutants of the four selected 
protease-encoding genes in substrate zymography experiments still degraded 
fibrinogen, multiple gene deletions of the previously selected protease-encoding 
genes were generated. Combined effect of these proteases on fibrinogen degradation 







tetracycline resistance of single gene deletion mutants was performed prior to 
generating multiple markerless deletions to render stability to the mutant and for 
easier genetic manipulations of the mutant. The generation of a quadruple gene 
deletion mutant in any bacterial model is rare and was specifically tedious with 
respect to B. fragilis strain NCTC 9343 owing to the lack of antibiotic resistance 
markers. ΔBF3775 was made tetracycline sensitive by repeated sub-culturing in 
BHI-S without selection and was used as recipient for the generation of double 
deletion. Recombinant  E.coli strain S17-1 λpir carrying BF1979 gene deletion 
construct was mobilized into tetracycline sensitive BF3775 gene deletion mutant in 
B. fragilis by conjugation. As described earlier, erythromycin resistant 
transconjugants were electroporated with pGB920. Erythromycin sensitive colonies 
were confirmed for the presence of BF1979 gene deletion construct by PCR 
amplification using LOF3 and ROR3 primers. Amplicons of  ̴ 1100 bp were confirmed 
on 1% agarose gels (Figure 4.9 lanes A1-A3, A6, A7, A8, A11, A12, B1-B6, B7, 
B10). The ΔBF1979ΔBF3775 mutants thus generated were the recipients for the 
mobilization of BF0275 gene deletion construct to generate the 
ΔBF1979ΔBF3775ΔBF0275 mutant with  ̴ 1000 bp amplicon corresponding to 
BF0275 delection construct observed on agarose gel (Figure 4.10 lane 3). In a similar 
manner, a quadruple gene deletion mutant, ΔBF1979ΔBF3775ΔBF0275ΔBF0657 
was generated (Figure 4.11 lanes 1-4) using BF0657 gene deletion construct in E. 
coli strain S17-1 λpir. 
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4.5.1. Detection of fibrinogen degradation by the multiple deletion mutants 
Fibrinogen zymography was repeated to analyse the ability of multiple deletion 
mutants to degrade fibrinogen. Concentrated culture supernatants of the double, 
triple and quadruple gene deletion mutants grown on BHI-S as well as glucose-DM  
were prepared. Cell-free supernatants concentrated from cultures grown in glucose 
DM produced a single proteolytic band at ~45 kDa on fibrinogen-SDS zymograms 
after reactivation of proteases and was detected in wild-type strain NCTC 9343 as 
well as the quadruple deletion mutant. Three replicates of the zymography 
experiments were performed and a representative example is shown (Figure 4.12). 
Concentrated BHI-S media was used as a control sample in which no proteolytic 
activity was detected (Figure 4.12 B lane 3). Two proteolytic bands at ~45 and 50 
kDa were detected in SDS-zymograms of electrophoresed samples of multiple 
deletion mutant and wild-type 9343 concentrated supernatants grown in BHI-S 
media (Figure 4.13 lanes 1, 2 and 3).The observed proteolytic bands in zymography 
experiments suggest that fibrinogen degradation is independent of the combined 
proteolytic activity of all 4 selected proteases. Fibrinogenolytic bands were observed 
in all the samples after incubation in metalloprotease activation buffer alone and 
omitting serine protease activation buffer, thus suggesting that a metalloprotease is 









Figure 4.12: Analysis of fibrinogen degradation by the quadruple deletion mutant 
(A) SDS gel analysis of concentrated culture supernatants of  glucose-DM-grown 
ΔBF0657ΔBF0275ΔBF1979ΔBF3775 quadruple gene deletion mutant (lane 1) and wild-
type 9343 (lane 2) and (B) Fibrinogen zymography analysis of the corresponding samples 
(lanes 1 and 2). The positions of molecular weight markers (M) are shown in kDa adjacent to 










Figure 4.13: Analysis of fibrinogen degradation by the triple deletion mutant 
Fibrinogen zymography analysis of concentrated culture supernatants of BHI-S-grown wild-
type 9343 (lane 1), triple protease encoding gene deletion mutant (lane 2) and quadruple 
protease encoding gene deletion mutant (lane 3). The positions of molecular weight markers 
(M) are shown in kDa adjacent to the gel. Fibrinogenolytic bands are observed at  ̴ 45 kDa 
and 50 kDa in the three samples. 
 
4.6. Identification, cloning and expression of metalloproteases secreted by         
B. fragilis 
4.6.1. Identification of secreted proteases and peptidases in B. fragilis 
Multiple deletion mutants generated in the present study retained the fibrinogenolytic 
activity displayed by the wild-type B. fragilis on zymograms. Therefore, other 
secreted protease-encoding genes within the molecular weight range (30-70 kDa) of 
the observed fibrinogenolytic activity (45-50 kDa) were investigated for their role in 
fibrinogen degradation. Additionally, Chen et al., (1995) detected fibrinogenolytic 
activity in relation to a putative 100 kDa serine-thiol-like protease from B. fragilis 
YCH46 albeit neither candidate gene nor an extracellular  proteolytic activity has 
been conformed. Therefore, we included four protease-encoding genes with 
molecular weights > 75kDa in our investigation to detect a possible fibrinogenolysis 
at  ̴ 100 kDa on account of the described putative protease. Also, proteases belonging 







degradation was detected in zymograms incubated with the metalloprotease 
activation buffer alone. Previous studies have detected fibrinolytic and 
fibrinogenolytic activities in relation to elastase secreted by P. aeruginosa. Elastase 
which was similar to B. subtilis thermolysin-like zinc-protease resulted in the 
complete hydrolysis of Aα- and Bβ-chains of fibrinogen (Komori et al., 2001). 
Elastase-mediated fibrinogen degradation increased hemorrhagic tendency in animals 
suffering from acute pneumonia caused by P. aeruginosa. Albeit the present study 
deals with the non enterotoxic B. fragilis strain NCTC 9343, the enterotoxin 
associated with certain strains of B. fragilis implicated in diarrheal disease in animals 
and humans has been associated with the metzincin family of metalloproteases 
(Moncrief et al., 1995). Moreover, Houston et al. (2010) observed inhibition of 
fibrinogen degradation when zymograms containing concentrated culture 
supernatants of NCTC 9343 were pre-incubated with the metalloprotease inhibitor 
EDTA but not when pre-incubated with the serine protease inhibitor PMSF. 
Other secreted protease and peptidase encoding genes in the B. fragilis NCTC 9343 
genome were identified using Artemis genome browser. Apart from the previously 
identified four genes, 11 out of 35 protease encoding genes and 17 out of 49 
peptidase encoding genes present in NCTC 9343 were annotated as containing signal 
peptide sequences (Table 4.2). 8 out of these genes were selected for expression 
analysis based on the  expressed protein size and type of protease or peptidase 







Table 4.2: List of the genes encoding putative secreted proteases and peptidases in 
NCTC 9343 genome  
List of 27 genes encoding signal peptide-containing putative proteases and peptidases in 
NCTC 9343 genome. The hightlighted 8 genes, 7 of which encode metallopeptidase and 1 
encodes a serine peptidase, BF2517, were selected for expression and analysis. The selected 
peptidase-encoding genes expressed proteins  >45 kDa in size, except  BF1335 and BF1496 
metallopeptidase encoding genes, and shared significant identities with protease-encoding 
genes in other bacterial spp. 
Feature Name CDS Size Hits 
BF0899 
Peptidase S9 




DPP IV (723 aa)              
E value : 1.6e-124 
and 51.01% identity 
in 741 aa 
BF0097 
Peptidase S9 





IV (741 aa)     E 
value : 2.2e-56 and 




151089...152021 c 933 bp 311 aa 
35.795 kDa 
Low similarity to 
Bradyrhizobium 
japonicum signal 
peptidase SipS (259 
aa) E value : 0.00072 
and 29.68% identity 
in 128 aa 
BF0146 
Peptidase S26 
152032...153513 c 1482 bp 494 aa 
57.3 kDa 
C terminus of E. coli 
06 signal peptidase I 
LepB or C3092 (324 
aa) E value : 2.2e-06 








PipD (433 aa) E 
value : 8.5e-21 and 
29.38% identity in 
405 aa 











(260 aa) E value : 7e-
71 and 78.86% 








549 bp  183 aa 
20.251 kDa 
 




related to metallo 
endopeptidases 
NlpD4  and TTE1975 
(389 aa) E value : 
4.9e-19 and 44.02% 









PepC (449 aa) E 
value : 1.4e-59 and 









protein CC1986 (683 
aa) E value : 5e-71 
and 32.12% identity 
in 663 aa 
BF2764 
Peptidase 




VI (271 aa) E value : 
5e-10 and 25.09% 
identity in 267 aa 
BF2989 
Peptidase S26 Signal 
peptidase I 
3479480...3480367 888 bp 296 aa  
34.258 kDa 
Chlorobium tepidum 
signal peptidase I 
LepB ot CT1450 
(280 aa) E value : 
1.1e-13 and 35.14% 
















  value : 6.9e-111 and 
43.31% identity in 




Peptidase C39 like 




BT1789 (394 aa) E 
value : 6.7e-136 and 




3806942...3809476 2535 bp 845 aa 
95.310 kDa 
B. thetaiotaomicron 
putative alanyl  
dipeptidyl peptidase 
BT1838 (840 aa) E 
value : 0 and 82.02% 






2049 bp  683 aa 
77.070 kDa 
 
 B. thetaiotaomicron 
putative dipeptidyl-
peptidase III BT1846 
(675 aa) E value : 0 
and 82.54% identity 





879 bp  293 aa 
32.884 kDa 
 
P. gingivalis W83 
peptidase M23/37 
family PG2192 (337 
aa) E value : 6.6e-43 
and 46.34% identity 











protein Pep0 (689 aa) 
E value : 8.5e-137 
and 51.08% identity 
in 689 aa 
BF0080 
Peptidase S41B 
76143...79412 c 3270 bp 1090 aa 
122.3 kDa 
 
S. coelicolor tricorn 
protease homolog 1 
Tri1 sco2549 (1067 
aa) E value : 4.7e-27 














49.509 kDa transporter 
component ZapD 
(449 aa) E value : 
3.6e-12 and 24.57% 
identity in 407 aa 
BF0935  
Peptidase M 16 
complement 
1168153...1170969 
2817 bp  939 aa 
106.556 kDa 
 
 E. coli probable zinc 
protease PqqL (931 
aa) E value : 1.5e-56 
and 26.75% identity 
in 927 aa  
BF1640 
Peptidase C10 
1914390...1915844 1455 bp 485 aa 
56.677 kDa 
 
Limited similarity to 
B. thetaiotaomicron 
putative pyrogenic 
exotoxin B BT2451 
(426 aa) E value : 
0.0088 and 27.53% 





3231 bp  1077 aa 




protease homolog 1 
Tri 1or SC02549 
(1067 aa) E value : 
1e-51 and 29.6% 
identity in 1091 aa 
BF2762 
Cysteine protease 







TTE0036 (440 aa) E 
value : 2.9e-27 and 








protease Tri or 
TV0915 (1030 aa) E 
value : 1.2e-16 and 









protein AprF or 







value : 2.9e-10 and 










CtpA (434 aa) E 
value : 2.5e-33 and 










CtpA (434 aa) E 
value : 1.7e-33 and 
36.33% identity in 
355 aa 
 
4.6.2. Choice of vector for the expression of the selected proteases in E. coli 
To analyse their individual fibrinogenolytic potential, the selected B. fragilis 
protease-encoding genes were expressed in E. coli. The protease-/peptidase-encoding 
genes were expressed using pET-100/D-TOPO vector of 5764 bp size from the 
Champion pET Directional TOPO Expression kit (2.5.8 and 2.7.10). These 
expression kits utilise a highly efficient 5 minute TOPO cloning strategy to 
directionally clone a blunt-end PCR product into vector for high level T7 regulated 
expression in E. coli. Expression vectors available with the kit were originally 
developed by Studier & Moffatt (1986) and utilise the high activity and specificity of 
bacteriophage T7 RNA polymerase to facilitate regulated expression of heterologous 
genes in E. coli from T7 promoter. In the present study, pET-100/D-TOPO was the 
vector of choice which contains an N terminal expressed 6xHis fusion tag and 








Features of the chosen pET-100 vector: 
i. T7 lac promoter for high level IPTG inducible expression of gene of interest in E. 
coli 
ii. Directional TOPO cloning site for rapid and efficient directional cloning of PCR 
products 
iii. N terminal fusion tags for detection and purification of recombinant fusion 
proteins 
iv. Protease recognition for cleavage of fusion tag from protein of interest 
v. lacI gene encoding lac repressor to reduce basal transcription from T7 lac 
promoter in pET-TOPO vector and from lac UV5 promoter in E. coli host 
chromosome 
vi. Antibiotic resistance marker for selection in E. coli 
vii. pBR322 origin for low-copy replication and maintenance in E. coli 
Topoisomerase I from Vaccinia virus binds to double-stranded DNA at specific sites 
and cleaves the phosphodiester backbone after 5’-CCCTT in one strand (Shuman, 
1991). The energy produced is conserved by formation of a covalent bond between 
the 3’phosphate of the cleaved strand and a tyrosyl residue of topoisomerase I. The 
phospho-tyrosyl bond between the DNA and enzyme can subsequently be attacked 
by the 5’hydroxyl of the original cleaved strand thereby reversing the reaction and 
releasing topoisomerase (Shuman, 1994). TOPO cloning harnesses this reaction to 
clone blunt end PCR products into pET-TOPO vector.  
4.6.3. Primer design and cloning of expression construct into pET-100 vector 
Directional cloning was achieved by adding a 4 nucleotide (GTGG) overhang 
sequence to the TOPO-charged DNA coupled with the addition of a CACC overhang 
to the forward primer of the incoming DNA. GTGG overhang in the cloning vector 







PCR product in the correct orientation. This technique was originally developed by 
Cheng & Shuman (2000). Primers were designed for the eight selected 
protease/peptidase encoding genes for strain NCTC 9343. CACC tag was added to 
the 5’end of all primers followed by the start codon and gene sequence. Signal 
peptide sequences were omitted as the gene was to be expressed in E. coli. Stop 
codons were included in the reverse primers (Figure 4.14). The primers were used to 
amplify selected protease encoding genes using appropriate PCR conditions (2.5.3). 
The sizes of the PCR amplified  products were confirmed by 1% agarose gel 
electrophoresis (Figure 4.15 lanes 1-8). 
 
 
Figure 4.13: Graphic representation of the expression construct model 
Graphic representation of  the model of a gene (red box) along with forward primer (denoted 
in blue) and reverse primer (denoted in green) to amplify the expression construct. 
 





























































































































































































































































































































TOPO cloning reaction products were recovered in E. coli Top10 for characterisation 
of the construct, propagation and maintenance. The presence of recombinant pET-
TOPO in Top10 strain was confirmed by single colony analysis (Figure 4.16 C), 
PCR amplification of the recombinant pET-TOPO vector using specific primers 
(Figure 4.16 B and D) and restriction digestion analysis (Nde1 and Xmn1 double 
digestion for insert release) of the pET-TOPO clone carrying BF3021 (Figure 4.16 
A). Recombinant pET-TOPO vectors were also subjected to Sanger sequencing and 
the sequences generated were compared to the nucleotide sequences of the respective 
expression constructs by nucleotide BLAST analysis. Sequence identities ranging 
from 92%-100% were observed for each forward and reverse reaction, except for the 



















Figure 4.15: Confirmation of the clones positive for the protease-encoding gene 
expression constructs  
Arrows and numbers on the left side indicate size of DNA in kilo bases (kb) in a 1 kb ladder 
(M). (A) Agarose gel analysis of PCR amplification of recombinant vector carrying BF3021 
expression construct present in Top10 clones 1, 3 and 4 (lanes 1, 2 and 3) using BF3021-
specific primers F5 and R5  and their respective NdeI-XmnI double restriction digestion to 
release BF3021 expression construct from the recombinant pET-100 vector (lanes 4, 5 and 
6). Top10 clones 1 and 4 are positive for BF3021 expression construct as observed from the 







amplification of recombinant vector carrying BF3918 expression construct present in Top10 
clones 1, 2, 3, 4 and 5 (lanes 1-5) using BF3918-specific primers F8 and R8 and their 
respective plasmid extracts (lanes 6-10). Top10 clones 3 and 5 are positive for BF 3918 
expression construct as observed from the specific amplicon size ( ̴ 2000 bp) and increase in 
plasmid size. (C) Agarose gel analysis of single colony assay of plasmid size in recombinant 
vector extracted from Top10 clones 1, 2, 5, 6 and 10 (lanes A1-A5) carrying BF0935 
expression construct, clones 2, 4, 6, 7 and 9  (lanes A6-A8, A10 and A11) carrying BF1335 
expression construct, clones 1, 3, 5 and 7 (lanes A12-A15) carrying BF1496 expression 
construct, clones 2, 4, 6, 9 and 10 (lanes B1-B5) carrying BF2517 expression construct, 
clones 1, 5, 8, 9 and 10 (lanes B7-B11) carrying BF3247 expression construct and clones 2, 
4, 6 and 8 (lanes B12-B15) carrying BF3732 expression construct when compared to the size 
of the empty pET-100 vector backbone (lanes A9 and B6). An up-shift in size of the 
recombinant vectors carrying BF0935 (lanes A2-A5), BF1335 (lanes A7 and A10), BF1496 
(lanes A12-A15), BF2517 (lanes B3 and B5), BF3247 (lane B7) and BF3732 (lanes B12-
B14) when compared to the empty vector backbone (lanes A9 and B6) indicate the presence 
of the respective expression constructs in recombinant vector. (D) Agarose gel analysis of 
PCR amplification of BF3732 (lanes 1 and 2), BF3247 (lanes 3 and 4), BF 2517 (lanes 5 and 
6), BF1496 (lanes 7 and 8), BF1335 (lanes 9 and 10) and BF0935 (lanes 11 and 12) 
expression constructs using respective gene-specific forward (F, denoted in green) and 
reverse primer (R, denoted in blue) sets. The amplicons were in agreement with the sizes of 







4.6.4. Expression of recombinant pET-TOPO vector 
The selected protease-encoding genes were expressed in E. coli to determine their 
ability to degrade fibrinogen. The selected metalloprotease/peptidase- and serine 
peptidase- encoding genes in B. fragilis were expressed following IPTG induction in 
E. coli BL21 carrying the recombinant  pET-TOPO vector (2.7.10). In pET-TOPO 
vectors, gene expression is controlled by a strong bacteriophage T7 promoter which 
is modified to contain a lac operator sequence. In TOPO system, T7 RNA 
polymerase is supplied by E. coli BL21 Star (DE3) in a regulated manner and on 
production  of sufficient quantity of T7 RNA polymerase, it binds to T7 promoter 
and transcribes the gene of interest. BL21 carries the DE3 bacteriophage λ lysogen 
which contains a lac construct comprising the lacI gene encoding the lac repressor, 
the T7 RNA polymerase-encoding gene under the control of the lacUV5 promoter 
and a small portion of the lacZ gene. Addition of IPTG induces expression of T7 
RNA polymerase from the lacUV5 promoter. The lac operator sequence placed 
downstream of the T7 promoter in the vector binds to the lac repressor and represses 
T7 polymerase-induced basal transcription of the gene of interest in BL21 host cells. 
The absence of lon protease and a mutation in the outer membrane protease, OmpT, 
reduces the degradation of heterologous proteins expressed in the chosen E. coli 
strain BL21 Star (DE3). Moreover, the mRNA stability of the expressed protein is 
ensured by a mutation in the rne resulting in a truncated Rnase E enzyme which 
lacks the ability to degrade mRNA.  
The induced and uninduced cultures were electrophoresed through 12% SDS-
polyacrylamide gels and the molecular weight of the expressed proteins were 
confirmed (Figure 4.17). Expressions of BF1335 and BF3732 were induced at  ̴ 30 
kDa (Figure 4.17 lanes 3 and 14) when compared to their uninduced samples (Figure 
4.17 lanes 6 and 13). Induction of  BF3021, BF3247 and BF3918 were observed at  ̴ 
75 kDa (Figure 4.17 lanes 10, 12 and 16) when compared to uninduced samples 
(Figure 4.17 lanes 9, 11 and 14). BF2517 and BF0935 were induced at sizes above 
100 kDa (Figure 4.17 lanes 1 and 7) on comparison with the respective uninduced 







the SDS-polyacrylamide gels were in agreement with their expected sizes. However 
an induced protein corresponding to  ̴ 20 kDa was not observed for BF1496 when 
compared to the respective uninduced sample (Figure 4.17 lanes 5 and 6).  
 
 
Figure 4.16: Expression of the selected protease-encoding genes in E. coli 
SDS-PAGE analysis of IPTG-induced expression and uninduced samples of the selected B. 
fragilis protease-encoding genes in E. coli. The positions of molecular weight markers (M) 
in kDa are shown adjacent to the gel. Induced expression of BF 0935 at  ̴ 100 kDa (lane 1), 
BF1335 at ̴ 28 kDa (lane 3), BF2517 at  ̴ 120 kDa (lane 7), BF3021 at  ̴ 80 kDa (lane 10), 
BF3247 at  ̴ 77 kDa (lane 12), BF3732 at  ̴ 32 kDa (lane 14) and BF3918 at  ̴ 77 kDa (lane 
16) when compared to the respective uninduced samples (lanes 2, 4, 6, 8, 9, 11, 13 and 15). 
The protein expression in each lane is marked by an     .  No distinct band corresponding to 
BF1496 expression is observed (lane 5). 
 
4.7. Analysis of fibrinogen degradation by the expressed proteases/peptidases in 
fibrinogen zymography 
The ability of the induced strains to degrade human fibrinogen was examined by  
fibrinogen zymography using concentrated culture supernatant of wild-type NCTC 
9343 as the positive control (Figure 4.18 lane 1). No zones of clearance at ~45 kDa 
were detected  in the B. fragilis proteases/ peptidases expressed in E. coli on 
visualising the zymogram (Figure 4.18 lanes 2-8). Also, fibrinogenolysis was not 
detected at  ̴ 100 kDa confirming that the previously studied serine-thiol-like protease 







NCTC 9343. Absence of fibrinogenolytic bands indicated that the 
proteases/peptidases analysed here are not capable of degrading fibrinogen when 
expressed in this host. Future work would therefore require the expression of other 
identified secreted metallo or serine proteases/peptidases have to be expressed and 
their fibrinogenolytic property analysed. There is also a possibility that the expressed 
proteases and peptidases might not be functionally active in E. coli, which might 
explain the inability to degrade fibrinogen. A similar difficulty was experienced in 
functional analysis of P. gingivalis encoded proteases in E. coli (Barkocy-Gallagher 
et al., 1999). The proteases could be functionally expressed when ecologically 
similar Bacteroides spp. was used as expression strain instead of E. coli. 
 
 
Figure 4.17: Analysis of fibrinogen degradation by the protease-encoding genes 
expressed in E. coli 
Fibrinogen zymography analysis of concentrated culture supernatant of glucose-DM grown 
wild-type 9343 (lane 1) and E. coli expressed B. fragilis protease-encoding BF0935 (lane 2), 
BF1335 (lane 3), BF2517 (lane 5), BF3021 (lane 6), BF3247 (lane 7) and BF3732 (lane 8). 
The positions of molecular weight markers (M) in kDa are shown adjacent to the gel. Zone 
of clearance corresponding to fibrinogenolysis was observed at   ̴ 45 kDa in wild-type 9343 








Degradation of fibrinogen by B. fragilis was first observed by Houston et al., (2010)  
and a possible role of secreted proteins/proteases in fibrinogenolysis was predicted. 
However, Mass-Spectrometry analysis of the region of proteolysis in SDS-fibrinogen 
zymograms failed to identify any proteases secreted by B. fragilis. The clinical 
significance of fibrinogen involves its proteolytic activation by thrombin to fibrin, 
the principal component of abscesses formed during infections. Abscess formation is 
a defence mechanism adopted by the host to sequester bacteria and other infectious 
agents, thereby curtailing the spread of infections. B. fragilis has been frequently 
isolated from soft tissue abscesses and peritoneal infections. Therefore, the ability to 
degrade fibrinogen might aid the bacterium in escaping from abscesses and spreading 
infections and bacteraemia in the human body. 
It was observed in the present study that fibrinogen binding by BF1705 is not 
required for degradation since fibrinogen degradation was detected in both the wild-
type NCTC 9343 and the ΔBF1705 concentrated culture supernatants (Figure 3.27). 
Wild-type cultures incubated with fibrinogen, and analysed by electrophoresis at 
different time points in growth, were observed to partially degrade the Aα-chain of 
fibrinogen at 3h followed by complete degradation at 48h. On comparison, the Bβ-
chain and γ-chain of fibrinogen were only partially degraded even after 48h (Figure 
4.1 A). Previous studies have shown that the Aα-, Bβ- and γ-chains of fibrinogen 
extend outwards from the central E domain, which contains their N-termini, to form 
the two globular outer D domains. The C-termini of the Bβ- and γ-chains are located 
within the D domains whereas the Aα-chains extend outside the globular D domains 
and then reverse inwards towards the central E domain (Weisel, 2005; Weisel et al., 
1985). Thus, the accessible location of Aα-chains might play a role in its increased 
predisposition to proteolytic activation. Neerman-Arbez, (2001)  identified that a 
reduction or absence of the A-α subunit alone, even in the presence of the other two 
subunits, was sufficient to adversely affect clot formation in a health condition 







recognise and cleave fibrinogen which subsequently prevents clot and abscess 
formation. 
The ability of the ΔBF1705 to degrade fibrinogen led us to identify proteases 
secreted by B. fragilis that might be involved in fibrinogen degradation. 
Identification of a fibrinogen degrading protease might further help us in devoloping 
a small molecule to target the protein, and prevent escape of B. fragilis from 
abscesses. Since fibrinogen zymography using concentrated culture supernatants of 
wild-type B. fragilis  have revealed lytic bands at  ̴ 45 kDa and 50 kDa, four genes 
encoding secreted proteases predicted to be within this range were selected as targets 
for deletion (4.3). 
The role of the selected four secreted proteases in degrading fibrinogen was ruled out 
by the detection of fibrinogenolysis using single gene deletion mutants as well as 
multiple gene deletion mutants (Figure 4.8, Figure 4.12 and Figure 4.13). Medium 
contamination was not likely since the concentrated samples of plain BHI-S medium 
did not exhibit fibrinogenolytic bands. Although the construction of deletion mutants 
did not prevent fibrinogenolysis, technically, the present study was the first 
successful attempt at generating a quadruple gene deletion mutant in B. fragilis 
NCTC 9343. However, these proteases might still be involved in fibrinogen 
degradation, but the observed zone of lysis might represent more than one protease 
thereby suggesting redundancy of the secreted proteases. In addition to the four 
analysed proteases, 27 of the protease/peptidase-encoding genes which possessed a 
signal peptide were considered for their potential role in fibrinogen degradation. 
Eight of these 27 secreted peptidases/proteases were selected for expression studies. 
Selection of the protease/peptidase-encoding genes were based on their molecular 
weight in relation to fibrinogenolytic bands observed on fibrinogen-SDS zymograms 
in the present study as well as a previous study by Chen et al., (1995). Expression of 
these proteases in E. coli using pET-100/D-TOPO was followed by functional 
characterisation of the expressed proteases using fibrinogen zymography (Figure 







were similar to the E. coli control culture. Either the selected proteases were not 
involved in fibrinogenolysis or they were unable to mediate the fibrinogenolytic 
function when expressed in E. coli . Purification of the expressed proteases using 
nickel columns or the adoption of shuttle vectors to express the proteases in a 
genetically closer organism might have to be adopted for further analysis. 
An interesting observation was made while performing zymography experiments in 
the two growth media , BHI-S and glucose -DM. Two distinct fibrinogenolytic bands 
at  ̴ 45 kDa and 50 kDa were identified in cultures grown in BHI-S medium, whereas 
zymography using concentrated culture supernatants of B. fragilis NCTC 9343 
grown in glucose -DM detected a single zone of lysis at  ̴ 45 kDa. Therefore, a 
response to a condition in the glucose-DM is leading to the repression of the gene 
expression of the larger protease. The difference in the number of fibrinogenolytic 
bands detected in B. fragilis cultures grown in the two different media led to the 
investgation of factors determining the repressive/activating component in glucose-
DM and BHI-S growth media, respectively. Nutrient limitation-mediated protease 
secretion is already evident in B. fragilis (Gibson and Macfarlane, 1988a). Therefore, 
fibrinogenolysis, which could not be associated with a specific protease/proteases 
through deletion and expression studies in nutrient-rich growth media could be 
studied by analysing the transcriptional regulation of proteases under nitrogen-








Chapter 5 Effect of Nitrogen Limitation on the transcriptome of 
Bacteroides fragilis 
5.1. Introduction 
This chapter deals with the effect of nitrogen limitation on global gene expression in  
B. fragilis, an opportunistic pathogen. In addition, a transcriptomic analysis would 
allow us to measure changes in expression of BF1705 and if so, might allow the 
identification of one or more proteases which were regulated in a similar manner. A 
difference in fibrinogenolytic profile was observed when B. fragilis was grown on 
BHI-S and glucose-DM as presented in the previous chapter (4.2). This proteolytic 
variation might reflect a difference in nitrogen utilisation of the bacterium between 
the two media. An examination of the transcriptome under nitrogen stress might be 
able to address the differential expression of proteases. 
Previous studies conducted by Gibson and Macfarlane, (1988a, 1988b) observed that 
the secretion of proteases by B. fragilis  into the growth medium at the beginning of 
the stationary phase was induced under nitrogen limiting conditions. This induction 
was proposed as a mechanism to target proteinaceous substances for replenishing the 
intracellular nitrogen content. For example, a mucin-degrading glycoprotease was 
identified in a strain of B. fragilis which might perform a similar scavenging role 
within the gastrointestinal tract (Macfarlane and Gibson, 1991). Since mucin is 
present on the mucosal surface that lines the intestinal epithelium, its degradation 
might contribute to the escape of B. fragilis into the peritoneal cavity following 
intestinal injury, thereby suggesting that protease production and pathogenicity are 
under nitrogen regulation. A similar example has been reported in E. coli where 
inhibitor studies have indicated the specific involvement of a serine protease in 
starvation-induced degradation. The serine protease inhibitor, Diisopropyl 
fluorophosphate (DFP), drastically reduced the rate of protein degradation in an E. 
coli K strain starved simultaneously for nitrogen and leucine (reviewed in Miller, 
1975). An analogous behaviour was detected in Bacillus spp. by Adigüzel et al., 







proteases were detected in peptide-limited carbon-sufficient cultures of two strains of 
Bacillus cereus. Voigt et al., (2007) observed the induction of several transcripts 
encoding extracellular proteases and peptidases under nitrogen starved conditions in 
Bacillus licheniformis. Proteolytic induction was possibly brought about by 
deactivation of the global transcriptional repressor CodY due to lowering of the 
intracellular GTP levels under nutrient limitation and in media compositions that do 
not support maximal growth rates (Adigüzel et al., 2009; Molle et al., 2003). The 
intracellular GTP concentration was found to be decreased by a 5-fold when B. 
subtilis was transferred from medium containing casamino acids to a poorer 
glutamate-only medium (Lopez et al., 1981). 
In vivo, the ingested dietary proteins mix with the endogenous luminal proteins 
derived from sources including gastric and pancreatic secretory products, 
desquamated intestinal epithelial cells and mucous proteins, in the small intestine 
lumen. The protein mixture is digested in the small intestine by proteases and 
peptidases originating from the pancreas and enterocytes (Macfarlane et al., 1986). 
The oligopeptides and amino acids thus formed are transported from the lumen into 
the bloodstream through a variety of transporters present in the epithelial membrane 
of the small intestine (Bröer, 2008). Amino acid metabolism is facilitated during this 
transport for  use by the intestinal mucosa (Davila et al., 2013). Glutamine utilisation 
by enterocytes through mitochondrial glutaminase leads to the formation of ammonia 
and glutamate. Utilisation of glutamine in the intestine contributes significantly to 
the overall production of ammonia in the body (Duée et al., 1995). The microbiota 
inhabiting the small intestine utilize amino acids provided by dietary and endogenous 
proteins for protein synthesis, generation of metabolic energy and recycling of 
reduced cofactors. There is a progressive decrease in the luminal concentration of 
proteins, peptides and amino acids and increase in bacterial content from the 
duodenum to the ileum of the small intestine (Adibi and Mercer, 1973). The report 
by Millward, (2008) addresses the protein sufficiency in older people and describes 
that protein intakes above the Recommended Dietary Allowances (RDA) may have 







increase with age. Therefore, a high proportion of ileal protein digestion, either for 
mucosal absorption or by microbial utilisation, contributes to reducing the amount of 
endogenous and alimentary proteins and peptides entering the large intestine 
(Millward, 2008). A majority of the protein content required by the individual must 
be absorbed from the small intestine as the large intestine majorly accounts for only 
water absorption. The reduction in protein content entering the large intestine is also 
achieved by the presence of bacteria in the small intestine, such as Lactobacillus 
johnsonii, which lack relevant genes for amino acid biosynthesis and rely completely 
on the supply of exogenous amino acids and peptides for protein synthesis. The 
nitrogen acquiring functions in this bacterium require the expression of an 
extracellular protease, oligopeptide transporters, cytoplasmic peptidases and amino-
acid permease type transporters (Pridmore et al., 2004). However, in spite of tightly 
regulated and efficient digestion in the small intestine, substantial amounts of 
nitrogenous compounds from dietary and endogenous origins pass through the ileo-
caecal junction into large intestine. About 2-3 g of nitrogen content enter the large 
bowel every day, which comprises 10-15% urea, ammonia, and amino acids, 48-51% 
proteins and 34-42% peptides (Chacko and Cummings, 1988). The colonic 
microbiota along with residual pancreatic proteases degrade these proteins into 
peptides and amino acids followed by production of intermediary bacterial 
metabolites and end-products (Dai et al., 2011). Owing to the heavy bacterial load, 
transit of luminal material through the colon is considerably slower than the small 
intestine (Cummings et al., 1978). Due to low pH and high carbohydrate availability 
in the proximal colon, higher rates of protein degradation, fermentation and net 
ammonia production are confined to the distal part of the colon (Smith and 
Macfarlane, 1998). Thus the bacterial species residing in the proximal region of the 
colon are likely to experience a nitrogen limiting condition. A nitrogen-deprived 
environment in the colon might induce the secretion of nitrogen scavenging proteaes. 
The specific requirement of Bacteroides spp. for ammonia as an effective nitrogen 
source,  might impose a struggle among the gut microbiota for the limited ammonia 







face a carbon limiting condition due to their ability to degrade host and plant 
polysaccharides (Macfarlane and Gibson, 1993). Thus, the proteases induced under 
nitrogen-limiting carbon-sufficient conditions target the host epithelial barrier 
thereby posing a threat to the stability of the intestinal microbiome. Species 
belonging to the Bacteroides genus have been reported to secrete proteases in the 
intestine with presumed elastase activity near the brush border of adsorptive cells 
(Riepe et al., 1980). Therefore it is of clinical significance to analyse the 
collagenolytic and fibrinogenolytic potential of B. fragilis encoded at the 
transcriptional level in nitrogen-sufficient and limiting conditions. Also, analysis at 
the transcriptional level would provide new insights into the regulation of host matrix 
adhesins such as the fibrinogen binding protein, BF1705. Potential binding of 
fibronectin in addition to fibrinogen has been discussed in chapter 3, Section 
11(3.11). Since very few studies have dealt with the regulation of nitrogen utilisation 
in Bacteroides spp. at the genetic level, a nitrogen-limiting growth medium has been 
developed by comparing the enzymes involved in nitrogen metabolic pathway 
encoded in the B. fragilis genome to that of E. coli, a co-inhabitant of B. fragilis in 
the gastrointestinal tract as well as in polymicrobial infections (Farthmann and 
Schöffel, 1998). However, there are a few striking differences in the nutritional 
requirements and metabolism between the two which will be considered and 
discussed in this chapter. In addition to the regulation of proteases and enzymes 
involved in nitrogen assimilation, the nutrient limitation might also affect the 
regulation of stress and antibiotic resistance-related genes (Brown et al., 2014). A 
comparison of these genes under nutrient limiting and nutrient abundant conditions 
might provide a better understanding of the behaviour of this opportunistic pathogen 
within the gastrointestinal tract and also following its accidental release into the 







5.1.1. Metabolic regulation of E. coli in nitrogen-sufficient and nitrogen-limiting 
environments 
Bacteria sense changes in its intracellular environment, brought about by variation in 
concentrations of carbon, nitrogen and phosphate nutrient sources and in growth 
conditions like pH level and oxygen availability. These sensory signals modulate the 
transcriptional regulatory system, thereby affecting the physiological and 
morphological changes which enable the organism to adapt effectively for survival. 
Nitrogen is an essential element of many macromolecules in a bacterial cell, 
including proteins, nucleic acids and cell wall components. Although bacteria can 
assimilate a variety of nitrogen sources, ammonia/ammonium (NH4
+
) is preferred 
and supports the fastest growth rate (reviewed in Reitzer, 2003). In E. coli, ammonia 
is assimilated using α-ketoglutarate which results in the synthesis of glutamate and 
glutamine (reviewed in Shimizu, 2013). These two amino acids provide nitrogen for 
the synthesis of all other nitrogen-containing compounds. 88% of the cellular 
nitrogen comes from glutamate and the rest from glutamine. Glutamine synthetase, 
encoded by glnA, catalyses the only pathway for glutamine biosynthesis . Glutamate 
is synthesised by two pathways: 
1. GS/GOGAT pathway: The combined action of glutamine synthetase (GS) and 
glutamate synthase (GOGAT), encoded by gltBD (Figure 5.1). GS/GOGAT 
possesses high affinity for NH4
+
 (KM < 0.2mM) and is favoured in nitrogen-scarce, 
energy-sufficient environments since ATP is required for the reaction. 
 
Figure 5.1: GS/GOGAT pathway 
Synthesis of glutamine and glutamate using glutamine synthetase (GS) and glutamate 








2. GDH pathway: Glutamate dehydrogenase (GDH) encoded by gdhA has low 
affinity for NH4
+
 (Km < 1mM) and is dominant in nitrogen-sufficient, energy-limiting 
conditions (Yan, 2007) (Figure 5.2). 
 
Figure 5.2: GDH pathway 
Synthesis of glutamate using glutamate dehydrogenase in the presence of ammonia by GDH 
cycle. (Reitzer, 2003)  
 
E. coli responds to nitrogen starvation by activating the σ
54 
(rpoN) dependent 
nitrogen regulated response (Ntr). Microarray-based as well as other in silico 
analyses of σ
54
-dependent genes indicate that nitrogen limitation affects  ̴ 100 genes 
which facilitate nitrogen scavenging from alternate sources (Reitzer, 2003; Zimmer 
et al., 2000). It has been proposed that the absolute concentration of glutamine 
controls the Ntr regulatory cascade (Reitzer, 2003). The Ntr system is composed of 
three central functioning units: 
1. Uridylyl transferase or uridylyl-removing enzyme (UTase/UR) encoded by glnD 
2. PII trimeric nitrogen regulatory protein encoded by glnB and its paralogue encoded 
by glnK 
3. NtrB/NtrC (NRII/NRI) two-component system encoded by glnLG.  
GlnD controls GS activity by adenylylation or deadenylylation through the 
bifunctional glnE gene product, adenylyltransferase (ATase). Upon nitrogen 
limitation, UTase covalently modifies PII (GlnB) by addition of a uridine 
monophosphate (UMP) group at a specific residue. The NtrB/NtrC two-component 
system and GlnE are the receptors of the modified GlnB signal transduction. NtrC 
(NRI) transcriptionally activates σ
54 
-dependent promoters while NtrB (NRII) is a 







control dephosphorylation of NRI-P (Shimizu, 2013). GlnB-UMP formed during 
nitrogen limitation does not complex with NtrB and the histidine kinase activity of 
NtrB dominates which results in NtrC activation by phosphoryl transfer. NtrC (NRI) 
phosphorylation stimulates expression of the glnALG operon. The operon is 
controlled by tandem promoters glnAP1, a weak σ
70 
-dependent promoter which is 
transcriptionally activated by Crp and blocked by NtrC-P and glnAP2 which is 
transcribed by RNA polymerase (E σ
54
) and therefore activated by NtrC-P. Thus 
glnAP2 is responsible for glnA transcription under nitrogen limitation. The other 
receptor, GlnE, regulates GS activity by reversible adenylylation. NtrC-P also 
activates glnK (the second
 
PII paralogue) and nitrogen assimilation control (nac) 
promoters under ammonia-depleting conditions. The ability of the PII paralogues to 
regulate NRII is also regulated by intracellular carbon and nitrogen availability via 
allosteric control. The gltBDF operon which encodes glutamate synthase is bound by 
the global regulators, Fumarate and nitrate reductase (Fnr) and cAMP reactive 
protein (Crp). Under nitrogen limitation, fnr transcript is upregulated and crp 
downregulated. The regulatory region of gdhA, encoding glutamate dehydrogenase, 
lacks NRI-P binding sites and is transcriptionally repressed by Nac under nitrogen 
limitation (Figure 5.3). Even though the PII paralogue GlnB is constitutively 
expressed, it exists in the non-modified deuridylylated state which adenylylates GS 
(Maheswaran, 2003). Low intracellular glutamine levels signal PII uridylylation and 
so ATase activity is switched to deadenylylation thereby activating GS (Shimizu, 
2013). 
Under nitrogen rich conditions, the uridylyl-removing activity of GlnD predominates 
and deuridylylated PII promotes adenylylation of GS by ATase. Non-modified GlnB 
forms a complex with NtrB and dephosphorylates the NtrC response regulator thus 








Figure 5.3: Nitrogen assimilation pathway in E. coli 
Under nitrogen limitation, E. coli activates the rpoN (σ
54
)-dependent nitrogen regulated 
response (Ntr). UTase encoded by glnD covalently modifies PII (GlnK and GlnB) by addition 
of a UMP group. GlnB-UMP activates NtrC by phosphoryl transfer which stimulates the 
glnALG operon (glnA transcription), other ntr genes and nac. gdhA is transcriptionally 
repressed by Nac under nitrogen limitation. The other receptor of GlnB-UMP, GlnE 
promotes GS deadenylylation by ATase under nitrogen limitation. Under nitrogen rich 
condition, UR (uridylyl removing) activity of GlnD predominates and the deuridylylated PII 
promotes adenylation of GS by ATase. UR action on PII (UMP)
3
 occurs under higher 
nitrogen concentration (low C/N ratio). Phosphorylation of NtrB dephosphorylates NtrC 
which blocks glnA transcription. GlnB is also allosterically regulated by α-ketoglutarate 








5.1.2. The link between nitrogen and carbon metabolism 
The PII regulatory protein and phosphotransferase system (PTS) are considered the 
central processing units of nitrogen and carbon metabolism, respectively. As 
mentioned in the previous section (5.1.1), PII protein senses adenylate energy and 
regulates nitrogen assimilation in conjunction with the Ntr system. The focal point of  
the carbon and nitrogen pathway interdependence has been the conversion of α-
ketoglutarate to glutamate. At high α-ketoglutarate concentration, GlnB binding sites 
are completely occupied which blocks complex formation of non-uridylylated GlnB 
with NtrB, thereby blocking phosphorylation and activation of NtrC. Thus GlnB 
integrates signals of nitrogen status with a signal of central carbon metabolism to 
coordinate expression of key enzymes of nitrogen assimilation in response to the 
carbon  and nitrogen state. The tandem promoters that initiate glnALG transcription 
are also controlled by carbon and nitrogen states. The activity of the weak, σ
70
 -
dependent glnAP1 promoter requires binding of the cAMP receptor protein (Crp)-
cAMP complex to an upstream activating sequence. The complex is formed when 
cells are grown in the presence of a poor carbon source that is not transported by the 
PTS system. The complex dissociates during growth on glucose leading to catabolite 
repression of a large number of genes. The σ
54
 -dependent  strong glnAP2 promoter 
is activated by NtrC-P which blocks transcription from the weak promoter under 
nitrogen limiting conditions resulting in high levels of glnA transcript from glnAP2 
(Maheswaran, 2003). Elevated levels of cyclic adenosine monophosphate (cAMP) 
through formation of the CRP-cAMP complex caused a 21-fold downregulation in 
transcription from glnAP2 (Tian et al., 2001). All responses of glnA and glnK 
expression to carbon or cAMP signals were in agreement with the uridylylation 
status of PII. The effect of carbon source on NtrC-dependent gene expression is 
mediated through cAMP-dependent glutamine uptake, affecting the glutamine 








The main aims of this chapter are to identify the effect of nitrogen stress on the 
transcriptome of B. fragilis and to compare the differential expression of genes 
involved in nitrogen assimilation and scavenging, and stress responses under 
nitrogen limiting and abundant conditions.  
 The first step was to choose a growth medium which limits nitrogen 
availability 
 To determine the time point at which the growth slows, from the growth 
curve of B. fragilis in nitrogen limiting medium  
 To determine the differential gene expression of B. fragilis under nitrogen 
replete and limiting conditions through total RNA sequencing 
5.2. Choice of nitrogen-limiting medium for the growth of B. fragilis 
Changes in medium composition were required to determine the amount of nitrogen 
required to reduce the growth rate, which we are defining as nitrogen limitation, 
when compared to the growth rate measured in the presence of excess ammonium. A 
number of previous studies have shown the inability of single free amino acids, 
nitrate, urea or a complex mixture of L-amino acids to effectively replace ammonia 
as the sole nitrogen source in Bacteroides spp. (Hullah and Blackburn, 1971; Pittman 
and Bryant, 1964; Stevenson, 1979; Varel and Bryant, 1974; Yamamoto et al., 1984). 
However, uptake of amino acids and peptides by Bacteroides ruminicola and 
Bacteroides melaninogenicus in the presence of ammonia and trypticase-yeast-
extract-hemin medium has been observed (Miles et al., 1976; Pittman and Bryant, 
1964; Stevenson, 1979). Varel and Bryant, (1974) specifically focused on the 
inability of B. fragilis to use organic sources such as amino acids as the sole nitrogen 
source in the absence of ammonia. Therefore, the influence of nitrogen content on 
the growth rate of B. fragilis was assessed in glucose-DM where ammonium sulphate 
((NH4)2 SO4) served as the source of nitrogen. The requirements for nitrogen-
abundant, -sufficient and -limiting conditions were first tested by altering the 







sulphate present in the normal glucose-DM (0.02 M; ~ 0.58%) was considered as the 
nitrogen-abundant state. Nitrogen content was increased by incorporating 5 times the 
normal concentration of ammonium sulphate used (5x) to confirm that nitrogen was 
not limiting in the normal glucose-DM. Nitrogen-depleting conditions were brought 
about by reducing the amount of ammonium sulphate by 5 times (-5x) and 10 times 
(-10x) the normal concentration. Growth rates of B. fragilis in the nitrogen abundant 
and nitrogen limiting media and in the absence of L-cysteine were measured in 
comparison to the growth in normal glucose-DM, containing 0.02 M (NH4)2 SO4,  in 
a 15h growth curve experiment (2.4.1). No growth was observed in the absence of   
L-cysteine (data not shown). The inability of B. fragilis to grow in the absence of    
L-cysteine confirms the exclusive role of this amino acid in lowering the redox-
potential of the medium and rules out a probable contribution to cellular nitrogen 
requirement. Analysis of the semi-log plot representing the growth curve of B. 
fragilis under varying concentrations of ammonium sulphate, obtained by plotting 
OD600 values of biological triplicates of cultures corresponding to the three 
experimental conditions at 45 min intervals, revealed a difference in the growth rate 
of the bacterium when compared to the growth in normal glucose-DM (Figure 5.4). 
The doubling times of the populations were determined to be 84.99 min ± 6.56 min, 
100 min ± 1.5 min, 80.26 min ± 4.75 min and 100.77 min ± 1.91 min, respectively, 
in the normal, 5x, -5x and -10x glucose-DM. A difference in biomass yield was also 
observed, with the lowest yield corresponding to -10x glucose-DM (Figure 5.4). In 
recent work by Atkinson et al., (2002) and Bren et al., (2013) which examined the 
growth curve of E. coli grown on varying amounts of ammonia, it was observed that 
the limiting level of nutrient merely limits the final OD600 obtained rather than 
reducing the growth rate. The observation indicated the efficiency of E. coli in 
capturing ammonia, even at low concentrations. It was proposed that the substrate 
removed from the medium is incorporated into the bacterial biomass with a constant 
yield and that the total biomass produced is proportional to the OD600. This was in 
agreement with the B. fragilis growth curve observed in the present study. However, 







coli cells at low nitrogen levels in the former study was not detected under nitrogen 
limiting conditions in B. fragilis in the present study (Bren et al., 2013). Cells had 
gradually entered stationary phase from the exponential phase under all four 
conditions tested (Figure 5.4). A considerable reduction in growth rate was observed 
in cultures grown in 5x glucose-DM and -10x glucose-DM when compared to the 
other two conditions. Therefore the reduction in growth rate did not seem to be 
proportional to the decrease in the initial content of ammonia in the growth medium. 
However, since the reduction was pronounced as the cultures approach stationary 
phase, a marked distinction between the slowing of growth due to the onset of 
stationary phase and due to the nitrogen limitation could not be made. Therefore the 
medium and conditions for nitrogen limitation had to be further optimised to identify 









Figure 5.4: Effect of altered nitrogen (ammonium sulphate) content on B. fragilis 
growth 
Semi-log plot of a 15h growth curve of B. fragilis (Log mean OD600 vs time) on glucose-DM 
containing normal (denoted in blue), +5x (denoted in red), -5x (denoted in green) and -10x 
(denoted in purple) amounts of ammonium sulphate. Increase in bio-mass yield is observed 
upon increasing the concentration of ammonium sulphate from -10x to +5x, indicated by the 
asterisk mark. However, no significant difference in yield is observed between normal and 








5.2.1. Effect of glutamine as the sole nitrogen source on growth rate 
The similarities between the growth curves of cultures grown in the defined media 
containing ammonia as the nitrogen source made defining nitrogen limitation 
problematic. Therefore, we considered alternative nitrogen sources that could 
substitute for ammonia in the glucose-DM. Although studies on B. fragilis have 
emphasised the requirement of ammonia as the major nitrogen source, a minimal 
medium with glutamine as the sole nitrogen source has been referred to as a 
nitrogen-limiting condition for E. coli growth (Maheswaran, 2003). Atkinson et al., 
(2002) also studied gene regulation in E. coli when grown in a medium with 
glutamine as the nitrogen source and observed a reduction in growth rate in mid-log 
phase in the glutamine-grown E. coli cultures. The nitrogen-limiting condition was 
consistent with the activation of NtrC-dependent gene expression involved in the 
assimilation of nitrogen in the cells grown in this medium. The studies on E. coli  
coupled with the fact that glutamine and glutamate form the intermediary products in 
the bacterial nitrogen assimilation pathway, and the PII regulatory protein is signalled 
by the intracellular levels of glutamine, inspired us to assess the individual effect of 
these two amino acids as the sole nitrogen source on the growth of B. fragilis.  
The ammonium sulphate in the normal glucose-DM was replaced with either 0.1% 
glutamine or 0.1% glutamic acid. Overnight cultures of NCTC 9343 in glutamic 
acid-containing glucose-DM (referred to hereafter as GCM) did not grow even after 
a 24h anaerobic incubation when compared to glutamine-containing glucose-DM 
(referred to hereafter as GNM) which had reached growth saturation in a 12h 
incubation period. The growth conditions were checked by inoculating normal 
glucose-DM as a control which exhibited saturated growth and a better biomass yield 
when compared to GNM, an indication of the nutrient-abundant state. Lack of 
growth observed on GCM indicates the inability of B. fragilis to utilise glutamic acid 
as the sole nitrogen source and the observation is consistent with previous studies 
carried out on this species which had confirmed that amino acids can only 
supplement the growth of Bacteroides in an ammonia-containing medium. The 







deficient medium has not previously been investigated. However, increased uptake 
of amino acids and peptides by Bacteroides melaninogenicus in a glutamine-added 
trypticase medium has been studied (Lev, 1980). Therefore, to confirm the initial 
findings and to validate the observations on GCM, we compared the growth of 12h 
cultures of B. fragilis NCTC 9343 and E. coli MG1655 in normal glucose-DM, 
GNM and GCM in terms of OD600. The ability of E. coli to utilise amino acids as the 
sole nitrogen source is already known from previous literature (Atkinson et al., 2002; 
Goux et al., 1996). The glutamic acid content in the glucose-DM (GCM) was 
doubled to 0.2% for both the strains. It was observed that the 12h aerobic and 
anaerobic cultures of MG1655 and NCTC 9343, respectively, on GNM attained final 
OD600 values of 1.5 and 2.0 while growth of MG1655 on GCM reached a lower 
density with an OD600 of 1.23 (Figure 5.5 A and B). There was no growth observed 
for 12h NCTC 9343 culture on GCM. Thus, a lower biomass yield was observed 
when E. coli was grown on a nutrient-limiting GCM. However, it is evident from the 
OD600 values that E. coli can utilise glutamic acid whereas B. fragilis cannot. Even 
though, the genome of B. fragilis NCTC 9343 possesses glnA (glutamine synthetase) 
and gdhB (glutamate dehydrogenase) homologues for glutamine and glutamic acid 
utilisation, respectively, the bacterium can't use glutamic acid when supplied 
exogenously. The possible glutamine utilisation through the GS/GOGAT cycle for 
the production of glutamate in GNM and the failure to generate glutamine in the 
absence of ammonia in GCM by B. fragilis might be the reason for the observed 
differential utilisation. The inability of B. fragilis to grow on GCM even in the 
presence of L-cysteine indicates that this bacterium does not utilise cysteine as the 
sole nitrogen source in the absence of ammonia, unlike B. thetaiotaomicron (Atherly 
and Ziemer, 2014). Nevertheless, the observations made in the current study confirm 
that ammonia is the preferred source of nitrogen for bacterial growth (Figure 5.6 A 
and B), as demonstrated by the attainment of an OD600 of 2.5 and 3.0 after a 12h 








To determine changes in gene expression that occur during growth under nitrogen 
limiting conditions, an RNA sequencing approach was used to examine the 
transcriptome. Before samples were taken for RNA preparation, we first measured 
the growth rate in GNM to establish the OD600 at which the culture became nitrogen-
limited. The growth of NCTC 9343 was monitored in GNM containing 0.1% 
glutamine in comparison to that of normal glucose-DM containing  ̴  0.58% 
ammonium sulphate in a 15h growth curve measured at hourly intervals. A marked 
difference in growth rate was observed by late-log phase between the two media. To 
confirm reproducibility, the experiment was repeated twice and the results showed 
good agreement. The final experiment was performed in six biological replicates and 
the mean OD600 values were plotted against time (Figure 5.7). In early-log phase ( ̴ 
0.4 OD600), the mass doubling-times (Td) in the normal glucose-DM and GNM were 
78 min ± 4.2 min and 90 min ± 6 min, respectively. The growth curve for GNM was 
observed to be 'biphasic', where the initial doubling time of  90 min ± 6 min dropped 
by late-log phase (0.8 OD600) to a Td of  390 min ± 20 min in GNM (Figure 5.7). The 
observed 5h decrease in Td  is indicative of a nitrogen limitation in the medium. For 
transcriptomic analysis, RNA samples were extracted from the 6 biological replicates 
of normal glucose-DM cultures grown to early-log phase  ̴ 0.4 OD600 (N set) and 
from replicates of GNM  cultures grown to a similar  ̴ 0.4 OD600 (G1 set) as well as a 
time point in late-log phase, 0.8 OD600, where the reduced growth rate was observed 
(GA set). Analysis of the whole transcriptome under the three experimental 
conditions would provide a detailed description of the regulation of genes encoding 
nitrogen scavenging proteins, nutrient transport systems as well as stress-related 









Figure 5.5: Comparison of bacterial growth in glutamine-containing glucose-DM and 
glutamic acid-containing glucose-DM 
Overnight cultures of E. coli MG1655 and B. fragilis NCTC 9343 grown on 0.1% glutamine-
containing glucose-DM (GNM) and 0.2% glutamic acid-containing glucose-DM (GCM). (A) 
MG1655 has attained OD600 1.5 (1)  and 9343 attained OD600 2.0 (2), respectively on GNM. 
(B) MG1655 has attained sub-optimal growth of OD600 1.23 (1) while no growth is observed 








Figure 5.6: Comparison of B. fragilis growth in glutamic acid-containing glucose-DM 
and normal glucose-DM 
Overnight cultures of B. fragilis NCTC 9343 grown on 0.2% glutamic acid-containing 
glucose-DM (GCM), E. coli grown on GCM and B. fragilis grown on normal glucose-DM. 
(A) No growth is observed for B. fragilis (1) and E. coli has attained a final OD600 of 1.19 (2)  
on GCM. (B) No growth is observed for B. fragilis  on GCM (1) and has reached saturation 









Figure 5.7: Effect of nitrogen limitation on B. fragilis growth 
Semi-log plot of a growth curve of B. fragilis (mean OD600 vs time) on glucose-DM 
containing the normal concentration of ammonium sulphate( ̴ 0.58% and 0.02 M) (denoted 
by blue diamond) and 0.1% glutamine (denoted by red box). Reduction in growth rate is 
observed at late-log phase (0.8 OD600) in 0.1% glutamine-containing glucose-DM, indicated 







5.3. RNA sequencing 
The most suitable method for analysing and comparing the transcriptional 
upregulation or downregulation of genes associated with nutrient metabolism, stress, 
drug resistance and virulence under nutrient-abundant and nutrient-limiting 
conditions was RNA sequencing. RNA-Seq, also known as whole transcriptome 
shotgun sequencing, depicts a snapshot of RNA presence and quantity from a 
genome at a given moment in time by using the capabilities of next-generation 
sequencing. Unlike microarray studies, RNA sequencing does not require prior 
knowledge about the genome. Also, an increased dynamic range is observed in 
RNA-seq reads with an overall higher sensitivity, reliability and reproducibility 
levels when compared to that of microarrays (Wang et al., 2009). Therefore in the 
present study, RNA samples derived from five biological replicates of cultures 
belonging to the nitrogen abundant glucose-DM at  ̴  0.4 OD600 (referred to hereafter 
as N set) and nitrogen limiting GNM at  ̴  0.4 OD600 (referred to hereafter as G1set) 
and 0.8 OD600 (referred to hereafter as GA  set) were subjected to RNA sequencing 
(2.6). The process of RNA-sequencing proceeds through a multitude of laboratory 
and programming steps starting from the raw RNA extract to the final transcript 
reads, of which the differential expression can be compared and analysed. Each step 
needs to be performed carefully and with accuracy in order to get final, good quality 
reads that have an optimum genome coverage. Therefore, the quality control steps 








Figure 5.8: Schematic of RNA-Seq workflow 
The RNA-Seq work flow initially involves extraction of the starting material, RNA, at the 
desired time points followed by its quality control to confirm its suitability for library 
generation and sequencing work. Stranded libraries are then constructed for each of the RNA 
samples. The pooled libraries are subjected to RNA sequencing using the HiSeq v4 
(Illumina) instrument to generate 50 base paired-end reads. The read pairs corresponding to 
each sample are then examined by FastQC module to assess the quality of library 
construction and sequencing before processing and mapping the read pairs to the genome. 
Once mapped, the reads are assigned to features by gene quantification and finally the read-








5.3.1. Validation of RNA samples prior to sequencing 
Since the integrity of the starting RNA material is significant in determining the 
quality and yield of subsequent steps such as library preparation and sequencing, the 
quality of the extracted RNA samples was first analysed. Nanodrop readings of all 
eighteen (3x6) RNA samples were in the range of 220-360 ng/μl, with corresponding  
260/280 ratios of ~ 2. The best 5, in terms of concentration, from each experimental 
condition was selected for RNA sequencing (Table 5.1). Integrity of RNA samples 
were checked by agarose gel electrophoresis of formamide-treated aliquots (2.6.1.1). 
Two distinct bands corresponding to the 23S and 16S ribosomal RNA (rRNA) were 
observed (Figure 5.9). After examining the concentration, purity and integrity of the 
RNA samples and confirming that they met the specifications for sequencing, the 
samples were sent to the Edinburgh Genomics facility for whole transcriptome 
sequencing. A further quality control analysis was performed on the RNA samples at 
the facility using the RNA Integrity Number (RIN) software tool in combination with 
the 2100 Bioanalyzer (Agilent Technologies). On a scale of 1-10 RIN, '10' stands for 
a perfect RNA sample without any degradation products whereas '1' marks a 
completely degraded sample. All the 15 RNA samples were of good integrity since 







Figure 5.9: RNA extracted from B. fragilis grown on 
normal glucose-DM and GNM 
Agarose gel analysis of RNA samples extracted from B. 
fragilis grown on (A) normal glucose-DM (lanes 1-6) to  ̴
0.4 OD600 and (B) glutamine-containing glucose-DM at 
early-log phase  ̴ 0.4 OD600 (lanes 1-6) and late-log phase 
0.8 OD600 (lanes 8-13). RNA samples were intact and 






Table 5.1: Nanodrop-based quantification of RNA samples prior to sequencing 
Nanodrop-based quantification of RNA samples selected for RNA sequencing. A 260/280 





media) N set 






N1  360.2  2.11  2.25  7.2  
N3  214.6  2.12  2.23  4.3  
N4  278.4  2.11  2.21  5.5  
N5  316.7  2.1  2.07  6.3  




 media) G1 
set  
    







Gu2 278.2  2.17  2.14  5.5  
Gu3 220.6  2.07  1.82  4.4  
Gu4 309.4  2.15  1.81  6.2  






    
GuB 286.1  2.14  2.25  5.7  
GuC 165.2  2.13  2.28  3.3  
GuD 178.8  2.02  1.64  3.5  
GuE 219.3  2.14  2.27  4.4  



















Figure 5.10: RIN-based quantification of the extracted RNA samples 
(A) and (B) RIN (RNA Integrity Number) values of all the RNA samples submitted for 
sequencing were above 9 and concentrations were above 100 ng/µl, respectively. 
 
The majority, amounting to 50-80%, of the extracted and quantified total RNA 
content comprised of ribosomal RNAs, as was evident from the distinct bands 
observed by gel electrophoresis analysis (Figure 5.9). Therefore specialised methods 
were required to enrich the messenger RNA (mRNA) transcriptome for analysis. In 
the present study, the quantified RNA samples were subjected to Ribo-Zero 
(Illumina) treatment for the depletion of rRNA molecules through hybridization to 
magnetic bead-linked complementary oligonucleotides, thereby increasing the 
mRNA coverage for the subsequent complementary DNA (cDNA) library 
construction. Ribo-Zero kit performs well only on DNase-treated and purified RNA 
samples (2.6.1). The proficiency of the Ribo-Zero kit in rRNA depletion has been 
described in a study by Giannoukos et al., (2012) where different commercial rRNA 







as well as > 85% to 95% removal of 5S rRNA could be achieved through the use of 
Ribo-Zero kit. RIN software analysis was performed a second time to analyse the 
quality of the rRNA depleted samples. Since the RIN tool measures RNA integrity 
based on the presence of rRNA bands, poor RINs after Ribo-Zero treatment indicate 
successful removal of rRNAs. Consistently, RIN values of all 15 RNA samples were 
between 1.0 -1.8 after one round of Ribo-Zero treatment. Also, the distinct rRNA 
bands were missing from the electrophoresed agarose gel images of the samples post 

















Figure 5.11: RIN-based quantification of the RNA samples post rRNA depletion 
Agarose gel analysis, RIN values and concentration (µg/µl) of the RNA samples following 
Ribo-Zero treatment to remove rRNAs. No distinct bands are observed on the agarose gel 







5.3.2. Library construction and Illumina-based Sequencing 
The total RNA, following rRNA depletion, was converted into a library of cDNA 
molecules of known standard origin which facilitates downstream sequencing 
processes, such as cluster generation (TruSeq stranded total RNA-seq library kit, 
Illumina). Prior to cDNA library construction, the total RNA (1 µg/sample) from the 
15 samples was fragmented into small pieces using divalent cations under elevated 
temperature. Cleaved RNA fragments were then copied into first strand cDNA using 
reverse transcriptase enzyme and random primers, followed by second strand cDNA 
synthesis using DNA polymerase I and RNase H. The strand specificity in cDNA 
library generation is achieved during second strand synthesis when the RNA 
template is removed and  the second cDNA strand is constructed by incorporating 
dUTP in place of dTTP. Incorporation of dUTP quenches the second strand during 
amplification because the polymerase does not add past this nucleotide. Stranded 
libraries provide strand-specific information for each of the transcripts. The blunt 
ended double-stranded (ds) cDNA fragments are then prepared for hybridisation onto 
flow cell lanes of the sequencer by ligating multiple indexing adapters (2.6.2) to the 
adenylated 3' ends of the ds cDNA fragments. To enrich those DNA fragments that 
are adapter-ligated at both ends and to amplify the amount of DNA in the cDNA 
library, the fragments were subjected to 10 cycles of PCR (TruSeq stranded total 
RNA-seq library kit, Illumina). Finally, the cDNA libraries generated from the 15 
RNA samples were quantified, normalised to 10 nM concentration and pooled in 
equal volumes for the cluster generation step in sequencing. 
The pooled libraries were sequenced in a single lane of HiSeq v4 High Output  
(Illumina) using the 'sequence-by-synthesis' approach of the Solexa-Illumina 
sequencing platform. In brief, it involves the incorporation of novel reversible 
terminator nucleotides for the four bases, each labelled with a different fluorescent 
dye, to the cDNA strand followed by detection of the added bases at each step. 
Initially, the adapter-ligated DNA fragments in the cDNA library were denatured and 
one end was immobilised onto a solid support. The surface of the solid support is 







adapters hybridise to the free end of the immobilised single stranded fragment 
leading to the formation of a bridge structure. Adapters on the surface act as primers 
for the subsequent bridge PCR amplification (cluster generation). The reaction mixes 
for sequencing reactions and DNA synthesis comprise the four reversible terminator 
nucleotides, each uniquely labelled with a fluorescent dye. On incorporation into the 
DNA strand, the terminator nucleotides as well as its position on the solid support is 
detected and identified via its fluorescent dye using charge-coupled device (CCD) 
camera. Subsequently, the terminator group at the 3' end of the base and fluorescent 
dye are removed from the base and the synthesis cycle is repeated (Ansorge, 2009) 
(Figure 5.12). Each cluster progressively leads to over a million amplified copies of 
the original single-stranded fragment, the sequencing reaction from which is 
sufficient for reporting incorporated bases at the required signal intensity for 
detection during sequencing (Mardis, 2008). In the present study, the sequence read 
length was specified at 50 nucleotides and paired-end reads were achieved by 
modifying the clusters in situ to regenerate the template for the paired read after the 
first read. The same clusters are then sequenced using a second sequencing primer to 
generate the second read (2.6.2). The amount of duplication in the libraries could be 
evaluated with paired-end reads, unlike single-end reads. The ability to sequence 
atleast 40 million clusters in parallel defines the high throughput feature of Illumina 
sequencers. A total of 220 million + 220 million reads was generated from a single 
lane of HiSeq v4 High Output (Illumina) in the present study. R1 and R2 read pairs 
from each of the 15 RNA samples were obtained as fastq files from the Edinburgh 
Genomics facility. Five files in fastq format belonging to reads from RNA samples 
of N set (taken from ̴ 0.4 OD600 cultures in normal glucose-DM) were referred to as 
N1_1, N1_2 and N3( _1 and _2) - N6( _1 and _2). Fastq files containing read pairs 
from RNA samples of  G1 set (taken from ̴ 0.4 OD600 cultures in nitrogen-limiting 
glutamine medium) were referred as Gu1( _1 and _2) - Gu5( _1 and _2). In a similar 
manner read pair files from RNA samples of GA set (extracted from 0.8 OD600 
cultures in nitrogen-limiting glutamine medium) were given the nomenclature GuB( 








Figure 5.12: Outline of the Illumina (Solexa) sequencing platform 
I. ds cDNA (A) synthesised from RNA fragments is adeylated at the 3' end (B) for adapter 
ligation (C). Adapter ligated DNA fragments are enriched by PCR (D). II. Denatured cDNA 
is hybridised to the flow cell (E) and bridge PCR is performed (F) to generate clusters (G). 
Sequencing primer is annealed for sequencing reactions (H). III. The first terminator 
nucleotide is incorporated into the base, read and removed (I) and the step is repeated to 








5.3.3. Validation of RNA-Seq reads post RNA sequencing 
Quality of the generated read pairs was checked, processed and mapped against the 
reference B. fragilis NCTC 9343 genome using appropriate software tools and 
parameters for analysing regulation at the transcriptional level. 
5.3.3.1. Quality Control and Assessment 
To determine the quality of the read pairs in fastq files, FastQC v0.11.3 was 
performed intially (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The 
FastQC analysis is performed by a series of modules on each sequence read pair and 
the output is provided as an interactive display which summarises the modules that 
were run and provides a quick evaluation to check whether the results of the module 
seemed entirely normal (green tick), slightly abnormal (orange exclamation mark) or 
very unusual (red cross), an example of which is shown in Figure 5.13. Since the 
FastQC reports of all the 15 read pair files were similar, except for a few modules 
which have been discussed separately, the analysis of the FastQC read pair belonging 









Figure 5.13: Screenshot providing the summary of the FastQC report of a read pair file 
Summary of the N1_1 read pair file provides a quick evaluation of the results of the different 
modules in the FastQC analysis which identifies whether the results were normal (denoted 
by a green tick), slightly abnormal (denoted by an orange exclamation mark) or very unusual 








i. Basic Statistics 
The statistics table for each read pair file provides details of the filename, total 
sequence reads contained, sequences flagged as poor quality, sequence length and 
%GC content. None of the reads analysed in the present study contained sequences 
flagged as poor quality. The sequence length, 50, was identical for all read pairs as 
observed for N1_1 (Figure 5.14 A). 
(A) Basic Statistics 
Figure 5.14: Display of results of the 
modules performed by the FastQC tool 
on N1_1 fastq file 
(A) Basic statistics detailing the type and 
contents of the file. There are no sequences 







ii. Per Base Sequence Quality 
This plot provides an overview of the range of quality values across all bases at each 
position in the FastQ file. For each position, a BoxWhisker type plot is drawn. The 
elements of the plot are as follows:  
 The central red line is the median value  
 The yellow box represents the inter-quartile range (25-75%)  
 The upper and lower whiskers represent the 10% and 90% points  
 The blue line represents the mean quality  
The y-axis on the graph shows the quality scores. The higher the score the better the 
base call. The background of the graph divides the y axis into very good quality calls 
(green), calls of reasonable quality (orange), and calls of poor quality (red). Similar 
to N1_1, all the read pairs were confined within the green area which indicates a very 
good quality call in the present analysis (Figure 5.14 B). However, the base calls 
might fall into the orange area towards the end of the read owing to degradation as 








Figure 5.14 (B) Per base sequence quality plot of quality scores against position in N1_1 
read. A good quality base call is observed with a slight fall at the start of the read, indicative 







iii. Per Tile Sequence Quality 
The per tile sequence quality module is a distinct feature of the FastQC reports 
belonging to sequences generated from the Illumina library, which retains its original 
sequence identifiers. The flowcell tile coming from each read is encoded in this 
graph which also allows a check of quality scores from each tile across all bases to 
determine if a loss in quality was associated with only one part of the flowcell. The 
plot shows the deviation from the average quality for each tile. The colours are on a 
cold to hot scale, with cold colours (blues) being positions where the quality was at 
or below the average for that base in the run, and hotter colours (red) indicate that a 
tile had worse qualities than other tiles for that base. The reports from R1 reads 
across N, G1 and GA read sets in the present study issued a warning (orange 
triangle) for this plot. For instance, a few light blue and green spots are seen in N1_1 
read pair (Figure 5.14 C). A warning is issued in this module if any tile shows a 
mean Phred score  more than 2 less than the mean for that base across all tiles. 
Warnings or errors on this plot could be a result of transient problems such as 
bubbles going through the flowcell, or they could be more permanent problems such 
as smudges on the flowcell or debris inside the flowcell lane. Also, when a flowcell 
is generally overloaded, the variation in phred scores appears all over the flowcell 
rather than being specific to an area or range of cycles. Errors that mildly affect a 
small number of tiles for only 1 or 2 cycles are ignored whereas larger effects 
pertaining to high deviation in scores that persisted for several cycles are pursued. 
However, since the warnings posed by the module in this study were minimal and 








Figure 5.14 (C) Per tile sequence quality plot of the read file shows a deviation from the 
average quality in some tiles which indicate a bad quality (denoted in light blue and green)  








iv. Per Sequence Quality scores 
The graph is generated by computing the average quality of a read and then plotting 
the distribution of this average quality. It thus determines if a subset of the sequences 
have universally low quality values and whether this subset is distributed across all 
reads. The y-axis depicts the number of reads and the x-axis, the mean quality score. 
It is often the case that a subset of sequences will have low mean quality scores. 
However, no low quality bases were observed across any reads in the present study 
as shown in the example of N1_1 (Figure 5.14 D). Also, no warnings were raised in 
this module since the highest peak in the distribution of all read pairs were mapped to 
a score higher than 20 on the x-axis (37). 
 
Figure 5.14 (D) The plot of per sequence quality scores representing the number of reads on 
y-axis and the mean quality score on x-axis. Highest peak in the distribution of  reads in 








v. Per Base Sequence Content 
This graph plots the proportion of each base position in a file for which each of the 
four normal DNA bases has been called. A random library is expected to have little 
or no difference between the different bases of a sequence run, therefore, the lines in 
this plot must run parallel with each other. However, all the read pairs generated by 
RNA-Seq in the present study raised an error (red cross) for this graph which is 
consistent with a  >20% difference between A and T, or G and C in any position. It is 
common for some types of libraries, especially RNA-Seq libraries, to produce biased 
sequence composition, normally at the start of the read (first 12 bp of each run), as 
shown in N1_1 read pair (Figure 5.14 E). RNA-Seq libraries are produced by 
priming using random hexamers and those which were fragmented using 
transposases inherit an intrinsic bias in the positions at which the reads start. The bias 
is the result of an enrichment of a number of different K-mers at the 5' end of the 
reads. Nevertheless, this is not a problem which can be fixed by processing and the 









Figure 5.14 (E) Per base sequence content plot of each base position in a file for which each 
of bases has been called .  ̴ 50% difference between A and T or G and C is observed in the 








vi. Per Sequence GC Content  
This module measures the GC content across the whole length of each sequence in a 
file and compares it to a modelled normal distribution of GC content. A roughly 
normal distribution of GC content where the central peak corresponds to the overall 
GC content of the underlying genome, as expected in a normal library, was observed 
in all the read pairs analysed (Figure 5.14 F). 
 
Figure 5.14 (F) Per sequence GC content depicts a roughly normal distribution of GC 
content across the whole length of the sequence in N1_1 (denoted in red) when compared to 








vii. Per Base N Content 
The inability to make a base call with sufficient confidence will normally lead the 
sequencer to substitute an N in the place of a conventional base call. This module 
plots out the percentage of base calls at each position for which an N was called. 
However, the HiSeq v4 used in the present study has not made any such substitutions 
according to this plot (Figure 5.14 G). 
 
Figure 5.14 (G) Per base N content plot of N1_1 file does not detect any N substitutions in 








viii. Sequence Length Distribution 
This module generates a graph showing the distribution of fragment sizes in the file 
which was analysed. Since we generated 50 base reads using HiSeq, a graph showing 
a peak at 50 on x-axis was produced for all reads in the present study (Figure 5.14 
H). 
 
Figure 5.14 (H) The plot of sequence length distribution identifies a peak at 50 on x-axis 








ix. Sequence Duplication Levels 
This graph shows the number of sequences with different degrees of duplication 
(indicated on the x-axis) relative to the number of unique sequences (which is set to 
100%). In a diverse library most sequences will occur only once in the final set. A 
good coverage of the target sequence is indicated by a low level of duplication 
whereas a high level of duplication is more likely to indicate some kind of 
enrichment bias. To save memory, in this module, only sequences which first appear 
in the first 100 000 sequences in each file are analysed, which is adequate to get a 
good impression for the duplication levels in the whole file. A representative count 
of the overall duplication level is provided by tracking each sequence to the end of 
the file. To minimise the amount of information in the final plot any sequences with 
more than 10 duplicates are placed into grouped bins to give a clear impression of the 
overall duplication level without having to show each individual duplication value. 
The plot depicts the proportion of the library which is made up of sequences in each 
of the different duplication level bins. The blue line on the plot represents the full 
sequence set and shows how its duplication levels are distributed. Deduplicated 
sequences are indicated in the red plot and the proportions shown are the proportions 
of the deduplicated set which come from different duplication levels in the original 
data. The persistence of peaks even in the blue trace across all reads in the present 
analysis suggests a large number of different highly duplicated sequences in the read 
pairs, as seen in N1_1 (Figure 5.14 I). In addition, the module calculates an expected 
overall loss of sequence if the library were to be deduplicated. The calculated 
percentage value of sequences remaining after library deduplication varied across the 
read pairs analysed and fell within 13% - 20% range (Table 5.2). All the read pairs 
issued an error for this module since the non-unique sequences made up more than 
50% of the total sequence reads. In RNA-Seq libraries, sequences from different 
transcripts occur at wildly different levels in the starting population. Therefore, it is 
common to greatly over-sequence high expressed transcripts for observing lowly 
expressed transcripts. The over-expression will potentially create a large set of 







duplication bins in the present study. Examination of the distribution of duplicates in 
a specific genomic region will allow the distinction between over-sequencing and 
general technical duplication. 
 
Figure 5.14 (I) Sequence duplication level graph shows persistence of peaks in blue plot in 








x. Overrepresented Sequences 
A normal high-throughput library will contain a diverse set of sequences, with no 
individual sequence making up a tiny fraction of the whole. Finding of specific 
overrepresented sequences in the set either means that it is highly biologically 
significant, or indicates that the library is contaminated, or not very diverse. This 
module in the present study listed all sequences that made up more than 0.1% of the 
total and thus raised a warning as observed in N1_1 (Figure 5.14 J). Eighteen 
overrepresented sequences were identified across the 15 read pair files (Table 5.3). 
To conserve memory, only sequences which appear in the first 200 000 sequences 
are tracked to the end of the file. Thus it is possible that a sequence which is 
overrepresented but does not appear at the start of the file could be missed by this 
module. For each overrepresented sequence the program will look for matches in a 
database of common contaminants and will report the best hit it finds. The 18 unique 
sequences in the present study were analysed using BLASTN against nr-databases 
and were confirmed to be part of NCTC 9343 genome rather than a result of 
contamination. Therefore, these 18 sequences were reported to be overrepresented in 
the genome according to the FastQC analysis and were not discarded. 
(J) Overrepresented Sequences 
 
Figure 5.14 (J) List of  three overrepresented sequences identified in N1_1 file which was 








xi. Adapter Content 
This module does a specific search for adapter sequences and gives a view of the 
total proportion of the library which contain these separately defined Kmers. A result 
trace will always be generated for all of the sequences present in the adapter 
configuration file which enables the visualisation of the adapter content of the library 
even if its low. In the present FastQC report, the presence of the 4 analysed adapter 
sequences are almost close to zero across all reads suggesting that the adapter content 
is negligible (Figure 5.14 K).  
 








xii. Kmer Content 
The Kmer module measures the number of each 7-mer at each position in the library 
and uses a binomial test to look for significant deviations from an even coverage at 
all positions. Any Kmers with positionally biased enrichment are reported. The top 6 
most biased Kmers are additionally plotted to show their distribution. Only 2% of the 
whole library is analysed and the results are extrapolated to the rest of the library. 
Sequences longer than 500 bp are truncated to 500 bp for analysis. This module had 
issued an error for all reads in the present study due to a Kmer imbalance with a 
binomial p-value < 10
-5 
(Figure 5.14 L). Individually overrepresented sequences that 
are not present at an adequate threshold to trigger the overrepresented sequences 
module will cause Kmers from those sequences to be highly enriched in this module, 
which appear as sharp spikes, as seen here, rather than a progressive or broad 









Figure 5.14 (L) Plot of distribution of the top 6 most biased Kmers in N1_1 file observed as 








Even though, the FastQC report issued a few errors and warnings, which are 
commonly observed in RNA-Seq libraries, the overall quality of each file was stated 
as 'Good' by the FastQC standards (Table 5.2). The unique set of 18 overrepresented 
sequences across the 15 read pair files were retained in downstream analyses since 
they were all part of the NCTC 9343 genome (Table 5.3). 
 
Table 5.2: Fast QC report of the read pair files of the G1, GA and N sets 
 FastQC analysis indicating the number of reads, percentage of sequences remaining after 
deduplication and overall quality for the read pairs corresponding to each sample of G1, GA 
and N sets.  
File Name No. of 
Reads 
Percent of sequences 
remaining after deduplication 
Overall quality 
(inferred through the 
fastqc report) 
Gu1_1 19,747,613 14.95% Good 
Gu1_2 19,747,613 13.97% Good 
Gu2_1 15,194,819 16.83% Good 
Gu2_2 15,194,819 16.18% Good 
Gu3_1 18,350,715 15.4% Good 
Gu3_2 18,350,715 14.34% Good 
Gu4_1 17,762,906 15.9% Good 
Gu4_2 17,762,906 15.23% Good 
Gu5_1 15,553,594 16.55% Good 
Gu5_2 15,553,594 16.52% Good 
GuB_1 18,321,211 15.2% Good 
GuB_2 18,321,211 14.56% Good 
GuC_1 17,509,499 14.88% Good 
GuC_2 17,509,499 14.72% Good 
GuD_1 16,127,604 14.66% Good 







GuE_1 14,148,510 16.14% Good 
GuE_2 14,148,510 16.49% Good 
GuF_1 10,563,179 18.61% Good 
GuF_2 10,563,179 19.06% Good 
N1_1 15,425,050 16.99% Good 
N1_2 15,425,050 16.06% Good 
N3_1 20,837,400 14.62% Good 
N3_2 20,837,400 14.1% Good 
N4_1 19,525,023 15.66% Good 
N4_2 19,525,023 14.32% Good 
N5_1 14,952,840 18.09% Good 
N5_2 14,952,840 16.54% Good 
N6_1 23,240,069 14.28% Good 
N6_2 23,240,069 13.58% Good 
 
Table 5.3: List of the unique overrepresented sequences  






















































5.3.4. Alignment against the reference genome 
Adapter sequences were removed from raw fastq files and reads that were shorter 
than 20 nucleotides and longer than 50 nucleotides were discarded (2.8.2). The 
trimmed read pairs were aligned against the reference NCTC 9343 genome using 
Bowtie2-2.2.5 program. The genome sequence is available at: 
ftp://ftp.ncbi.nlm.nih.gov/genomes/Bacteria/Bacteroides_fragilis_NCTC_9343_uid5
7639/NC_003228.fna.  
The overall alignment rate was above 98% for all the read pairs processed which is 
indicative of a good genome coverage by the reads (Table 5.4). The number of 
unaligned reads in the alignment table are individual reads that could not be aligned 
to the genome anywhere under the parameters specified by Bowtie2 alignment. The 
failure to align these reads might be due to DNA/RNA contamination at the level of 
RNA extraction, library preparation or sequencing. A maximum of two mismatches 
were allowed while mapping reads to the genome. Alignment rate might lower if the 
sequence reads are significantly different at nucleotide levels, owing to events such 
as Single Nucleotide Polymorphisms. However, since the data presented here were of 
good quality with more than a 98% overall alignment rate, the number of unaligned 
reads was insignificant. 
 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.3.6. Differential Expression 
The read pairs that were successfully aligned against the reference genome and 
assigned a feature were finally analysed using DESeq2 (DeSeq2_1.6.1) software to 
determine the differentially expressed genes. The DeSeq2 tool applies the Wald 
significance test to identify the differential expression in read pairs. The Wald test is 
used to test the true value of a parameter based on a sample estimate, wherever a 
relationship within or between data items can be expressed as a statistical model with 
parameters to be estimated from the sample.  
5.3.6.1. Analysis of the read pairs belonging to N, G1 and GA sets post gene 
quantification 
Prior to analysing the differential expression of genes, it is essential to validate the  
read pairs belonging to the three sets of experimental conditions using analysis plots. 
Firstly, the raw read-count data matrix ('genes' as rows and 'read pairs from the 
sample sets' as columns, as compiled from the HTSeq-count result) was transformed 
to log2 scale and normalized with respect to library size using rlog transformation 
(https://www.bioconductor.org/packages/release/bioc/vignettes/DESeq2/inst/doc/DE
Seq2.pdf). Qualitative analysis of the five read pair files belonging to each of the 
three sets was performed using Euclidean distance, Poisson distance and Principal 
Component Analysis (PCA) plots (Figure 5.15 A and B and Figure 5.16). For 
Euclidean distance plot, ‘dist’ function (https://stat.ethz.ch/R-manual/R-
patched/library/stats/html/dist.html) in R programming language was used to 
compute Euclidean distance by the formula sqrt(sum((x_i - y_i)
2
))) between the 
sample records from the complete rlog transformed data matrix. This dissimilarity 
information was provided to ‘hclust’ function (https://stat.ethz.ch/R-manual/R-
patched/library/stats/html/hclust.html) which uses an agglomerative method, 
‘complete’ for hierarchical cluster analysis (Figure 5.15 A). For Poisson distance 
plot, ‘PoissonDistance’ function from library ‘PoiClaClu’ (https://cran.r-
project.org/web/packages/PoiClaClu/PoiClaClu.pdf)  has been used on transpose of 







called deseq method) to normalize the count data and power transformation to 
transform the data so that the data fits the Poisson model more accurately and then, 
calculates Poisson distance matrix. The distance information was fed to ‘hclust’ for 
hierarchical cluster analysis (Figure 5.15 B). Heirarchial clustering using Euclidean 
and Poisson distance plots revealed a closer relationship between the N and G1 sets 
of read pairs when compared to the GA (Figure 5.15 A and B). This observation was 
in agreement with the growth rate of the culture samples used for RNA extraction, 
where N and G1 sets were extracted from cultures growing at similar growth rates 
and GA set was from cultures where the growth rate was reduced due to nitrogen 
limitation. PCA is a statistical procedure that uses an orthogonal information to 
convert a set of observations of possibly correlated variables into a set of values of 
linearly uncorrelated variables called principal components. In the present study, 
PCA plot was performed to analyse the top 500 genes, which were selected by 
highest variance across the 3 sample sets as per the rlog transformed matrix, using 
their first two principal components (Figure 5.16). The plot suggests that there was 
no effect of experimental covariates and batch effects as the samples belonging to the 









Figure 5.15: Distance plots of the normalized RNA-Seq reads 
(A) Euclidean distance and (B) Poisson distance plots. The genes are represented in rows 
whereas columns represent sets of read pairs that have been transformed using rlog function. 
According to the colour key white-light blue shades depict genes that are separated by 
distance in each set and dark blue shades depict genes with zero distance. The clustering has 
grouped each read set together. N and G1 read pairs are more closely grouped than GA set 









Figure 5.16: Principal component analysis of the normalized RNA-Seq reads  
PCA plot representing samples belonging to N set (denoted in blue), GA set (denoted in 
green) and G1 set (denoted in red) spanned by their first two principal components. Samples 








5.3.6.2. Significance of normalization in differential expression  
Having confirmed that the read pairs were clustered into three groups based on the 
sample set they originated from, we examined their normalized expression values 
and determined whether they could be compared across the three sample sets. 
Boxplot is a convenient way to compare the distribution of expression values among 
the different groups of interest. In RNA-Seq experiment, where we assume that the 
abundance of most genes will remain unchanged between groups, it is expected to 
have similar distribution for the normalized expression values for all the groups. 
Similar distribution indicates that the problem of having different sequencing depth 
in libraries in a next-generation sequencing (NGS) experiment has been minimized. 
Figure 5.17 suggests that the distribution of normalized expression values across all 
the three experimental sets were similar, and hence the normalized values of a gene 
can be compared across these sets of read pairs for identifying differential 
expression. 
5.3.6.3. Assessing changes in gene expression across N, G1 and GA sets 
The overall distribution of differentially expressed genes across the transcriptome 
from reads from the three sample sets were observed before analysing the regulation 
of genes of specific interest. Our primary aim was to compare the expression of 
genes in the GA set (from the transcriptome derived from glutamine-grown cultures 
at a Td of 390 min ± 20 min) with that in N set (from the transcriptome derived from 
normal glucose-DM cultures at a Td of 78 min ± 4.2 min) to identify the 
differentially expressed genes in the GA set as a result of a reduction in growth rate 
due to nitrogen limitation. Additionally, comparison of the G1 set (from the 
transcriptome derived from glutamine-grown cultures at a Td of 90 min ± 6min) with 
the reference N set was also performed to determine if the regulation of gene 
expression observed in the GA set was merely growth rate related or a combined 
effect of growth and nitrogen limitation. Differential gene expression of the GA set 







Gene regulation was measured as a function of log2 fold-change, such that, a log2 
FC (fold-change) value of 1 corresponds to the expression of a gene that has 
increased 2-fold (2
1
) and a log2 FC value of -1 corresponds to the expression of a 
gene that has decreased 2-fold (inverse of 2
-1
) in the test sample when compared to 
the reference sample. For the ease of qualitative analysis and to provide an overview, 
genes that were assigned a positive log2 fold-change value by DeSeq2 were 
considered as upregulated and those that were assigned a negative value, 
downregulated (no cut-off for log2 fold-change value was assigned). The 
significance of the expression values was calculated by taking into account the false 
discovery rate (FDR). A FDR-adjusted p value (q value) of 0.05 implies 5% of the 
tests found to be statistically significant by p value could probably be false positives. 
Therefore, while performing multiple tests on the same sample, the use of q values 
instead of p values becomes advantageous. We have assigned a q value cut-off of  < 
0.05 all through our analyses. The q values (adjusted p values) that were above 0.05 
were considered non-significant and omitted from the analyses. 
Log2 fold-change values of expression between the three groups were compared 
using scatter, MA and volcano plots by assigning a q value of 0.05 as cut-off. A 
three-way qualitative comparison based upon expression values, namely N 
(reference) vs GA (test), G1 (reference) vs GA (test) and N (reference) vs G1 (test) 
were performed using the plots to get an overview of the quantity and degree of the 
differentially expressed genes under the three  experimental conditions. Scatter plots 
investigate the possible relationship between two groups. It highlights general 
similarities and specific outliers between two groups (or conditions). While 
comparing expression values of the GA set with G1 or N sets as references, a wide 
distribution of upregulated or downregulated genes was observed, which was 
indicative of high and low log2 FC values (Figure 5.18 A, Figure 5.19 A). In these 
two plots, there was a remarkable decrease in the statistically non-significant values 
(at the specified cut-off), when compared to N vs G1 scatter plot, (Figure 5.20 A) 
and the number of not-applicable values (owing to the inability of DESeq2 to assign 







the reference N set displayed a significant proportion of genes as upregulated or 
downregulated. A slightly higher proportion of genes were either statistically non-
significant at the specified cut-off or not applicable (Figure 5.20 A) when compared 
to GA plots with N or G1 as references. However, the majority of differentially 
regulated genes were close to the baseline indicating that the log2 FC values of the 
upregulated or downregulated genes were not high and a stringent log2 FC cut-off 
value might render the observed differential expression in the G1 set non-significant. 
These statistics suggest a higher magnitude of differentially expressed genes in the 
GA test set when compared to the G1 set as the test condition. Observations from the 
scatter plots agree with the experimental condition where the GA set pertained to 
RNA extracted from slow-growing cultures limited by nitrogen and therefore might 
possess a considerable difference in transcriptome when compared to the G1 and N 
sets. 
In a two group-comparison problem, an MA plot depicts the trend of difference in 
expression over the average expression. The plot is a function of M=log2 
(Group2/Group1) vs. A=(log2Group2+log2Group1)/2 where group 2 is the test 
sample and group1 is the reference sample. Under the assumption that most genes 
will have no change in their expression, most points are expected to lie around 
‘M’=0. A typical MA plot helps to spot the ‘A’ regions (such as low expressed, high 
expressed or moderately expressed) to which the differentially expressed genes 
belong at a user specified p.adj value and log2 FC cut-off. In the present study 
differentially expressed genes were analysed across N vs GA, G1 vs GA and N vs 
G1 using MA plots at p.adj value (q value) < 0.05 and all log2 FC values. In all the 
three plots, it was observed that a larger proportion of genes were significantly 
upregulated or downregulated when compared to the M0 line (Figure 5.18 B, Figure 
5.19 B, Figure 5.20 B). MA plots do not indicate a considerable difference in 
differentially regulated genes between GA and G1 when using N as the reference. 
However, quantification of genes at stringent log2 FC expression values would be 







Qualitative analysis was also performed using volcano plots to spot the differentially 
expressed genes by considering both fold-change value and test statistic. It is used to 
display both the test statistic’s p.adj value (signal-to-noise ratio) and fold-change 
(signal)  using -log10 (p.adj-value) vs. log2 fold-change, respectively. Consistent 
with the experimental observation, a larger proportion of  differentially expressed 
genes at high or low log2 FC values was observed when GA was used as the test 
sample instead of G1 test with N as the reference set (Figure 5.18 C, Figure 5.19 C, 









Figure 5.17: Representation of the normalized expression values 
Box plot representing normalized expression values across G1 (denoted in pink), GA 
(denoted in green) and N (denoted in blue) read sets. The normalized values are similar and 


















Figure 5.18: Qualitative analysis of the differentially expressed genes in the GA set with 
reference to the N set 
Genes are represented as upregulated (denoted by red dots), downregulated (denoted by 
green dots), non-significant (denoted by yellow dots) and not-applicable (denoted by black 
dots) based on expression values at p.adj value < 0.05 and all log2 FC values for GA when 
compared to reference N. (A) Scatter plot of log2 FC values of genes in N vs GA. Higher 
proportion of genes are either upregulated or downregulated with very few number of genes 
represented by non-significant or not-applicable p.adj values. (B) MA plot as a function of  
M=log2 (GroupGA/GroupN) vs. A= (log2GroupGA+log2GroupN)/2. Dots farther from the 
M0 line represent genes that are highly differentially expressed (upregulated or 
downregulated). (C) Volcano plot representing differentially expressed genes by considering 

















Figure 5.19: Qualitative analysis of the differentially expressed genes in the GA set with  
reference to the G1 set 
Genes are represented as upregulated (denoted by red dots), downregulated (denoted by 
green dots), non-significant (denoted by yellow dots) and not-applicable (denoted by black 
dots) based on expression values at p.adj value < 0.05 for GA when compared to reference 
G1 (A) Scatter plot of log2 expression values of genes in G1 vs GA. Higher proportion of 
genes are either upregulated or downregulated with very few number of genes represented by 
non-significant or not-applicable p.adj values. (B) MA plot as a function of  M=log2 
(GroupGA/GroupG1) vs. A= (log2GroupGA+log2GroupG1)/2. Dots farther from the M0 
line represent genes that are highly expressed (upregulated or downregulated). (C) Volcano 
plot representing differentially expressed genes by considering both fold-change and test 


















Figure 5.20: Qualitative analysis of the differentially expressed genes in the G1 set with 
reference to the N set 
Genes are represented as upregulated (denoted by red dots), downregulated (denoted by 
green dots), non-significant (denoted by yellow dots) and not-applicable (denoted by black 
dots) based on expression values at p.adj value < 0.05 for G1 set when compared to 
reference N. (A) Scatter plot of log2 expression values of genes in N vs G1. Higher 
proportion of genes are either upregulated or downregulated with a smaller proportion of 
genes represented by non-significant or not-applicable p.adj values. (B) MA plot as a 
function of  M=log2 (GroupG1/GroupN) vs. A= (log2GroupG1+log2GroupN)/2. Dots 
farther from the M0 line represent genes that are  differentially expressed (upregulated or 
downregulated). (C) Volcano plot representing differentially expressed genes by considering 
both fold-change and test static. A higher proportion of differentially regulated genes are 








5.3.6.4. Quantification of differentially expressed genes across N, G1 and GA 
To substantiate the qualitative analysis and to provide more information about the 
overall differential regulation, the DeSeq2 results of differential expression were 
quantified. At first, we determined the total number of differentially expressed genes 
at q value < 0.05 and no specified cut-off for log2 FC value (Table 5.6). All the 
values above 0 were considered as upregulated and below, downregulated. This was 
done to correlate the quantification results with the qualitative analysis plots which 
specified no log2 fold-change cut-offs. Of the 3433 differentially expressed genes in 
the N (reference) vs GA (test) sets, 1721 were upregulated and 1712 were 
downregulated. In the G1 (reference) vs GA (test) sets, 3312 were differentially 
expressed, of which an equal number of genes were determined as upregulated and 
downregulated. In N (reference) vs G1 (test) set, 2469 genes were diferentially 
expressed (1249 upregulated and 1220 downregulated), which was surprising since 
the N and G1 sets belonged to reads from RNA extracts taken from cultures grown to 
similar OD600 values (0.4) with similar doubling times. Probably, more stringent log2 
FC cut-offs have to be applied to observe its impact on the differential gene 
expression in the N vs G1 sets. In a microarray-based analysis of the global 
transcription response of Mycobacterium smegmatis to nitrogen stress, genes were 
considered to be significantly differentially expressed if their expression changed 
more than 2-fold at a q value < 0.05 for multiple analysis. A significant change in the 
differential expression of 16% of the genome was observed under these conditions 
(Williams et al., 2013). Therefore, we applied  a log2 FC cut-off of 1 (2-fold 
increase) and -1 (2-fold decrease) at q  value < 0.05 to the present analyses for 
determining the effect of higher stringent conditions on the number of genes 
differentially expressed (Table 5.7). There was an expected reduction in the number 
of differentially expressed genes, since genes with log2 FC values between -1 and +1 
(< 2-fold decrease and increase) were not considered significant under the revised 
stringency conditions. Appendices 8 and 9 provide the list of genes that were 
significantly upregulated and downregulated in the GA set when compared to the 







differentially expressed, with 784 upregulated and 806 downregulated genes. 33% of 
the genome was differentially expressed in G1 vs GA. However, only 5.75% of the 
genome (230 genes) was differentially expressed in N vs G1 of which, 111 were 
upregulated and 119 were downregulated. Appendices 6 and 7 provide the list of 
genes that were significantly upregulated and downregulated in the G1 set with 
reference to the N set. Therefore, applying a log2FC cut-off of 1 decreased the 
magnitude of differentially expressed genes in N vs G1 analysis. A difference of  ̴ 12 
min was observed between the doubling times of cultures used for RNA extraction 
from N and G1 set of reads. This slight decrease in Td might have an effect on the 
RNA derived from glutamine-grown cultures (G1 set) which might account for the 
observed differential expression. This difference in gene expression might indicate 
that the glutamine medium was posing a nitrogen limitation on bacterial growth even 
at an OD600 of  ̴ 0.4 (at which RNA for the G1 set was extracted), commensurate with 
the slight decrease in Td. To assess the influence of growth rate variation in the 
regulation of gene expression in the GA set of samples, the number of differentially 
regulated genes in both the G1 and GA set of samples were compared using the N set 
of samples as reference. Of the 111 significantly upregulated genes in G1 (p adj. 
value < 0.05 and log2 FC cut-off 1), 35 were not upregulated and 5 were 
significantly downregulated in GA. On comparison of the 119 significantly 
downregulated genes in G1, 26 were not downregulated and 3 were upregulated in 
GA. This difference observed in the regulation of the transcriptome derived from two 
time points in the diauxic growth of cultures in glutamine medium might be an effect 
of nitrogen limitation as well as growth rate reduction. The GA sample set was 
derived from cultures with a considerably lower mass Td when compared to that from 







Table 5.6: List of the number of genes differentially expressed in N vs GA, G1 vs GA 
and N vs G1 analyses at q value < 0.05 
Quantification of the differentially expressed genes in N vs GA, G1 vs GA and N vs G1 
using DESeq2 software at q value < 0.05. A higher number of differentially expressed genes 
were upregulated than downregulated in GA and G1 when compared to N. 
 
 
Table 5.7: List of the number of genes differentially expressed in N vs GA, G1 vs GA 
and N vs G1 analyses at q value < 0.05 and log2 FC cut-off of 1 
Quantification of the differentially expressed genes in N vs GA, G1 vs GA and N vs G1 
using DESeq2 software at q value < 0.05 and log2 fold-change cut-off of 1. A reduction in 









5.4. Analysis of differential gene expression with respect to nitrogen limitation 
To examine the transcriptional regulation of the B. fragilis NCTC 9343 genome 
under nitrogen-limiting, ammonia-deficient conditions, the normalized data obtained 
from DESeq2 analytical tool was utilised to identify groups of genes that were 
significantly upregulated or downregulated in the GA set of reads (glutamine-grown 
cultures at 0.8 OD600 with a calculated Td of 390 min ± 20 min) and G1 set of reads 
(transcriptome derived from the  glutamine-grown cultures at  ̴ 0.4 OD600, non 
growth-limiting phase with a calculated Td of 90 min ± 6 min) with reference to the 
N set (transcriptome derived from ammonia-grown cultures at  ̴ 0.4 OD600 and Td of 
78 min ± 4.2 min). The results were considered reliable owing to the fact that each 
experimental set was obtained from the RNA extracted from samples from five 
culture replicates. Additionally, heat maps were obtained using heatmap.2 function 
from the R package "gplots" generated for each group of genes to visualize the 
pattern of differential expression. Regulation of genes in the N set were considered 
as reference and compared across the G1 and GA sets in heat maps. Being colour-
coded, the heat maps help to illustrate the associated values in a graphic 
representation. Furthermore, the function clusters the genes by heirarchical clustering 
which indicates the evolutionary relationship of the genes involved. Although 
Williams et al., (2013) mentioned that a 2-fold cut-off for  expression values was 
convenient in comparing significant changes in the differential expression of the M. 
smegmatis transcriptome under nitrogen limitation, they also acknowledged that the 
application of an arbitrary cut-off could mask less dramatic changes in gene 
expression and metabolism that may contribute to a co-ordinated response at the 
level of a metabolic pathway. Thus, in their study, the expression levels from the 
microarray data of all 6578 genes of the M. smegmatis genome were compared under 
varying nitrogen conditions using AMBIENT and KEGG analyses. Therefore, in the 
present analyses of differential expression of different groups of genes in B. fragilis 
under nitrogen limiting conditions, no log2 FC cut-off was applied, albeit a log2 FC 
value >= 1 ( >= 2-fold increase) and <= -1 (>= 2-fold decrease) were considered 







5.4.1. Nitrogen assimilation and metabolism 
Since biphasic growth was observed in a nitrogen-limiting glutamine medium (GA 
set), it is likely to pose a direct and immediate influence on the genes involved in 
nitrogen regulation. Also, the nitrogen metabolic pathway that facilitates the growth 
of B. fragilis on glutamine but not on glutamic acid has to be identified (5.2.1). 
Appendix 1 of the 'gene groups' folder provides the list of differentially expressed 
genes involved in overall nitrogen assimilation, glutamine and glutamate metabolism 
by annotation. The protein product encoded by BF9343_2369 was homologous to the  
E. coli nitrogen regulation protein NtrC (35.62% identity in 480 aa) and was found to 
be upregulated in GA with a log2 fold-change value of 0.1572 when compared to N 
reference (Figure 5.21 A). This was concurrent with the increase in expression of E. 
coli NtrC observed in nitrogen-limiting condition in E. coli (Shimizu, 2013). 
Upregulation of NtrC transcription factor is essential for the activation of glnA, glnK 
and nac promoters for the conversion of glutamine into ammonia via the 
GS/GOGAT pathway (Atkinson et al., 2002). Examination of the glutamine-related 
reactions identified two genes, the raw annotations of which shared amino acid (aa) 
similarity with glutamine synthetase and were upregulated in GA reads in the present 
study. One homologue encoded by BF9343_2258, was similar to B. thetaiotaomicron 
glutamine synthetase I (88.2% identity in 500 aa) was upregulated to a log2 fold-
change value of 0.2330 in GA. BF9343_2936 expressing the other homologue was 
similar to a P. gingivalis W83 glutamine-dependent nicotinamide adenine 
dinucleotide  (NAD
+
) synthetase NadE (55.43% identity in 644 aa) was upregulated 
to a log2 fold-change of 0.1729 in GA. BF9343_0877 was found to encode a 
homologue of a Fnr-like (fumarate and nitrate reductase) protein in Lactococcus 
lactis (24.29% identity in 214 aa) and a transcription regulator in B. thetaiotaomicron 
(68.98% identity in 216 aa) and was upregulated to a value of 1.5748 log2 fold-
change, ie  ̴ 3-fold increase in GA (Figure 5.21 A and B). It was observed in E. coli 
nitrogen regulation studies that fnr transcript level increases under nitrogen limitation 
and the gltBDF, operon encoding glutamate synthase (GOGAT), had a high binding 







transcription factor homologues in the GA samples coupled with the activation of  
genes encoding glutamine synthetase-I homologue suggests that the GS/GOGAT 
pathway is favoured in B. fragilis during conditions of nitrogen limitation. However, 
the log2 FC values of expression were all lower than a significant 2-fold increase, 
except for the fnr transcript, which questions the reliability of the observed 
upregulation. Apart from these regulatory enzymes, considerable upregulation was 
also detected in gene products encoding glutamine amidotransferase enzyme 
homologues, two of them sharing identity with glutamine amidotransferase Class I 
and  three with glutamine amidotransferase Class II family (Appendix 1 and Figure 
5.21 B). Glutamine amidotransferase (GATase) enzymes catalyse removal of 
ammonia from a glutamine molecule and its transfer to a specific substrate thus 
creating a new C-N group on the substrate. On the basis of sequence similarities, 
GATases are classified into Class I (TrpG-type) and Class II (PurF-type). Class I 
GATase domains are defined by a conserved catalytic triad consisting of cysteine, 
histidine and glutamate. They have been found in enzymes such as the second 
component of anthranilate synthase and 4-amino 4-deoxychorismate synthase, CTP 
synthase, GMP synthase, glutamine-dependent carbamoyl phosphate synthase and 
histidine amidotransferase HisH. ClassII GATase domains have been identified in 
amidophosphoribosyl transferases, glucosamine fructose-6 phosphate 
aminotransferases, asparagine synthase and glutamate synthase (Weng and Zalkin, 
1987). The upregulation of GATases in the GA set might account for the effective 
glutamine utilisation through ammonia generation and in the formation of a 
glutamate pool from glutamine via GOGAT in the absence of ammonia for B. 
fragilis growth. Albeit three out of the five GATases were not upregulated by a 
significant 2-fold in GA, they all posed a > 2-fold increase in  G1, except hisH 
(0.7905 log2 FC) when compared to the reference N. This observation suggests that 
the reduction to non-significant FC value in GA might be growth rate related 
(Appendix 1 and Figure 5.21 B). Also, two significantly downregulated GATases in 







However, BF9343_1251, a gene encoding a homologue of Neisseria gonorrhoeae 
glutamine synthase (23.17% identity in 410 aa) was downregulated in G1 and GA 
with reference to N, and a gene identical to E. coli glnA was downregulated in GA, 
but upregulated in G1 (Figure 5.21 B). The log2 fold-change value of  glnA reduction 
was -1.1887 (2.27-fold decrease) in GA, whereas the gene was upregulated by a 5.3-
fold (log2 FC of 2.3990) in G1. Upregulation of glnA in G1 is in agreement with the 
upregulation of this gene by sigma-54 in E. coli under nitrogen limitation (Shimizu, 
2013). In addition, downregulation of BF9343_0887 gene product which was 
annotated as a nicotinamide adenine dinucleotide phosphate (NADPH)-dependent 
glutamate synthase small chain homologue (91.35% identity in 763 aa) in GA was 
also observed by a < 2-fold decrease (Figure 5.21 C). Two genes encoding 
homologues of N utilization substances A and B were downregulated in GA. Also, 
BF9343_4052, a gene annotated to be similar to both Shewanella violacea RNA 
polymerase sigma-54 factor RpoN (31.16% id in 507 aa) and B. thetaiotaomicron 
RNA polymerase σ
54
 BT2521 (86.84% id in 494 aa) was found to be downregulated 
in GA, indicative of slow growth. These findings suggest a different pathway than 
GS/GOGAT for nitrogen assimilation and glutamate generation in B. fragilis under 
nitrogen stress. Nevertheless, the fold-change values in expression of the 
downregulated genes was not greater than a 2-fold decrease except BF9343_1107 (N 
utilization substance B homologue) downregulation with a log2 fold-change value 
corresponding to -1.1685 (2.27-fold decrease). 
In contrast to E. coli, where the GDH pathway for glutamate synthesis is inactive 
during nitrogen limitation, the low ammonia concentration in batch cultures of B. 
fragilis has been shown to account for a higher cellular GDH activity. Low KM 
values for ammonia and α-ketoglutarate in reactions with NADPH suggest that GDH 
encoded by B. fragilis functions in ammonia assimilation even under ammonia-
limited conditions (Yamamoto et al., 1984). Although the medium of choice in the 
present study was ammonia-deficient, a significant upregulation ( > 5-fold increase) 
was observed in GA and a 4-fold upregulation in G1 for gdhB2, the product of which 







identity in 445 aa) and Prevotella ruminicola NADP-specific glutamate 
dehydrogenase GdhA (76.52% identity in 443 aa) (Figure 5.21 C). Nevertheless 
gdhB, which is identical to the gene encoding previously sequenced B. fragilis NAD-
specific glutamate dehydrogenase GdhB and similar to E. coli NADP-specific 
glutamate dehydrogenase GdhA (56.98% id in 444 aa) was significantly 
downregulated in both the G1 and GA sets of reads when compared to the reference 
N (Figure 5.21 C). This difference in regulation observed in two homologues of 
glutamate dehydrogenase suggests a possible redistribution of resources as a 
consequence of reduced growth rate and nitrogen stress, similar to the differential 
regulation of four modules related to fatty acid metabolism via AMBIENT analysis 
of the differentially expressed genes in M. smegmatis (Williams et al., 2013).  
A downregulation of the genes encoding homologues of enzymes involved in the aa 
(proline and histidine) catabolic process to form glutamate was observed in GA. This 
was surprising since the bacterium was in need of ammonia under nitrogen stress. 
However, the observed downregulation in aa catabolism in GA could be related to 
the reduction in growth rate since the downregulation of these genes were identified 
by a < 2-fold decrease in G1 (Figure 5.21 C). Consistent with the downregulation of 
genes involved in aa catabolic process in the present study, Petridis et al., (2015) 
identified a 5-40-fold downregulation in a large cohort of genes involved in the 
catabolism of amino acids in the transcriptome derived from M. smegmatis 
continuous culture in response to nitrogen limitation, some of which (valine 
degradation) were attributed to a need to prevent unnecessary consumption of amino 
acids for CoA biosynthesis. A significant downregulation was also detected in murF 
encoding a homologue of Bacteroides thetaiotaomicron UDP-N-
acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate-d-alanyl-d-alanyl ligase 
BT3644 (82.87% id in 432 aa) and a Pfam match to glutamate ligase domain (score 
42.1, E-value 1.1e-09) in GA. Mur ligases are involved in the synthesis of 
peptidoglycan, specifically in the successive additions of L-alanine, D-glutamate, 
meso-diaminopimelate or L-lysine, and D-alanyl-D-alanine to UDP-N-







under extreme nitrogen stress, as was observed in culture samples from which RNA 
was extracted for GA set, the cell size becomes smaller leading to a decrease in the 
amount of peptidoglycan required. The fold-change values observed for genes 























Figure 5.21: Qualitative analysis of the differentially expressed genes involved in 
nitrogen metabolism in the GA and G1 sets with reference to the N set 
Heat map based analysis of differentially expressed genes using N as the reference set of 
reads and GA and G1 reads from RNA extracted from the biphasic growth in glutamine 
medium as the two tests (no cut-offs applied). Green-red colour key represents 
downregulated to upregulated genes based on log2 fold-change values with yellow 
representing unchanged gene expression. (A) Genes involved in overall nitrogen 
metabolism. Although a few genes are downregulated in GA, a larger number of genes are 
upregulated in G1 and GA when compared to N. BF9343_2384 encoding a carbon-nitrogen 
hydrolase homologue is highly expressed in GA (B) A majority of the genes involved in 
glutamine metabolism are upregulated in G1 and GA. Glutamine hydrolyzing asparagine 
synthase (asnB) is highly upregulated in both G1 and GA with reference to N. More number 
of genes are upregulated in G1. The differential regulation of glnA is observed when GA and 
G1 sets are compared to N (C) Differential expression of genes involved in glutamate 







both G1 and GA while gdhB is significantly downregulated in both sets. Gene involved in 
aspartate/glutamate transport (BF9343_2196 and BF9343_2387) are also upregulated in GA. 
 
As per the DeSeq analysis, if the GDH pathway is the favoured pathway for 
glutamate synthesis (upregulation of gdhB2 in both the G1 and GA sets) in the 
nitrogen limiting phase of B. fragilis growth in glutamine-containing medium, the 
ammonia required for the synthesis needs to be generated by an alternative pathway. 
A striking upregulation corresponding to a log2 fold-change value of 7.2795 ( ̴ 155-
fold increase) was identified for the asnB gene product which shares similarity to E. 
coli glutamine-dependent asparagine synthetase B (64.09% id in 557 aa) in GA  
(Figure 5.21 B). A 30-fold increase in asnB expression was also detected in G1 
which suggests that the upregulation is not exclusively growth rate induced. Albeit 
non-significant, there was also a 1.688-fold increase in regulation (0.7557 log2 FC) 
of a BF9343_2387 gene product, a homologue of Escherichia coli O157:H7 
glutamate/aspartate transport ATP-binding protein GltL (28.5% id in 200 aa) (Figure 
5.21 B). The upregulation of these two genes suggests their involvement in B. 
fragilis growth under nitrogen limiting condition. This observation led to the analysis 
of aspartate-related, amino-acid transport related and deaminase-encoding genes        
(Figure 5.25) in GA. Appendix 2 of the 'gene groups' folder provides the list of 
differentially expressed genes involved in general amino acid metabolism, aspartate 
and arginine metabolism, and deaminase activity by annotation. Of the identified 10 
genes that encoded proteins predicted to be involved in amino acid metabolism two 
enzyme-encoding genes, apart from the previously mentioned glutamate/aspartate 
transport protein, were found to be upregulated in GA more than a 1.5-fold. These 
were involved in amino acid catabolic processes and branched chain amino acid 
biosynthetic process, respectively (Appendix 2 and Figure 5.25).  The reasons for the 
upregulation of these two specific genes is unknown, despite a 4.3-fold increase in 
expression of the gene encoding a homologue involved in branched chain amino acid 
biosynthetic process. Downregulation of the other genes involved in aa transport in 







genes were significantly upregulated in G1 too. The reduction in expression might 
either be a mechanism of conserving energy or a possible regulation at the level of 
transcription by non-coding regulatory RNAs. Kim et al., (2012) reported the 
presence of multiple transcription start sites (TSSs), in both E. coli and Klebsiella 
pneumoniae operons involved in amino acid biosynthesis, central metabolism and 
transport, which provided alternative transcripts and regulated gene expression.        
A  > 2-fold decrease was detected in opuAA and opuAB genes encoding homologues 
of proteins involved in glycine betaine transport. Among aspartate-related 
metabolism group, the majority of gene products that were upregulated in B. fragilis 
were homologous to aspartate aminotransferases/transaminases which are involved 
in the conversion of glutamate to aspartate (Appendix 2). The synthesis of asparagine 
from glutamine and aspartate via asparagine synthetase (AsnB) involves ammonia 
generation (Figure 5.22). Therefore the small proportion of glutamate synthesised by 
the GOGAT pathway during growth in nitrogen limiting glutamine medium could be 
boosted via GDH pathway following ammonia generation, to be used in cellular 
biosynthetic process in the absence of exogenous ammonia. A study in E. coli using 
aspartate as the sole nitrogen source demonstrates ammonia generation as a product 
of arginine catabolism during aspartate degradation (Goux et al., 1996). Enzymes of 
the Krebs-Henseleit pathway incorporates the amino nitrogen of aspartate into the 
imino nitrogen of arginine (Figure 5.23). The ArgG catalyzes the condensation of 
aspartate and citrulline to form arginosuccinate, the immediate precursor of arginine 
(Figure 5.23). Consistent with this pathway, a significant upregulation of argG 
(1.5332 log2 FC, ̴ 3-fold upregulation), encoding a homologue of the B. 
thetaiotaomicron argininosuccinate synthase BT3760 (93.5% id in 400 aa) was 
observed in GA (Appendix 2). Arginine deiminase (ADI pathway), previously 
studied in Streptococcus faecalis and Pseudomonas aeruginosa catalyses arginine 
decomposition into ornithine, carbon dioxide and ammonia (Cunin et al., 1986) 
(Figure 5.24). The transcript from BF9343_2385 encoding a protein homologous to 
Porphyromonas-type peptidyl-arginine deiminase (score 440.8, E-value 1e-129)  was 







upregulation of these genes suggests a similar pathway for ammonia generation in B. 
fragilis. However three genes encoding homologues of arginine decarboxylase, 
arginine-ornithine carbamoyltransferase and arginine-ornithine antiporter were 
downregulated in GA and G1, but to values < a 2-fold decrease, which could be 
considered non-significant (Appendix 2). 
The regulation of genes annotated as deaminases was also analysed since 
deamination of amino acids leads to ammonia generation. Seven out of 10 genes 
encoding enzymes similar to deaminases were upregulated in GA when compared to 
the reference N (Appendix 2). Two of the genes, BF9343_2059 and cdd homologous 
to the genes encoding Rhizobium loti probable riboflavin-specific deaminase 
mlr2151 (29.61% id in 233 aa) and B. thetaiotaomicron cytidine deaminase BT1539 
(89.31% id in 131 aa) were upregulated to a significant log2 FC value of 3.16 and 
1.22 (8.94- and 1.33-fold increase), respectively. This observation underlines the 




Figure 5.22: Synthesis of asparagine by glutamine hydrolysis 
Reactions involved in the synthesis of asparagine by glutamine hydrolysis catalysed by 









Figure 5.23: Krebs-Henseleit pathway-mediated formation of arginine as an 
intermediate in aspartate metabolism   
Reactions involved in the condensation of aspartate and citrulline to form arginine with 









Figure 5.24: Arginine deiminase pathway for ammonia generation 
Reactions involved in ammonia generation from arginine through the formation of ornithine 
by arginine deiminase (ADI) pathway. The first reaction involving conversion of arginine to 
citrulline is catalysed by arginine deiminase, the second reaction is catalysed by ornithine 
carbamoyltransferase whereas the the third reaction of the ADI pathway concerned with the 
generation of ammonia from carbamoyl phosphate is catalysed by carbamate kinase. (Cunin 







Additionally, the gene encoding a homologue of B. subtilis guanosine triphosphate 
(GTP) pyrophosphokinase RelA (36.04% identity in 763 aa) involved in guanosine 
tetraphosphate (ppGpp) metabolism, with a Pfam match to nitrogenases component 1 
alpha and beta subunits, was found to be upregulated < 2-fold in both G1 and GA 
when compared to N (Figure 5.21 A). Albeit not significant in the present analysis, 
relA-induced ppGpp synthesis was activated by NtrC during nitrogen starvation in E. 
coli. ppGpp served as an effector alarmone of the bacterial stringent response and its 
level was modulated in E. coli by ppGpp synthetase RelA and ppGpp 
synthetase/hydrolase SpoT (Brown et al., 2014). Since RelA and SpoT contribute to 
stress adaptation, antibiotic resistance, expression of virulence traits and acquisition 
of persistent phenotype in pathogens, the induction of related genes were examined 
in B. fragilis during nitrogen depletion, which are discussed in the following 
sections. Genes encoding two enzymes belonging to the carbon-nitrogen hydrolase 
family were also found to be upregulated in the GA culture in the present study. 
Increased expression of these two genes might have an effect on the nitrogen 







Figure 5.25: Qualitative analysis of the differentially expressed genes involved in 
general amino acid metabolism and  transport in GA and G1 with reference to N 
Heat map based visual analysis of differentially expressed genes involved in amino acid 
transport using N as the reference set and GA and G1 as the two tests (no cut-offs applied).  
Green-red colour key represents downregulated to upregulated genes based on log2 fold-
change values with yellow representing unchanged gene expression. Although a higher 
number of genes are downregulated in GA than G1 , a few genes are upregulated to a 
significantly higher fold  in GA (BF9343_3456, BF9343_2677, BF9343_2387) when 
compared to G1. BF9343_1878 and BF9343_2951, involved in amino acid transport, are 







5.4.2. Host Matrix adhesins and Secreted proteases 
Analysis of the regulation of extracellular protease-encoding genes under nitrogen 
limiting conditions was performed with the intention of identifying proteases that 
might contribute to replenishing the nitrogen requirement of the bacteria via protein 
degradation, which might possibly include fibrinogen degradation. Studies related to 
B. fragilis growth in varying  nutrient conditions have pointed out that secretion of 
proteases by B. fragilis is related to nitrogen starvation (Gibson and Macfarlane, 
1988a). A similar correlation was also observed with an increase in the rate of 
protein degradation in E. coli and S. typhimurium (Miller, 1975). Protein degradation 
might help the bacterium scavenge for alternative nitrogen sources to satisfy the 
limitation and facilitate amino acid synthesis. Therefore, it is also possible that the 
expression of adhesin proteins, like MSCRAMMs, that recognise host matrix 
molecules might also be upregulated under nitrogen depleting conditions to facilitate 
nutrient binding for effective protein degradation by proteases. Appendix 3 provides 
the list of differentially expressed genes involved in host matrix adhesion and 
proteolytic activity by annotation. 
The regulation of BF1705, which was found to bind both fibronectin and fibrinogen 
in the present study, was hence examined (3.9 and 3.11). Transcription of 
BF9343_1624 (BF1705 gene in artemis nomenclature) was upregulated by 0.4585 
log2 FC value (1.37-fold increase) in GA when compared to the reference N (Figure 
5.26 A). However, the BF1705 differential expression was not significant when a 2-
fold cut-off stringency is applied which suggests the function of BF1705 as an 
adhesin in the gastrointrestinal tract. In contrast to BF1705,  a > 2-fold upregulation 
of BF0586 (BF9343_0559), a hypothetical protein which was previously identified 
as a collagen binding protein (Cbp1) was also detected in GA  (Galvão et al., 2014) 
(Appendix 3).  
Sijbrandi et al., (2005) had identified a cytoplasmic α-enolase in B. fragilis strain 
BE1 that was upregulated under conditions of iron- or heme-starvation. This enzyme 







enabling bacteria to respond efficiently on the dynamic fluctuation of environmental 
signals. It was also proposed that the upregulation of α-enolase is essential under 
conditions of infection. The transcriptomic analysis of B. fragilis NCTC 9343 
performed in the present study confirmed that a gene encoding enolase was 
upregulated to a log2 FC value of 0.9351 (1.9-fold increase) in GA (Appendix 3). 
Therefore, in addition to iron-starvation, nitrogen limitation might also regulate B. 
fragilis α-enolase activity with potentially profound effects under conditions of 
infection.  
Studies on B. fragilis strains BE1 and 638R had associated the laminin-1 binding and 
plasminogen activating functions of the bacterium with an outer membrane protein, 
Bfp60 (Ferreira et al., 2013; Sijbrandi et al., 2008). The activation of plasminogen to 
plasmin, a broad-spectrum serine protease is required for degradation of fibrin, 
collagen and other structural components of the matrix tissue. BF9343_4169 
(BF4280) present in the NCTC 9343 genome encodes a protein (559 aa) that is 99%  
identical (558/559 aa; E-value:0) to the putative plasminogen binding protein Bfp60 
of BE1. Differential gene expression analysis of BF9343_4169 detected an 
upregulation corresponding to a log2 FC value of 0.86 (1.8-fold increase) in the GA 
set (Appendix 3). 
The observed changes in expression of genes putatively involved in host protein 
binding and degradation, under nitrogen depleting environment led us to analyse the 
regulation of NCTC 9343-secreted proteases under similar conditions. A specific 
protease involved in the observed fibrinogen degrading activity in B. fragilis was not 
detected among the 12 proteases studied using gene-deletion and gene-expression 
strategies coupled with functional analysis using zymography (Chapter 4). However, 
the medium used for of B. fragilis growth in the zymography experiments was not 
the nitrogen limiting glutamine medium. To determine if nitrogen limitation induced  
degradation capabilities in the B. fragilis secreted proteases to scavenge for nitrogen, 
the expression levels of protease-encoding genes in the GA set were analysed. Seven 







upregulated in GA with reference to N (Appendix 3 and Figure 5.26 A). Two of the 
proteases were assigned non-significant fold-change values at the assigned q value 
cut-off < 0.05. Among the three that were downregulated when compared to 
reference N, one matched the serine protease family while the other two matched 
metallopeptidases (Appendix 3 and Figure 5.26 A). The observed pattern of 
regulation indicates that during nitrogen-limiting conditions, a major proportion of 
the secreted proteases are upregulated in B. fragilis. However, when the 2-fold 
stringency (log2 FC 1) cut-offs were applied, only one of the previously studied 
proteases, BF3021 (BF9343_2935) could be considered as upregulated in the GA set 
(log2 FC value of 1.5625 corresponding to a 3-fold increase in expression). BF3021 
encodes an  Escherichia coli peptidyl-dipeptidase Dcp homologue (42.03% id in 678 
aa) with a Pfam match to metallopeptidase M3 family (score 466.1, E-value 2.5e-
137). These observations might suggest that the rest of the proteases studied are not 
differentially regulated under nitrogen limiting conditions which led us to extend our 
analysis to include the other known secreted proteases and peptidases that were not 
previously examined for their fibrinogenolytic potential in this study. Among the 
ninteen protease/peptidase-encoding genes that were analysed, eight were identified 
to be upregulated in GA when compared to N under no cut-off for log2 FC value 
(Appendix 3 and Figure 5.26 B). Three were assigned non-significant values for           
q value<0.05, however, two of these proteases were upregulated in the G1 set. Of the 
remaining eight, three were upregulated in G1 when compared to N indicating that 
the downregulation of these three peptidase-encoding genes in GA might pertain to 
reduced growth rate conditions. Of the nine upregulated genes in GA, two, namely, 
BF9343_0144 and BF9343_0145 matched B. thetaiotaomicron signal peptidase I 
BT3319 (25.64% id in 429 aa) and B. thetaiotaomicron signal peptidase I BT3319 
(85.83% id in 494 aa), respectively. Another gene, BF9343_2903 exhibited 
similarities to Chlorobium tepidum signal peptidase I LepB (35.14% id in 276 aa) 
and was upregulated in G1 despite being non-significant at the q value cut-off in GA 
(Figure 5.26 B). Upregulation of signal peptidase-encoding genes is probably a 







peptidases. The other GA-upregulated secreted peptidase/protease-encoding genes 
matched aminopeptiase C, dipeptidyl peptidase VI, alanyl dipeptidyl peptidase, 
tricorn protease, cysteine protease and an alkaline protease secretion protease, one or 
more of which might possess a non-specific fibrinogenolytic function under nutrient 
limiting conditions (Appendix 3 and Figure 5.26 B). 
Under a log2 FC cut-off of 1 (2-fold increase), three protease-encoding genes, 
BF9343_1980, BF9343_2676 and BF9343_2678 encoding putative homologues of 
B. thetaiotaomicron putative aminopeptidase C (81.54% id in 466 aa), 
Thermoanaerobacter tengcongensis transglutaminase-like enzymes, putative 
cysteine proteases (31.81% id in 418 aa) and Bacillus sphaericus dipeptidyl-
peptidase VI (25.09% id in 267 aa), respectively were upregulated. BF9343_0483 
and BF9343_3652, encoding homologues of Proteus mirabilis metalloprotease 
transporter component (24.57% id in 407 aa) and Thermoplasma volcanium tricorn 
protease (21.73% id in 1104 aa) with a Pfam match serine peptidase S41B family, 

















Figure 5.26: Qualitative analysis of the differentially expressed genes involved in host 
matrix adhesion and proteolytic activity in GA and G1 with reference to N 
Heat map based visual analysis of differentially expressed genes involved in adhesion and 
proteolysis using N as the reference and GA and G1 as the two tests (no cut-offs applied). 
Green-red colour key represents downregulated to upregulated genes with yellow 
representing unchanged gene expression. (A) Genes putatively involved in host matrix 
adhesion and  proteolytic activity as per previous studies. The gene nomenclature according 
to Artemis is given in brackets. A significant proportion of genes are highly upregulated in 
GA than in G1. (B) Genes annotated as proteases and peptidases. Although 4 genes are 








5.4.3. Response to shock/stress 
Owing to an upregulation detected in an open reading frame (ORF) homologous to a 
gene involved in ppGpp metabolism (5.4.1) under nitrogen limitation, the regulation 
of genes involved in stress/shock responses were analysed in detail in the GA set  
(Figure 5.27 A). Appendix 4 of the 'gene groups' folder provides the list of 
differentially expressed genes involved in shock/stress, oxidative stress and DNA 
repair by annotation. A higher proportion of these genes involved in general 
shock/stress were upregulated in both G1 and GA sets of reads when compared to the 
reference N, suggesting that the increase in transcript level was not a mere 
consequence of a sudden reduction in growth rate observed in the transcriptome 
derived from lower Td phase cultures in glutamine medium. The observed 
upregulation might be the result of a prevalent nitrogen limitation in the glutamine 
growth medium, which is evident from the slight drop in Td in cultures from which 
the transcriptome for G1 was taken, when compared to that of the reference N 
(Figure 5.27 A). Since nutrient limitation is sensed as a stress by the bacterium, the 
growth in nitrogen-limiting glutamine medium upregulates an array of genes in 
response to stress and shock which included genes encoding general stress proteins 
and a heat shock protein, in the present study. In agreement with the increase in 
ppGpp metabolism, a relA gene encoding a homologue of B. thetaiotaomicron GTP 
pyrophosphokinase BT0700 (82.52% id in 738 aa) was upregulated to a log2 FC 
value of 1.0394 in GA  (Figure 5.27 A). The protein product of BF9343_3784 is 
annotated as being involved in the maintenance of stationary phase and shows 
homology to Salmonella typhimurium survival protein SurA  (25.38% id in 461 aa) 
(Figure 5.27 A). This gene was upregulated in GA, which is consistent with the 
observation that the bacteria prepare to enter into stationary phase of growth in 
response to nutrient limiting conditions (Peterson et al., 2005). However, in the 
present study, culture replicates, from which RNA was extracted for the GA set of 
reads, were still growing, albeit at a slower rate, preparative of stationary phase entry  
The upregulation of the SurA homologue was lower than 2-fold increase and 







endopeptidase Clp ATP-binding chain B BT4597 (93.85% id in 862 aa) and to a 
Synechococcus spp. heat shock ClpB protein (54.86% id in 873 aa)  was also 
upregulated in GA. Of the four stress-related genes that were downregulated in GA, 
two were upregulated in G1 with reference to N (Appendix 4 and Figure 5.27 A).  
Another interesting observation was the upregulation of seven genes, that were 
exclusively related to oxidative stress response, in GA. A similar upregulation of 
genes involved in peroxide metabolism was observed when the transcriptome of M. 
smegmatis was assessed in relation to nitrogen stress (Williams et al., 2013). B. 
fragilis, an obligate anaerobe requires protection against reactive oxygen species 
(ROS) when exposed to aerobic conditions following initial stages of infection 
(Rocha and Smith, 1997). However, the observed upregulation in genes was mostly 
not significant in G1, suggesting that the differential expression might be growth rate 
induced in GA. The oxyR gene product, redox-sensitive transcriptional activator 
OxyR, and sodB product, similar to Bacteroides fragilis superoxide dismutase [Fe] 
SodB (99.48% id in 193 aa) were upregulated to log2 fold-change values of 1.26 
(2.4-fold increase) and 1.36 (2.5-fold increase) in GA, respectively (Figure 5.27 B). 
SodB contains iron and functions to convert superoxide anions to hydrogen peroxide. 
A catalase encoding gene, katA/katB and three genes encoding enzymes similar to 
the Alkyl Hydroperoxide reductase/Thiol Specific Antioxidant (AhpC/TSA) family 
namely BF9343_2277, bcp and tpx were also upregulated in GA when compared to 
the N reference (Appendix 4). Catalases mediate the conversion of hydrogen 
peroxide into water and oxygen. In a previous study, it was observed that B. fragilis 
katB mRNA was strongly repressed by glucose under anaerobic condition (Rocha 
and Smith, 1997). However, no transcriptional regulation of katB mRNA has been 
reported under nitrogen limitation. Upregulation of genes encoding homologues of 
AhpC enzymes was also observed in the GA. AhpC enzymes function to reduce 
peroxides to alcohols with the aid of a reduced thiol donor and provide protection 
against oxidative burst generated by macrophages and neutrophils during host 
immune response to infection (Henry et al., 2012). The transcriptional regulation 







that the ability to regulate gene expression in response to changes in nitrogen 
availability facilitates the survival of this obligate anaerobe in extraintestinal habitats 
by combating oxidative stress. In the study of M. smegmatis under nitrogen 
limitation, over a 500-fold upregulation in genes involved in ROS detoxification was 
explained with respect to the upregulation of a gene encoding amine oxidase, which 
released hydrogen peroxide during breakdown of primary amines into ammonia 
under nitrogen stress. Therefore, the upregulation in oxidative stress response might 
be a means by which the cell detoxifies ROS. However, since a significant 
upregulation of the genes described above were not observed in the G1 set, it implies 
that the increased expression in GA was related to reduction in growth rate in the 
present study. The regulation of a gene (BF9343_1121) encoding a protein similar to 
RecA (99.68% id in 318 aa)  was also analysed since recA is co-transcribed as an 
operon alongwith two genes putatively involved in repairing oxygen damage 
(Steffens et al., 2010). RecA is a major DNA repair protein which performs strand 
exchange during homologous recombination in bacterial species through SOS 
response. However, the log2 FC value of upregulation of RecA homologue was not 
















Figure 5.27: Qualitative analysis of the differentially expressed genes involved in 
response to shock and oxidative stress in GA and G1 with reference to N  
Heat map based visual analysis of differentially expressed genes involved in response to 
shock/stress using N as the reference and GA and G1 as the two tests (no cut-offs applied). 
Green-red colour key represents downregulated to upregulated genes with yellow 
representing moderately regulated genes. (A) A major proportion of the genes involved in 
general response to shock/stress are significantly upregulated in GA. (B) All the four genes 








5.4.4. Drug/Antibiotic resistance 
Concurrent with the upregulation of stress-response genes, transcriptional activation 
of a few genes encoding antibiotic resistance and drug transport activity were also 
identified in the transcriptome of B. fragilis under nitrogen-depleting conditions. 
Appendix 5 of the 'gene groups' folder provides the list of differentially expressed 
genes involved in drug/antibiotic resistance by annotation. Appendix 6 and Appendix 
8 provides the list of genes that are significantly upregulated in the G1 and GA set, 
repectively, with the N set as the reference. Activation of the multi-drug resistance 
genes was reflected by an upregulation of multi-drug efflux pumps and drug 
transporters (Appendix 5 and Appendix 8) which operate to remove toxic drugs from 
the cytoplasm. Resistance to metronidazole, a 5-nitroimidazole pro-drug, is often 
attributed to a nitroimidazole  resistance gene (nim) that encodes a nitroimidazole 
reductase which mediates the reduction of the nitro group of 5-nitroimidazole to an 
amino group resulting in the formation of an inactive 5-aminoimidazole (Husain et 
al., 2013). Two ORFs, BF9343_0350 and BF9343_4246, encoding homologues of B. 
fragilis nitroimidazole resistance protein NimE (38.41% id in 151 aa) and previously 
sequenced B. fragilis 5-nitroimadazole resistance determinant NimD protein (30.43% 
id in 161 aa), respectively were upregulated in GA by 1.5-fold compared to N 
(Figure 5.28). The regulation of theses genes in G1 were  not significant at the 
specified q value cut-off. Although downregulation was observed in a major 
proportion of resistance related genes, upregulation of nimE and nimD is significant 
owing to the fact that B. fragilis is primarily metronidazole-sensitive and the drug 
has been used in treating infections caused by this opportunistic pathogen (Schapiro 
et al., 2004). Five ORFs annotated to encode drug resistance proteins were 
significantly downregulated in GA, as shown by a > 2-fold decrease. These include 
genes encoding homologues of bicyclomycin resistance protein, NorM multidrug 
resistance protein and fosmidomycin resistance protein. Bicyclomycin selectively 
inbits Rho and is used in the treatment of nonspecific diarrhoea. The drug exhibits 
activity against a broad spectrum of Gram-negative bacteria and against the Gram-







specific activity of bicyclomycin against B. fragilis has not been reported. 
Fosmidomycin is primarily an antimalarial drug and therefore does not play a role in 
the treatment of anaerobic infections (Jomaa, 1999). Nevertheless, activation of 
metronidazole resistance-related genes and a mechanism to combat oxidative stress 
observed under nitrogen-limitation-induced reduction in growth rate are reminiscent 
of the conditions which facilitate the survival of B. fragilis in the extraintestinal 









Figure 5.28: Qualitative analysis of the differentially expressed genes involved 
drug/antibiotic resistance in GA and G1 with reference to N  
Heat map based visual analysis of differentially expressed genes involved in using N  as the 
reference and GA and G1 as the two tests (no cut-offs applied). Green-red colour key 
represents downregulated to upregulated genes with yellow representing moderately 
regulated genes. Although most of the genes involved in drug/antibiotic resistance and 
transport are downregulated in GA when compared to G1, seven genes including two that are 
annotated as metronidazole-resistance genes (BF9343_4246 and BF9343_0350) are  









The effect of nitrogen on transcriptional regulation of the B. fragilis NCTC 9343 
genome was studied by altering the nitrogen content of the growth medium from 
abundant to depleting conditions. A state of nitrogen limitation was achieved by 
substituting the ammonium sulphate ( ̴ 0.58%, 0.02 M) present in the conventional 
defined medium (glucose-DM) with glutamine. The point of limitation of  nitrogen  
was established by growth curve analysis (Figure 5.7). The stress posed by nitrogen 
limitation was utilised to examine the transcriptome for differential gene expression 
and address the mechanisms of nitrogen metabolism of this bacterium. The presence 
of glucose (10%) in both normal medium and nitrogen limiting medium ensured 
carbon sufficiency under the conditions tested. 
5.5.1. Glutamine in the nitrogen-limiting medium  
Based upon previous literature which emphasized the necessity of ammonia for the 
optimal growth of B. fragilis, the concentration of ammonium sulphate in the defined 
medium was altered initially to check for growth limitation (Smith and Macfarlane, 
1998; Varel and Bryant, 1974). Studies as early as 1974 by Varel and Bryant,  
observed that this anaerobic bacterium grew well in defined medium containing 
NH4Cl as the nitrogen source. A variant of this medium was used in our study where 
ammonium sulphate (0.02 M) was used in the glucose-DM instead of ammonium 
chloride. A decrease in the concentration of ammonia by 10x succeeded in reducing 
the biomass yield and the growth rate considerably in the present study (Figure 5.4). 
However, the inability to identify a difference between stationary phase-induced and 
nitrogen limitation-induced reduction in growth rate addressed the need for an 
alternative nitrogen source to study limitation. Attainment of similar growth rates 
and biomass yields by growth in normal glucose-DM and in a medium where the 
concentration of ammonia was increased by 5x indicated that the nitrogen content is 
not limiting in the normal glucose-DM. Neither single amino acids, nitrate, urea, nor 
a complex mix of L-amino acids or peptides were effective in replacing ammonia as 







availability of organic nitrogen for B. fragilis growth in  its natural colonic habitat is 
limited since the bacterium is unable to utilise nitrogen from organic compounds 
(Varel and Bryant, 1974). Ammonia, which is an inorganic nitrogen source, was  
more readily available since  ̴ 20-25% of a person's daily urea excretion is normally 
recycled to the intestine from blood and hydrolysed to NH4
+
 by ureolytic bacteria, 
thereby releasing 3-4 g ammonia. Based upon studies in E. coli by Atkinson et al., 
(2002); Goux et al., (1996); Liang and Houghton, (1981) and Maheswaran, (2003), 
where nitrogen-limiting growth conditions were attained by using glutamine or 
single free amino acids such as aspartate and arginine as the sole nitrogen source, 
growth of B. fragilis was examined in low concentrations of the two major 
intermediary amino acids of nitrogen metabolism, glutamine and glutamate (5.1.1). 
Additionally, studies have indicated that internal glutamine serves as a sensor of 
external nitrogen availability and its pool decreases upon nitrogen limitation 
(Maheswaran, 2003; Yan, 2007). Annotation of the  NCTC 9343 genome indicates 
the presence of genes encoding enzymes involved in glutamine and glutamate 
utilisation which are required by the bacterium to utilise these  metabolic products 
for nutrition and biosynthesis. Interestingly, no growth was observed on glutamic 
acid containing medium (GCM) whereas B. fragilis attained growth saturation with 
overnight OD600 2.0 on glutamine containing medium (GNM). The limiting condition 
in late-log phase imposed a slow growth rate of the cell population on reaching the 
preparatory stationary phase in a growth curve. A decrease in growth rate is the most 
direct indication of nutrient limitation and therefore was of significance in the 
present work on transcriptome analysis which identified a change in growth rate in 
the log phase of B. fragilis growth in GNM. The inability to utilise glutamic acid by 
B. fragilis is consistent with previous reports (Varel and Bryant, 1974). However, the 
ability to grow on GNM with glutamine as the sole nitrogen source has not been 
previously documented to the best of our knowledge. Ammonia which is found at 
millimolar concentrations in the large intestinal lumen as a result of  amino acid 
deamination and urea hydrolysis by intestinal microbes, increases proportionally to 







represents a balance between deamination by amino acids, subsequent uptake by 
bacterial cells as nitrogen source for protein synthesis and colonic absorption (Davila 
et al., 2013). Also, the luminal concentration of ammonia increases progressively 
from ascending to descending colon owing to the low pH and high carbohydrate 
availability in the proximal colon. The reduced net production of ammonia in the 
proximal colon might exert a condition of nitrogen limitation on B. fragilis. In 
addition to the direct assimilation of ammonia by the intestinal microbiota, recent 
work by Eklou-Lawson et al., (2009) suggests that part of the ammonia produced is 
condensed with L-glutamate through the activity of glutamine synthetase  for the 
synthesis of glutamine thereby ensuring that the intestinal ammonia concentration 
does not reach toxic levels. The activity of glutamine synthetase is relatively high in 
colonocytes in comparison with enterocytes. Therefore, a pathway has evolved in B. 
fragilis that enables utilisation of glutamine as the sole nitrogen source which is 
consistent with the observation of the bacterium growing in the glutamine medium.  
5.5.2. Inability to grow on glutamic acid as the sole nitrogen source 
The inability of B. fragilis to utilise glutamic acid in a similar manner to glutamine 
was confirmed by doubling the concentration of glutamic acid in GCM to 0.2% and 
examining growth in comparison with E. coli MG1655 strain (Figure 5.5 and Figure 
5.6). GCM favoured E. coli growth when compared to B. fragilis. However, GNM 
was considered a more favourable growth medium even for E. coli, than GCM 
(Figure 5.5 and Figure 5.6). Studies have indicated that intestinal microbes prefer to 
assimilate nitrogen in the form of peptides or ammonia, rather than free amino acids. 
Eventhough B. fragilis and ruminobacter B. amylophilus failed to utilise amino acids 
as the sole energy source, amino acids are assimilated and incorporated  by these 
organisms via six transport systems if ammonia is available, leading to the 
production of SCFA and ammonia, the major products of amino acid fermentation 
(Smith and Macfarlane, 1998). It was found that B. amylophilus proteases have a 
tryptic-type specificity when supplied with tryptic peptides and amino acids (Hullah 







energetically advantageous and would be physiologically important in an energy 
deficient environment such as the large intestine (Pittman and Bryant, 1964).  
Since adequate literature was not available on the uptake of glutamine and other 
single amino acids by B. fragilis, the search was extended to other species of the 
Bacteroides genera to address the rationale behind differential utilisation of 
glutamine and glutamate observed in B. fragilis. Miles et al., (1976) showed that the 
addition of individual amino acids to a trypticase-yeastextract-hemin medium 
affected growth rates and final yields of asaccharolytic and saccharolytic strains of B. 
melaninogenicus, an opportunistic pathogen inhabiting oral and intestinal niches, 
with maximum growth attained in aspartate. However, since fermentation of 
proteinaceous material was the main energy source of this bacterium it was more 
permeable to peptides than amino acids. The addition of  50 mM glutamine induced 
maximum uptake of glycine or alanine by B. melaninogenicus when added to a 
growth medium containing trypticase. Uptake of amino acids and peptides was 
stimulated by glutamine, and was concentration- and energy-dependent (Lev, 1980).  
In a similar manner, the only compounds that replaced ammonia as the main nitrogen 
source in Bacteroides ruminicola  were tryptic protein digests, peptide-rich fractions 
of tryptic digests of casein and octapeptides (Pittman and Bryant, 1964). It was found 
that ammonia served as the main source of nitrogen and that glutamine and 
potassium cyanide supported the growth of both the strains tested. However, it was 
doubtful whether glutamine and potassium cyanide  were directly utilised since 
production of ammonia was detected from each compound in uninoculated media at 
a rate sufficient to account for the cellular growth observed in the inoculated media. 
Therefore, ammonia might be the only low molecular weight compound used 
efficiently as a nitrogen source for growth by B. ruminicola. The ability of the 
bacterium to grow on acid hydrolysate of casein during prolonged incubation was 
attributed to ammonia production, presumably due to the the release of intracellular 
amino acid deaminases from old cultures (Pittman and Bryant, 1964). The reason for 







either due to the difficulty in specific amino acid transport into the cell or due to the 
destruction of amino acids by the bacterium prior to its utilisation. Peptides 
containing more than two or three amino acids were observed to be most effective in 
bacterial nutrition. However the study by Stevenson, (1979) which focused on the 
uptake of amino acids in complete defined medium containing ammonia as nitrogen 
source identified six different amino acid uptake systems specific for L-isomers and 
barring proline transport in B. ruminicola confirming that the failure of free amino 
acids to act as sole nitrogen source is not due to the absence of transport systems. 
Centrifugation and resuspension of 18h culture pellets in fresh basal medium led to a 
10-fold increase in amino acid uptake. Therefore it was hypothesised that the initial 
inhibition in aa uptake could be due to the depletion of a required substance or 
assimilation of an inhibitory substance resulting in bacterial growth. Omission of 
ammonium sulphate from the culture medium resulted in slowing and finally 
cessation of growth as well as amino acid uptake. Also, high levels of acetate, a 
volatile fatty acid, inhibited amino acid uptake. It was observed that the amino acid 
uptake required active cellular growth and effects of inhibitors of uptake were 
predicted to be either due to a direct effect on the energy mechanism of transport or 
due to indirect effects on cell energy levels. In conclusion, the uptake systems in B. 
ruminicola facilitate auxiliary supply of amino acids for immediate use in 
biosynthesis despite failing to fulfil the entire nitrogen requirement of the bacterium. 
These observations suggest that the ability of B. fragilis to utilise glutamine as the 
sole nitrogen source might be due to a mechanism by which it can generate 
ammonia, the principal nitrogen source for the bacterium, thereby initiating the 
conventional GS/GOGAT or GDH nitrogen assimilation pathways. The failure to 
utilise glutamic acid could be attributed to the inability to generate ammonia. 
5.5.3. Choice of time points for RNA-Seq 
Analysis of the NCTC 9343 transcriptome at the nutrient and growth limiting time 
point in GNM was performed to elucidate the regulatory mechanisms which control 







bacterium. With the exception of studies dealing with nutritional requirements and 
regulation of enzymes involved in nitrogen metabolism, a whole transcriptome 
analysis of B. fragilis by RNA-Seq under nitrogen limiting conditions had not been 
previously reported. While examining the differential regulation of genes involved in 
E. coli nitrogen metabolism under varying nitrogen-limiting conditions, Atkinson et 
al., (2002) had suggested that expression analysis in glutamine-containing medium 
was risky since the bacterial growth rate dropped by mid-log phase (0.5 OD600) 
which led to a sharp increase in the expression of genes involved in nitrogen 
assimilation. However, the growth rate of B. fragilis in GNM in the present study 
was similar to that in normal medium till late-log phase (0.8 OD600). The drop in 
growth rate at  this OD value, defined by a change in doubling time from 90 min ± 6 
min to 390 min ± 20 min, thereby provided an opportunity to use two RNA samples 
taken from cultures with similar growth rate (78 min ± 4.2 min and 90 min ± 6 min), 
one from normal medium (N set) and the other from GNM (G1set ) to compare with 
the test GA set (0.8 OD600) in GNM (Figure 5.7) in RNA-Seq experiments. The 
reproducibility of the growth curve was confirmed by performing the experiment in 
five biological replicates. 
5.5.4. Analysis of differentially regulated genes under nitrogen-limiting 
conditions 
5.5.4.1. Nitrogen metabolism 
RNA-Seq analysis of N vs GA differential gene expression indicated a significant 
downregulation of glnA (> 2-fold decrease) in B. fragilis (Figure 5.21 B). The 
differential regulation of glnA in G1 and GA with respect to N was most likely a 
reflection of growth rate since glnA expression had increased by over 2-fold in G1. 
Previous studies have confirmed the upregulation of GS, the glnA gene product, 
during conditions of nitrogen limitation thereby activating the GS/GOGAT pathway 
for nitrogen assimilation in E. coli (Shimizu, 2013; Yamamoto et al., 1984). GS 
expressed by B. fragilis was identified as a hexamer of  ̴ 490000 Da, with each 







than and exhibited no similarity to the previously characterised GSI and GSII 
enzymes, the holoenzymes of which were dodecamers and octamers, respectively, 
and therefore led to the introduction of the GSIII group of enzymes to categorize the 
GS expressed by B. fragilis (Hill et al., 1989). The inability of B. thetaiotaomicron to 
recognise the B. fragilis glnA promoter in a reporter gene assay suggested that 
species belonging to the colonic Bacteroides genera are genetically distinct from one 
another (Abratt et al., 1993). However, in spite of less than 50% homology between 
the E. coli and B. fragilis strain Bf-1 GS encoding genes, E. coli glnA deletion 
mutant when complemented with a recombinant plasmid carrying B. fragilis glnA 
was able to utilise ammonium sulphate as the sole nitrogen source. GS activity was 
repressed in the presence of glutamate and glutamine (Southern et al., 1986). The 
majority of previous studies on B. fragilis were focused on ammonia-limiting 
nitrogen regulation since glutamine utilisation by the bacterium had not been 
analysed in the past. The speculation that the observed glnA downregulation in GA 
was a function of growth rate reduction (Figure 5.21 B) was consistent with the study 
by Bren et al., (2013) on E. coli assimilation genes with respect to limiting amounts 
of nitrogen in M9 minimal growth medium. GFP reporter assays revealed moderate 
activity of the glnA during growth and, at about one generation preceding cessation 
of growth owing to nutrient limitation, the promoter activity rose by about a 4-6 fold. 
However, the activity dropped to low levels when growth stopped. In the present 
study, in G1 of GNM where the growth rate was similar to normal medium, the 
detected upregulation of  glnA might allow the cells to maintain their growth rate for 
about a few more generations where they utilise the low glutamine levels. However, 
GA in the present study was not characterised by a complete cessation of growth 
although there was a decrease in growth rate when compared to the faster-growing 
phase in GNM. The observed decrease in growth rate might have contributed to glnA 
downregulation in GA. In a similar manner, glnA mutants complemented with 
glnRAP-lacZ fusion constructs in B. subtilis failed to induce GlnA expression in a 
slow-growing glnA mutant strain with a doubling time of around 150 min (Hu et al., 







(BF9343_2258) was slightly upregulated in GA, which might contribute to nitrogen 
assimilation during growth under nitrogen limitation (Figure 5.21 B). A gene that 
was 100% identical to the gene encoding GOGAT, the second enzyme of 
GS/GOGAT pathway for nitrogen assimilation and the major glutamine hydrolyzing 
enzyme, has not been annotated in the B. fragilis NCTC 9343 genome. However, an 
ORF, BF9343_0887, was observed to encode a product similar to B. 
thetaiotaomicron NADPH-dependent glutamate synthase small chain (91.35% id in 
763 aa) on raw annotation (Figure 5.21 B). Although the expression level was 
unchanged in G1 and GA (log2 FC cut-off 1 and q value <0.05), the enzyme might 
contribute to the initial glutamate synthesis from glutamine in the absence of 
ammonia. Previous studies have measured GOGAT activity as NADPH oxidation 
depending on glutamine and ketoglutarate. It was also  observed that GOGAT 
activity was very low and might be associated with GS to produce glutamate from α-
ketoglutarate and ammonia but not strong enough to play a main role in ammonia 
assimilation by B. fragilis (Yamamoto et al., 1984). Therefore, alternate methods of 
ammonia generation that supported the GOGAT activity were examined in the 
present study. 
While considering the GDH pathway for nitrogen assimilation, a gene annotated as 
gdhB was downregulated in GNM, however another gene annotated as gdhB2, which 
shared similarity with gdhB  (69.21% id in 445 aa) was upregulated in both G1 and 
GA (Figure 5.21 B). Studies have identified two electrophoretically distinct GDHs in 
B. fragilis: GDH with dual-specificity for pyridine nucleotides and NAD
+
-specific 
GDH. In the dual-specificity enzyme, NADPH-GDH has an anabolic role whereas 
NADH-GDH fulfils a catabolic function (Abrahams and Abratt, 1998). NADPH-
GDH (gdhA) was found to be induced at low ammonia concentrations whereas high 
ammonia concentrations partially induced NADH-GDH. The highest NADH-sp 
(gdhB) activity was observed when B. fragilis was grown in the presence of organic 
nitrogen such as tryptone as the nitrogen source. A similar upregulation was 
observed under low concentration of glutamine, an organic nitrogen source, in the 







identified in NCTC 9343 genome. Regulation of gdhB was suggested to be linked to 
proteolytic activity in vivo and hence to pathogenesis. This is consistent with the 
detection of  reduced protease activity in B. fragilis under excess nitrogen (ammonia) 
conditions (Gibson and Macfarlane, 1988a). gdhB also displayed high amino acid 
identity and similarity to NADH-GDH of the oral pathogen Porphyromonas 
gingivalis which supported the predicted role of GDH in the pathogenic transition of 
B. fragilis (Abrahams and Abratt, 1998). 
Yamamoto et al., (1984) analysed the activities of NADPH and NADH linked 
glutamate dehydrogenase and glutamine synthetase in B. fragilis. In their study, it 
was found that the cells exhibited higher activity of glutamate dehydrogenase at low 
ammonia concentrations, unlike E. coli which adopted the GDH pathway of 
ammonia assimilation under nitrogen excess conditions. However, GS was also 
observed to be higher in cultures with limited ammonia. In the rumen bacterium B. 
amylophilus  GS was inactivated by addition of excess ammonia whereas GDH was 
active across all conditions tested. GOGAT activity was not detected in ammonia-
limited continuous cultures. Nevertheless, activities of all three enzymes were 
detected in B. fragilis batch cultures harvested at early stationary phase of growth. In 
batch cultures, the highest NADPH-linked GDH activity was observed in cells grown 
in 0.5 mM ammonia. In NADPH-linked reactions with an optimal pH range (7.8-8.4) 
Km values for ammonia, ketoglutarate and NADPH were 0.8 mM, 0.15 mM and 7 
µM, respectively. Low Km values for ammonia and ketoglutarate in reactions with 
NADPH ensured that GDH functions in ammonia assimilation even at low ammonia 
conditions.  When the ammonia concentrations were increased to 5 mM and 50 mM, 
GDH specific activities were 50% and 15%, respectively of that observed at 0.5 mM 
concentration. Moreover, NADPH- and NADH-linked GDH activities were not 
altered by the addition 20 mM L-glutamate to the growth medium (Yamamoto et al., 
1984). Further studies on the dual coenzyme-specific GDH regulation by 
extracellular concentration of ammonia in the B. fragilis group identified that Km 
values of GDH for NH4Cl was in the range of 1-5 mM in NADPH-dependent 







and GOGAT which was twice as high as that in other species under low ammonia 
conditions (Yamamoto et al., 1987).  
In a study by Liang and Houghton, (1981) that analysed the coregulation of oxidised 
NADPH and GDH activities in enteric bacteria in differing concentrations and 
sources of nitrogen, it was found that at concentrations exceeding 20 mM ammonia, 
both GS and NADP-linked GDH activities declined in E. coli owing to the direct 
involvement of NH4
+
 in GDH for glutamate synthesis. In Klebsiella aerogenes GDH 
was regulated inversely to that of GS. Glutamine as the sole nitrogen source in the 
presence of glucose led to an increase in the levels of GS with repressed GDH and 
transhydrogenase. NAD(P)
+
 transhydrogenase catalyses the reversible transfer of 
reducing equivalents between the pyridine nucleotides and therefore is of importance 
in reactions involving GDH. Incorporation of excess NH4Cl restored high levels of 
GDH and transhydrogenase concurrent with repressed GS activity.  
In nitrogen-fixing Bacillus macerans it was found that ammonia is assimilated 
predominantly by the GDH pathway during nitrogen fixation. GDH of B. macerans 
was found to be specific for NADPH and no NADH-GDH activity was detected. 
GOGAT activity in crude cell extracts was too low to be detected through 
measurement of the rate of oxidation of NADPH (Kanamori et al., 1987). Therefore 
it was concluded that GDH plays a significant role in ammonia assimilation in 
organisms that have a GDH with Km for NH4
+
 in the range of 1-5 mM with very low 
levels of GOGAT. The lower energy requirement of the GDH pathway might be 
advantageous to nitrogen-fixing cells that require 4-29 ATP molecules to reduce 1 
molecule of nitrogen. Ammonia assimilation by GDH, provided that it has moderate 
affinity for NH4
+
, seemed feasible during nitrogen fixation.  
The studies on GDH regulation described above, confirm the existence of a variation 
in GDH activities across species and from the existing literature, it could be 
predicted that B. fragilis grown at low concentrations of glutamine activates a 
homologue of catabolic NADH-GDH encoded by gdhB2 which results in glutamate 







activity. The requirement for ammonia could be partially satisfied by the 
deamination of GOGAT-formed glutamate and of the compounds formed from the 
activity of glutamine amidotransferases (GATases), which were identified to be 
upregulated in GA  (Appendix 1 and Figure 5.21 B). The enzymatic mechanism of 
glutamine amidotransferases, which comprise enzymes such as carbamoyl phosphate 
synthase, involves binding of glutamine to the cysteine residue in the glutamine 
binding site (small subunit), release of ammonia from the amide group of glutamine 
followed by its transfer to an ammonia binding site often located on a separate 
subunit (large subunit) where it is used for an amination reaction. Therefore 
interactions between small and large subunits of the GATase enzyme mediates its 
catalytic function (Cunin et al., 1986).  
Another interesting observation was the significant upregulation of glutamine-
hydrolysing asparagine synthetase B (AsnB) in GNM. The upregulation was 
commensurate with that of aspartate amino transferases and an aspartate/glutamate 
transporter potentially involved in conversion of glutamate to aspartate (Figure 5.21 
B). Synthesis of asparagine from glutamine and aspartate via AsnB generates 
ammonia which could support the requirements of B. fragilis for nitrogen under the 
limiting conditions that were observed in the biphasic growth in GNM. In a separate 
study on carbon-source-dependent nitrogen regulation in E. coli, it was found that the 
bacterium possesses a low affinity glutamine transport system mediated by 
periplasmic asparaginase (AsnB) which displays low glutaminase activity. The 
transport system was found to be activated either by CRP-cAMP complex or when E. 
coli was grown on poor carbon sources in the presence of glutamine (Maheswaran, 
2003). Thus, a high concentration of exogenous glutamine was found to increase 
intracellular glutamine levels through an indirect mechanism which involved 
periplasmic glutaminase activity and uptake of hydrolysed ammonium followed by 
intracellular GS-mediated ammonium reaccumulation. However, in the present 
study, glucose, which is an efficient carbon source was used in conjunction with 
limiting glutamine concentration and hence the activation of a low affinity transport 







E. coli through a previously uncharacterised degradation pathway of arginine, 
formed by aspartate catabolism when the bacterium was grown on aspartate as the 
sole nitrogen source. It was suggested that arginine might be an intermediate of 
aspartate metabolism since amino nitrogen of aspartate is incorporated into imino 
nitrogen of arginine via the Krebs-Henseleit pathway. Concurrent with this finding, 
in the present study, a gene annotated as argG (arginosuccinate synthase) was 
upregulated in GA (1.53 log2 FC) (Appendix 2). ArgG catalyses the condensation of 
aspartate and citrulline to form arginosuccinate, the immediate precursor of arginine 
(Figure 5.23). An increase in expression of a homologue of arginine deiminase  
(BF9343_2385) was observed in GA (Appendix 2). Arginine deiminase, together 
with ornithine carbamoyltransferase and carbamate kinase enzymes comprise the 
arginine deiminase (ADI) pathway which catalyse the step-wise conversion of 
arginine into ornithine, ammonia and carbondioxide with the formation of 1 mol of 
ATP/mol of arginine consumed (Cunin et al., 1986) (Figure 5.24). The ADI pathway 
has been identified in lactic bacteria, Bacilli, Pseudomonas spp., Aeromonas spp., 
Clostridia, Mycoplasma spp. and Cyanobacteria. Besides arginine utilisation for the 
generation of energy in Streptococcus faecalis, Mycoplasma spp., Bacillus spp., P. 
aeruginosa and Halobacteria, the ADI pathway might provide nitrogen when 
arginine is the only source for the bacterium. Utilisation of arginine via the ADI 
pathway as a nitrogen source has been studied in Aeromonas formicans and Bacillus 
licheniformis. In a  P. aeruginosa strain, the three enzymes in the ADI pathway were 
induced strongly up to 50 or 100 fold by a shift from aerobic growth condition to a 
very low oxygen tension (reviewed in Mercenier et al., 1980). Arginine utilisation 
either via ADI pathway or decarboxylation is also of significance under conditions of 
nutrient depletion. 
The present study suggests a similar mechanism of arginine utilisation as a source of 
ammonia in B. fragilis too. Nitrogen catabolite repression of ADI pathway by 
ammonia occurs in the presence of a good energy source such as glucose, consistent 
with the downregulation of arginine deiminase homologue observed in the normal 







ornithine carbamoyltransferase (OTCase) (BF9343_0422) was downregulated in GA, 
an increase in expression was detected in G1 (Appendix 2). Moreover, a gene 
annotated as pyrB with a Pfam match to aspartate/ornithine carbamoyltransferase 
was upregulated in G1 and GA (Appendix 2). Ornithine carbamoyltransferase serves 
two functions in arginine metabolism; arginine biosynthesis in which it catalyses the 
transfer of carbamoyl moiety of carbamoyl phosphate to 5-amino group of ornithine, 
forming citrulline and in the catabolic arginine deiminase pathway where it mediates 
the thermodynamically less favoured reverse reaction favouring citrulline 
phosphorolysis thereby yielding ornithine and carbamoyl phosphate. Organisms 
using both these functions possess distinct anabolic and catabolic OTCases. 
Repression of anabolic OTCase was detected in growing B. subtilis cells but was 
induced by arginine at the end of exponential growth (Cunin et al., 1986). 
5.5.4.2. Secreted proteins 
Consistent with the studies by Gibson and Macfarlane, (1988a, 1988b) which 
demonstrated that the nutrient limitation in stationary phase induced secretion of 
proteases by B. fragilis, a higher proportion of secreted proteases (possessing signal 
peptides) were identified to be upregulated in GA (Figure 5.26 A and B), albeit only 
four were upregulated to a significant > 2-fold increase. Although the culture had not 
completely attained stationary phase, there was a drop in growth rate owing to 
nitrogen limitation in the glutamine medium.  
In Salmonella typhimurium, an enteric bacterium, nitrogen starvation was found to 
degrade over 40% of the bacterial protein during an 8h period. The observed 
degradation provided amino acids which were a source for synthesis of new proteins 
under shift-down conditions (Miller, 1975). Adigüzel et al., (2009) investigated the 
proteolytic activities of two Bacillus cereus strains grown in peptide-restricted, 
carbon sufficient medium and observed the sequential induction of different secreted 
proteases. Peptone was the preferred nitrogen source and its limitation led to the 
production of collagenolytic and elastolytic proteases which were later replaced by 







affinity profile in response to organic nitrogen and sequentially secreted proteases 
with activities targeted against increasingly inaccessible proteinaceous substrates as 
nutritional availability in the environment deteriorated.  
In addition to secreted proteases, three genes encoding signal peptidases were found 
to be upregulated in B. fragilis grown on nitrogen-limiting GNM (Figure 5.26 B). 
The direction of exported bacterial proteins, such as those involved in the usage of 
nutrient sources, in cell-cell communication, and proteins with antimicrobial activity 
and virulence factors, to transport machineries in the cytoplasmic membrane requires 
their synthesis as precursors with an N-terminal signal peptide (Voigt et al., 2006). 
Signal peptides are recognised in the cytoplasm and the proteins are targeted to the 
transport machinery in the membrane in an energy-dependent manner. Once the 
protein reaches the outer membrane, the signal peptide is cleaved by signal 
peptidases belonging to the serine protease type, to form the mature protein. 
Therefore, the activation of signal peptidases in B. fragilis suggest an upregulation of 
the proteins cleaved by them thereby enhancing protein transport and secretion. 
Different pathways have evolved in bacteria to secrete proteins, of which the major 
ones include the general secretory (Sec), twin arginine translocation pathway, ABC 
transporters and pseudopilin pathway. Of the 79 identified proteins containing         
N-terminal signal peptides in the B. licheniformis proteome under starved conditions, 
18 were involved in transport processes and several among them were ABC transport 
binding proteins (Voigt et al., 2006). Consistent with this, an upregulation of proteins 
involved in ABC transport was observed in the present study (Appendix 6 and 
Appendix 8). 
Apart from bacteria, serine proteases in pathogenic fungi, have been related to 
pathogenesis and nitrogen starvation. The Paracoccidioides brasiliensis Serine 
Protease (PbSp) transcript and the protein (serine protease) encoded by 
Paracoccidioides brasiliensis were induced during nitrogen starvation. PbSp, a 
serine thiol protease cleaved murine laminin, human fibronectin, type IV collagen 







of a nitrogen metabolite repression (nmr) region binding protein responsible for 
positive regulation of genes in response to nitrogen metabolite presence. Therefore 
PbSp could be a molecule regulated by nitrogen metabolite presence (Parente et al., 
2010). Since B. fragilis is an actively proteolytic organism, the proteases upregulated 
during nitrogen starvation need to be examined for host protein degradation. 
5.5.4.3. Shock/Stress response 
Brown et al., (2014) identified a link between the nitrogen stress response and 
stringent response in E. coli. Nitrogen starved E. coli cells synthesised guanosine 
tetraphosphate (ppGpp), an effector alarmone of bacterial stringent response. Levels 
of ppGpp in E. coli were modulated by ppGpp synthetase, RelA and ppGpp 
synthetase/hydrolase, SpoT. Phosphorylation of NtrC following nitrogen starvation 
was found to activate relA from a σ
54
-dependent promoter in E. coli and other 
members of the Enterobacteriaceae family. RelA and SpoT contribute to stress 
adaptation, antibiotic resistance, expression of virulence traits and acquisition of 
persistent phenotype in pathogenesis. In agreement with this finding, an upregulation 
of an NtrC homologue (BF9343_2369) identified in GA in the present study was 
coupled with an upregulation of a ppGpp homologue (BF9343_0658) sharing 
similarities with B. subtilis RelA (Figure 5.21 A). 
Reactive Oxygen Species (ROS) in the form of the superoxide anion radicals, 
hydrogen peroxide and hydroxyl radical can lead to oxidative damage of lipids, 
proteins and nucleic acids resulting in mutagenesis and cell death. Organisms evolve 
defence mechanisms to combat oxidative environment through genes that encode 
proteins involved in oxidative stress response. Rocha and Smith, (1997) examined 
the regulation of B. fragilis katB mRNA (catalase) by oxidative stress and carbon 
limitation and detected a 15- fold increase when anaerobic mid-log phase cultures 
were exposed to oxygen, oxygen paraquats or hydrogen peroxide and carbon 
limitation. Catalases prevent the accumulation of toxic hydrogen peroxide. However, 
under anaerobic conditions, levels of katB mRNA were found to increase in a 







by a decrease in stationary phase. The katA/katB upregulation detected  in GA (0.707 
log2 fold-change) is different from the conventional upregulation detected in 
anaerobic condition since the observed depression in growth curve, at which the GA 
set of samples were extracted, was induced by nitrogen limitation (Figure 5.27 B). 
Although earlier studies failed to identify a link between nitrogen limitation and katB 
mRNA regulation, total RNA-Seq analysis carried out in the present study detected 
an upregulation under nitrogen-deprived conditions albeit by < 2-fold. Induction of 
katA/katB catalase mRNA in the absence of oxygen under nitrogen limitation 
suggests that this enzyme maybe important to protect cells against eventual oxygen 
exposure or hydrogen peroxide decomposition that might be formed from stationary 
phase or dormancy metabolism.  Since carbon and nitrogen regulatory pathways are 
related, nitrogen limitation might also affect catalase expression as observed in the 
present study. In E. coli, the redox-sensitive regulator OxyR transcriptionally 
regulates katG and nine other genes induced in the presence of sublethal doses of 
hydrogen peroxide. OxyR acts as repressor under reduced condition and shifts to act 
as transcription activator under oxidative conditions (Rocha and Smith, 1997). The 
oxyR gene was upregulated both in the GA and G1 set of samples extracted from 
GNM (1.26 and 0.13 log2 fold-changes, respectively), however the significant 
differential regulation in GA might be a consequence of the reduction in growth rate 
(Figure 5.27 B). OxyR and KatA/KatB upregulation might facilitate resistance to the 
oxidative burst of macrophages and phagocytic cells of the immune system 
encountered by B. fragilis on accidental escape from the gastrointestinal tract during 
transition to an opportunistic pathogen. Ohara et al., (2006) demonstrated that the 
superoxide dismutase-encoding gene of the obligate anaerobe P. gingivalis was 
regulated by the OxyR transcription activator. Investigation of oxidative-stress 
response proteins in P. gingivalis detected two proteins that were predominantly 
upregulated in oxidative conditions. N terminal amino acid sequencing revealed 
these two proteins to be superoxide dismutase and alkyl hyperoxide reductase which 
were positively regulated by OxyR. OxyR functioned as an intracellular redox-sensor 







gene (sodB) of B. fragilis, which is taxonomically related to P. gingivalis, was 
observed to be inducible by redox stresses but not controlled by oxyR. In addition to 
OxyR, SodB was also found to be upregulated in the present study (1.36 log2 fold-
change) (Figure 5.27 B). E. coli cells produce two types of superoxide dismutase 
(Sod), Mn-containing Sod (SodA) and Fe-containing Sod (SodB) which converts 
superoxide to hydrogen peroxide and sodB was found to be constitutively expressed 
independent of oxidative stress. An upregulation of genes annotated as bcp, tpx and a 
homologue encoding AhpC/TSA family were also identified in GA, potentially in 
relation with oxidative stress response (Appendix 4). Alkyl hydroperoxide reductase 
subunit C (AhpC), thiol-dependent peroxidase (Tpx) and bacterioferritin-comigratory 
protein (Bcp) are peroxiredoxins which confer resistance to hydrogen peroxide in 
other bacteria.  
5.5.4.4. Antibiotic resistance 
B. fragilis is inherently resistant to a wide range of drugs which makes the bacterium 
a challenging candidate for current therapeutic regimens. Resistant B. fragilis strains 
have been associated with adverse outcomes including increased morbidity and 
mortality. However, metronidazole has been regarded as one among a few drugs that 
are still reliable for treatment of infections involving B. fragilis and is the most 
commonly prescribed drug worldwide for anaerobic infections. Metronidazole 
belongs to the class of 5-nitroimidazole drugs which also include tinidizole and 
ornidizole, and exerts antimicrobial action via inhibition of DNA synthesis (Schapiro 
et al., 2004). The drug was first introduced against protozoal infections in the middle 
of the 20th century. Metronidazole-resistant B. fragilis strains have been isolated 
more frequently, resulting in adverse outcomes including death or amputation 
(Sherwood et al., 2011). 
While determining the response of nitrogen limitation to the transcriptional 
regulation of genes involved in drug/antibiotic resistance in the present study,            
a > 1.5-fold increase in the expression of BF9343_4246 and BF9343_0350 gene 







determinant proteins NimD and NimE, respectively, was detected in the GA set of 
samples (Figure 5.28). Activation of metronidazole from its prodrug state requires 
partial reduction of the nitro group to the toxic nitroso radical intermediate that then 
binds to DNA causing single and double-stranded breaks (Zahoor et al., 1987). 
Pathogens which do not possess this activation mechanism are intrinsically resistant 
to metronidazole. However, active metronidazole resistance in sensitive organisms is 
attributed to a nitroimidazole resistant gene (nim), which encodes a nitroimidazole 
reductase involved in the reduction of nitro group to amino group to make inactive 5-
aminoimidazole as observed in B. fragilis (Carlier et al., 1997). Nim homologs have 
been identified in both Gram-positive and Gram-negative aerobic and anaerobic 
bacteria. Therefore the nim family is ancient, widespread and found on chromosomes 
or on mobilizable plasmids, thus posing a significant threat to the continuing utility 
of 5-nitroimidazole drugs (Husain et al., 2013). Molecular detection of nim genes in 
Bacteroides isolates was first described in 1996 using specific primers (Trinh and 
Reysset, 1996). To date, ten nim genes (nimA-J) have been described in B. fragilis 
(Alauzet et al., 2009; Gal and Brazier, 2004; Löfmark et al., 2005). Other 
mechanisms of metronidazole resistance in B. fragilis include upregulation of 
transcript levels of genes encoding proteins involved in drug efflux, alterations in 
DNA repair systems, metabolic changes and lack of activation of the metronidazole 
molecule. In agreement with this observation, a multitude of genes involved in drug 
transport and drug efflux systems were identified as upregulated in nitrogen-limiting 
GA in the present study (Appendix 5 and Appendix 8). 
The upregulation of nim genes identified in GA in the present study suggests that 
nitrogen-limiting conditions in B. fragilis confers increased metronidazole resistance 
to this anaerobe. A similar dependence of antibiotic resistance on nitrogen conditions 
was previously reported in Staphylococcal and Streptococcal species. In            
Gram-positive bacteria nitrogen-dependent transcriptional regulation is primarily 
mediated  by negative regulators GlnR and TnrA, unlike NtrB/C positive regulation 
in      Gram-negative bacteria. It was observed that GlnR regulation and presence of 







aureus. GlnR target genes, glnA and glnP, mediated colonization and survival of 
Streptococcus pneumoniae during infection. Additionally, the repression of lctE and 
alsS genes by NreC of NreABC system, similar to fumarate nitrate reductase 
regulator (Fnr), was necessary for biofilm formation and maturation in S. aureus 
(Somerville and Proctor, 2009). Nevertheless, nitrogen limitation might not be 
responsible for the observed metronidazole resistance in the present study since there 
was no significant increase in the G1 set. The upregulation of the two nim genes in 
GA might be a consequence of decrease in growth rate when compared to G1. 
5.5.5.5. Conclusions 
The study of transcriptional regulation under nitrogen limiting conditions is of 
significance in opportunistic pathogens to study the responses of  the bacterium 
under nitrogen limitation in vivo (Parente et al., 2010). While studying the 
environmental regulation of glycosidase and peptidase production by Streptococcus 
gordonii involved in infective endocarditis, Mayo et al., (2000) observed that a shift 
from low oral pH to blood pH induced expression of several genes, including msrA 
(protection against oxidative stress) and enhanced bacterial growth. S. gordonii is a 
commensal organism of the oral cavity which becomes an  opportunistic pathogen 
during colonisation of heart valves thereby contributing to infective endocarditis. The 
present work describes the upregulation of a group of oxidative-stress and virulence 
associated genes in nitrogen limiting conditions in B. fragilis. The study also 
emphasizes the requirement of ammonia for B. fragilis growth and presents possible 
mechanisms of ammonia generation from glutamine in an ammonia deficient 
medium. The differential regulation holds significance when the bacterium is 
accidentally released into the peritoneal cavity from its natural habitat, the GI tract. 
The changes in regulation at the transcriptomic level under nitrogen stress might aid 
the bacterium in its opportunistic pathogenic phase where it is exposed to oxygen and 
nitrogen-limiting conditions in the extraintestinal sites. Since the results of the RNA-
Seq analysis discussed in this chapter are pioneering, they need to be validated with 







reaction (RT-PCR) on selected differentially expressed genes to provide additional 
















Chapter 6 General Discussion 
 
The human gastrointestinal tract hosts the major proportion of the human microbiota, 
amounting to  ̴ 10
12
 microbes per ml of luminal contents from 500-1000 diverse 
species (Savage, 1977; Xu and Gordon, 2003). The microorganisms that comprise 
the gut microbiome thrive in the gastrointestinal tract through specialised interactions 
with the intestinal epithelial mucosa as well as MSCRAMM-based interactions with 
the host extracellular matrix (Patti et al., 1994). Bacteroides fragilis, one among the  
commensals of the gastrointestinal tract, engage in various beneficial interactions 
with the host, encompassing host nutrition and immunomodulation activities (Troy 
and Kasper, 2010). However, it is also the most frequently isolated Gram-negative 
obligate anaerobe from peritoneal abscesses and systemic infections (Patrick and 
Duerden, 2006). Through the study presented here, we examined potential 
mechanisms involved in the transition of this commensal into an opportunistic 
pathogen. B. fragilis is known to interact with human fibrinogen, a protein which is 
involved in the formation of fibrin-containing abscess walls that curtail pathogens 
and other infectious agents. However, the ability to bind and degrade fibrinogen 
presents the bacterium with a possible opportunity to escape from abscesses and 
disseminate infection (Houston et al., 2010). Initially we focussed on identifying a 
specific protein involved in fibrinogen binding and on investigating its interaction 
with proteases. Reverse genetics revealed the involvement of the outer membrane 
protein, BF1705, in fibrinogen binding through the analysis of concentrated 
supernatant extracts of wild-type NCTC 9343 and the ΔBF1705 cultures. In addition 
to fibrinogen binding, a possible involvement of BF1705 in the previously 
established B. fragilis fibronectin binding activity was also confirmed. Fibronectin, 
an ECM component, recruits fibrinogen which colocalizes with the fibronectin at the 
site of injury, thereby functioning in wound healing (Pereira et al., 2002). However, a 
potential link between fibrinogen binding by 1705 and degradation was not detected 







possibly involved in survival within the gastrointestinal tract, where fibrinogen is not 
present. 
Previous studies in B. fragilis indicated the induction of proteases to enhance 
nitrogen scavenging under conditions of nitrogen limitation in the growth 
environment (Gibson and Macfarlane, 1988a). Urease catalyses the hydrolysis of 
urea to carbamate and ammonia, thereby replenishing the nitrogen source necessary 
for bacterial growth. The Nac-dependent induction of urease enzyme has been 
identified in Klebsiella pneumoniae under  nitrogen limiting conditions (Collins et 
al., 1993). Therefore we attempted to find a relation between nitrogen limitation and 
the regulation in the expression of binding proteins, including BF1705, and secreted 
proteases. Comparison of the transcriptomes derived from cultures grown in defined 
medium and glutamine-containing medium was performed. Culture mass doubling 
times were similar in defined medium (N) and glutamine medium (G1) till mid-log 
phase. A diauxic shift was apparent in the glutamine medium wherein the growth 
rate decreased when the culture reached an OD600 of 0.8 (GA). Analysis of 
differential expression in the GA set with N set as the reference, demonstrated that 
the gene encoding the BF1705 binding protein was not significantly upregulated in 
the nitrogen limiting medium, which suggests its primary function as an adhesin 
rather than a role in nutrient binding. However, BF0586 (BF9343_0559), encoding a 
homologue of a previously identified collagen binding protein (Cbp1) and 
BF9343_4169 (BF4280) encoding a protein identical to a laminin-1 binding protein, 
were significantly upregulated by a  ̴ 2-fold at a q value < 0.05 (De et al., 2006; 
Galvão et al., 2014). The laminin-1 binding protein was identified to possess 
plasminogen activating function to plasmin, a serine protease known to degrade 
fibrin, collagen and other structural components of the matrix tissue (Ferreira et al., 
2013; Sijbrandi et al., 2008). Moreover, among the four protease-encoding genes that 
were upregulated by 2-fold under nitrogen limiting conditions, three, namely 
BF9343_1980, BF9343_2676 and BF9343_2678 encoding putative homologues of  
aminopeptidase C, transglutaminase-like enzymes, cysteine proteases and dipeptidyl-







45-55 kDa. The molecular sizes of these three proteases corresponded to the 
molecular size of the fibrinogenolytic zone of clearance (45-50 kDa) detected by 
fibrinogen zymography of wild-type B. fragilis protein extracts. However, the ability 
of B. fragilis to degrade fibrinogen had been detected in BHI-S and glucose-DM 
growth media but was not examined in the nitrogen limiting glutamine medium. The 
upregulation of the genes encoding these binding proteins and proteases suggest an 
increased proteolytic activity, including fibrinogen degradation, under nitrogen 
limiting conditions to assuage the cell's growing need for nitrogen. 
While considering an overview of the number of differentially expressed genes, both 
in G1 and GA compared to the reference N at a 2-fold cut-off  (q value < 0.05),           
̴ 40% of the genome was differentially expressed in GA whereas only 5.75% of the 
genome was differentially expressed in G1. The proportion of the genes differentially 
expressed in G1, albeit smaller, indicates that the bacterial growth was affected by 
nitrogen limitation in glutamine medium even at the time-point the G1 samples were 
extracted, despite similar doubling times of the cultures in N and G1 samples. The 
difference in the regulation of genes in G1 and GA sets when compared to the N 
reference was evident from the fact that 31% of the upregulated genes in G1 were not 
significantly upregulated in GA. Moreover, five  genes that were upregulated in G1 
were significantly downregulated in GA. A similar differential regulation was 
identified even in the proportion of downregulated genes in G 1 wherein  ̴  22% of the 
genes that were downregulated in G1 were not significantly regulated in GA and 
three were significantly upregulated in GA. The observed differential regulation was 
most likely attributed to the reduction in growth rate, observed after 0.4 OD600 in 
glutamine medium, between the samples extracted for GA when compared to that 
from which the G1 samples were extracted. Therefore, the differential gene 
expression observed in GA might be an effect of both nitrogen limitation and growth 
rate reduction on the B. fragilis transcriptome. An example is the differential 
regulation of the glutamine synthetase encoding gene, glnA, between G1 and GA  
when compared to the N reference. Even though glnA was significantly upregulated 







However, previous studies using E. coli have confirmed the upregulation of glnA 
expression under nitrogen limiting conditions, owing to a reduction in intracellular 
glutamine concentration and activation of sigma 54 (Atkinson et al., 2002). 
Therefore, the downregulation observed in GA in the present study is most likely a 
consequence of the growth condition. A similar alteration in the number of 
differentially expressed genes was observed when the response of Mycobacterium 
smegmatis to nitrogen limitation was studied using microarray-based nitrogen run-
out experiments in batch culture and RNA-Seq based study using continuous culture 
in a nitrogen-limited chemostat (Petridis et al., 2015; Williams et al., 2013). The 
former had identified a total of 1090 differentially expressed genes whereas the latter 
revealed significant changes in the expression of 357 genes. 52% of the 357 genes 
overlapped with the previous study using batch cultures. The study emphasized the 
difficulty in assigning transcriptional changes to a single stimulus in batch cultures 
due to the simultaneous changes in growth rate, nutrient depletion and end-product 
build up. However a comparative analysis of the individual gene expressions in G1 
and GA with respect to the reference N helped us to focus on genes affected 
exclusively by nitrogen limitation in the present study.  
The downregulation of genes involved in amino acid (aa) transport, including glycine 
betaine transport, both in G1 and GA were surprising since the bacterial cell would 
require an efficient transport of amino acids to adapt to the nitrogen limiting 
conditions and therefore should account for an upregulation of genes involved in aa 
transport. Petridis et al., (2015) detected the upregulation of eight GlnR-regulated 
amino acid transporters through the RNA-Seq analysis of the nitrogen limited 
Mycobacterium smegmatis transcriptome. Nevertheless, a previous study which had 
examined the interrelationships between diets, structure and operations of the human 
gut microbiota reported that total transcript levels corresponded to the protein intake  
(Faith et al., 2011). Microbial RNA-Seq on mice faecal samples, demonstrated that 
the number of Bacteroides caccae exhibited a positive correlation with casein 
(protein diet) with the transcripts remaining roughly constant per unit of casein. High 







or carbon energy sources were predicted for species that positively correlated with 
casein, which included the three Bacteroides spp. examined. Therefore, in the present 
study a reduction in the nitrogen content in the medium might correlate with the 
observed downregulation of B. fragilis  genes involved in aa transport pathways.  
Another possibility for the downregulation might  be that expression of these genes 
are under the regulation of upstream non-coding small RNAs (sRNA), antisense 
RNAs or multiple transcription start sites (TSS) and 5' untranslated regions (UTR) of 
the coding mRNA. Contradictory to the previous conception that the prokaryotic 
transcriptome is not as complex as the eukaryotic transcriptome, bacteria have been 
shown to produce antisense RNA and previously unidentified non-coding RNAs 
(ncRNA) that regulate transcription and translation (Güell et al., 2011). Regulatory 
RNAs differ from protein-encoding regions in that they possess no distinct start and 
stop codons that denote their boundaries or occurrence in a genome. In enteric 
bacteria they are generally of 50-200 nucleotides in length and control a multitude of 
processes including stress responses, metabolic reactions and pathogenesis 
(Raghavan et al., 2011). Albeit in the present study we have determined differential 
gene expression only on the basis of reads that aligned against the genes (coding 
regions), it is essential to extend the analysis to detect fragments aligning to 
intergenic regions, owing to the rate at which the presence of ncRNAs are 
revolutionizing the field of bacterial gene expression studies. Despite a few studies 
suggesting that many fragments aligning to intergenic regions might define non-
specific transcription initiation or leaky transcription termination of genes upstream, 
they might also account for the identification of novel ncRNAs (Livny et al., 2008; 
Raghavan et al., 2012). The presence and activity of ncRNAs has been analysed in 
many bacterial species. Thirteen previously unknown ncRNA species identified in 
the transcriptome of Bacillus anthracis were used to follow transcriptional changes 
during growth phases and sporulation. An RNA-Seq based study focussing on S. 
enterica serovar Typhi was used to correct annotation of genome sequence and also 
to identify transcriptionally active prophage genes and new members of the ompR 







involved in the regulation of carbon metabolism was made possible through RNA-
seq of V. cholerae transcriptome (van Vliet, 2010). sRNAs, especially antisense 
RNAs, work either in cis by targeting a gene within the same locus or in trans by 
targeting loci elsewhere in the genome. They regulate transcriptional interference, 
activation and control, and regulation of mRNA half life. The proportion of antisense 
RNA could be  ̴  10-20% of the genes in bacteria (Güell et al., 2011). Sequencing of 
stranded libraries can help in locating trans-acting sRNAs opposite to coding genes. 
sRNAs can also have multiple functions through encoding functional peptides. 
RNAIII in Staphylococcus aureus, one of the first identified cis-acting RNAs is 
involved in quorum sensing (Novick and Geisinger, 2008). The SgrS sRNA causes 
translational repression when pre-annealed with the ptsG transcript in E. coli. The 5' 
region of SgrS contains an ORF termed SgrT which is translated during glucose-PO4 
stress. Cells expressing SgrT alone have a defective glucose uptake. Therefore this 
bifunctional sRNA encodes physiologically redundant but mechanistically distinct 
functions that contribute to the same stress response (Maki et al., 2010). Are similar 
actions of sRNAs involved in the observed downregulation of B. fragilis genes 
involved in amino acid transport under nitrogen limiting conditions?  
In the present study, a > 2-fold increase in the expression of 17 and 13 consecutive 
genes beginning from BF9343_0698 to BF9343_0715 was observed  in the G1 and 
GA samples, respectively. These genes are within the polysaccharide G (PS G or PS 
7) locus of the 9343 genome. The detected upregulation suggest that these genes 
constitute an operon controlled by the same promoter. Previous studies analysing the 
NCTC 9343 genome revealed that eight PS loci (A-H) are related to micro-capsule 
(MC) expression, of which seven are reversibly switched on and off by the 
recombinase-mediated site-specific inversion of promoter sequences (Cerdeño-
Tárraga et al., 2005). Although each PS locus encodes proteins that produce an 
antigenically distinct and phase-variable MC, they share a common genetic structure 
where two genes encoding putative transcriptional regulators, Up(a-h) Y homologue 
and Up(a-h) Z homologue, are located upstream of genes for polysaccharide 







the phase-variable PS loci have been studied by Comstock, (2009). The cell 
population in a B. fragilis culture should  exhibit random phase variation of the PS 
loci encoding each PS such that the expression of each locus is nearly uniform in the 
culture population. However, in the present study we detected an expression bias 
towards the genes of the PS7/PSG locus under nitrogen limiting condition. RNA-Seq 
data were obtained by pooling the reads from transcriptomes derived from biological 
replicates of cultures inoculated from six different colonies. Therefore, the 
probability of a 'founder effect' based on the inoculum in the observed expression 
bias seems unlikely. This raised the possibility that a capsule composed of 
polysaccharide G is providing an advantage to the cells under nitrogen limiting 
conditions. 
Nevertheless, an increase in expression was observed only in a subset of genes 
belonging to the PSG locus which might suggest the presence of a suboperon within 
the putative operon. Mapping transcriptional initiation sites in H. pylori revealed 337 
operons but internal TSSs added 192 additional cistrons (Sharma et al., 2010). In M. 
pneumoniae 341 reference operons could be divided into 447 smaller sub operons 
(Guell et al., 2009). Promoters could engage various transcription complexes that 
could produce different RNA outputs. By mapping TSSs to single base precision 
using RNA-Seq, it is possible to map all internal promoters within an operon. The 
analysis of the upstream promoter binding region and TSSs of these genes would 
provide insights into the possible presence of an operon (Güell et al., 2011). Mapping 
of TSSs define novel promoter regions and 5' UTRs upstream of coding genes. A 
number of TSSs have been reported with specific focus on genes involved in 
virulence and nitrogen metabolism in Klebsiella pneumoniae. A significant fraction 
of operons had multiple TSSs in both E. coli and K. pneumoniae, and encoded genes 
with essential functions including aa biosynthesis, central metabolism and transport 
(Kim et al., 2012). Also, multiple promoters upstream of a gene can be regulated by 
transcription factors in different ways. The ure operon in K. pneumonaie possesses 
two core promoters with distinct TSSs. One core promoter is Nac-dependent whereas 







downstream gene or operon by functioning as a transcription factor binding site. The 
ArgR transcription regulator is known to bind to the promoter region and the 5' UTR 
of the ArgC in E. coli. The conserved nature of these regions is evident from 
sequence analysis (Caldara et al., 2006; Charlier et al., 1992). OxyR regulator which 
autoregulates its transcription also exhibits similar 5' UTR binding activity (Toledano 
et al., 1994). ArgC, and ArgR and OxyR transcription regulators were observed to be 
significantly upregulated in the GA set in the present study. The upregulation might 
be facilitated through the 5'UTR binding of these transcription regulators under 
nitrogen limitation. 
Another interesting observation from the transcriptomic analysis of B. fragilis under 
nitrogen limitation was the significant upregulation in the expression of eight genes 
encoding pseudogenes in the GA set. However, the expression of these genes were 
not significant in G1 and two separate genes encoding putative pseudogenes were 
downregulated in G1, suggesting that the upregulation of pseudogenes in GA might 
be a combined consequence of nitrogen limitation and growth reduction. Around 220 
pseudogenes have been identified in Salmonella enterica. Even though the majority 
of them are inactivated in the serovar Typhi, they are intact in related host-
promiscous serovars such as typhimurium (Perkins et al., 2009). Certain pseudogenes 
are known to express functional truncated protein domains, such as the truncated 
cytotoxin encoded by a Chlymadia trachomatis pseudogene (Carlson et al., 2004). 
Genome degradation, as a consequence of pseudogene formation, is thought to 
restrict the host diversity of pathogens through a loss of pathways essential for 
survival in diverse hosts. However, a similar function is not likely in B. fragilis, 
which is not a host-specific pathogen. The pseudogenes in B. fragilis might 
correspond to incorrectly annotated genes or small functional polypeptides which 
might have a specific role under nitrogen limiting conditions. Althernatively, they 
might even be antisense RNAs regulating the expression of coding RNAs.  
The microbiota and the residual pancreatic proteases present in the lower 







involved in the production of ammonia from semi-digested dietary and host-derived 
proteins (Dai et al., 2011). However, the production of ammonia progressively 
increases from the proximal to the distal part of the colon (Smith and Macfarlane, 
1998). Therefore, it is likely that B. fragilis occupying certain niches in the proximal 
colon might face a nitrogen limitation. The accidental escape of B. fragilis from the 
gastrointestinal tract into the extraintestinal peritoneal cavity following intestinal 
injury would potentially leave the bacterium at a greater risk of being encountered by 
a shortage of ammonia. Although, no previous studies have reported the specific 
concentration of ammonia and other readily available nutrients in the peritoneal 
cavity, it is most likely that this site is limited in easily accessible sources of carbon 
and nitrogen especially when compared to the gastrointestinal tract where active 
digestion and absorption of diet-derived nutrients takes place. Moreover, 
extraintestinal sites represent an aerobic environment unlike the anaerobic 
gastrointestinal tract. Therefore, to persist in the peritoneal cavity following 
accidental release from the natural habitat, B. fragilis must regulate gene expression 
to adapt to carbon and nitrogen limitation, as well as oxygen exposure. Rocha and 
Smith, (1997) reported an increase in the expression of B. fragilis katB catalase gene 
when anaerobic cultures were exposed to oxygen. It was also shown that katB 
mRNA was strongly repressed by glucose. These findings suggest an increase in the 
expression of KatB as a means to adapt to the extraintestinal environment. An 
upregulation in katB transcription was also identified in the GA samples in the 
present study as a result of nitrogen and growth limitation. Therefore, it is possible 
that the transcriptional regulation of B. fragilis in the peritoneal cavity is similar to 
that analysed in the nitrogen limiting GA analysed in the present study. An increase 
in the expression of proteases and nutrient binding proteins observed in GA might 
therefore lead to the destruction of host tissues in the peritoneal cavity. Thus, in an 
attempt to scavenge for nitrogen in the extraintestinal environment, B. fragilis might 
promote tissue destruction and abscess formation. Prophylactic administration of 
metronidazole antibiotic (5-nitroimidazole) against anaerobic infections, especially 







antimicrobial agents, have been reported in the past (Brazier et al., 1999). However, 
metronidazole-resistant B. fragilis strains are on the rise and have been associated 
with detrimental outcomes (Löfmark et al., 2005). The nitroimidazole resistance gene 
(nim)-based resistance is regarded as the primary mechanism of metronidazole 
resistance in B. fragilis (Trinh and Reysset, 1996). A 1.5-fold increase in two 
metronidazole resistance-encoding genes was also observed in GA which might 
facilitate persistence of B. fragilis in peritoneal infections. However, these 
assumptions are based on the potential similarities between transcription under the 
conditions encountered in GA and those reported following exposure to oxygen and 
carbon limitation. A conclusive study of the pathogenic determinants that promote 
the opportunistic phase of B. fragilis can only be performed by analysing the 
transcriptome of the bacterium isolated from soft tissue abscesses in conjunction with 
the infected host tissue transcriptome. Recent advancements in the field of RNA-Seq, 
such as Dual RNA-Seq which is capable of analysing changes in gene expression of 
both the pathogen and the host simultaneously would provide a timed monitoring of 
the infection process. However, the technique is cumbersome owing to optimising 
the RNA extraction, library construction and fixing the parameters for  the effective 
analysis of both eukaryotic and prokaryotic transcriptomes simultaneously. Dual 
transcriptomics has been used recently to study Candida albicans and dendritic cells 
in mice (Westermann et al., 2012). The use of such techniques on B. fragilis clinical 
isolates and soft tissue abscesses would allow the quantification of transcriptomes of 
a small number of cells at the initial site of infection which would help us to 
understand changes during transition from commensal to pathogen and would also 
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